FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Maciel, EL
   Jabor, P
   Goncalves, E
   Tristao-Sa, R
   Lima, RDD
   Reis-Santos, B
   Lira, P
   Bussinguer, ECA
   Zandonade, E
AF Maciel, Ethel Leonor
   Jabor, Pablo
   Goncalves Junior, Etereldes
   Tristao-Sa, Ricardo
   Duarte Lima, Rita de Cassia
   Reis-Santos, Barbara
   Lira, Pablo
   Azevedo Bussinguer, Elda Coelho
   Zandonade, Eliana
TI Factors associated with COVID-19 hospital deaths in Espirito Santo,
   Brazil, 2020
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Article
DE Coronavirus Infections; Hospitalization; Health Status Disparities;
   Cross-Sectional Studies; Epidemics
ID SMOKING
AB Objective: To analyze factors associated with the deaths of individuals hospitalized with COVID-19 in the state of Espirito Santo, Brazil. Methods: This was a cross-sectional study using secondary data. Logistic regression models were used to estimate crude and adjusted odds ratios (OR). Results: As at May 14, 2020, 200 individuals had been discharged and 220 had died. Of the total number of people studied, 57.1% were male, 46.4% were >60 years old, 57.9% were cases notified by a private institution, and 61.7% had >1 comorbidity. In the adjusted analysis, hospital mortality was higher for the 51-60 age group (OR=4.33 - 95%CI 1.50;12.46), the over 60 age group (OR=11.84 - 95% CI 4.31;32.54), cases notified by public institutions (OR=8.23 - 95%CI 4.84;13.99) and cases with a greater number of comorbidities (two [OR=2.74 - 95%CI 1.40;5.34] and three [OR=2.90 - 95% CI 1.07;7.81]). Conclusion: Higher mortality was found in older individuals, those with comorbidities and users of public hospitals.
C1 [Maciel, Ethel Leonor; Reis-Santos, Barbara; Zandonade, Eliana] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Jabor, Pablo; Lira, Pablo] Inst Jones dos Santos Neves, Secretaria Estado Econ & Planejamento Espirito Sa, Vitoria, ES, Brazil.
   [Goncalves Junior, Etereldes] Univ Fed Espirito Santo, Dept Matemat, Vitoria, ES, Brazil.
   [Tristao-Sa, Ricardo] Univ Fed Espirito Santo, Dept Med Social, Vitoria, ES, Brazil.
   [Duarte Lima, Rita de Cassia] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29047105 Vitoria, ES, Brazil.
   [Azevedo Bussinguer, Elda Coelho] Fac Direito Vitoria, Vitoria, ES, Brazil.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29047105 Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
CR Agencia Nacional de Saude Suplementar-ANS (BR), 2020, ANS TABN
   Agencia Nacional de Saude Suplementar-ANS (BR), 2020, ANS TABN INF SAUD SU
   Alkundi A, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108263
   Bazotti A, 2016, CIENC SAUDE COLETIVA, V21, P45, DOI 10.1590/1413-81232015211.16802014
   Dunlop Catherine, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101041
   Enga KF, 2012, J THROMB HAEMOST, V10, P2068, DOI 10.1111/j.1538-7836.2012.04880.x
   Governo do Estado do Espirito Santo. Instituto Jones dos Santos Neves, 2020, NUCL INT EST EP
   Instituto Brasileiro de Geografia e Estatistica-IBGE, 2020, CID EST ESP SANT
   Lira P, 2017, TERRITORIOS NUMEROS
   Luzuriaga MJ, 2018, PRIVADOS SALUD POLIT, P121
   Ministerio da Saude (BR), 2020, E GEST AT BAS COB AT
   Ministerio da Saude (BR), 2020, CNES EST COM TIP AT
   Ministerio da Saude (BR), 2020, PAIN COR
   Office for National Statistics, 2020, DEATHS INV COVID 19
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Sarti TD, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.5123/s1679-49742020000200024, 10.5123/S1679-49742020000200024]
   Sistema de Informacoes Contabeis e Fiscais do Setor Publico Brasileiro-SICONFI, 2020, COR COVID 19 TES NAC
   Souza FJPS, 2020, CAPITALISMO COVID 19
   Suleyman G, 2020, CLIN CHARACTERISTICS
   Viacava Francisco, 2005, Cad. Saúde Pública, V21, pS119, DOI 10.1590/S0102-311X2005000700013
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
NR 21
TC 0
Z9 0
U1 0
U2 0
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2020
VL 29
IS 4
AR e2020413
DI 10.5123/S1679-49742020000400022
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA NX6KO
UT WOS:000575817900023
PM 32997070
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Sales, CMM
   da Silva, AI
   Maciel, ELN
AF Martins Sales, Carolina Maia
   da Silva, Adriana Ilha
   Noia Maciel, Ethel Leonor
TI COVID-19 health surveillance in Brazil: investigation of contacts by
   primary health care as a community protection strategy
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Article
ID TUBERCULOSIS
C1 [Martins Sales, Carolina Maia; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [da Silva, Adriana Ilha] Univ Fed Espirito Santo, Dept Serv Social, Vitoria, ES, Brazil.
RP Sales, CMM (corresponding author), Av Marechal Campos 1468, BR-29041295 Vitoria, ES, Brazil.
EM carolina.sales@outlook.com
CR Cheng HY, 2020, JAMA INTERN MED, V180, P1156, DOI 10.1001/jamainternmed.2020.2020
   Ribeiro FKC, 2015, CLIN INFECT DIS, V61, P758, DOI 10.1093/cid/civ365
   de Oliveira WK, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.5123/S1679-49742020000200023, 10.5123/s1679-49742020000200023]
   Gomes CC, 2020, POPULATION BASED STU, DOI [10.1101/2020.06.13. 20130559, DOI 10.1101/2020.06.13.20130559]
   Mark K, 2020, EUROSURVEILLANCE, V25, P15, DOI 10.2807/1560-7917.ES.2020.25.12.2000217
   Ministerio da Saude (BR), 2020, MIN SAUD DECL TRANSM
   Ministerio da Saude (BR), 2019, MANUAL RECOMENDACOES
   Ministerio da Saude (BR), 2020, PROT MAN CLIN COR CO
   Ministerio da Saude (BR), 2018, MIN SAUD LANC SERV C
   Maciel ELN, 2016, EPIDEMIOL SERV SAUDE, V25, P175, DOI 10.5123/S1679-49742016000100018
   Organizacao Pan-Americana da Saude-PAHO, 2020, FOLH INF COVID 19 DO
   Quirino TRL, 2020, REV PORT SAUDE SOC, V5, P1299
   Resende PC, 2020, BIORXIV
   SANTOS M., 1996, NATUREZA ESPACO TECN
   Sarti TD, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.5123/s1679-49742020000200024, 10.5123/S1679-49742020000200024]
   World Health Organization, 2020, COVID 19 STRAT UPD
NR 16
TC 0
Z9 0
U1 0
U2 0
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2020
VL 29
IS 4
AR 2020373
DI 10.5123/S1679-49742020000400011
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA NX6KO
UT WOS:000575817900019
PM 32756828
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Goncalves, E
   Dalcolmo, MMP
AF Noia Maciel, Ethel Leonor
   Goncalves Junior, Etereldes
   Pretti Dalcolmo, Margareth Maria
TI Tuberculosis and coronavirus: what do we know?
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Editorial Material
C1 [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Goncalves Junior, Etereldes] Univ Fed Espirito Santo, Dept Matemat, Vitoria, ES, Brazil.
   [Pretti Dalcolmo, Margareth Maria] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, RJ, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Ave Marechal Campos 1468, BR-29043260 Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
CR BRAZIL, 2019, B EP SECR VIG SAUD, V50
   BRAZIL, 2018, B EP SECR VIG SAUD, V49
   Ferguson N. M, IMPACT NONPHARMACEUT
   Liu Y, 2020, ACTIVE LATENT TUBERC, DOI [10.1101/2020.03.10.20033795, DOI 10.1101/2020.03.10.20033795]
   WHO, 2015, END TB STRAT 2015
NR 5
TC 1
Z9 1
U1 0
U2 0
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2020
VL 29
IS 2
AR e2020128
DI 10.5123/S1679-49742020000200010
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA NX6KK
UT WOS:000575817500024
PM 32294755
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Macedo, LR
   Maciel, ELN
   Struchiner, CJ
AF Macedo, Laylla Ribeiro
   Noia Maciel, Ethel Leonor
   Struchiner, Claudio Jose
TI Factors associated with tuberculosis in persons deprived of liberty in
   Espirito Santo
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Prisoners; Tuberculosis, epidemiology; Tuberculosis,
   Multidrug-Resistant, epidemiology
ID BRAZIL; DETERMINANTS
AB OBJECTIVES: To calculate the rate of tuberculosis cases per prison unit in Espirito Santo; present the individual, clinical, and institutional characteristics of the cases in persons deprived of liberty (PPL); and analyze the association between these characteristics and treatment outcome in this population.
   METHODS: The study included cases of tuberculosis in the PPL of Espirito Santo from 2014 to 2016. Rate calculation, descriptive analysis and hierarchical logistic regression were performed considering the individual, clinical and institutional levels.
   RESULTS: The rate of diagnosed cases per prison unit in the state ranged from 0 to 17.3 cases per 1,000 inmates. Of all reported cases, 218 (72.6%) healed, 21(7.0%) dropped out, 1(0.3%) died of tuberculosis, 2 (0.7%) died from other causes, 56 (18.7%) transferred the treatment site and 2 (0.7%) developed drug-resistant tuberculosis. The adjusted analysis showed that supervised treatment ensures success (CR = 0.29; 95%CI 0.01-0.76).
   CONCLUSIONS: The study highlighted the importance of knowing the TB treatment outcome in the PPL to implement measures to reduce failure, and the contribution of supervised treatment in this process.
C1 [Macedo, Laylla Ribeiro] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Serio Arouca, Programa Posgrad Epidemiol Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Dept Enfermagem, Vitoria, ES, Brazil.
   [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Serio Arouca, Rio De Janeiro, RJ, Brazil.
RP Macedo, LR (corresponding author), Ctr Ciencias Saude, Av Marechal Campos 1468, BR-29047105 Vitoria, ES, Brazil.
EM layllarm@hotmail.com
RI Macedo, Laylla Ribeiro/AAV-5154-2020
CR Bourdillon PM, 2017, EMERG INFECT DIS, V23, P496, DOI 10.3201/eid2303.161006
   Conselho Nacional do Ministerio Publico (BR), 2013, REL VIS FISC EST ESP
   Harling G, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4435-0
   Macedo LR, 2017, EPIDEMIOL SERV SAUDE, V26, P783, DOI [10.5123/s1679-49742017000400010, 10.5123/S1679-49742017000400010]
   Maciel EL, 2015, REV PANAM SALUD PUBL, V38, P28
   Ministerio da Justica e Seguranca Publica, 2017, LEV NAC INF PEN INF
   Ministerio da Justica e Seguranca Publica (BR), 2017, LEV NAC INF PEN AT J
   Ministerio da Justica e Seguranca Publica (BR) Departamento Penitenciario Nacional, LEV NAC INF PEN INF
   Ministerio da Saude (BR) Secretaria de Atencao a Saude Departamento de Acoes Programaticas Estrategicas Area Tecnica de Saude no Sistema Penitenciario, 2004, SECR AT SAUD
   Ministerio da Saude (BR) Secretaria de Atencao a Saude Departamento de Acoes Programaticas Estrategicas Coordenacao de Saude no Sistema Prisional, 2014, SECR AT SAUD
   Ministerio da Saude (BR) Secretaria de Vigilancia em Saude Departamento de Vigilancia das Doencas Transmissiveis, 2018, SECR VIG SAUD
   Ministerio da Saude (BR) Secretaria de Vigilancia em Saude Departamento de Vigilancia Epidemiologica, 2011, NORM MAN TECN A
   Ministerio da Saude (BR) Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica Coordenacao Geral de Doencas Endemicas, 2017, SECR VIG SAUD
   Reis-Santos B, 2015, INT J TUBERC LUNG D, V19, P1188, DOI 10.5588/ijtld.14.0776
   Ricas EC, 2017, REV BRAS SEGUR PUBLI, V11, P64
   Santo M, 2012, MANUAL INTERVENCOES
   Secretaria de Estado da Justica do Espirito Santo, PROC SEL ORG SOC SAU
   Valenca MS, 2015, INT J TUBERC LUNG D, V19, P1182, DOI 10.5588/ijtld.15.0126
NR 18
TC 0
Z9 0
U1 1
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2020
VL 54
AR 67
DI 10.11606/s1518-8787.2020054001818
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA MK3AU
UT WOS:000548657100002
PM 32638882
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Castor, K
   Mota, FB
   da Silva, RM
   Cabral, BP
   Maciel, EL
   de Almeida, IN
   Arakaki-Sanchez, D
   Andrade, KB
   Testov, V
   Vasilyeva, I
   Zhao, YL
   Zhang, H
   Singh, M
   Rao, R
   Tripathy, S
   Gray, G
   Padayatchi, N
   Bhagwandin, N
   Swaminathan, S
   Kasaeva, T
   Kritski, A
AF Castor, Kamaiaji
   Mota, Fabio Batista
   da Silva, Roseli Monteiro
   Cabral, Bernardo Pereira
   Maciel, Ethel Leonor
   de Almeida, Isabela Neves
   Arakaki-Sanchez, Denise
   Andrade, Kleydson Bonfim
   Testov, Vadim
   Vasilyeva, Irina
   Zhao, Yanlin
   Zhang, Hui
   Singh, Manjula
   Rao, Raghuram
   Tripathy, Srikanth
   Gray, Glenda
   Padayatchi, Nesri
   Bhagwandin, Niresh
   Swaminathan, Soumya
   Kasaeva, Tereza
   Kritski, Afranio
TI Mapping the tuberculosis scientific landscape among BRICS countries: a
   bibliometric and network analysis
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE tuberculosis; scientific landscape; BRICS; bibliometrics; research
   network analysis
AB BACKGROUND The five BRICS (Brazil, Russian, Indian, China, and South Africa) countries bear 49% of the world's tuberculosis (TB) burden and they are committed to ending tuberculosis.
   OBJECTIVES The aim of this paper is to map the scientific landscape related to TB research in BRICS countries.
   METHODS Were combined bibliometrics and social network analysis techniques to map the scientific publications related to TB produced by the BRICS. Was made a descriptive statistical data covering the full period of analysis (1993-2016) and the research networks were made for 2007-2016 (8,366 records). The bubble charts were generated by VantagePoint and the networks by the Gephi 0.9.1 software (Gephi Consortium 2010) from co-occurrence matrices produced in VantagePoint. The FruchtermanReingold algorithm provided the networks' layout.
   FINDINGS During the period 1993-2016, there were 38,315 peer-reviewed, among them, there were 11,018 (28.7%) articles related by one or more authors in a BRICS: India 38.7%; China 23.8%; South Africa 21.1%; Brazil 13.0%; and Russia 4.5% (The total was greater than 100% because our criterion was all papers with at least one author in a BRICS). Among the BRICS, there was greater interaction between India and South Africa and organisations in India and China had the highest productivity; however, South African organisations had more interaction with countries outside the BRICS. Publications by and about BRICS generally covered all research areas, especially those in India and China covered all research areas, although Brazil and South Africa prioritised infectious diseases, microbiology, and the respiratory system.
   MAIN CONCLUSIONS An overview of BRICS scientific publications and interactions highlighted the necessity to develop a BRICS TB research plan to increase efforts and funding to ensure that basic science research successfully translates into products and policies to help end the TB epidemic.
C1 [Castor, Kamaiaji; Mota, Fabio Batista; da Silva, Roseli Monteiro; Cabral, Bernardo Pereira] Fundacao Oswaldo Cruz Fiocruz, Ctr Estudos Estrategicos, Rio De Janeiro, RJ, Brazil.
   [Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [de Almeida, Isabela Neves] Univ Fed Minas Gerais, Fac Med, Lab Pesquisa Micobacterias, Belo Horizonte, MG, Brazil.
   [Arakaki-Sanchez, Denise; Andrade, Kleydson Bonfim] Minist Saude, Programa Nacl Controle TB, Brasilia, DF, Brazil.
   [Testov, Vadim; Vasilyeva, Irina] Natl Med Res Ctr Pthtisiopulmonol & Infect Dis, MoH, Moscow, Russia.
   [Zhao, Yanlin; Zhang, Hui] Natl Ctr TB Control & Prevent, China CDC, Beijing, Peoples R China.
   [Singh, Manjula] Indian Council Med Res, New Delhi, India.
   [Rao, Raghuram] Govt India, Minist Hlth & Family Welf, Cent TB Div, New Delhi, India.
   [Tripathy, Srikanth] Natl Inst Res TB, Chennai, Tamil Nadu, India.
   [Gray, Glenda; Padayatchi, Nesri; Bhagwandin, Niresh] Univ KwaZulu Natal, Doris Duke Med Res Inst, South African Med Res Council, HIV TB Pathogenesis & Treatment Res Unit, Congella, South Africa.
   [Swaminathan, Soumya; Kasaeva, Tereza] Cent TB Res Inst, Phthisiol, Moscow, Russia.
   [Kritski, Afranio] Univ Fed Rio de Janeiro, Fac Med, Programa Acad TB, Rio De Janeiro, RJ, Brazil.
   [Swaminathan, Soumya; Kasaeva, Tereza] World Hlth Org, Geneva, Switzerland.
RP de Almeida, IN (corresponding author), Univ Fed Minas Gerais, Fac Med, Lab Pesquisa Micobacterias, Belo Horizonte, MG, Brazil.
EM isabelanalmeida@gmail.com
RI Mota, Fabio/AAQ-7019-2020; Kritski, Afranio/I-6760-2016; Mota, Fabio
   B/G-3164-2015; Cabral, Bernardo P/U-8453-2018
OI Mota, Fabio/0000-0003-2401-7336; Mota, Fabio B/0000-0003-2401-7336;
   Cabral, Bernardo P/0000-0001-8242-1244; padayatchi,
   nesri/0000-0003-2543-9071
FU National Science and Technology Institute for Tuberculosis (CNPq/INCT)
   [465318/2014-2]
FX Dr IA received funds for this work as a post-doc scholarship from the
   National Science and Technology Institute for Tuberculosis (CNPq/INCT
   465318/2014-2).
CR Atkins S, 2016, GLOB HLTH ACTION, V9, P1
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Gephi, 2010, OP GRAPH VIZ PLATF
   Golbeck J., 2013, ANAL SOCIAL WEB
   Golbeck J., 2013, ANAL SOCIAL WEB, V1
   Gonzalez-Albo B, 2011, J INFORMETR, V5, P369, DOI 10.1016/j.joi.2011.01.011
   Gorin S. V., 2016, EUROPEAN SCI EDITING, V42, P60
   Government of India, 2016, IND TAK LEAD TB RES, P10
   Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021
   Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679
   Kirton J, 2012, BRICS NEW DELHI SUMM
   Kochi A, 1996, Kekkaku, V71, P319
   Kritski A, 2016, REV SOC BRAS MED TRO, V49, P135, DOI 10.1590/0037-8682-0330-2015
   Lienhardt C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001135
   Mike Brennan, 2011, INT ROADMAP TUBERCUL, P1
   Nafade V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199706
   Pai M, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002544
   Raviglione M, 2018, LANCET GLOB HEALTH, V6, pE20, DOI 10.1016/S2214-109X(17)30449-7
   Santoro FS, 2011, PROSPETTIVA, P3
   Sweileh WM, 2016, MULTIDISCIP RESP MED, V11, P1
   United Nations General Assembly, 2015, TRANSF OUR WORLD 203
   United Nations General Assembly, 2018, POL DECL HIGH LEV M
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Wasserman S, 1994, SOCIAL NETWORK ANAL, V1
   WHO-World Health Organization, GLOB INV TUB RES DEV
   World Health Organization, 2015, GLOB ACT FRAM TB RES
   Xiaodong W., 2017, TIANJ HOST 7 BRICS H
NR 29
TC 1
Z9 1
U1 3
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2020
VL 115
AR e190342
DI 10.1590/0074-02760190342
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KX0LP
UT WOS:000521575300001
PM 32187325
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Freitas, PSS
   Soares, GB
   Mocelin, HJS
   Lamonato, LCXL
   Sales, CMM
   Linde-Arias, AR
   Bussinger, ECA
   Maciel, ELN
AF Freitas, Paula S. S.
   Soares, Gabriella B.
   Mocelin, Helaine J. S.
   Lamonato, Larissa C. X. L.
   Sales, Carolina M. M.
   Linde-Arias, Ana R.
   Bussinger, Elda C. A.
   Maciel, Ethel L. N.
TI How do mothers feel? Life with children with congenital Zika syndrome
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Brazil; Children with disabilities; Congenital Zika syndrome;
   Microcephaly; Mother-child relationships; Public Health; Zika virus
ID BRAZIL; VIRUS
AB Objective To describe the repercussions, from the perspectives of caregiver mothers, of confirmed congenital Zika syndrome (CZS) in their offspring. Methods A descriptive-exploratory study with a qualitative approach was carried out in the state of Espirito Santo in southeastern Brazil, with 25 women who had a child diagnosed with CZS. Results Emerging themes from the content analysis were grouped into two categories: (1) inequalities experienced by mothers, including social inequality, poverty, and gender inequality; (2) the impact of a child with CZS on mothering, including feelings at the time of diagnosis, maternal isolation and mental health, experiences of stigma and prejudice, and exhausting itineraries searching for therapeutic care. Conclusion The repercussions of CZS were a huge burden on already vulnerable women, and social inequalities and poverty were important markers in the mothers' reports. Many of the families affected by CZS already lived in precarious social conditions and these conditions were exacerbated further. Robust public and social policies to support these mothers need effective implementation given that babies born with CZS need long-term care and support.
C1 [Freitas, Paula S. S.; Mocelin, Helaine J. S.; Sales, Carolina M. M.; Maciel, Ethel L. N.] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Freitas, Paula S. S.; Mocelin, Helaine J. S.; Sales, Carolina M. M.; Maciel, Ethel L. N.] Univ Fed Espirito Santo, Grad Program Collect Hlth, Vitoria, ES, Brazil.
   [Soares, Gabriella B.] Univ Fed Paraiba, Med Sci Ctr, Dept Hlth Promot, Joao Pessoa, Paraiba, Brazil.
   [Lamonato, Larissa C. X. L.] Univ Fed Espirito Santo, Hlth Sci Dept, Sao Mateus, ES, Brazil.
   [Linde-Arias, Ana R.] Univ Massachusetts, Mauricio Gaston Inst, Boston, MA 02125 USA.
   [Bussinger, Elda C. A.] Grad Sch Law, Fac Law, Vitoria, ES, Brazil.
RP Freitas, PSS (corresponding author), Univ Fed Espirito Santo, Vitoria, ES, Brazil.
EM paulassfreitas@gmail.com
OI Maciel, Ethel Leonor/0000-0003-4826-3355
FU HRP Alliance, part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation.
CR Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Brazil. Presidency of the Republic. Policy Secretariat for Women, 2018, WOM SOC ANN REP, P227
   Brazilian Institute of Geography and Statistics (IGBE), 2018, PAN CIT
   Brunoni D, 2016, CIENC SAUDE COLETIVA, V21, P3296, DOI 10.1590/1413-812320152110.16832016
   Carvalho LP, 2017, CAD GENERO DIVERS, V3, P134
   Costa AM, 2016, SOCIAL DETERMINATION, V3, P44
   Leite FMC, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006815, 10.1590/s1518-8787.2017051006815]
   de Mello DF, 2007, REV LAT-AM ENFERM, V15, P820, DOI 10.1590/S0104-11692007000700017
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Freitas AAF, 2019, REV ENFERMAGEM ATUAL, V87, P1
   Gondim Kamilla de Mendonça, 2012, Esc. Anna Nery, V16, P11, DOI 10.1590/S1414-81452012000100002
   Guerra SC, 2015, TEXT CONTEXT NURS, V24, P459
   Human Rights Watch, 2017, FORG UNPR IMP ZIK VI
   Kotzky K, 2019, J DEV BEHAV PEDIATR, V40, P344, DOI 10.1097/DBP.0000000000000666
   Machado MEC, 2012, REV SBPH, V15, P86
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   Rezende JMM, 2010, REV PESQUI-CUID FUND, P22
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Minayo MCS, SOCIAL RES METHOD TH
   Ministry of Health, 2017, ZIK VIR BRAZ SUS RES
   Ministry of Health, 2017, INT GUID IMPR HLTH C
   Ministry of Health Health Surveillance Secretariat, EP B INT MON GROWTH
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira MC, 2017, REV PESQ FISIO, V7, P64, DOI [10.17267/2238-2704rpf.v7i4.1602, DOI 10.17267/2238-2704RPF.V7I4.1602]
   Osorio LC, 2009, FAMILY THERAPY MANUA
   Pimentel PLB, 2018, P 1 MICR HEAR C CESM, P28
   Pinheiro DAJP, 2017, CAD GENERO DIVERS, V3, P113
   Pinto JMM, 2013, THESIS
   Ramos LW, 2015, MONOGRAPH UNDERGRADU
   Ribeiro B, 2018, SOC SCI MED, V200, P137, DOI 10.1016/j.socscimed.2018.01.023
   Santos JHA, 2017, P 2 BRAZ C HLTH SCI, V1, P1
   Silva A. F., 2016, THESIS
   Freitas PDS, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.24
   State Secretariat of Health of Espirito Santo, 2017, SESA REL ZIK MICR NE
   UNICEF Brazil Altino Ventura Foundation, 2018, INCL NETW SEC RIGHTS
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 38
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 20
EP 28
DI 10.1002/ijgo.13044
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700005
PM 31975400
OA Green Published, Other Gold
DA 2020-12-15
ER

PT J
AU Mocelin, HJS
   Catao, RC
   Freitas, PSS
   Prado, TN
   Bertolde, AI
   Castro, MC
   Maciel, ELN
AF Mocelin, Helaine J. S.
   Catao, Rafael C.
   Freitas, Paula S. S.
   Prado, Thiago N.
   Bertolde, Adelmo, I
   Castro, Marcia C.
   Maciel, Ethel L. N.
TI Analysis of the spatial distribution of cases of Zika virus infection
   and congenital Zika virus syndrome in a state in the southeastern region
   of Brazil: Sociodemographic factors and implications for public health
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Brazil; Congenital Zika virus syndrome; Public health; Spatial
   distribution; Zika virus infection
AB Objective To perform spatial distribution analysis of reported cases of Zika virus and congenital Zika syndrome (CZS) in the state of Espirito Santo, Brazil, by neighborhood, and relate the results to sociodemographic indicators and implications for the health process. Methods An ecological study using data from the 2016 National Notifiable Diseases Surveillance System, epidemiological records, and information on neighborhoods of families confirmed with CZS from qualitative field research. Results Sociodemographic indicators were analyzed in three distinct groups: general population with Zika virus, pregnant women with Zika virus, and cases of CZS visited. For the three groups, average literacy rates were 71.1%, 71.0%, and 68.3%; the average income per minimum wage was 1.4, 1.1, and 1.4; sanitary sewage coverage was 75.6%, 76.1%, and 71.4%; garbage coverage was 90.8%, 91.2%, and 89.2%; and water supply was 93.8%, 94.1% and 93.8%, respectively. Socioeconomic indicators showed no significant differences between groups, although they were above the national average. A nonsignificant variation of 68.3%-71.1% was seen in the average literacy level above 15 years of age. Conclusion Socioeconomic and demographic indicators of cases of Zika virus infection and CZS may indicate that the outbreak had different impacts according to class, social group, or gender, reflecting the persistence and social geography of inequality in Brazil.
C1 [Mocelin, Helaine J. S.; Freitas, Paula S. S.; Prado, Thiago N.; Bertolde, Adelmo, I; Maciel, Ethel L. N.] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Mocelin, Helaine J. S.; Freitas, Paula S. S.; Prado, Thiago N.; Maciel, Ethel L. N.] Univ Fed Espirito Santo, Grad Program Collect Hlth, Vitoria, ES, Brazil.
   [Catao, Rafael C.] Univ Fed Espirito Santo, Dept Geog, Vitoria, ES, Brazil.
   [Bertolde, Adelmo, I] Univ Fed Espirito Santo, Dept Stat, Vitoria, ES, Brazil.
   [Castro, Marcia C.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA.
RP Freitas, PSS (corresponding author), Univ Fed Espirito Santo, Vitoria, ES, Brazil.
EM paulassfreitas@gmail.com
RI Catao, Rafael/AAT-6351-2020
OI Catao, Rafael/0000-0003-2837-0364; Maciel, Ethel
   Leonor/0000-0003-4826-3355
FU HRP Alliance part of the UNDP/UNFPA/UNICEF/WHO/World Bank Special
   Programme of Research, Development and Research Training in Human
   Reproduction (HRP); UNICEF/UNDP/World Bank/WHO Special Programme for
   Research and Training in Tropical Diseases (TDR)World Health
   Organization
FX This work was funded by the HRP Alliance, part of the
   UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research,
   Development and Research Training in Human Reproduction (HRP) and the
   UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training
   in Tropical Diseases (TDR), both cosponsored programs hosted by the
   World Health Organization (WHO). The Pan American Health Organization
   (PAHO) provided technical support throughout project implementation.
CR [Anonymous], 2017, UN NEWS
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Institute of Geography and Statistics, 2017, SUMM SOC IND AN LIV
   Brazilian Institute of Geography and Statistics, 2016, IBGE DISCL CAP HOUS
   Brazilian Instiute of Geography and Statistics, 2018, RES DIR WORK INC COO
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V63, P143, DOI 10.33588/rn.6303.2016274
   Centers for Disease Control and Prevention, ZIK VIR
   Closs EV, 2014, GERIATRICS GERONTOLO
   Costa AM, 2016, SOCIAL DETERMINATION
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duarte E, 2016, EPIDEMIOL SERV SAUDE, V25, P231, DOI [10.5123/S1679-49742016000200001, 10.5123/s1679-49742016000200001]
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Garcia LP, 2018, ZIKA VIRUS EPIDEMIC
   Human Rights Watch, 2017, FORG UNPR IMP ZIK VI
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/s1518-8787.2016050006791, 10.1590/S1518-8787.2016050006791]
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   Ministry of Citizenship, 2017, SOC ASS MICR CAR
   Ministry of Health. Health Care Secretariat, 2015, HLTH CAR PROT RESP O
   Ministry of Health . Health Surveillance Secretariat, 2017, HLTH SURV SECR EP B
   Ministry of Health Health Surveillance Secretariat, 2017, EPIDEMIOLOGICAL B
   Ministry of Health . Health Surveillance Secretariat, HLTH SURV SECR ZIK V
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan-American Health Organization, 2019, COMM DIS HLTH SIT AN
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pimenta Mariana, 2016, Acta Obstet Ginecol Port, V10, P92
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Quinn SC, 2014, BIOSECUR BIOTERROR, V12, P263, DOI 10.1089/bsp.2014.0032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Freitas PDS, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.24
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Soares FCA, 2017, EVALUATING IMPACT BR
   Stevens P., 2004, DIS POVERTY 10 90 GA
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   United Nations Development Program, 2017, INT FED RED CROSS RE
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI [10.5123/s1679-49742016000400003, 10.5123/S1679-49742016000400003]
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 44
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JAN
PY 2020
VL 148
SU 2
SI SI
BP 61
EP 69
DI 10.1002/ijgo.13049
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KE9VY
UT WOS:000508899700010
PM 31975398
OA Other Gold, Green Published
DA 2020-12-15
ER

PT J
AU Loureiro, RB
   Macie, ELN
   Caetano, R
   Peres, RL
   Fregona, G
   Golub, JE
   Braga, JU
AF Loureiro, Rafaela Borge
   Noia Macie, Ethel Leonor
   Caetano, Rosangela
   Peres, Renata Lyrio
   Fregona, Geisa
   Golub, Jonathan E.
   Braga, Jose Ueleres
TI Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin
   test for diagnosis and treatment of Latent Tuberculosis Infection in
   primary health care workers in Brazil
SO PLOS ONE
LA English
DT Article
ID GAMMA RELEASE ASSAYS; BLOOD INTERFERON-GAMMA; ISONIAZID PREVENTIVE
   THERAPY; MYCOBACTERIUM-TUBERCULOSIS; INCREASED RISK; UNITED-STATES;
   HEPATOTOXICITY; RECOMMENDATIONS; TRANSMISSION; PERFORMANCE
AB Objectives
   The goal of this study was to perform a cost-effectiveness analysis from the public health system perspective, comparing five strategies for Latent Tuberculosis Infection (LTBI) diagnosis in primary health care workers in Brazil.
   Design
   Analytical model for decision making, characterized by cost-effectiveness analysis.
   Setting
   Primary Care Level, considering primary health care workers in Brazil.
   Participants
   An analytical model for decision making, characterized by a tree of probabilities of events, was developed considering a hypothetical cohort of 10,000 primary health care workers, using the software TreeAge ProT 2013 to simulate the clinical and economic impacts of new diagnostic technology (QuantiFERON (R)-TB Gold in-Tube) versus the traditional tuberculin skin test.
   Methods
   This model simulated five diagnostic strategies for LTBI in primary health care workers (HCW) in Brazil: tuberculin skin testing using >= 5 mm cut-off, tuberculin skin testing >= 10 mm cut-off, QuantiFERON (R)-TB Gold in-Tube, tuberculin skin testing using >= 5 mm cut-off confirmed by QuantiFERON (R)-TB Gold In-Tube if TST positive, tuberculin skin testing using >= 10 mm cut-off confirmed by QuantiFERON (R)-TB Gold In-Tube if TST positive.
   Primary and secondary outcome measures
   The outcome measures are the number of individuals correctly classified by the test and the number of Tuberculosis cases avoided.
   Results
   The most cost-effective strategy was the tuberculin skin test considering >= 10mm cut-off. The isolated use of the QuantiFERON (R)-TB Gold In-Tube revealed the strategy of lower efficiency with incremental cost-effectiveness ratio (ICER) of US$ 146.05 for each HCW correctly classified by the test.
   Conclusions
   The tuberculin skin test using >= 10 mm cut-off was the most cost-effective strategy in the diagnosis of Latent Tuberculosis Infection in primary health care works in Brazil.
C1 [Loureiro, Rafaela Borge; Braga, Jose Ueleres] Univ Estado Rio de Janeiro UERJ, Inst Social Med IMS, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
   [Loureiro, Rafaela Borge; Noia Macie, Ethel Leonor; Peres, Renata Lyrio; Fregona, Geisa] Univ Fed Espirito Santo UFES, Lab Epidemiol Lab Epi, Vitoria, ES, Brazil.
   [Noia Macie, Ethel Leonor] Univ Fed Espirito Santo UFES, Grad Program Collect Hlth PPGSC, Vitoria, ES, Brazil.
   [Caetano, Rosangela] Univ Estado Rio de Janeiro UERJ, Inst Social Med IMS, Dept Hlth Policy Planning & Adm, Rio De Janeiro, RJ, Brazil.
   [Peres, Renata Lyrio] Univ Fed Espirito Santo UFES, Ctr Infect Dis NDI, Vitoria, ES, Brazil.
   [Golub, Jonathan E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Div Infect Dis, Baltimore, MD USA.
RP Braga, JU (corresponding author), Univ Estado Rio de Janeiro UERJ, Inst Social Med IMS, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
EM ueleres@gmail.com
OI Maciel, Ethel Leonor/0000-0003-4826-3355; Fregona,
   Geisa/0000-0001-5835-8222
FU CNPq (Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico)
   MCT/CNPq - UniversalNational Council for Scientific and Technological
   Development (CNPq) [14/2009]; International Clinical, Operational and
   Health Services Research Training Award grant ICOHRTA [AIDS/TB]
FX This study was supported by CNPq (Conselho Nacional de Desenvolvimento
   Cienti ' fico e Tecnologico) MCT/CNPq No. 14/2009 - Universal and by the
   International Clinical, Operational and Health Services Research
   Training Award grant ICOHRTA [AIDS/TB]. None of the funding agencies is
   responsible for the statements in this article. The funders had no role
   in study design, data analysis, decision to publish, or preparation of
   the manuscript.
CR Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2
   [Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]
   [Anonymous], 1972, Bull World Health Organ, V46, P371
   [Anonymous], 2000, MMWR Recomm Rep, V49, P1
   Arend SM, 2002, J INFECT DIS, V186, P1797, DOI 10.1086/345760
   Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004
   BRASIL Sau de Md Secretaria de TeIE Tecnologia DdCe, 2009, DIR MET EST EC TECN
   Canada C Health Mo Diseases CfC Control I of PHA, 2014, CANADIAN TUBERCULOSI
   Canadian Tuberculosis Committee (CTC), 2008, Can Commun Dis Rep, V34, P1
   Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab
   Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   Control ECfDPa, 2011, US INT GAMM REL ASS
   de Leon DP, 2008, J RHEUMATOL, V35, P776
   de Perio MA, 2009, ARCH INTERN MED, V169, P179, DOI 10.1001/archinternmed.2008.524
   Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x
   Deuffic-Burban S, 2010, INT J TUBERC LUNG D, V14, P471
   Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110
   Diel R, 2007, CHEST, V131, P1424, DOI 10.1378/chest.06-2728
   Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350
   Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048
   Do AN, 1999, INT J TUBERC LUNG D, V3, P377
   Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767
   Esteban J, 2001, INT J TUBERC LUNG D, V5, P583
   Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC
   Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6
   Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116
   Fox BD, 2009, LUNG, V187, P413, DOI 10.1007/s00408-009-9182-2
   Garcia-Garcia MD, 2001, INFECT CONT HOSP EP, V22, P88
   Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358
   Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394
   Horton KC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002119
   HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968
   Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045
   Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099
   Kowada A, 2015, J HOSP INFECT, V89, P99, DOI 10.1016/j.jhin.2014.10.002
   Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906
   Leung CC, 2011, EUR RESPIR J, V37, P690, DOI 10.1183/09031936.00079310
   Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC
   LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC
   MALONEY SA, 1995, ANN INTERN MED, V122, P90, DOI 10.7326/0003-4819-122-2-199501150-00002
   Mancuso JD, 2011, INT J TUBERC LUNG D, V15, P1223, DOI 10.5588/ijtld.10.0542
   Marra F, 2008, INT J TUBERC LUNG D, V12, P1414
   Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1
   Mazurek Gerald H, 2003, MMWR Recomm Rep, V52, P15
   McKenna MT, 1996, AM J RESP CRIT CARE, V154, P587, DOI 10.1164/ajrccm.154.3.8810591
   Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006
   Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410
   Millard PS, 1996, WESTERN J MED, V164, P486
   Nienhaus A, 2008, INT ARCH OCC ENV HEA, V81, P295, DOI 10.1007/s00420-007-0212-1
   Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247
   Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014
   Nolan CM, 2003, AM J RESP CRIT CARE, V168, P412, DOI 10.1164/rccm.2306004
   Ozdemir D, 2007, JPN J INFECT DIS, V60, P102
   Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746
   Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241
   Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208
   Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC
   Player S, 1998, Healthc Financ Manage, V52, P66
   Pollock NR, 2008, INFECT CONT HOSP EP, V29, P878, DOI 10.1086/590262
   Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7
   Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2
   Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335
   Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001
   Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3
   Saude B Saude Md em SdV, 2014, B EPIDEMIOLOGICO, V44, P1
   Saude Md em SdV, 2019, B EPIDEMIOLOGICO, V50, P1
   Saude Md Saude SdVe Vigilancia Dd, 2011, VIG DD MAN REC BRAS
   Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST
   SEPKOWITZ KA, 1995, CLIN INFECT DIS, V21, P1098, DOI 10.1093/clinids/21.5.1098
   Shahidi N, 2012, INFLAMM BOWEL DIS, V18, P2034, DOI 10.1002/ibd.22901
   STEELE MA, 1991, CHEST, V99, P465, DOI 10.1378/chest.99.2.465
   Steffen RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059546
   Tan LH, 2002, INFECT CONT HOSP EP, V23, P584, DOI 10.1086/501975
   THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555
   Tissot F, 2005, CLIN INFECT DIS, V40, P211, DOI 10.1086/426434
   Trajman A, 2010, INT J TUBERC LUNG D, V14, P551
   Transmissiveis B, 2017, BRASIL LIVRE TUBERCU
   UK NCCfCC NICE CfCPa, 2011, TUB CLIN DIAGN MAN T
   Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917
   WHO Department ST Epidemic Alert P Department R Department HA, 2009, WHO POL TB INF CONTR
   World Health Organization, 2019, GLOB TUB REP 2018
   Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180
NR 83
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 14
PY 2019
VL 14
IS 11
AR e0225197
DI 10.1371/journal.pone.0225197
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LN2HK
UT WOS:000532764500066
PM 31725786
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Vieira, AC
   Maciel, EL
   Nascimento, TP
   Salles, CM
   Bertolde, AI
   da Motta, MCS
AF Vieira, Anne Caroline
   Maciel, Ethel Leonor
   Nascimento, Thiago Prado
   Salles, Carolina Maia
   Bertolde, Adelmo Inacio
   Salvador da Motta, Maria Catarina
TI Profile of tuberculosis mortality in Brazil, 2001-2011
SO REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO
LA English
DT Article
DE Tuberculosis; Mortality; Information Systems; Observational study;
   Health Profile
ID STATE
AB Rationale: In the health-disease process of tuberculosis (TB), mortality is one of the health indicators that most reflects the social link with the biological aspect. Death from TB is a sentinel event because it is preventable and indicates a failure of the social network and the health system. Objectives: To describe the sociodemographic and operational characteristics of patients who died of TB and the temporal distribution of the TB mortality rate in Brazil. Methods: A descriptive, cross-sectional, quantitative study performed from the database of the Mortality Information System (Portuguese acronym: SIM), in which all deaths with TB as the main cause registered from 2001 to 2011 were considered. Data analyzed through descriptive statistics. Results: During the study period, 53,747 deaths were recorded with TB as the basic cause. There was a higher percentage of cases of male sex (n = 39,597; 73.6%), mixed race (n=21,697; 40.3%), single marital status (n=23,518; 43.8%), schooling of up to eight years (n=19,443; 36.2%). A higher number of deaths occurred at the hospital (n=43,028; 80.1%) and 19,712 cases (36.7%) received medical assistance before death. The annual crude mortality rate decreased during the study period, ranging from 3.2 to 2.4 deaths per 100 thousand inhabitants. Conclusion: The results show the need for strategies differentiated by sex, age and education at the local level in TB control programs, as well as for planning health promotion and prevention actions available to populations living in these areas.
C1 [Vieira, Anne Caroline; Maciel, Ethel Leonor; Nascimento, Thiago Prado; Salles, Carolina Maia; Bertolde, Adelmo Inacio] Univ Fed Espirito Santo, Vitoria, ES, Brazil.
   [Salvador da Motta, Maria Catarina] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
RP Vieira, AC (corresponding author), Rodovia BR-101 Norte,Km 60, BR-29932540 Sao Mateus, ES, Brazil.
EM anne_enf@hotmail.com
CR Aljohaney AA, 2018, SAUDI MED J, V39, P267, DOI 10.15537/smj.2018.3.22280
   [Anonymous], 2018, GLOB TUB REP
   Augusto CJ, 2013, J BRAS PNEUMOL, V39, P357, DOI 10.1590/S1806-37132013000300013
   Bartholomay P, 2014, CAD SAUDE PUBLICA, V30, P2459, DOI 10.1590/0102-311X00116313
   Bierrenbach AL, 2007, REV SAUDE PUBL, V41, P1, DOI DOI 10.1590/S0034-89102007000800004
   BRASIL. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2019, B EP BRAS LIVR TUB E, V50
   de Almeid ER, 2018, REV PANAM SALUD PUBL, V42, DOI 10.26633/RPSP.2018.180
   Correia LOD, 2014, CIENC SAUDE COLETIVA, V19, P4467, DOI 10.1590/1413-812320141911.02822013
   Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96
   Lindoso Ana Angélica Bulcão Portela, 2008, Rev. Saúde Pública, V42, P805, DOI 10.1590/S0034-89102008000500004
   Maciel EL, 2015, REV PANAM SALUD PUBL, V38, P28
   Cecilio HPM, 2018, CIENC SAUDE COLETIVA, V23, P241, DOI 10.1590/1413-81232018231.25242015
   Oliveira Gisele Pinto de, 2012, Rev. bras. epidemiol., V15, P468
   Rocha MS, 2015, CAD SAUDE PUBLICA, V31, P709, DOI 10.1590/0102-311X00101214
   San Pedro A, 2013, REV PANAM SALUD PUBL, V33, P294, DOI 10.1590/S1020-49892013000400009
   Santos-Neto M, 2014, J BRAS PNEUMOL, V40, P543, DOI 10.1590/S1806-37132014000500011
   Freire ILS, 2019, REV PESQUI-CUID FUND, V11, P555, DOI 10.9789/2175-5361.2019.v11i3.555-559
   Siqueira T. C., 2018, Saude e Pesquisa, V11, P441, DOI 10.17765/1983-1870.2018v11n3p441-450
   Vieira Katiucia Letiele Duarte, 2013, Esc. Anna Nery, V17, P120, DOI 10.1590/S1414-81452013000100017
   Wardani DW SR, 2018, 2 INT M PUBL HLTH 20, DOI DOI 10.18502/KLS.V4I4.2314
NR 20
TC 0
Z9 0
U1 0
U2 0
PU UNIV SANTA CRUZ DO SUL
PI SANTA CRUZ DO SUL
PA AV INDEPENDENCIA, 2293, BAIRRO UNIVERSITARIO, SANTA CRUZ DO SUL,
   96815-900, BRAZIL
SN 2238-3360
J9 REV EPIDEMIOL CONTRO
JI Rev. Epidemiol. Control. Infecc.
PD OCT-DEC
PY 2019
VL 9
IS 4
BP 323
EP 329
DI 10.17058/.v9i4.12202
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA NL0DO
UT WOS:000567097100012
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Leal, ML
   Maciel, ELN
   Cade, NV
AF Leal, Marcelle Lemos
   Noia Maciel, Ethel Leonor
   Cade, Nagela Valadao
TI Factors associated with tuberculosis in a population of diabetics: A
   case-control study
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Diabetes mellitus; Tuberculosis; Case-control studies; Epidemiology
ID RISK; MELLITUS
AB This study analyzed the factors associated with tuberculosis in diabetics seen at health units of Vitoria, ES, Brazil. This is a case-control study of 45 cases of diabetics seen in the 30 units of the municipality and reported in the SINAN with a diagnosis of tuberculosis in the 2007-2013 period and 90 cases of diabetic controls. We used data from the SINAN, the Health Information System of Vitoria, and the Central Municipal Laboratory, as well a structured interview. Bivariate and multivariate analyses were performed, using logistic regression with the significant variables (p < 0.05). The case group presented a higher frequency of health-damaging life habits as compared to the control group, such as compulsive drinking (p < 0.001) and tobacco smoking (p = 0.060), as well as worse biochemical parameters, such as fasting blood sugar (p < 0.001) and glycosylated hemoglobin (p = 0.034). Regular drinking (OR 6.612, CI 2,151-20.330), previous contact with people with tuberculosis (OR 4.418, CI 1.678-11.631), and fasting blood sugar (OR 1.017, CI 1.007-1.026) were associated with tuberculosis in diabetics. The study reveals that poorer lifestyle habits and glycemic control and previous contact with active tuberculosis increase the chance of diabetics developing tuberculosis.
C1 [Leal, Marcelle Lemos; Noia Maciel, Ethel Leonor; Cade, Nagela Valadao] Univ Fed Espirito Santo, Programa Posgrad Grad Saude Colet, Ctr Ciencias Saude, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
RP Leal, ML (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Grad Saude Colet, Ctr Ciencias Saude, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM marcelle.leal@outlook.com
OI Maciel, Ethel Leonor/0000-0003-4826-3355
CR Abep. Associacao Brasileira de Empresas de Pesquisa-ABEP, CRIT CLASS EC BRAS 2
   [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001
   [Anonymous], 2014, LANCET DIABETES ENDO, V2, P677, DOI DOI 10.1016/S2213-8587(14)70192-5
   Baker MA, 2012, CLIN INFECT DIS, V54, P818, DOI 10.1093/cid/cir939
   Brasil. Ministerio da Saude (MS), 2015, B EPIDEMIOLOGICO, V46
   Brasil. Ministerio da Saude (MS), 2015, VIG BRAS 2014 VIG FA
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2011, MANUAL RECOMENDACOES
   Cailleaux-Cezar M, 2009, INT J TUBERC LUNG D, V13, P190
   Caron-Ruffino M, 1979, Rev Saude Publica, V13, P183, DOI 10.1590/S0034-89101979000300003
   Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238
   Gomez DI, 2013, TUBERCULOSIS, V93, P192, DOI 10.1016/j.tube.2012.10.003
   Hodgson K, 2015, IMMUNOLOGY, V144, P171, DOI 10.1111/imm.12394
   Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152
   Jose EPO, 2014, DIRETRIZES SOC BRASI
   Kumpatla S, 2013, PUBLIC HEALTH ACTION, V3, pS23, DOI 10.5588/pha.13.0035
   Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075
   Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289
   Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301
   Martinez-Aguilar G, 2015, ARCH MED RES, V46, P221, DOI 10.1016/j.arcmed.2015.03.009
   Melo Elizabeth Mesquita, 2011, Rev. Enf. Ref., VserIII, P37, DOI 10.12707/RIII1107
   Patra J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096433
   Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450
   Reis-Santos B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100082
   Restrepo BI, 2014, DIABETES RES CLIN PR, V106, P191, DOI 10.1016/j.diabres.2014.06.011
   Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909
   Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234
   Suleiman SAS, 2012, INT J ENDOCRINOL, DOI 10.1155/2012/645362
   United States of America. Centers for Disease Control and Prevention (CDC) Division of Tuberculosis Elimination Fact Sheets, 2013, TUB BLACKS
   Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367
   World Health Organization, 2011, COLL FRAM CAR CONTR
NR 30
TC 0
Z9 0
U1 0
U2 1
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD SEP
PY 2019
VL 24
IS 9
BP 3247
EP 3256
DI 10.1590/1413-81232018249.30392017
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IW3BE
UT WOS:000484854500008
PM 31508745
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Gomes, MGM
   Oliveira, JF
   Bertolde, A
   Ayabina, D
   Nguyen, TA
   Maciel, EL
   Duarte, R
   Nguyen, BH
   Shete, PB
   Lienhardt, C
AF Gomes, M. Gabriela M.
   Oliveira, Juliane F.
   Bertolde, Adelmo
   Ayabina, Diepreye
   Tuan Anh Nguyen
   Maciel, Ethel L.
   Duarte, Raquel
   Binh Hoa Nguyen
   Shete, Priya B.
   Lienhardt, Christian
TI Introducing risk inequality metrics in tuberculosis policy development
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CONDITIONAL CASH TRANSFER; HETEROGENEITY; SELECTION; DISEASE;
   TRANSMISSION; HEALTH; IMPACT; BRAZIL
AB Global stakeholders including the World Health Organization rely on predictive models for developing strategies and setting targets for tuberculosis care and control programs. Failure to account for variation in individual risk leads to substantial biases that impair data interpretation and policy decisions. Anticipated impediments to estimating heterogeneity for each parameter are discouraging despite considerable technical progress in recent years. Here we identify acquisition of infection as the single process where heterogeneity most fundamentally impacts model outputs, due to selection imposed by dynamic forces of infection. We introduce concrete metrics of risk inequality, demonstrate their utility in mathematical models, and pack the information into a risk inequality coefficient (RIC) which can be calculated and reported by national tuberculosis programs for use in policy development and modeling.
C1 [Gomes, M. Gabriela M.; Ayabina, Diepreye] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
   [Gomes, M. Gabriela M.; Oliveira, Juliane F.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, P-4485661 Vairao, Portugal.
   [Bertolde, Adelmo] Univ Fed Espirito Santo, Dept Estat, BR-29075910 Vitoria, ES, Brazil.
   [Tuan Anh Nguyen; Binh Hoa Nguyen] Natl Lung Hosp, Hanoi 10000, Vietnam.
   [Maciel, Ethel L.] Univ Fed Espirito Santo, Lab Epidemiol, BR-29047105 Vitoria, ES, Brazil.
   [Duarte, Raquel] Univ Porto, Inst Saude Publ, Fac Med, P-4050091 Porto, Portugal.
   [Duarte, Raquel] Univ Porto, Inst Saude Publ, EPIUnit, P-4050091 Porto, Portugal.
   [Shete, Priya B.] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA.
   [Lienhardt, Christian] WHO, Global TB Programme, CH-1211 Geneva 27, Switzerland.
   [Lienhardt, Christian] Univ Montpellier, IRD, Unite Mixte Int TransVIHMI UMI 233 IRD U1175 INSE, F-34394 Montpellier, France.
RP Gomes, MGM (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.; Gomes, MGM (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, P-4485661 Vairao, Portugal.
EM gabriela.gomes@lstmed.ac.uk
RI de Oliveira, Juliane Fonseca/W-6438-2018; Gomes, Gabriela/H-7218-2014;
   Oliveira, Juliane/AAX-9476-2020; B, Hoa/AAF-4933-2020
OI de Oliveira, Juliane Fonseca/0000-0002-7167-8754; Gomes,
   Gabriela/0000-0002-1454-4979; Oliveira, Juliane/0000-0002-7167-8754;
   Maciel, Ethel Leonor/0000-0003-4826-3355; Nguyen,
   Anh/0000-0003-2608-0152; Duarte, Raquel/0000-0003-2257-3099; Bertolde,
   Adelmo Inacio/0000-0002-1747-9957
FU Bill and Melinda Gates FoundationBill & Melinda Gates Foundation
   [OPP1131404]; Fundacao para a Ciencia e a TecnologiaPortuguese
   Foundation for Science and Technology [IF/01346/2014]; European Union's
   Horizon 2020 research and innovation programme [733174]
FX The Bill and Melinda Gates Foundation is acknowledged for its support
   through grant project number OPP1131404. M.G.M.G. and J.F.O. received
   additional support from Fundacao para a Ciencia e a Tecnologia
   (IF/01346/2014), and M.G.M.G. and D.A. from the European Union's Horizon
   2020 research and innovation programme under grant No 733174 (IMPACT
   TB).
CR Aalen OO, 2015, INT J EPIDEMIOL, V44, P1408, DOI 10.1093/ije/dyu192
   Andrews JR, 2015, INT J TUBERC LUNG D, V19, P375, DOI 10.5588/ijtld.14.0423
   Boccia D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5539-x
   Carter J. C., 2019, BMJ GLOB HLTH, V4
   Colijn C, 2007, J THEOR BIOL, V247, P765, DOI 10.1016/j.jtbi.2007.04.015
   de Souza RA, 2018, INT J TUBERC LUNG D, V22, P1300, DOI 10.5588/ijtld.17.0907
   Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109
   Gelman A, 2013, CHAPMAN HALL CRC TEX
   Gini C, 1912, VARIABILITA MUTUABIL
   Gomes M. G. M., CIM B
   Gomes MGM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1464-8
   Gomes MGM, 2012, P ROY SOC B-BIOL SCI, V279, P2473, DOI 10.1098/rspb.2011.2712
   Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Horton KC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002119
   Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051
   Kendall BE, 2011, ECOLOGY, V92, P1985, DOI 10.1890/11-0079.1
   KEYFITZ N, 1979, POP STUD-J DEMOG, V33, P333, DOI 10.2307/2173538
   King JG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03981-8
   Kissler SM, 2019, EPIDEMICS-NETH, V26, P86, DOI 10.1016/j.epidem.2018.10.002
   Langwig KE, 2017, MBIO, V8, DOI 10.1128/mBio.00796-17
   Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807
   Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7
   Lopes JS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-340
   Lorenz MO, 1905, J AM STAT ASSOC, V9, P209
   Marx FM, 2018, LANCET GLOB HEALTH, V6, pE426, DOI 10.1016/S2214-109X(18)30022-6
   Mauguen A, 2016, EPIDEMIOLOGY, V27, P531, DOI 10.1097/EDE.0000000000000499
   Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347
   Moreno V, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0049-6
   Nery JS, 2017, INT J TUBERC LUNG D, V21, P790, DOI 10.5588/ijtld.16.0599
   Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358
   Reis-Santos B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212617
   Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674
   Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307
   Stensrud MJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01284-y
   Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172
   Trauer J. M., CLIN INFECT DIS
   TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322
   United Nations General Assembly, 2015, TRANSF OUR WORLD 203
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224
   VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925
   Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552
   Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   World Health Organization, 2017, GLOB TUB REP 2017
NR 48
TC 3
Z9 3
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 6
PY 2019
VL 10
AR 2480
DI 10.1038/s41467-019-10447-y
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IB4NA
UT WOS:000470248100012
PM 31171791
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-15
ER

PT J
AU Reis-Santos, B
   Oliosi, JGN
   Maciel, ELN
AF Reis-Santos, Barbara
   Nascimento Oliosi, Janaina Gomes
   Noia Maciel, Ethel Leonor
TI Effect of the Bolsa Familia Programme on tuberculosis treatment outcomes
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID CASH TRANSFER PROGRAM
C1 [Reis-Santos, Barbara; Nascimento Oliosi, Janaina Gomes; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI ; Reis-Santos, Barbara/A-3149-2014
OI Maciel, Ethel Leonor/0000-0003-4826-3355; Reis-Santos,
   Barbara/0000-0001-6952-0352
CR Durovni B, 2018, J PUBLIC HEALTH-UK, V40, pE359, DOI 10.1093/pubmed/fdx132
   Herman MA, 2006, BMJ-BRIT MED J, V60, P553
   Hirano K, 2003, ECONOMETRICA, V71, P1161, DOI 10.1111/1468-0262.00442
   Oliosi JGN, 2019, LANCET GLOB HEALTH, V7, pE219, DOI 10.1016/S2214-109X(18)30478-9
   Nery JS, 2017, INT J TUBERC LUNG D, V21, P790, DOI 10.5588/ijtld.16.0599
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32
   Torrens AW, 2016, T ROY SOC TROP MED H, V110, P199, DOI 10.1093/trstmh/trw011
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD MAY
PY 2019
VL 7
IS 5
BP E566
EP E566
DI 10.1016/S2214-109X(19)30153-6
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HT6PJ
UT WOS:000464685800019
PM 31000127
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Pratte-Santos, R
   Miagostovich, MP
   Fumian, TM
   Maciel, EL
   Martins, SA
   Cassini, ST
   Keller, R
AF Pratte-Santos, Rodrigo
   Miagostovich, Marize Pereira
   Fumian, Tulio Machado
   Maciel, Ethel Leonor
   Martins, Sara Angelino
   Cassini, Servio Tulio
   Keller, Regina
TI High prevalence of enteric viruses associated with acute gastroenteritis
   in pediatric patients in a low-income area in Vitoria, Southeastern
   Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE acute gastroenteritis; adenovirus; enteric viruses; norovirus;
   phylogenetic analysis; rotavirus
ID HOSPITALIZED CHILDREN; RT-PCR; ADENOVIRUSES; NOROVIRUSES; INFECTIONS;
   ROTAVIRUS; OUTBREAK
AB Acute gastroenteritis (AGE) is a significant cause of child mortality worldwide. In Brazil, despite the reduction in infant mortality achieved in recent years, many children still die because of undiagnosed AGE. The prevalence, viral load, and circulating genotypes of rotavirus A (RVA), human adenovirus (HAdV), and norovirus GII (NoV GII) were investigated in children with AGE during 12 months in Vitoria, Espirito Santo, Southeastern Brazil. Enteric viruses were detected in stool samples, quantified by quantitative polymerase chain reaction, sequenced, and compared phylogenetically. The overall prevalence was 93.3% (125/134). Cases of single infection (41.8%) and mixed infection (51.5%) were observed; in 21.6% of cases, all the three viruses were detected. RVA had the highest number of copies in all infections. Phylogenetic analysis revealed predominantly the presence of RVA genotype G3, followed by G2 and G9. HAdV clustered within subgroup C, but some samples harbored subgroups A, D, or F. All sequenced NoV-positive samples clustered within the prevalent genotype GII.4. The high prevalence of RVA, HAdV, and NoV in diarrheal feces clarifies the etiology of AGE in this population, and the presence of RVA in vaccinated children reinforces the importance of monitoring programs to identify the causes of gastroenteritis and contribute to the reliability of diagnosis.
C1 [Pratte-Santos, Rodrigo; Martins, Sara Angelino; Cassini, Servio Tulio; Keller, Regina] Univ Fed Espirito Santo, Lab Saneamento, BR-29075910 Vitoria, ES, Brazil.
   [Miagostovich, Marize Pereira; Fumian, Tulio Machado] Fiocruz MS, Inst Oswaldo Cruz, Lab Virol Comparada & Ambiental, Rio De Janeiro, RJ, Brazil.
   [Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
RP Keller, R (corresponding author), Univ Fed Espirito Santo, Lab Saneamento, BR-29075910 Vitoria, ES, Brazil.
EM kellygtr@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; CASSINI, SERVIO TULIO
   ALVES/O-7320-2019
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; CASSINI, SERVIO TULIO
   ALVES/0000-0001-5200-3666; Keller, Regina/0000-0002-9163-0715
FU Brazilian National Research Council - CNPQNational Council for
   Scientific and Technological Development (CNPq) [14/2009]
FX Brazilian National Research Council - CNPQ, Grant/Award Number: (no.
   14/2009)
CR Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001
   Aragao GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056608
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Chen Y, 2013, PEDIATR INFECT DIS J, V32, pE285, DOI 10.1097/INF.0b013e31828c3de4
   Amaral MSC, 2015, MEM I OSWALDO CRUZ, V110, P215, DOI 10.1590/0074-02760140381
   Demiray T, 2016, J IMMUNOL CLIN MICRO, V1, P37
   Fields BN, 1990, FIELDS VIROLOGY
   Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008
   Fistarol GO, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01232
   Fumian TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145391
   Grabow WOK, 2007, PERSP MED V, V17, P1, DOI 10.1016/S0168-7069(07)17001-4
   Hafliger D, 1997, INT J FOOD MICROBIOL, V37, P27, DOI 10.1016/S0168-1605(97)00041-X
   Hernroth BE, 2002, APPL ENVIRON MICROB, V68, P4523, DOI 10.1128/AEM.68.9.4523-4533.2002
   Iturriza-Gomara M, 1999, J VIROL METHODS, V78, P93, DOI 10.1016/S0166-0934(98)00168-2
   Jain S, 2014, VACCINE, V32, P3367, DOI 10.1016/j.vaccine.2014.04.037
   Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003
   Keller R, 2013, J WATER HEALTH, V11, P573, DOI 10.2166/wh.2013.245
   Lee JI, 2012, MICROBIOL IMMUNOL, V56, P523, DOI 10.1111/j.1348-0421.2012.00469.x
   Mendes PSD, 2013, J PEDIAT-BRAZIL, V89, P315, DOI 10.1016/j.jped.2012.10.002
   Neves MAO, 2016, J MED VIROL, V88, P782, DOI 10.1002/jmv.24404
   Organizacion Panamericana De La Salud, 2014, MAP INTR NUEV VAC
   Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009
   da Costa STP, 2017, MEM I OSWALDO CRUZ, V112, P391, DOI 10.1590/0074-02760160357
   Raboni SM, 2014, MEM I OSWALDO CRUZ, V109, P428, DOI 10.1590/0074-0276140066
   Portes SAR, 2016, MEM I OSWALDO CRUZ, V111, P403, DOI 10.1590/0074-02760160030
   Roman E, 2003, J MED MICROBIOL, V52, P435, DOI 10.1099/jmm.0.05079-0
   Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434
   Shimizu H, 2007, INFECT GENET EVOL, V7, P279, DOI 10.1016/j.meegid.2006.11.005
   Soares LD, 2014, J MED VIROL, V86, P1065, DOI 10.1002/jmv.23797
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   UNICEF, ANN REPORT
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6
   Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004
   Zhou X, 2012, EPIDEMIOLOGY INFECT, V8, P1
NR 34
TC 4
Z9 4
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2019
VL 91
IS 5
BP 744
EP 750
DI 10.1002/jmv.25392
PG 7
WC Virology
SC Virology
GA HN8UK
UT WOS:000460471800005
PM 30614007
DA 2020-12-15
ER

PT J
AU Siqueira, PC
   de Souza, FM
   Alves, CG
   Sanchez, MN
   Maciel, ELN
   do Prado, TN
AF Siqueira, Priscila Carminati
   de Souza, Fernanda Mattos
   Alves, Caroline Gava
   Sanchez, Mauro Niskier
   Noia Maciel, Ethel Leonor
   do Prado, Thiago Nascimento
TI Yellow Fever Outbreak in Brazil: A crucial time for epidemiologic
   surveillance
SO REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO
LA English
DT Letter
DE Yellow Fever; Epidemiological Monitoring; Epidemiology
C1 [Siqueira, Priscila Carminati; Noia Maciel, Ethel Leonor; do Prado, Thiago Nascimento] Univ Fed Espirito Santo, Vitoria, ES, Brazil.
   [de Souza, Fernanda Mattos] Univ Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Alves, Caroline Gava] Escola Saude Publ Sergio Arouca, Manguinho, RJ, Brazil.
   [Sanchez, Mauro Niskier] Univ Brasilia, Brasilia, DF, Brazil.
RP do Prado, TN (corresponding author), Ave Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM thiagonprado@gmail.com
RI Sanchez, Mauro/AAU-2404-2020
OI Sanchez, Mauro/0000-0002-0472-1804
CR Brasil. Ministerio da Saude, 10 MIN SAUD
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Secretaria de Saude do Estado (Espirito Santo), 2017, FEBR AM
   WHO, YELL FEV BRAZ
NR 5
TC 1
Z9 1
U1 0
U2 1
PU UNIV SANTA CRUZ DO SUL
PI SANTA CRUZ DO SUL
PA AV INDEPENDENCIA, 2293, BAIRRO UNIVERSITARIO, SANTA CRUZ DO SUL,
   96815-900, BRAZIL
SN 2238-3360
J9 REV EPIDEMIOL CONTRO
JI Rev. Epidemiol. Control. Infecc.
PD APR-JUN
PY 2019
VL 9
IS 2
BP 185
EP 186
DI 10.17058/reci.v9i2.12422
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA IJ4EH
UT WOS:000475856800013
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Reis-Santos, B
   Shete, P
   Bertolde, A
   Sales, CM
   Sanchez, MN
   Arakaki-Sanchez, D
   Andrade, KB
   Gomes, MGM
   Boccia, D
   Lienhardt, C
   Maciel, EL
AF Reis-Santos, Barbara
   Shete, Priya
   Bertolde, Adelmo
   Sales, Carolina M.
   Sanchez, Mauro N.
   Arakaki-Sanchez, Denise
   Andrade, Kleydson B.
   Gomes, M. Gabriela M.
   Boccia, Delia
   Lienhardt, Christian
   Maciel, Ethel L.
TI Tuberculosis in Brazil and cash transfer programs: A longitudinal
   database study of the effect of cash transfer on cure rates
SO PLOS ONE
LA English
DT Article
ID MISSING VALUE IMPUTATION; DETERMINANTS; IMPACT
AB Introduction
   Tuberculosis incidence is disproportionately high among people in poverty. Cash transfer programs have become an important strategy in Brazil fight inequalities as part of comprehensive poverty alleviation policies. This study was aimed at assessing the effect of being a beneficiary of a governmental cash transfer program on tuberculosis (TB) treatment cure rates.
   Methods
   We conducted a longitudinal database study including people. 18 years old with confirmed incident TB in Brazil in 2015. We treated missing data with multiple imputation. Poisson regression models with robust variance were carried out to assess the effect of TB determinants on cure rates. The average effect of being beneficiary of cash transfer was estimated by propensity-score matching.
   Results
   In 2015, 25,084 women and men diagnosed as new tuberculosis case, of whom 1,714 (6.8%) were beneficiaries of a national cash transfer. Among the total population with pulmonary tuberculosis several determinants were associated with cure rates. However, among the cash transfer group, this association was vanished in males, blacks, region of residence, and people not deprived of their freedom and who smoke tobacco. The average treatment effect of cash transfers on TB cure rates, based on propensity score matching, found that being beneficiary of cash transfer improved TB cure rates by 8% [Coefficient 0.08 (95% confidence interval 0.06-0.11) in subjects with pulmonary TB].
   Conclusion
   Our study suggests that, in Brazil, the effect of cash transfer on the outcome of TB treatment may be achieved by the indirect effect of other determinants. Also, these results suggest the direct effect of being beneficiary of cash transfer on improving TB cure rates.
C1 [Reis-Santos, Barbara; Sales, Carolina M.; Maciel, Ethel L.] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Shete, Priya] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.
   [Bertolde, Adelmo] Univ Fed Espirito Santo, Dept Estat, Vitoria, ES, Brazil.
   [Sanchez, Mauro N.] Univ Brasilia Asa Norte, Dept Saude Colet, Brasilia, DF, Brazil.
   [Arakaki-Sanchez, Denise; Andrade, Kleydson B.] Minist Saude, Programa Nacl Controle TB, Brasilia, DF, Brazil.
   [Gomes, M. Gabriela M.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Gomes, M. Gabriela M.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal.
   [Boccia, Delia] London Sch Hyg & Trop Med Keppel St, London, England.
   [Lienhardt, Christian] WHO, Global TB Programme, Geneva, Switzerland.
   [Lienhardt, Christian] Univ Montpellier, Inst Rech Dev, Unite Mixte Int TransVIHMI, INSERM,UMI 233,IRD,U1175, Montpellier, France.
RP Reis-Santos, B (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
EM reissantos.barbara@gmail.com
RI Sanchez, Mauro/AAU-2404-2020; Maciel, Ethel Leonor LN/G-1027-2012;
   Gomes, Gabriela/H-7218-2014; Reis-Santos, Barbara/A-3149-2014
OI Sanchez, Mauro/0000-0002-0472-1804; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Gomes, Gabriela/0000-0002-1454-4979;
   Reis-Santos, Barbara/0000-0001-6952-0352; Bertolde, Adelmo
   Inacio/0000-0002-1747-9957
FU World Health Organization through Brazil Research Investment Case
FX The study was supported by World Health Organization through Brazil
   Research Investment Case. This funding source had no role in the design
   of this study and will not have any role during its execution, analyses,
   interpretation of the data, or decision to publish the manuscript.
CR [Anonymous], 2017, TUB PAT COST SURV HD
   Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438
   Boccia D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1529-8
   BRASIL, PROGRAMA BOLSA FAMIL
   Brasil. Ministerio da Saude, 2017, NON TRADITIONAL REF
   Chandola T, 2014, HDB EPIDEMIOLOGY, P1551
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   de Souza RA, 2018, INT J TUBERC LUNG D, V22, P1300, DOI 10.5588/ijtld.17.0907
   Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982
   dos Santos NP, 2013, J BRAS PNEUMOL, V39, P221, DOI 10.1590/S1806-37132013000200014
   Ferro AR, 2010, RES LABOR ECON, V31, P193, DOI 10.1108/S0147-9121(2010)0000031010
   de Andrade KVF, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00153116, 10.1590/0102-311x00153116]
   Glewwe P, 2012, J DEV ECON, V97, P505, DOI 10.1016/j.jdeveco.2011.05.008
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   Hirano K, 2003, ECONOMETRICA, V71, P1161, DOI 10.1111/1468-0262.00442
   Liao SG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0346-6
   Little RJA, 2014, STAT ANAL MISSING DA
   Maciel EL, 2015, REV PANAM SALUD PUBL, V38, P28
   Medeiros M, 2008, WORKING PAPER
   Nery JS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003357
   Oliosi JN, 2018, NON TRADITIONAL REF
   Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1
   Raviglione M., 2016, INFECT DIS REPORTS, V8
   Reis-Santos B, 2015, INT J TUBERC LUNG D, V19, P1188, DOI 10.5588/ijtld.14.0776
   Rocha Marli Souza, 2015, Cad. saúde colet., V23, P150, DOI 10.1590/1414-462X201500020092
   Rudgard WE, UPTAKE GOVT SOCIAL P
   Shah AD, 2014, AM J EPIDEMIOL, V179, P764, DOI 10.1093/aje/kwt312
   Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597
   Torrens AW, 2016, T ROY SOC TROP MED H, V110, P199, DOI 10.1093/trstmh/trw011
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   White I, 2001, STAT MED, V20, P3441, DOI 10.1002/sim.908
   Wingfield T, 2017, B WORLD HEALTH ORGAN, V95, P270, DOI [10.2471/BLT.16.170167, 10.2471/blt.16.170167]
   World Health Organization, 2016, GLOB TUB REP
   World Health Organization, 2015, HLTH 2015 MDGS MILL
NR 36
TC 4
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2019
VL 14
IS 2
AR e0212617
DI 10.1371/journal.pone.0212617
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM8DR
UT WOS:000459709100098
PM 30794615
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-15
ER

PT J
AU Carter, DJ
   Daniel, R
   Torrens, AW
   Sanchez, MN
   Maciel, ELN
   Bartholomay, P
   Barreira, DC
   Rasella, D
   Barreto, ML
   Rodrigues, LC
   Boccia, D
AF Carter, Daniel J.
   Daniel, Rhian
   Torrens, Ana W.
   Sanchez, Mauro N.
   Maciel, Ethel Leonor N.
   Bartholomay, Patricia
   Barreira, Draurio C.
   Rasella, Davide
   Barreto, Mauricio L.
   Rodrigues, Laura C.
   Boccia, Delia
TI The impact of a cash transfer programme on tuberculosis treatment
   success rate: a quasi-experimental study in Brazil
SO BMJ GLOBAL HEALTH
LA English
DT Article
ID PROPENSITY-SCORE; DETERMINANTS; AGENDA; RISK
AB Background Evidence suggests that social protection policies such as Brazil's Bolsa Familia Programme (BFP), a governmental conditional cash transfer, may play a role in tuberculosis (TB) elimination. However, study limitations hamper conclusions. This paper uses a quasi-experimental approach to more rigorously evaluate the effect of BFP on TB treatment success rate.
   Methods Propensity scores were estimated from a complete-case logistic regression using covariates from a linked data set, including the Brazil's TB notification system (SINAN), linked to the national registry of those in poverty (CadUnico) and the BFP payroll.
   Results The average effect of treatment on the treated was estimated as the difference in TB treatment success rate between matched groups (ie, the control and exposed patients, n=2167). Patients with TB receiving BFP showed a treatment success rate of 10.58 percentage points higher (95% CI 4.39 to 16.77) than patients with TB not receiving BFP. This association was robust to sensitivity analyses.
   Conclusions This study further confirms a positive relationship between the provision of conditional cash transfers and TB treatment success rate. Further research is needed to understand how to enhance access to social protection so to optimise public health impact.
C1 [Carter, Daniel J.; Rodrigues, Laura C.; Boccia, Delia] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Carter, Daniel J.; Daniel, Rhian] London Sch Hyg & Trop Med, Dept Med Stat, London, England.
   [Torrens, Ana W.] Univ Brasilia, Trop Med Dept, Brasilia, DF, Brazil.
   [Sanchez, Mauro N.] Fed Univ Brasilia, Brasilia, DF, Brazil.
   [Maciel, Ethel Leonor N.] Univ Fed Espirito Santo, Vitoria, ES, Brazil.
   [Bartholomay, Patricia] Minist Hlth, Natl TB Programme, Brasilia, DF, Brazil.
   [Barreira, Draurio C.] Minist Hlth Brazil, Natl TB Programme, Brasilia, DF, Brazil.
   [Rasella, Davide] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Muniz, Salvador, BA, Brazil.
   [Barreto, Mauricio L.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Barreto, Mauricio L.; Rodrigues, Laura C.] Fundacao Oswaldo Cruz, Ctr Integracao Dados Conhecimentos Satide CIDACS, Salvador, BA, Brazil.
   [Daniel, Rhian] Cardiff Univ, Div Populat Med, Cardiff, S Glam, Wales.
RP Boccia, D (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
EM delia.boccia@lshtm.ac.uk
RI Sanchez, Mauro/AAU-2404-2020; Rasella, Davide/ABG-4182-2020; Maciel,
   Ethel Leonor LN/G-1027-2012; L. Barreto, Mauricio/B-1752-2008
OI Sanchez, Mauro/0000-0002-0472-1804; Rasella, Davide/0000-0002-7260-4386;
   Maciel, Ethel Leonor LN/0000-0003-4826-3355; L. Barreto,
   Mauricio/0000-0002-0215-4930
FU Wellcome TrustWellcome Trust [104473/Z/14/Z]
FX This work was sponsored by a grant from the Wellcome Trust to the PI (No
   104473/Z/14/Z).
CR Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333
   Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480
   Boccia D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5539-x
   Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x
   Ciobanu A, 2014, PUBLIC HEALTH ACTION, V4, pS59, DOI 10.5588/pha.14.0047
   Cluver L, 2013, LANCET GLOB HEALTH, V1, pE362, DOI 10.1016/S2214-109X(13)70115-3
   Durovni B, 2018, J PUBLIC HEALTH-UK, V40, pE359, DOI 10.1093/pubmed/fdx132
   Ebken C., 2014, DISCUSSION PAPERS SO
   Freitas RS, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00067617, 10.1590/0102-311x00067617]
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   King Gary, 2016, WHY PROPENSITY SCORE
   Lonnroth K, 2016, T ROY SOC TROP MED H, V110, P148, DOI 10.1093/trstmh/trv108
   Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041
   Lutge E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-154
   Maciel EL, 2015, REV PANAM SALUD PUBL, V38, P28
   Nery JS, 2017, INT J TUBERC LUNG D, V21, P790, DOI 10.5588/ijtld.16.0599
   Raviglione M, 2018, LANCET GLOB HEALTH, V6, pE20, DOI 10.1016/S2214-109X(17)30449-7
   Raviglione M, 2012, LANCET, V379, P1077, DOI 10.1016/S0140-6736(12)60373-0
   Richterman A, 2018, B WORLD HEALTH ORGAN, V96, P471, DOI 10.2471/BLT.18.208959
   Roelen K., 2017, INNOCENTI WORKING PA
   ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581
   Rudgard WE, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00274-2018
   Rudgard WE, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002418
   Soares TS, 2012, 89 INT POL CTR INCL
   Sripad A, 2014, INT J TUBERC LUNG D, V18, P44, DOI 10.5588/ijtld.13.0253
   Torrens AW, 2016, T ROY SOC TROP MED H, V110, P199, DOI 10.1093/trstmh/trw011
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   van Hoorn R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154095
   WHO, 2017, GLOB TUB REP
   Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483
   Wingfield T, 2017, B WORLD HEALTH ORGAN, V95, P270, DOI [10.2471/BLT.16.170167, 10.2471/blt.16.170167]
   Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675
NR 33
TC 6
Z9 6
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD FEB
PY 2019
VL 4
IS 1
AR e001029
DI 10.1136/bmjgh-2018-001029
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ID6VM
UT WOS:000471818300007
PM 30740248
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-15
ER

PT J
AU Oliosi, JGN
   Reis-Santos, B
   Locatelli, RL
   Sales, CMM
   Filho, WGD
   da Silva, KC
   Sanchez, MN
   Andrade, KVF
   Shete, PB
   Pereira, SM
   Riley, LW
   Lienhardt, C
   Maciel, ELN
   De Araojo, GS
AF Nascitnento Oliosi, Janaina Gotnes
   Reis-Santos, Barbara
   Locatelli, Rodrigo Leite
   Martins Sales, Carolina Maia
   da Silva Filho, Walter Gomes
   da Silva, Kerollen Cristina
   Sanchez, Mauro Niskier
   Freitasde Andrade, Kaio Vinicius
   Shete, Priya B.
   Pereira, Susan Martins
   Riley, Lee W.
   Lienhardt, Christian
   Noia Maciel, Ethel Leonor
   De Araojo, Gleide Santos
TI Effect of the Bolsa Familia Programme on the outcome of tuberculosis
   treatment: a prospective cohort study
SO LANCET GLOBAL HEALTH
LA English
DT Article
ID CASH TRANSFER PROGRAM; DETERMINANTS; SUPPORT; BRAZIL
AB Background Social protection interventions might improve tuberculosis outcomes and could help to control the epidemic in Brazil. The aim of this study was to evaluate the independent effect of the Bolsa Familia Programme (BFP) on tuberculosis treatment outcomes in Brazil.
   Methods We prospectively recruited and followed up individuals (aged >= 18 years) who initiated tuberculosis treatment at 42 health-care centres across seven cities in Brazil, between March 1, 2014, and April 30, 2017. Patients were interviewed at health-care centres and information about individual characteristics, socioeconomic status, living conditions, lifestyle, and comorbidities was recorded. Patients were separated into two groups according to BFP beneficiary status: BFP (exposed) or non-BFP (not exposed). Treatment outcome (cure, dropout, death, or development of drug-resistant tuberculosis or treatment failure) was recorded after 6 months of therapy. Pearson's chi(2) test and ANOVA were used to compare tuberculosis treatment outcomes between the two groups, and we estimated the propensity score of being a beneficiary of the BFP using a logit model. We used multinomial regression models to evaluate the effect of the BFP on tuberculosis treatment outcomes.
   Findings 1239 individuals were included in the study, of whom 196 (16%) were beneficiaries of the BFP and 1043 (84%) were not. After 6 months of treatment, 912 (87%) of 1043 patients in the non-BFP group and 173 (88%) of 196 patients in the BFP group were cured of tuberculosis, 103 (10%) patients in the non-BFP group and 17 (9%) patients in the BFP group had dropped out, and 25 (3%) patients in the non-BFP group and six (3%) patients in the BFP group had died. Three (< 1%) of 1043 patients in the non-BFP group developed drug-resistant tuberculosis. Being a BFP beneficiary had a positive effect for cure (average effect 0.076 [95% CI 0.037 to 0.11]) and a negative effect for dropout (-0.070 [-0.105 to 0.036]) and death (-0.002 [-0.021 to 0.017]).
   Interpretation BFP alone had a direct effect on tuberculosis treatment outcome and could greatly contribute to the goals of the WHO End TB Strategy.
   Funding Brazilian National Council for Scientific and Technological Development (CNPq) and Brazilian Ministry of Health Department of Science and Technology (DECIT). Copyright (c) 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
C1 [Nascitnento Oliosi, Janaina Gotnes; Reis-Santos, Barbara; Locatelli, Rodrigo Leite; Martins Sales, Carolina Maia; da Silva Filho, Walter Gomes; da Silva, Kerollen Cristina; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, BR-29043900 Santo, Vitoria, Brazil.
   [Sanchez, Mauro Niskier] Univ Brasilia, Dept Publ Hlth, Brasilia, DF, Brazil.
   [Freitasde Andrade, Kaio Vinicius; Pereira, Susan Martins; De Araojo, Gleide Santos] Univ Fed Bahia, Dept Publ Hlth, Salvador, BA, Brazil.
   [Freitasde Andrade, Kaio Vinicius] State Univ Feira de Santana, Dept Hlth, Feira De Santana, Brazil.
   [Lienhardt, Christian] WHO, Global TB Program, Geneva, Switzerland.
   [Shete, Priya B.] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Lienhardt, Christian] Inst Res Dev, UMI 233, Montpellier, France.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, BR-29043900 Santo, Vitoria, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; Sanchez, Mauro/AAU-2404-2020;
   Reis-Santos, Barbara/A-3149-2014
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Sanchez,
   Mauro/0000-0002-0472-1804; Reis-Santos, Barbara/0000-0001-6952-0352
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Brazilian Ministry of Health Department of Science and
   Technology (DECIT)
FX Brazilian National Council for Scientific and Technological Development
   (CNPq) and Brazilian Ministry of Health Department of Science and
   Technology (DECIT).
CR Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480
   Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438
   Brasil. Ministerio da Saude, 2011, MAN REC CONTR TUB BR
   Brasil Ministerio da Saude, 2017, B EPIDEMIOLOGICO
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2017, COORD GER DES EP SER
   Carter DJ, 2018, LANCET GLOB HEALTH, V6, pE514, DOI 10.1016/S2214-109X(18)30195-5
   Ciobanu A, 2014, PUBLIC HEALTH ACTION, V4, pS59, DOI 10.5588/pha.14.0047
   Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982
   Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453
   Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   Hernan MA, 2017, CAUSAL INFERENCE
   Hirano K, 2003, ECONOMETRICA, V71, P1161, DOI 10.1111/1468-0262.00442
   Hoffmann R NM, 2008, ECONOMICA, V10, P7
   Lonnroth K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001693
   Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041
   Maciel EL, 2015, REV PANAM SALUD PUBL, V38, P28
   Ministerio do Desenvolvimento Social e Agrario, 2015, BOLS FAM COM FUNC
   Ministerio do Desenvolvimento Social e Combate a Fome, 2013, SECR NAC REND CID PR
   Ministerio do Desenvolvimento Social e Combate a Fome. Instituto de Pesquisa Economica Aplicada (Ipea), 2010, BOLS FAM 2003 2010 A
   Nery JS, 2017, INT J TUBERC LUNG D, V21, P790, DOI 10.5588/ijtld.16.0599
   Paim J, 2011, LANCET
   Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1
   Shah AD, 2014, AM J EPIDEMIOL, V179, P764, DOI 10.1093/aje/kwt312
   Santos MDSG, 2007, REV LAT-AM ENFERM, V15, P762, DOI 10.1590/S0104-11692007000700008
   The World Bank, 2017, WORLD BANK COUNTR LE
   Torrens AW, 2016, T ROY SOC TROP MED H, V110, P199, DOI 10.1093/trstmh/trw011
   Ukwaja KN, 2017, INT J TUBERC LUNG D, V21, P564, DOI 10.5588/ijtld.16.0741
   Wingfield T, 2017, B WORLD HEALTH ORGAN, V95, P270, DOI [10.2471/BLT.16.170167, 10.2471/blt.16.170167]
   World Health Organization, 2016, GLOB TUB REP 2016
NR 30
TC 11
Z9 12
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD FEB
PY 2019
VL 7
IS 2
BP E219
EP E226
DI 10.1016/S2214-109X(18)30478-9
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HI4SO
UT WOS:000456441300025
PM 30584050
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Mocelin, HJS
   do Prado, TN
   Freitas, PDS
   Bertolde, AI
   Perez, F
   Riley, LW
   Maciel, ELN
AF Salvador Mocelin, Helaine Jacinta
   do Prado, Thiago Nascimento
   Silva Freitas, Paula de Souza
   Bertolde, Adelmo Inacio
   Perez, Freddy
   Riley, Lee W.
   Noia Maciel, Ethel Leonor
TI Variations in the detection of congenital Zika syndrome associated with
   changes in protocols
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA Portuguese
DT Article
DE Zika virus; microcephaly; communicable diseases; public health; Brazil
ID VIRUS
AB In 2015, Brazil faced a Zika virus epidemic that spread to other countries in the world. As a result, recommendations regarding reporting criteria for congenital Zika syndrome (CZS) were issued in the form of protocols. The frequent changes in these recommendations may have affected clinical management and the access to post-diagnostic support by children who were affected by CZS, but who ended up not being identified. In the present study, 39 cases of CZS reported in the state of Espirito Santo, Brazil, from 2015 to 2016 were re-classified in terms of diagnosis using the current protocol, which is different from the protocol used in 2015. According to this re-classification, only eight out of 36 cases would be confirmed, based on the criterion of two or more signs or symptoms of CZS with or without microcephaly plus positive serologic results. Also, considering the decrease in the head circumference cut-off point defining microcephaly, 17 cases would no longer meet the definition for this condition. Even though the current protocol does not rely on head circumference alone for CZS reporting and confirmation, it should be noted that this is still the main sign considered by health care teams, and therefore the decrease in the cut-off point might have compromised early CZS detection. A review of "ruled out" cases would be advisable in moments of protocol transition to determine whether these cases have been correctly classified.
C1 [Salvador Mocelin, Helaine Jacinta; do Prado, Thiago Nascimento; Silva Freitas, Paula de Souza; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol Lab Epi, Vitoria, ES, Brazil.
   [Bertolde, Adelmo Inacio] Univ Fed Espirito Santo, Dept Estat, Vitoria, ES, Brazil.
   [Perez, Freddy] OPAS, Dept Doencas Transmissiveis & Determinantes Ambie, Washington, DC USA.
   [Riley, Lee W.] Univ Calif Berkeley, Escola Saude Publ, Div Doencas Infecciosas & Vacinol, Berkeley, CA 94720 USA.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol Lab Epi, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Perez, Freddy/AAN-3893-2020
OI Perez, Freddy/0000-0003-2001-0057
CR Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Lesser J, 2016, ESTUD AV-SAO PAULO, V30, P167, DOI DOI 10.1590/S0103-40142016.30880012
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atencao a Saude, 2017, OR INT VIG AT SAUD A
   Secretaria de Estado da Saude do Espirito Santo (SESA), 2017, SAUD DIV DAD ZIK MIC
   Freitas PDS, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.24
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 11
TC 0
Z9 0
U1 0
U2 0
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2019
VL 43
AR e79
DI 10.26633/RPSP.2019.79
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA JE1FE
UT WOS:000490437700001
PM 31579398
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Freitas, PDS
   Soares, GB
   Mocelin, HJS
   Lacerda, LCX
   do Prado, TN
   Sales, CMM
   Perez, F
   Bussinger, ECD
   Maciel, ELN
AF Silva Freitas, Paula de Souza
   Soares, Gabriella Barreto
   Salvador Mocelin, Helaine Jacinta
   Xavier Lacerda, Larissa Carolina
   do Prado, Thiago Nascimento
   Martins Sales, Carolina Maia
   Perez, Freddy
   de Azevedo Bussinger, Elda Coelho
   Noia Maciel, Ethel Leonor
TI Congenital Zika syndrome: sociodemographic profile of mothers
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA Portuguese
DT Article
DE Zika virus; microcephaly; communicable diseases; public health; social
   determinants of health; epidemiology; Brazil
ID VIRUS; BRAZIL; MUNICIPALITIES; REGION; STATE
AB Objective. Describe the sociodemographic profile of mothers of children with congenital Zika syndrome.
   Method. This is a descriptive, cross-sectional, quantitative study. The 39 mothers of live born babies among the cases notified in 2015 and 2016 with confirmed diagnosis of congenital Zika syndrome in the state of Espirito Santo, Brazil, were invited to participate. Of these, 25 mothers were enrolled. Data were collected using a socioeconomic questionnaire and a field diary.
   Results. Skin color was self-reported as non-white by 19/25 mothers (74.0%), and 16 (64.0%) reported having a partner. Regarding schooling, 12 (48.0%) had completed high school. Per capita income varied from no income to US$ 1 111.11, and ranged from none to US$ 61.72 for 12 women (48.0%). Seventeen women (68.0%) lived in underprivileged periphery areas with poor living conditions. Of the 25 women, 16 (64.0%) had a job prior to the pregnancy; and of these, 12 (75.0%) were fired or quit after the baby was born.
   Conclusions. The profile of mothers shows that the Zika epidemics was not equanimous and preferentially affected women with low income and lower social class. In this sense, we believe that congenital Zika syndrome may be determined by social inequalities in Brazil. The data described in the present study may be useful for the planning of effective actions to ensure a social protection network for children with congenital Zika syndrome and their families.
C1 [Silva Freitas, Paula de Souza; Soares, Gabriella Barreto; Salvador Mocelin, Helaine Jacinta; do Prado, Thiago Nascimento; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
   [Xavier Lacerda, Larissa Carolina] UFES, Dept Ciencias Saude, Sao Mateus, ES, Brazil.
   [Martins Sales, Carolina Maia] Univ Fed Espirito Santo, LabEpi, Vitoria, ES, Brazil.
   [Perez, Freddy] PAHO, Communicable Dis & Environm Determinants Hlth Dep, Washington, DC USA.
   [de Azevedo Bussinger, Elda Coelho] FDV, Programa Posgrad Direito, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Perez, Freddy/AAN-3893-2020
OI Perez, Freddy/0000-0003-2001-0057; Maciel, Ethel
   Leonor/0000-0003-4826-3355
CR Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   [Anonymous], 2013, CARACTERISTICAS ETNI
   [Anonymous], 2016, WATERLAT GOBACITY NE, V3, P38
   Barata RB, 2009, COMO QUE DESIGUALDAD
   Brasil. Ministerio da Saude, 2016, PROT AT BAS SAUD MUL
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2018, B EPIDEMIOLOGICO, V49, P1
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Cabral CM, 2017, EPIDEMIOL SERV SAUDE, V26, P245, DOI [10.5123/S1679-49742017000200002, 10.5123/s1679-49742017000200002]
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   IBGE. Instituto Brasileiro de Geografia e Estatistica, 2016, SINT IND SOC AN COND
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2016, IBGE DIV REND DOM CA
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Linde AR, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00178917
   Luz Elizangela Pletsch da, 2014, Rev. bras. geriatr. gerontol., V17, P303, DOI 10.1590/S1809-98232014000200008
   Ministerio da Saude, 2015, PROT AT SAUD RESP OC
   Pan American Health Organization (PAHO) World Health Organization (WHO), 2017, ZIK SUSP CONF CAS RE
   Pereira EL, 2017, CIENC SAUDE COLETIVA, V22, P3557, DOI 10.1590/1413-812320172211.22182017
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   PNUD, 2017, AV IMP SOC VIR ZIK A
   Secretaria de Estado da Saude do Espirito Santo, 2017, SESA DIV B ZIK MICR
   Fantinato FFST, 2016, EPIDEMIOL SERV SAUDE, V25, P683, DOI [10.5123/s1679-49742016000400002, 10.5123/S1679-49742016000400002]
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI [10.5123/s1679-49742016000400003, 10.5123/S1679-49742016000400003]
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   VASCONCELOS PFD, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 28
TC 7
Z9 7
U1 0
U2 0
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2019
VL 43
AR e24
DI 10.26633/RPSP.2019.24
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA IU2NA
UT WOS:000483415900006
PM 31093248
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Fontenelle, LF
   Sarti, TD
   de Camargo, MBJ
   Maciel, ELN
   Barros, AJD
AF Fontenelle, Leonardo Ferreira
   Sarti, Thiago Dias
   Junqueira de Camargo, Maria Beatriz
   Noia Maciel, Ethel Leonor
   Barros, Aluisio J. D.
TI Utilization of the Brazilian public health system by privately insured
   individuals: a literature review
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Review
DE Unified Health System; Health Insurance; Delivery of Health Care; Health
   Services
ID CARE-SYSTEMS; SERVICES; ACCESS; INSURANCE; COVERAGE; MIX; INEQUALITIES;
   COUNTRIES; PATTERNS; PLANS
AB More than one in four Brazilians have private health insurance (PHI), even thought it covers mostly the same procedures as the Brazilian Unified National Health System (SUS). This literature review included articles and monographs published since 1990 about the utilization of SUS by privately insured individuals. Considering outpatient care and hospitalization, privately insured people in Brazil use SUS in approximately 13% of the times they receive health care, and approximately 7% of people receiving care paid by SUS are privately insured; these findings vary depending on the type of service studied and on study methods. Utilization of SUS is more frequent in less developed regions, by people with more restricted PHI plans and by people with worse health status. Privately insured people report the limitations of PHI plans as their reasons for resorting to SUS. Sometimes, beneficiaries of PHI plans owned by nonprofit hospitals (which also provide health care financed by SUS) have easier access to care than uninsured people financed by SUS. Anecdotally, privately insured people are satisfied with SUS, but not to the point of adopting SUS as their preferred source of care. In short, for privately insured people, SUS only plays a secondary role in their health care. Despite PHI taking over part of the SUS's health care demand, PHI represents a restriction of the universal, equitable character of the SUS.
C1 [Fontenelle, Leonardo Ferreira; Barros, Aluisio J. D.] Univ Fed Pelotas, Programa Posgrad Epidemiol, Rua Marechal Deodoro 1160,3 Piso, BR-96020220 Pelotas, RS, Brazil.
   [Sarti, Thiago Dias; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Vitoria, ES, Brazil.
   [Junqueira de Camargo, Maria Beatriz] Univ Fed Pelotas, Fac Odontol, Pelotas, Brazil.
RP Fontenelle, LF (corresponding author), Univ Fed Pelotas, Programa Posgrad Epidemiol, Rua Marechal Deodoro 1160,3 Piso, BR-96020220 Pelotas, RS, Brazil.
EM leonardof@leonardof.med.br
RI Barros, Aluisio JD/A-7417-2008; Fontenelle, Leonardo/G-3942-2013
OI Barros, Aluisio JD/0000-0002-2022-8729; Sarti,
   Thiago/0000-0002-1545-6276; Maciel, Ethel Leonor/0000-0003-4826-3355;
   Fontenelle, Leonardo/0000-0003-4064-433X; Camargo, Maria
   Beatriz/0000-0001-7908-5999
CR Agencia Nacional de Saude Suplementar, 2012, GLOSS TEM SAUD SUPL
   Albuquerque C, 2008, CIENC SAUDE COLETIVA, V13, P1421, DOI 10.1590/S1413-81232008000500008
   Amorim Vivian Mae Schmidt Lima, 2014, Rev. bras. epidemiol., V17, P136, DOI 10.1590/1809-4503201400060012
   Andreazzi Maria de Fátima Siliansky de, 2007, Physis, V17, P521, DOI 10.1590/S0103-73312007000300007
   Bahia L., 1999, THESIS
   Bahia L, 2008, CIENC SAUDE COLETIVA, V13, P1385, DOI 10.1590/S1413-81232008000500002
   Barata R. B., 2008, SAO PAULO PERSPECT, V22, P19
   BARRETO JR I. F., 2008, SAO PAULO PERSPECT, V22, P5
   Barros AJD, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-57
   Bousquat A, 2012, CIENC SAUDE COLETIVA, V17, P2913, DOI 10.1590/S1413-81232012001100008
   Conill EM, 2008, CIENC SAUDE COLETIVA, V13, P1501, DOI 10.1590/S1413-81232008000500015
   da Silva NN, 2000, REV SAUDE PUBL, V34, P44, DOI 10.1590/S0034-89102000000100009
   da Silva ZP, 2011, CIENC SAUDE COLETIVA, V16, P3807, DOI 10.1590/S1413-81232011001000016
   de Arruda GO, 2017, CIENC SAUDE COLETIVA, V22, P279, DOI 10.1590/1413-81232017221.20532015
   Sestelo JAD, 2013, CAD SAUDE PUBLICA, V29, P851
   Bonello AADM, 2014, CIENC SAUDE COLETIVA, V19, P4397, DOI 10.1590/1413-812320141911.13922013
   Santiago Adriana Xavier de, 2014, Rev. bras. epidemiol., V17, P39, DOI 10.1590/1809-4503201400060004
   Azevedo BD, 2015, ACTA BIOETH, V21, P117, DOI 10.4067/S1726-569X2015000100015
   Drechsler D, 2007, J HEALTH POLIT POLIC, V32, P497, DOI 10.1215/03616878-2007-012
   FARIAS LO, 2001, CIENC SAUDE COLETIVA, V6, P405
   Farias Luís Otávio, 2003, Ciênc. saúde coletiva, V8, P585, DOI 10.1590/S1413-81232003000200019
   Fernandes LCL, 2009, REV SAUDE PUBL, V43, P595, DOI 10.1590/s0034-89102009005000040
   Fleury S, 2013, SALUD COLECT, V9, P11, DOI [10.1590/S1851-82652013000100002, 10.1590/s1851-82652013000100002]
   Garcia-Subirats I, 2014, GAC SANIT, V28, P480, DOI 10.1016/j.gaceta.2014.05.010
   Gerschman S, 2007, CIENC SAUDE COLETIVA, V12, P487, DOI 10.1590/S1413-81232007000200025
   Gerschman S, 2008, CIENC SAUDE COLETIVA, V13, P1441, DOI 10.1590/S1413-81232008000500010
   Pires MRGM, 2013, SAUDE SOC-SAO PAULO, V22, P211, DOI 10.1590/S0104-12902013000100019
   Hernandes ESC, 2012, REV SAUDE PUBL, V46, P1030, DOI 10.1590/s0034-89102012000600013
   Ministerio da Saude; Organizacao Pan- Ame- ricana da Saude; Associacao Brasileira de Eco- nomia da Saude, 2013, PROD CONH EC SAUD PE
   Ministerio da Saude; Organizacao Pan- Ame- ricana da Saude; Associacao Brasileira de Eco- nomia da Saude, 2016, OS NUCL EC SAUD HIST
   Mullachery P, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0431-8
   Ocke- Reis CO, 2004, TEXTO DISCUSSAO, V1013
   Ocke-Reis CO, 2000, REV SERVICO PUBLICO, V51, P124
   Oliveira C., 2009, THESIS
   Oliveira LS, 2012, CIENC SAUDE COLETIVA, V17, P3047, DOI 10.1590/S1413-81232012001100021
   Olsen JM, 2014, THESIS
   Organisation for Economic Co- Operation and Development, 2004, PRIV HLTH INS OECD C
   Pereira RJ, 2010, REV MED MINAS GERAIS, V20, P5
   Pessoto UC, 2007, CIENC SAUDE COLETIVA, V12, P351, DOI 10.1590/S1413-81232007000200011
   Porto SM, 2011, CIENC SAUDE COLETIVA, V16, P3795, DOI 10.1590/S1413-81232011001000015
   Ribeiro Manoel Carlos Sampaio de Almeida, 2006, Ciênc. saúde coletiva, V11, P1011, DOI 10.1590/S1413-81232006000400022
   Santos IS, 2000, THESIS
   Santos IS, 2011, CIENC SAUDE COLETIVA, V16, P2743, DOI 10.1590/S1413-81232011000600013
   Santos IS, 2008, CIENC SAUDE COLETIVA, V13, P1431, DOI 10.1590/S1413-81232008000500009
   Sekhri N, 2005, B WORLD HEALTH ORGAN, V83, P127
   Sisson MC, 2011, INTERFACE-BOTUCATU, V15, P123, DOI 10.1590/S1414-32832010005000042
   TRAVASSOS C, 2000, CIENC SAUDE COLETIVA, V5, P133, DOI DOI 10.1590/S1413-81232000000100012
   Travassos Claudia, 2006, Ciênc. saúde coletiva, V11, P975, DOI 10.1590/S1413-81232006000400019
   Tuohy CH, 2004, J HEALTH POLIT POLIC, V29, P359, DOI 10.1215/03616878-29-3-359
   Viacava Francisco, 2005, Cad. Saúde Pública, V21, pS119, DOI 10.1590/S0102-311X2005000700013
   Viacava F, 2016, CIENC SAUDE COLETIVA, V21, P351, DOI 10.1590/1413-81232015212.19422015
   Viana Ana Luiza D'Ávila, 2008, Physis, V18, P645, DOI 10.1590/S0103-73312008000400004
   ZANON Lubieska Rangel, 2016, RGO, Rev. Gaúch. Odontol., V64, P411, DOI 10.1590/1981-863720160003000073043
NR 53
TC 1
Z9 1
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2019
VL 35
IS 4
AR e00004118
DI 10.1590/0102-311X00004118
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HY0NA
UT WOS:000467807500001
PM 31066771
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Ahmad, N
   Ahuja, SD
   Akkerman, OW
   Alffenaar, JWC
   Anderson, LF
   Baghaei, P
   Bang, D
   Barry, PM
   Bastos, ML
   Behera, D
   Benedetti, A
   Bisson, GP
   Boeree, MJ
   Bonnet, M
   Brode, SK
   Brust, JCM
   Cai, Y
   Caumes, E
   Cegielski, JP
   Centis, R
   Chan, PC
   Chan, ED
   Chang, KC
   Charles, M
   Cirule, A
   Dalcolmo, MP
   D'Ambrosio, L
   de Vries, G
   Dheda, K
   Esmail, A
   Flood, J
   Fox, GJ
   Frechet-Jachym, M
   Fregona, G
   Gayoso, R
   Gegia, M
   Gler, MT
   Gu, S
   Guglielmetti, L
   Holtz, TH
   Hughes, J
   Isaakidis, P
   Jarlsberg, L
   Kempker, RR
   Keshavjee, S
   Khan, FA
   Kipiani, M
   Koenig, SP
   Koh, WJ
   Kritski, A
   Kuksa, L
   Kvasnovsky, CL
   Kwak, N
   Lan, ZY
   Lange, C
   Laniado-Laborin, R
   Lee, M
   Leimane, V
   Leung, CC
   Leung, ECC
   Li, PZ
   Lowenthal, P
   Maciel, EL
   Marks, SM
   Mase, S
   Mbuagbaw, L
   Migliori, GB
   Milanov, V
   Miller, AC
   Mitnick, CD
   Modongo, C
   Mohr, E
   Monedero, I
   Nahid, P
   Ndjeka, N
   O'Donnell, MR
   Padayatchi, N
   Palmero, D
   Pape, JW
   Podewils, LJ
   Reynolds, I
   Riekstina, V
   Robert, J
   Rodriguez, M
   Seaworth, B
   Seung, KJ
   Schnippel, K
   Shim, TS
   Singla, R
   Smith, SE
   Sotgiu, G
   Sukhbaatar, G
   Tabarsi, P
   Tiberi, S
   Trajman, A
   Trieu, L
   Udwadia, ZF
   van der Werf, TS
   Veziris, N
   Viiklepp, P
   Vilbrun, SC
   Walsh, K
   Westenhouse, J
   Yew, WW
   Yim, JJ
   Zetola, NM
   Zignol, M
   Menzies, D
AF Ahmad, Nafees
   Ahuja, Shama D.
   Akkerman, Onno W.
   Alffenaar, Jan-Willem C.
   Anderson, Laura F.
   Baghaei, Parvaneh
   Bang, Didi
   Barry, Pennan M.
   Bastos, Mayara L.
   Behera, Digamber
   Benedetti, Andrea
   Bisson, Gregory P.
   Boeree, Martin J.
   Bonnet, Maryline
   Brode, Sarah K.
   Brust, James C. M.
   Cai, Ying
   Caumes, Eric
   Cegielski, J. Peter
   Centis, Rosella
   Chan, Pei-Chun
   Chan, Edward D.
   Chang, Kwok-Chiu
   Charles, Macarthur
   Cirule, Andra
   Dalcolmo, Margareth Pretti
   D'Ambrosio, Lia
   de Vries, Gerard
   Dheda, Keertan
   Esmail, Aliasgar
   Flood, Jennifer
   Fox, Gregory J.
   Frechet-Jachym, Mathilde
   Fregona, Geisa
   Gayoso, Regina
   Gegia, Medea
   Gler, Maria Tarcela
   Gu, Sue
   Guglielmetti, Lorenzo
   Holtz, Timothy H.
   Hughes, Jennifer
   Isaakidis, Petros
   Jarlsberg, Leah
   Kempker, Russell R.
   Keshavjee, Salmaan
   Khan, Faiz Ahmad
   Kipiani, Maia
   Koenig, Serena P.
   Koh, Won-Jung
   Kritski, Afranio
   Kuksa, Liga
   Kvasnovsky, Charlotte L.
   Kwak, Nakwon
   Lan, Zhiyi
   Lange, Christoph
   Laniado-Laborin, Rafael
   Lee, Myungsun
   Leimane, Vaira
   Leung, Chi-Chiu
   Leung, Eric Chung-Ching
   Li, Pei Zhi
   Lowenthal, Phil
   Maciel, Ethel L.
   Marks, Suzanne M.
   Mase, Sundari
   Mbuagbaw, Lawrence
   Migliori, Giovanni B.
   Milanov, Vladimir
   Miller, Ann C.
   Mitnick, Carole D.
   Modongo, Chawangwa
   Mohr, Erika
   Monedero, Ignacio
   Nahid, Payam
   Ndjeka, Norbert
   O'Donnell, Max R.
   Padayatchi, Nesri
   Palmero, Domingo
   Pape, Jean William
   Podewils, Laura J.
   Reynolds, Ian
   Riekstina, Vija
   Robert, Jerome
   Rodriguez, Maria
   Seaworth, Barbara
   Seung, Kwonjune J.
   Schnippel, Kathryn
   Shim, Tae Sun
   Singla, Rupak
   Smith, Sarah E.
   Sotgiu, Giovanni
   Sukhbaatar, Ganzaya
   Tabarsi, Payam
   Tiberi, Simon
   Trajman, Anete
   Trieu, Lisa
   Udwadia, Zarir F.
   van der Werf, Tjip S.
   Veziris, Nicolas
   Viiklepp, Piret
   Vilbrun, Stalz Charles
   Walsh, Kathleen
   Westenhouse, Janice
   Yew, Wing-Wai
   Yim, Jae-Joon
   Zetola, Nicola M.
   Zignol, Matteo
   Menzies, Dick
CA Collaborative Grp Meta-Analysis In
TI Treatment correlates of successful outcomes in pulmonary
   multidrug-resistant tuberculosis: an individual patient data
   meta-analysis
SO LANCET
LA English
DT Article
ID SOUTH-AFRICA; HIGH-RATES; XDR-TB; DRUG; BEDAQUILINE; REGIMENS; SAFETY;
   MANAGEMENT; PROGRAM; SURGERY
AB Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of individual drugs, and the optimal number and duration of treatment with those drugs in patients with multidrug-resistant tuberculosis.
   Methods In this individual patient data meta-analysis, we searched MEDLINE, Embase, and the Cochrane Library to identify potentially eligible observational and experimental studies published between Jan 1, 2009, and April 30, 2016. We also searched reference lists from all systematic reviews of treatment of multidrug-resistant tuberculosis published since 2009. To be eligible, studies had to report original results, with end of treatment outcomes (treatment completion [success], failure, or relapse) in cohorts of at least 25 adults (aged >18 years). We used anonymised individual patient data from eligible studies, provided by study investigators, regarding clinical characteristics, treatment, and outcomes. Using propensity score-matched generalised mixed effects logistic, or linear regression, we calculated adjusted odds ratios and adjusted risk differences for success or death during treatment, for specific drugs currently used to treat multidrug-resistant tuberculosis, as well as the number of drugs used and treatment duration.
   Findings Of 12030 patients from 25 countries in 50 studies, 7346 (61%) had treatment success, 1017 (8%) had failure or relapse, and 1729 (14%) died. Compared with failure or relapse, treatment success was positively associated with the use of linezolid (adjusted risk difference 0.15, 95% CI 0.11 to 0.18), levofloxacin (0.15, 0.13 to 0.18), carbapenems (0.14,0.06 to 0.21), moxifloxacin (0.11, 0.08 to 0.14), bedaquiline (0.10, 0.05 to 0.14), and clofazimine (0.06, 0.01 to 0.10). There was a significant association between reduced mortality and use of linezolid (-0.20, -0.23 to -0.16), levofloxacin (-0.06, -0.09 to -0.04), moxifloxacin (-0.07, -0.10 to -0.04), or bedaquiline (-0.14, -0.19 to -0.10). Compared with regimens without any injectable drug, amikacin provided modest benefits, but kanamycin and capreomycin were associated with worse outcomes. The remaining drugs were associated with slight or no improvements in outcomes. Treatment outcomes were significantly worse for most drugs if they were used despite in-vitro resistance. The optimal number of effective drugs seemed to be five in the initial phase, and four in the continuation phase. In these adjusted analyses, heterogeneity, based on a simulated I-2 method, was high for approximately half the estimates for specific drugs, although relatively low for number of drugs and durations analyses.
   Interpretation Although inferences are limited by the observational nature of these data, treatment outcomes were significantly better with use of linezolid, later generation fluoroquinolones, bedaquiline, clofazimine, and carbapenems for treatment of multidrug-resistant tuberculosis. These findings emphasise the need for trials to ascertain the optimal combination and duration of these drugs for treatment of this condition.
C1 [Ahmad, Nafees] Univ Baluchistan, Fac Pharm & Hlth Sci, Quetta, Pakistan.
   [Ahuja, Shama D.; Trieu, Lisa] New York City Dept Hlth & Mental Hyg, Bur TB Control, New York, NY 10013 USA.
   [Akkerman, Onno W.; van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands.
   [Akkerman, Onno W.] Univ Groningen, Univ Med Ctr Groningen, TB Ctr Beatrixoord, Groningen, Netherlands.
   [Alffenaar, Jan-Willem C.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.
   [van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Infect Dis, Groningen, Netherlands.
   [Anderson, Laura F.; Gegia, Medea; Zignol, Matteo] WHO, Global TB Program, Geneva, Switzerland.
   [Baghaei, Parvaneh; Tabarsi, Payam] Shahid Beheshti Univ Med Sci, Clin TB & Epidemiol Res Ctr, NRITLD, Tehran, Iran.
   [Bang, Didi] Statens Serum Inst, Copenhagen, Denmark.
   [Barry, Pennan M.; Flood, Jennifer; Lowenthal, Phil; Westenhouse, Janice] Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, TB Control Branch, Sacramento, CA USA.
   [Bastos, Mayara L.; Trajman, Anete] Univ Estado Rio De Janeiro, Epidemiol Dept, Social Med Inst, Rio De Janeiro, Brazil.
   [Behera, Digamber] WHO, Collaborating Ctr Res & Capac Bldg Chron Resp Dis, Dept Pulm Med, Chandigarh, India.
   [Behera, Digamber] Postgrad Inst Med Educ & Res, Chandigarh, India.
   [Benedetti, Andrea; Khan, Faiz Ahmad; Lan, Zhiyi; Li, Pei Zhi; Trajman, Anete; Menzies, Dick] McGill Univ, Hlth Ctr, Res Inst, Montreal Chest Inst, Montreal, PQ, Canada.
   [Bisson, Gregory P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Boeree, Martin J.] Radboud Univ Nijmegen, Med Ctr Nijmegen & Dekkerswald Radboudumc, Dept Pulm Dis, Groesbeek, Netherlands.
   [Bonnet, Maryline] Epictr MSF, Paris, France.
   [Bonnet, Maryline] Univ Montpellier, INSERM, U1175, Inst Rech Dev UM233, Montpellier, France.
   [Brode, Sarah K.] Univ Toronto, Univ Hlth Network, West Pk Healthcare Ctr, Dept Med,Div Respirol, Toronto, ON, Canada.
   [Brode, Sarah K.] Sinai Hlth Syst, Toronto, ON, Canada.
   [Brust, James C. M.] Albert Einstein Coll Med, Montefiore Med Ctr, Div Gen Internal Med, New York, NY USA.
   [Brust, James C. M.] Albert Einstein Coll Med, Montefiore Med Ctr, Div Infect Dis, New York, NY USA.
   [Cai, Ying] NIAID, TB Res Sect, Lab Clin Immunol & Microbiol, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Fregona, Geisa; Maciel, Ethel L.] Univ Fed Espirito Santo, Vitoria, Brazil.
   [Caumes, Eric] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Serv Malad Infectieuses & Trop, Paris, France.
   [Cegielski, J. Peter; Holtz, Timothy H.; Podewils, Laura J.; Smith, Sarah E.] Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA USA.
   [Centis, Rosella; D'Ambrosio, Lia; Migliori, Giovanni B.] WHO, Collaborating Ctr TB & Lung Dis, Maugeri Care & Res Inst, Tradate, Italy.
   [Chan, Pei-Chun] Taiwan Ctr Dis Control, Div Chron Infect Dis, Taipei, Taiwan.
   [Chan, Edward D.; Gu, Sue; Reynolds, Ian] Univ Colorado Denver, Dept Med, Aurora, CO USA.
   [Chan, Edward D.] Natl Jewish Hlth, Dept Med, Denver, CO USA.
   [Chan, Edward D.] VA Med Ctr, Denver, CO USA.
   [Chang, Kwok-Chiu; Leung, Chi-Chiu; Leung, Eric Chung-Ching] Ctr Hlth Protect, Dept Hlth, TB & Chest Serv, Hong Kong, Hong Kong, Peoples R China.
   [Charles, Macarthur] Haiti Country Off, Ctr Dis Control & Prevent, Port Au Prince, Haiti.
   [Kuksa, Liga] Riga East Univ Hosp, Dept MDR TB, Riga, Latvia.
   [Cirule, Andra; Leimane, Vaira; Riekstina, Vija] Riga East Univ Hosp, Ctr TB & Lung Dis, Riga, Latvia.
   [Dalcolmo, Margareth Pretti; Gayoso, Regina] Ctr Referencia Helio Fraga, Fiocruz, Brazil.
   [D'Ambrosio, Lia] Publ Hlth Consulting Grp, Lugano, Switzerland.
   [de Vries, Gerard] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.
   [de Vries, Gerard] KNCV TB Fdn, The Hague, Netherlands.
   [Dheda, Keertan] Univ Cape Town, Ctr Lung Infect & Immun, Dept Med, Cape Town, South Africa.
   [Dheda, Keertan] Univ Cape Town, UCT Lung Inst, Cape Town, South Africa.
   [Schnippel, Kathryn] Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Cape Town, South Africa.
   [Fox, Gregory J.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.
   [Gler, Maria Tarcela] Trop Dis Fdn, Manila, Philippines.
   [Guglielmetti, Lorenzo; Robert, Jerome; Veziris, Nicolas] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Lab Bacteriol Hyg, Ctr Natl Reference Mycobacteries & Resistance Myc, Paris, France.
   [Guglielmetti, Lorenzo; Robert, Jerome; Veziris, Nicolas] Sorbonne Univ, CIMI, INSERM, U1135,UMRS CR7,CNRS,ERL 8255,Bacteriol Fac Med, Paris, France.
   [Frechet-Jachym, Mathilde; Guglielmetti, Lorenzo] Ctr Hosp Bligny, Briis Sous Forges, France.
   [Hughes, Jennifer; Mohr, Erika] Med Sans Frontieres, Khayelitsha, South Africa.
   [Isaakidis, Petros] Med Sans Frontieres, Bombay, Maharashtra, India.
   [Jarlsberg, Leah; Nahid, Payam] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.
   [Kempker, Russell R.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA.
   [Keshavjee, Salmaan; Miller, Ann C.; Mitnick, Carole D.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA.
   [Keshavjee, Salmaan; Koenig, Serena P.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.
   [Kipiani, Maia] Natl Ctr TB & Lung Dis, Tbilisi, Georgia.
   [Koenig, Serena P.; Pape, Jean William; Vilbrun, Stalz Charles; Walsh, Kathleen] Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti.
   [Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea.
   [Kritski, Afranio; Trajman, Anete] Univ Fed Rio de Janeiro, Sch Med, Acad TB Program, Rio De Janeiro, Brazil.
   [Kvasnovsky, Charlotte L.] Cohen Childrens Med Ctr, Hofstra Northwell Sch Med, Div Pediat Surg, New Hyde Pk, NY USA.
   [Kwak, Nakwon; Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med, Seoul, South Korea.
   [Lange, Christoph] Res Ctr Borstel, Div Clin Infect Dis, Sulfeld, Germany.
   [Lange, Christoph] German Ctr Infect Res, Clin TB Unit, Borstel, Germany.
   [Lange, Christoph] Univ Lubeck, Int Hlth Infect Dis, Lubeck, Germany.
   [Lange, Christoph] Karolinska Inst, Dept Med, Stockholm, Sweden.
   [Laniado-Laborin, Rafael] Tijuana Gen Hosp, TB Clin & Lab, Tijuana, Mexico.
   [Lee, Myungsun] Int TB Res Ctr, Seoul, South Korea.
   [Marks, Suzanne M.; Mase, Sundari] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA.
   [Mase, Sundari] Reg WHO Off, New Delhi, India.
   [Mbuagbaw, Lawrence] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.
   [Mbuagbaw, Lawrence] St Josephs Healthcare Hamilton, Father Sean OSullivan Res Ctr, Biostat Unit, Hamilton, ON, Canada.
   [Milanov, Vladimir] Med Univ Sofia, Med Fac, Univ Hosp Resp Dis St Sofia, Sofia, Bulgaria.
   [Modongo, Chawangwa; Zetola, Nicola M.] Botswana UPenn Partnership, Gaborone, Botswana.
   [Monedero, Ignacio] Int Union TB & Lung Dis, TB HIV Dept, Paris, France.
   [Ndjeka, Norbert] South African Natl Dept Hlth, Natl TB Programme, Pretoria, South Africa.
   [O'Donnell, Max R.] Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, New York, NY USA.
   [O'Donnell, Max R.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   [O'Donnell, Max R.; Padayatchi, Nesri] CAPRISA, MRC TB HIV Treatment & Pathogenesis Res Unit, Durban, South Africa.
   [Palmero, Domingo] Municipal Hosp FJ Muniz, Pulmonol Div, Buenos Aires, DF, Argentina.
   [Pape, Jean William] Weill Cornell Med Coll, Ctr Global Hlth, Dept Med, New York, NY USA.
   [Rodriguez, Maria] Natl TB Control Program, Santo Domingo, Dominican Rep.
   [Seaworth, Barbara] Univ Texas Hlth Sci Ctr Tyler, Heartland Natl TB Ctr, Tyler, TX USA.
   [Seung, Kwonjune J.] Partners Hlth, Boston, MA USA.
   [Shim, Tae Sun] Univ Ulsan, Coll Med, Dept Pulm & Crit Care Med, Seoul, South Korea.
   [Singla, Rupak] Natl Inst TB & Resp Dis, New Delhi, India.
   [Sotgiu, Giovanni] Univ Sassari, Clin Epidemiol & Med Stat Unit, Dept Med Surg & Expt Sci, Sassari, Italy.
   [Sukhbaatar, Ganzaya] Minist Hlth Mongolia, Ulaanbaatar, Mongolia.
   [Tiberi, Simon] Royal London Hosp, Barts Hlth NHS Trust, London, England.
   [Tiberi, Simon] Queen Mary Univ London, Blizard Inst, London, England.
   [Tiberi, Simon] Queen Mary Univ London, London Sch Med & Dent, London, England.
   [Udwadia, Zarir F.] Hinduja Hosp & Res Ctr, Bombay, Maharashtra, India.
   [Viiklepp, Piret] Natl Inst Hlth Dev, Estonian TB Registry, Tallinn, Estonia.
   [Yew, Wing-Wai] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
RP Menzies, D (corresponding author), McGill Univ, RECRU, Montreal Chest Inst, Hlth Ctr,Res Inst, Montreal, PQ H4A 3S5, Canada.
EM dick.menzies@mcgill.ca
RI Maciel, Ethel Leonor LN/G-1027-2012; padayatchi, nesri/Q-2780-2019;
   Milanov, Vladimir/AAI-5838-2020; Kritski, Afranio/I-6760-2016; Migliori,
   Giovanni Battista/AAB-8589-2020; Guglielmetti, Lorenzo/D-6207-2014;
   ROBERT, Jerome/C-3993-2011; Sotgiu, Giovanni/N-1032-2017; Koh,
   Won-Jung/D-9586-2018; Tiberi, Simon/I-2552-2019; Koh, Won
   Jung/C-9595-2011; Lange, Christoph/J-6289-2012; Mbuagbaw,
   Lawrence/D-9381-2015
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; padayatchi,
   nesri/0000-0003-2543-9071; Migliori, Giovanni
   Battista/0000-0002-2597-574X; Guglielmetti, Lorenzo/0000-0003-0886-9635;
   ROBERT, Jerome/0000-0002-9380-0570; Sotgiu,
   Giovanni/0000-0002-1600-4474; Koh, Won-Jung/0000-0002-4756-3527; Tiberi,
   Simon/0000-0001-9424-6551; Lange, Christoph/0000-0002-9691-4741;
   Mbuagbaw, Lawrence/0000-0001-5855-5461; de Vries,
   Gerard/0000-0003-1278-4503; Hughes, Jennifer/0000-0002-5349-9509; Nahid,
   Payam/0000-0003-2811-1311; Isaakidis, Petros/0000-0002-7881-1554;
   Schnippel, Kathryn/0000-0003-0757-4325; Fregona,
   Geisa/0000-0001-5835-8222
FU American Thoracic Society; Canadian Institutes of Health
   ResearchCanadian Institutes of Health Research (CIHR); US Centers for
   Disease Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA; European
   Respiratory Society; Infectious Diseases Society of America; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW007124, D43TW007124, D43TW007124,
   D43TW007124, D43TW007124, D43TW007124, D43TW007124, D43TW007124,
   D43TW007124, D43TW007124, D43TW007124, D43TW007124, D43TW007124,
   D43TW007124, D43TW007124] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [K23AI098479, K23AI098479, K23AI098479, K23AI098479, K23AI098479]
   Funding Source: NIH RePORTER
FX American Thoracic Society, Canadian Institutes of Health Research, US
   Centers for Disease Control and Prevention, European Respiratory
   Society, Infectious Diseases Society of America.
CR Ahmad N, 2015, INT J TUBERC LUNG D, V19, P1109, DOI 10.5588/ijtld.15.0167
   Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300
   Anderson LF, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.40.20601
   Anger HA, 2010, J ANTIMICROB CHEMOTH, V65, P775, DOI 10.1093/jac/dkq017
   Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480
   Baghaei P, 2011, AM J THER, V18, pE29, DOI 10.1097/MJT.0b013e3181c0806d
   Bang D, 2010, SCAND J INFECT DIS, V42, P288, DOI 10.3109/00365540903456282
   Barry PM, UNPUBLISHED DATA
   Bastos ML, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2810-1
   Bastos ML, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00803-2016
   Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023081
   Borisov SE, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00387-2017
   Brode SK, 2015, CAN RESPIR J, V22, P97, DOI 10.1155/2015/359301
   Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413
   Burgos M, 2005, CLIN INFECT DIS, V40, P968, DOI 10.1086/428582
   Cegielski JP, 2016, CLIN INFECT DIS, V62, P418, DOI 10.1093/cid/civ910
   Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC
   Chan PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058064
   Chang KC, 2013, ANTIMICROB AGENTS CH, V57, P3445, DOI 10.1128/AAC.00388-13
   Chang KC, 2012, ANTIMICROB AGENTS CH, V56, P5465, DOI 10.1128/AAC.01300-12
   Charles M, 2014, AM J TROP MED HYG, V91, P715, DOI 10.4269/ajtmh.14-0161
   Chen B, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0630-4
   Dalcolmo M, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02445-2016
   Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8
   Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865
   Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427
   Eker B, 2008, EMERG INFECT DIS, V14, P1700, DOI 10.3201/eid1411.080729
   Fox GJ, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00993-2016
   Fox GJ, 2016, CLIN INFECT DIS, V62, P887, DOI 10.1093/cid/ciw002
   Ganzaya S, 2013, PUBLIC HEALTH ACTION, V3, P333, DOI 10.5588/pha.13.0052
   Gegia M, 2012, INT J INFECT DIS, V16, pE391, DOI 10.1016/j.ijid.2011.12.018
   Guglielmetti L, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01799-2016
   Guglielmetti L, 2015, CLIN INFECT DIS, V60, P188, DOI 10.1093/cid/ciu786
   Harausz EP, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002591
   Hughes J, 2015, EUR RESPIR J, V46, P271, DOI 10.1183/09031936.00188114
   Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781
   Jeong BH, 2015, J ANTIMICROB CHEMOTH, V70, P3127, DOI 10.1093/jac/dkv215
   Jo KW, 2014, INT J TUBERC LUNG D, V18, P39, DOI 10.5588/ijtld.13.0307
   Kempker RR, 2015, EMERG INFECT DIS
   Khan FA, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00061-2017
   Koh WJ, 2012, J ANTIMICROB CHEMOTH
   Kvasnovsky CL, 2016, EMERG INFECT DIS, V22, P1529, DOI 10.32301/eid2209.160084
   Kvasnovsky CL, 2011, JAIDS-J ACQ IMM DEF, V57, P146, DOI 10.1097/QAI.0b013e31821190a3
   Kwak N, 2015, INT J TUBERC LUNG D, V19, P525, DOI 10.5588/ijtld.14.0739
   Laniado-Laborin R, 2012, INT J TUBERC LUNG D, V16, P610, DOI 10.5588/ijtld.11.0544
   Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640
   Lee M, 2015, NEW ENGL J MED, V373, P290, DOI 10.1056/NEJMc1500286
   Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964
   Lockman S, 2001, CLIN INFECT DIS, V32, P373, DOI 10.1086/318489
   Malla P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008313
   Marks SM, 2014, EMERG INFECT DIS
   Milanov V, 2015, INT J MYCOBACT, V4, P131, DOI 10.1016/j.ijmyco.2015.03.005
   Modongo C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-542
   Ndjeka N, 2015, INT J TUBERC LUNG D, V19, P979, DOI 10.5588/ijtld.14.0944
   O'Donnell MR, 2013, EMERG INFECT DIS, V19, P416, DOI 10.3201/eid1903.120998
   Palmero Domingo, 2015, Arch Bronconeumol, V51, pe49, DOI 10.1016/j.arbres.2015.03.012
   Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6
   Podewils LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070064
   Pym AS, 2016, EUR RESPIR J, V47, P564, DOI 10.1183/13993003.00724-2015
   Riekstina V, 2007, INT J TUBERC LUNG D, V11, P585
   Rodriguez M, 2013, INT J TUBERC LUNG D, V17, P520, DOI 10.5588/ijtld.12.0481
   Seung KJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002062
   Shean K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063057
   Shin SS, 2017, JAIDS-J ACQ IMM DEF, V74, P65, DOI 10.1097/QAI.0000000000001169
   Singla R, 2012, EUR RESPIR J, V39, P956, DOI 10.1183/09031936.00076811
   Smith SE, 2015, EMERG INFECT DIS, V21, P1002, DOI 10.3201/eid2106.141907
   Tabarsi P, 2011, AM J THER, V18, P343, DOI 10.1097/MJT.0b013e3181dd60ec
   Tabarsi P, 2010, MICROB DRUG RESIST, V16, P81, DOI 10.1089/mdr.2009.0073
   Tiberi S, 2016, EUR RESPIR J, V47, P1235, DOI 10.1183/13993003.02146-2015
   Tiberi S, 2016, EUR RESPIR J, V47, P333, DOI 10.1183/13993003.01278-2015
   Udwadia ZF, 2010, EUR RESPIR J, V35, P936, DOI 10.1183/09031936.00132009
   van Altena R, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01400-16
   van Altena R, 2015, INT J TUBERC LUNG D, V19, P406, DOI 10.5588/ijtld.14.0838
   WHO, 2015, US BED TREATM MULT R
   World Health Organization, 2011, GUID PROGR MAN DRUG
   World Health Organization, 2016, WHO TREATM GUID DRUG
   World Health Organization, 2017, GLOB TUB REP 2017
   World Health Organization, 2016, US DEL TREATM MULT R
   World Health Organization (WHO), DEF REP FRAM TUB 201
   Yuen CM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001932
NR 80
TC 144
Z9 149
U1 7
U2 44
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD SEP 8
PY 2018
VL 392
IS 10150
BP 821
EP 834
DI 10.1016/S0140-6736(18)31644-1
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA GT0KV
UT WOS:000444130000028
PM 30215381
OA Green Accepted
DA 2020-12-15
ER

PT J
AU Sales, CMM
   Sanchez, MN
   Ramalho, W
   Bertolde, AI
   Maciel, ELN
AF Martins Sales, Carolina Maia
   Sanchez, Mauro Niskier
   Ramalho, Walter
   Bertolde, Adelmo Inacio
   Noia Maciel, Ethel Leonor
TI Social determinants of tuberculosis via a zero-inflated model in small
   areas of a city in Southeastern Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Tuberculosis; Epidemiology; Social determinants of health; Spatial
   analysis; Statistical model; Negative binomial distribution
ID SPATIAL-PATTERNS; RIBEIRAO-PRETO; SAO-PAULO; STATE; VULNERABILITY;
   ASSOCIATION; VITORIA
AB Introduction: This study aimed to analyze social factors involved in the spatial distribution and under-reporting of tuberculosis (TB) in the city of Vitoria, Espirito Santo State, Brazil. Methods: This was an ecological study of the reported cases of TB between 2009 and 2011, according to census tracts. The outcome was TB incidence for the study period and the variables of exposure were proportions of literacy, inhabitants with an income of up to half the minimum monthly wage (MMW), and inhabitants associated with sewer mains or with access to safe drinking water. We used a zero-inflated process, zero-inflated negative binomial regression (ZINB), and selected an explanatory model based on the Akaike Information Criterion (AIC). Results: A total of 588 cases of tuberculosis were reported in Vitoria during the study period, distributed among 223 census tracts (38.6%), with 354 (61.4%) tracts presenting zero cases. In the ZINB model, the mean value of p(i) was 0.93, indicating that there is a 93% chance that an observed false zero could be due to sub-notification. Conclusions: It is important to prioritize areas exhibiting determinants that influence the occurrence of TB in the municipality of Vitoria. The zero-inflated model can be useful to the public health sector since it identifies the percentage of false zeros, generating an estimate of the real epidemiological condition of TB in Vitoria.
C1 [Martins Sales, Carolina Maia; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
   [Martins Sales, Carolina Maia; Bertolde, Adelmo Inacio; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Sanchez, Mauro Niskier] Univ Brasilia, Dept Saude Colet, Brasilia, DF, Brazil.
   [Ramalho, Walter] Univ Brasilia, Campus Ceilandia, Brasilia, DF, Brazil.
   [Bertolde, Adelmo Inacio] Univ Fed Espirito Santo, Dept Estat, Vitoria, ES, Brazil.
RP Sales, CMM (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.; Sales, CMM (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
EM carolina.sales@outlook.com
RI Sanchez, Mauro/AAU-2404-2020; Maciel, Ethel Leonor LN/G-1027-2012
OI Sanchez, Mauro/0000-0002-0472-1804; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Bertolde, Adelmo Inacio/0000-0002-1747-9957
CR Acosta Lisiane Morelia Weide, 2014, Rev. bras. epidemiol., V17, P88, DOI 10.1590/1809-4503201400060008
   Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15
   Vieira RDA, 2008, REV SOC BRAS MED TRO, V41, P82, DOI 10.1590/S0037-86822008000100017
   Ribeiro FKC, 2015, CLIN INFECT DIS, V61, P758, DOI 10.1093/cid/civ365
   da Roza DL, 2012, REV SOC BRAS MED TRO, V45, P607, DOI 10.1590/S0037-86822012000500013
   Brunello MEF, 2011, REV SAUDE PUBL, V45, P556, DOI [10.1590/S0034-89102011005000018, 10.1590/s0034-89102011005000018]
   Gomez-Barroso D, 2015, EUROSURVEILLANCE, V20, P11, DOI 10.2807/1560-7917.ES2015.20.7.21037
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   Hino P, 2011, CIENC SAUDE COLETIVA, V16, P4795, DOI 10.1590/S1413-81232011001300028
   IBGE - Instituto Brasileiro de Geografia e Estatistica, 2010, CID
   Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059
   Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395
   Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
   Ministerio da Saude Saude (MS). Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2014, PAN TUB BRAS IND EP
   Mota Fábio Frias, 2003, Cad. Saúde Pública, V19, P915, DOI 10.1590/S0102-311X2003000400014
   Pang PTT, 2010, INT J TUBERC LUNG D, V14, P585
   Pinheiro RS, 2013, REV PANAM SALUD PUBL, V34, P446
   Reis-Santos B, 2013, J BRAS PNEUMOL, V39, P585, DOI 10.1590/S1806-37132013000500009
   Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427
   Silva VD, 2008, CAD SAUDE PUBLICA, V24, P1013, DOI 10.1590/S0102-311X2008000500008
   Souza Fabiana Barbosa Assumpção de, 2007, J. bras. pneumol., V33, P318, DOI 10.1590/S1806-37132007000300014
   Souza W V, 2000, Rev Panam Salud Publica, V8, P403, DOI 10.1590/S1020-49892000001100005
   Souza WV, 2005, REV SAUDE PUBL, V39, P82, DOI [10.1590/S0034-89102005000100011, 10.1590/s0034-89102005000100011]
   Santos MDSG, 2007, REV LAT-AM ENFERM, V15, P762, DOI 10.1590/S0104-11692007000700008
   WHO, 2017, GLOB TUB CONTR WHO R
NR 26
TC 0
Z9 0
U1 0
U2 4
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2018
VL 51
IS 5
BP 638
EP 643
DI 10.1590/0037-8682-0015-2018
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GW0WU
UT WOS:000446591400012
PM 30304270
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Boccia, D
   Rudgard, W
   Shrestha, S
   Lonnroth, K
   Eckhoff, P
   Golub, J
   Sanchez, M
   Maciel, E
   Rasella, D
   Shete, P
   Pedrazzoli, D
   Houben, R
   Chang, S
   Dowdy, D
AF Boccia, D.
   Rudgard, W.
   Shrestha, S.
   Loennroth, K.
   Eckhoff, P.
   Golub, J.
   Sanchez, M.
   Maciel, E.
   Rasella, D.
   Shete, P.
   Pedrazzoli, D.
   Houben, R.
   Chang, S.
   Dowdy, D.
TI Modelling the impact of social protection on tuberculosis: the S-PROTECT
   project
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Evaluation; Cash transfers; Tuberculosis; Control; Brazil
ID CASH TRANSFER PROGRAMS; END TB STRATEGY; PULMONARY TUBERCULOSIS;
   LIFE-COURSE; HEALTH; EPIDEMIOLOGY; DISEASE; BRAZIL; HETEROGENEITY;
   DETERMINANTS
AB Background: Tackling the social determinants of Tuberculosis (TB) through social protection is a key element of the post-2015 End TB Strategy. However, evidence informing policies are still scarce. Mathematical modelling has the potential to contribute to fill this knowledge gap, but existing models are inadequate. The S-PROTECT consortium aimed to develop an innovative mathematical modelling approach to better understand the role of social protection to improve TB care, prevention and control.
   Methods: S-PROTECT used a three-steps approach: 1) the development of a conceptual framework; 2) the extraction from this framework of three high-priority mechanistic pathways amenable for modelling; 3) the development of a revised version of a standard TB transmission model able to capture the structure of these pathways. As a test case we used the Bolsa Familia Programme (BFP), the Brazilian conditional cash transfer scheme.
   Results: Assessing one of these pathways, we estimated that BFP can reduce TB prevalence by 4% by improving households income and thus their nutritional status. When looking at the direct impact via malnutrition (not income mediated) the impact was 33%. This variation was due to limited data availability, uncertainties on data transformation and the pathway approach taken. These results are preliminary and only aim to serve as illustrative example of the methodological challenges encountered in this first modelling attempt nonetheless they suggest the potential added value of integrating TB standard of care with social protection strategies.
   Conclusions: Results are to be confirmed with further analysis. However, by developing a generalizable modelling framework, S-PROTECT proved that the modelling of social protection is complex, but doable and allowed to draw the research road map for the future in this field.
C1 [Boccia, D.; Rudgard, W.; Pedrazzoli, D.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Shrestha, S.; Dowdy, D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Loennroth, K.] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   [Eckhoff, P.; Chang, S.] Inst Dis Modeling, Bellevue, WA USA.
   [Golub, J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Med Epidemiol & Int Hlth, Baltimore, MD USA.
   [Sanchez, M.] Fed Univ Brasilia, Brasilia, DF, Brazil.
   [Maciel, E.] Univ Fed Espirito Santo, Maruipe, Vitoria, Brazil.
   [Rasella, D.] Fiocruz MS, Oswaldo Cruz Fdn, Brasilia, DF, Brazil.
   [Shete, P.] WHO, Global TB Programme, Geneva, Switzerland.
   [Shete, P.] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.
   [Houben, R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, TB Ctr, TB Modelling Grp, London, England.
   [Houben, R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, CMMID, London, England.
RP Boccia, D (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
EM Delia.Boccia@lshtm.ac.uk
RI Rasella, Davide/ABG-4182-2020; Sanchez, Mauro/AAU-2404-2020; Maciel,
   Ethel Leonor LN/G-1027-2012; Lonnroth, Knut/H-5470-2017; Shrestha,
   Sourya/P-6540-2016
OI Rasella, Davide/0000-0002-7260-4386; Sanchez, Mauro/0000-0002-0472-1804;
   Maciel, Ethel Leonor LN/0000-0003-4826-3355; Lonnroth,
   Knut/0000-0001-6944-0256; rudgard, william/0000-0002-7301-5217;
   Shrestha, Sourya/0000-0002-6106-6834; Pedrazzoli,
   Debora/0000-0002-6434-4457
FU TB Modelling and Analysis Consortium (Bill and Melinda Gates Foundation)
   [OPP1084276]; Wellcome TrustWellcome Trust [104473/7/14/Z]
FX This work was funded by the TB Modelling and Analysis Consortium (Bill
   and Melinda Gates Foundation, OPP1084276. Delia Boccia was funded by the
   Wellcome Trust (104473/7/14/Z).
CR Andrews JR, 2015, INT J TUBERC LUNG D, V19, P375, DOI 10.5588/ijtld.14.0423
   Attanasio O, 2012, ECON J, V122, P92, DOI 10.1111/j.1468-0297.2011.02473.x
   Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285
   Bernabe-Ortiz A, 2008, REV CHIL INFECTOL, V25, P104, DOI [10.4067/S0716-10182008000200002, /S0716-10182008000300002]
   Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722
   Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438
   Boccia D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1529-8
   de Almeida CPB, 2015, CAD SAUDE PUBLICA, V31, P321, DOI 10.1590/0102-311X00195413
   Ciobanu A, 2014, PUBLIC HEALTH ACTION, V4, pS59, DOI 10.5588/pha.14.0047
   Colchero MA, 2012, SOC SCI MED, V75, P120, DOI 10.1016/j.socscimed.2012.01.010
   Devereux S., 2004, 232 IDS U SUSS
   Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109
   Dye C, 2013, NATURE, V502, pS13, DOI 10.1038/502S13a
   Falagas ME, 2010, INT J TUBERC LUNG D, V14, P141
   Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026
   Hoa NB, 2010, INT J TUBERC LUNG D, V14, P1303
   Honorati M., 2015, STATE SOCIAL SAFETY
   Huynh GH, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0341-4
   Kabeer N, 2015, J DEV EFFECT, V7, P290, DOI 10.1080/19439342.2015.1068833
   Kapata N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146392
   Kritchevsky SB, 2016, INT J EPIDEMIOL, V45, P1036, DOI 10.1093/ije/dyw155
   Lonnroth K, 2016, T ROY SOC TROP MED H, V110, P148, DOI 10.1093/trstmh/trv108
   Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1403
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395
   Murray M, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P64, DOI 10.5588/ijtld.10.0535
   Oxlade O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128187
   Perova E, 2012, REV ECON, V35, P53
   Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498
   Reeves A, 2014, LANCET INFECT DIS, V14, P1105, DOI 10.1016/S1473-3099(14)70927-2
   Siroka A, 2015, LANCET INFECT DIS
   Soares TS, 2012, 89 INT POL CTR INCL
   Solar O, 2010, 2 WHO SOC DET HLTH
   Sripad A, 2014, INT J TUBERC LUNG D, V18, P44, DOI 10.5588/ijtld.13.0253
   Torrens AW, 2016, T ROY SOC TROP MED H, V110, P199, DOI 10.1093/trstmh/trw011
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247
   Ward J, 2015, CAD SAUDE PUBLICA, V31, pS182, DOI 10.1590/0102-311X00126914
   Wingfield T, 2015, 46 UN WORLD C LUNG H
   Wingfield T, 2016, EUR RESPIR J, V48, P1396, DOI 10.1183/13993003.00066-2016
NR 42
TC 5
Z9 5
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUN 26
PY 2018
VL 18
AR 786
DI 10.1186/s12889-018-5539-x
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GL0BT
UT WOS:000436628400002
PM 29940906
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-15
ER

PT J
AU Maciel, EL
   Braga, JU
   Bertolde, AI
   Zandonade, E
AF Maciel, Ethel Leonor
   Braga, Jose Ueleres
   Bertolde, Adelmo Inacio
   Zandonade, Eliana
TI Reflections upon the article "Evaluation of the impact that the changes
   in tuberculosis treatment implemented in Brazil in 2009 have had on
   disease control in the country"
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA English
DT Letter
ID TIME-SERIES ANALYSIS
C1 [Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Dept Epidemiol & Metodos Quantitat, Rio De Janeiro, RJ, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, RJ, Brazil.
   [Bertolde, Adelmo Inacio; Zandonade, Eliana] Univ Fed Espirito Santo, Dept Estat, Vitoria, ES, Brazil.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Zandonade,
   Eliana/0000-0001-5160-3280; Barreto Conte, Marcus/0000-0002-7249-4455
CR Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098
   Braga JU, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0820-4
   Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766
   Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208
   Maciel EL, 2015, REV PANAM SALUD PUBL, V38, P28
   Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002
   Rabahi MF, 2017, J BRAS PNEUMOL, V43, P437, DOI [10.1590/S1806-37562017000000004, 10.1590/s1806-37562017000000004]
NR 7
TC 2
Z9 2
U1 1
U2 1
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD MAY-JUN
PY 2018
VL 44
IS 3
BP 249
EP 250
DI 10.1590/S1806-37562018000000096
PG 2
WC Respiratory System
SC Respiratory System
GA GJ7QC
UT WOS:000435582000021
PM 30043894
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Fregonese, F
   Ahuja, SD
   Akkerman, OW
   Arakaki-Sanchez, D
   Ayakaka, I
   Baghaei, P
   Bang, DD
   Bastos, M
   Benedetti, A
   Bonnet, M
   Cattamanchi, A
   Cegielski, P
   Chien, JY
   Cox, H
   Dedicoat, M
   Erkens, C
   Escalante, P
   Falzon, D
   Garcia-Prats, AJ
   Gegia, M
   Gillespie, SH
   Glynn, JR
   Goldberg, S
   Griffith, D
   Jacobson, KR
   Johnston, JC
   Jones-Lopez, EC
   Khan, A
   Koh, WJ
   Kritski, A
   Lan, ZY
   Lee, JH
   Li, PZ
   Maciel, EL
   Galliez, RM
   Merle, CSC
   Munang, M
   Narendran, G
   Nguyen, VN
   Nunn, A
   Ohkado, A
   Park, JS
   Phillips, PPJ
   Ponnuraja, C
   Reves, R
   Romanowski, K
   Seung, K
   Schaaf, HS
   Skrahina, A
   van Soolingen, D
   Tabarsi, P
   Trajman, A
   Trieu, L
   Banurekha, VV
   Viiklepp, P
   Wang, JY
   Yoshiyama, T
   Menzies, D
AF Fregonese, Federica
   Ahuja, Shama D.
   Akkerman, Onno W.
   Arakaki-Sanchez, Denise
   Ayakaka, Irene
   Baghaei, Parvaneh
   Bang, Didi
   Bastos, Mayara
   Benedetti, Andrea
   Bonnet, Maryline
   Cattamanchi, Adithya
   Cegielski, Peter
   Chien, Jung-Yien
   Cox, Helen
   Dedicoat, Martin
   Erkens, Connie
   Escalante, Patricio
   Falzon, Dennis
   Garcia-Prats, Anthony J.
   Gegia, Medea
   Gillespie, Stephen H.
   Glynn, Judith R.
   Goldberg, Stefan
   Griffith, David
   Jacobson, Karen R.
   Johnston, James C.
   Jones-Lopez, Edward C.
   Khan, Awal
   Koh, Won-Jung
   Kritski, Afranio
   Lan, Zhi Yi
   Lee, Jae Ho
   Li, Pei Zhi
   Maciel, Ethel L.
   Galliez, Rafael Mello
   Merle, Corinne S. C.
   Munang, Melinda
   Narendran, Gopalan
   Viet Nhung Nguyen
   Nunn, Andrew
   Ohkado, Akihiro
   Park, Jong Sun
   Phillips, Patrick P. J.
   Ponnuraja, Chinnaiyan
   Reves, Randall
   Romanowski, Kamila
   Seung, Kwonjune
   Schaaf, H. Simon
   Skrahina, Alena
   van Soolingen, Dick
   Tabarsi, Payam
   Trajman, Anete
   Trieu, Lisa
   Banurekha, Velayutham V.
   Viiklepp, Piret
   Wang, Jann-Yuan
   Yoshiyama, Takashi
   Menzies, Dick
TI Comparison of different treatments for isoniazid-resistant tuberculosis:
   an individual patient data meta-analysis
SO LANCET RESPIRATORY MEDICINE
LA English
DT Article
ID TREATMENT OUTCOMES; DRUG-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS;
   REGIMEN; EFFICACY; RELAPSE; RETREATMENT; MUTATIONS; FAILURE; SAFETY
AB Background Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most common form of drug resistance, and is associated with failure, relapse, and acquired rifampicin resistance if treated with first-line anti-tuberculosis drugs. The aim of the study was to compare success, mortality, and acquired rifampicin resistance in patients with INH-R pulmonary tuberculosis given different durations of rifampicin, ethambutol, and pyrazinamide (REZ); a fluoroquinolone plus 6 months or more of REZ; and streptomycin plus a core regimen of REZ.
   Methods Studies with regimens and outcomes known for individual patients with INH-R tuberculosis were eligible, irrespective of the number of patients if randomised trials, or with at least 20 participants if a cohort study. Studies were identified from two relevant systematic reviews, an updated search of one of the systematic reviews (for papers published between April 1, 2015, and Feb 10, 2016), and personal communications. Individual patient data were obtained from authors of eligible studies. The individual patient data meta-analysis was performed with propensity score matched logistic regression to estimate adjusted odds ratios (aOR) and risk differences of treatment success (cure or treatment completion), death during treatment, and acquired rifampicin resistance. Outcomes were measured across different treatment regimens to assess the effects of: different durations of REZ (<= 6 months vs >6 months); addition of a fluoroquinolone to REZ (fluoroquinolone plus 6 months or more of REZ vs 6 months or more of REZ); and addition of streptomycin to REZ (streptomycin plus 6 months of rifampicin and ethambutol and 1-3 months of pyrazinamide vs 6 months or more of REZ). The overall quality of the evidence was assessed using GRADE methodology.
   Findings Individual patient data were requested for 57 cohort studies and 17 randomised trials including 8089 patients with INH-R tuberculosis. We received 33 datasets with 6424 patients, of which 3923 patients in 23 studies received regimens related to the study objectives. Compared with a daily regimen of 6 months of (H) REZ (REZ with or without isoniazid), extending the duration to 8-9 months had similar outcomes; as such, 6 months or more of (H) REZ was used for subsequent comparisons. Addition of a fluoroquinolone to 6 months or more of (H) REZ was associated with significantly greater treatment success (aOR 2.8, 95% CI 1.1-7.3), but no significant effect on mortality (aOR 0.7, 0.4-1.1) or acquired rifampicin resistance (aOR 0.1, 0.0-1.2). Compared with 6 months or more of (H) REZ, the standardised retreatment regimen (2 months of streptomycin, 3 months of pyrazinamide, and 8 months of isoniazid, rifampicin, and ethambutol) was associated with significantly worse treatment success (aOR 0.4, 0.2-0.7). The quality of the evidence was very low for all outcomes and treatment regimens assessed, owing to the observational nature of most of the data, the diverse settings, and the imprecision of estimates.
   Interpretation In patients with INH-R tuberculosis, compared with treatment with at least 6 months of daily REZ, addition of a fluoroquinolone was associated with better treatment success, whereas addition of streptomycin was associated with less treatment success; however, the quality of the evidence was very low. These results support the conduct of randomised trials to identify the optimum regimen for this important and common form of drug-resistant tuberculosis. (C) 2016. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved.
C1 [Fregonese, Federica; Benedetti, Andrea; Lan, Zhi Yi; Li, Pei Zhi; Trajman, Anete; Menzies, Dick] McGill Univ, Ctr Hlth, Res Inst, Montreal Chest Inst, Montreal, PQ, Canada.
   [Benedetti, Andrea; Lan, Zhi Yi] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.
   [Ahuja, Shama D.; Trieu, Lisa] New York City Dept Hlth & Mental Hyg, Bur TB Control, New York City Dept Hlth, Queens, NY USA.
   [Akkerman, Onno W.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands.
   [Arakaki-Sanchez, Denise] Natl TB Control Program, Brasilia, DF, Brazil.
   [Ayakaka, Irene] Uganda TB Res Consortium, Kampala, Uganda.
   [Baghaei, Parvaneh; Tabarsi, Payam] Shahid Beheshti Univ Med Sci, NRITLD, Clin TB & Epidemiol Res Ctr, Tehran, Iran.
   [Bang, Didi] Statens Serum Inst, Copenhagen, Denmark.
   [Bastos, Mayara; Trajman, Anete] Univ Rio De Janeiro, Social Med Inst, Epidemiol Dept, BR-21941 Rio De Janeiro, Brazil.
   [Bonnet, Maryline] Univ Montpellier, INSERM, Inst Rech Dev, UM233,U1175, Montpellier, France.
   [Bonnet, Maryline] Epicentre MSF, Paris, France.
   [Cattamanchi, Adithya] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.
   [Cattamanchi, Adithya] Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94143 USA.
   [Phillips, Patrick P. J.] Univ Calif San Francisco, Div Pulm & Crit Med, San Francisco, CA 94143 USA.
   [Cegielski, Peter] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Atlanta, GA USA.
   [Goldberg, Stefan; Khan, Awal] Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA USA.
   [Chien, Jung-Yien; Wang, Jann-Yuan] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.
   [Cox, Helen] Univ Cape Town, Div Med Microbiol, Cape Town, South Africa.
   [Cox, Helen] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa.
   [Dedicoat, Martin; Munang, Melinda] Heart England NHS Fdn Trust, Birmingham, W Midlands, England.
   [Erkens, Connie] KNCV TB Fdn, Team Netherlands & Eliminat, The Hague, Netherlands.
   [Escalante, Patricio] Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN USA.
   [Escalante, Patricio] Mayo Clin, Mayo Clin Ctr TB, Rochester, MN USA.
   [Falzon, Dennis; Gegia, Medea] WHO, Global TB Programme, Geneva, Switzerland.
   [Merle, Corinne S. C.] WHO, Special Programme Res & Training Trop Dis, Geneva, Switzerland.
   [Garcia-Prats, Anthony J.; Schaaf, H. Simon] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa.
   [Gillespie, Stephen H.] Univ St Andrews North Haugh, Sch Med, St Andrews, Fife, Scotland.
   [Glynn, Judith R.; Merle, Corinne S. C.; Nunn, Andrew] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Griffith, David] Univ Texas Hlth Ctr Tyler, Tyler, TX USA.
   [Jacobson, Karen R.; Jones-Lopez, Edward C.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA.
   [Jacobson, Karen R.; Jones-Lopez, Edward C.] Boston Med Ctr, Boston, MA USA.
   [Johnston, James C.] Univ British Columbia, Dept Med, Vancouver, BC, Canada.
   [Johnston, James C.; Romanowski, Kamila] British Columbia Ctr Dis Control, Vancouver, BC, Canada.
   [Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea.
   [Kritski, Afranio] Univ Fed Rio de Janeiro, Sch Med, Acad TB Program, Rio De Janeiro, Brazil.
   [Galliez, Rafael Mello] Univ Fed Rio de Janeiro, Fac Med, Ctr Res & TB, State Inst Infectol Sao Sebastiao, Rio De Janeiro, Brazil.
   [Lee, Jae Ho; Park, Jong Sun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea.
   [Maciel, Ethel L.] Univ Fed Espirito Santo, Lab Epidemiol, Espirito Santo, Brazil.
   [Narendran, Gopalan; Banurekha, Velayutham V.] Natl Inst Res TB, Dept Clin Res, Madras, Tamil Nadu, India.
   [Viet Nhung Nguyen] Natl Lung Hosp, Hanoi, Vietnam.
   [Viet Nhung Nguyen] Hanoi Med Univ, Hanoi, Vietnam.
   [Ohkado, Akihiro] Japan AntiTB Assoc, Res Inst TB, Dept Epidemiol & Clin Res, Tokyo, Japan.
   [Ohkado, Akihiro] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan.
   [Ponnuraja, Chinnaiyan] Natl Inst Res TB, Chetpet, India.
   [Reves, Randall] Denver Publ Hlth Dept, Denver, CO USA.
   [Seung, Kwonjune] Partners Hlth, Boston, MA USA.
   [Skrahina, Alena] Minist Hlth, Republican Sci & Pract Ctr Pulmonol & TB, Minsk, BELARUS.
   [van Soolingen, Dick] Natl Inst Publ Hlth & Environm, TB Reference Lab, Bilthoven, Netherlands.
   [Viiklepp, Piret] Natl Inst Hlth Dev, Estonian TB Registry, Tallinn, Estonia.
   [Yoshiyama, Takashi] Res Inst TB, Tokyo, Japan.
RP Menzies, D (corresponding author), McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ H4A 3S5, Canada.
EM dick.menzies@mcgill.ca
RI Galliez, Rafael Mello/AAA-2724-2020; Trajman, Anete/C-7679-2016; Maciel,
   Ethel Leonor LN/G-1027-2012; Kritski, Afranio/I-6760-2016; Koh,
   Won-Jung/D-9586-2018; Koh, Won Jung/C-9595-2011; Garcia-Prats,
   Anthony/AAS-6597-2020; Phillips, Patrick/B-6347-2008
OI Galliez, Rafael Mello/0000-0003-0348-8374; Trajman,
   Anete/0000-0002-4000-4984; Maciel, Ethel Leonor LN/0000-0003-4826-3355;
   Koh, Won-Jung/0000-0002-4756-3527; Schaaf, Hendrik
   Simon/0000-0001-5755-4133; Gillespie, Stephen/0000-0001-6537-7712;
   CHIEN, JUNG-YIEN/0000-0002-7718-0594; Phillips,
   Patrick/0000-0002-6336-7024; baghaei shiva,
   parvaneh/0000-0002-6361-315X; Jones Lopez, Edward/0000-0001-6323-286X;
   Akkerman, Onno/0000-0001-5638-9260; WANG, JANN-YUAN/0000-0003-3406-366X;
   Jacobson, Karen/0000-0003-4239-3685
FU World Health OrganizationWorld Health Organization; Canadian Institutes
   of Health ResearchCanadian Institutes of Health Research (CIHR)
FX World Health Organization and Canadian Institutes of Health Research.
CR Andres S, 2014, ANTIMICROB AGENTS CH, V58, P590, DOI 10.1128/AAC.01752-13
   [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603
   [Anonymous], 1997, Int J Tuberc Lung Dis, V1, P509
   [Anonymous], 2018, DRUG RES TB GLOB SIT
   Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480
   Bang D, 2010, J INFECTION, V60, P452, DOI 10.1016/j.jinf.2010.03.017
   Bastos ML, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00803-2016
   Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023081
   Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689
   Chen B, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0630-4
   Chien JY, 2015, CLIN MICROBIOL INFEC, V21, P59, DOI 10.1016/j.cmi.2014.08.008
   Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384
   Escalante P, 2013, INT J TUBERC LUNG D, V17, P644, DOI 10.5588/ijtld.12.0380
   Escalante P, 2001, CHEST, V119, P1730, DOI 10.1378/chest.119.6.1730
   Falzon D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02308-2016
   Garcia-Prats AJ, 2016, INT J TUBERC LUNG D, V20, P1469, DOI 10.5588/ijtld.16.0293
   Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637
   Gegia M, 2017, LANCET INFECT DIS, V17, P223, DOI 10.1016/S1473-3099(16)30407-8
   Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426
   Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Huyen MNT, 2013, ANTIMICROB AGENTS CH, V57, P3620, DOI 10.1128/AAC.00077-13
   Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406
   Jones-Lopez EC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000427
   Kim YH, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-6
   Lee H, 2016, ANTIMICROB AGENTS CH, V60, P471, DOI 10.1128/AAC.01377-15
   Menzies D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000150
   Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817
   Munang ML, 2015, QJM-INT J MED, V108, P19, DOI 10.1093/qjmed/hcu139
   Ohkado A, 2006, INT J TUBERC LUNG D, V10, P283
   Park JS, 2016, ANTIMICROB AGENTS CH, V60, P92, DOI 10.1128/AAC.00693-15
   Public Health Agency of Canada, 2014, CANADIAN TUBERCULOSI
   Quy HT, 2006, INT J TUBERC LUNG D, V10, P45
   Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631
   Rekha VVB, 2012, NATL MED J INDIA, V25, P196
   Reves R, 2014, INT J TUBERC LUNG D, V18, P571, DOI 10.5588/ijtld.13.0304
   Romanowski K, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2706-0
   Swaminathan S, 2011, CLIN INFECT DIS, V53, P716, DOI 10.1093/cid/cir447
   Swaminathan S, 2010, AM J RESP CRIT CARE, V181, P743, DOI 10.1164/rccm.200903-0439OC
   Tabarsi P, 2009, East Mediterr Health J, V15, P1346
   Trajman A, 2016, 47 WORLD C LUNG HLTH
   WHO, 2008, MOL LIN PROB ASS RAP
   *WHO IUATLD, 2008, 4 WHO IUATLD
   Winters N, 2015, EUR RESPIR J, V46, P1461, DOI 10.1183/13993003.00649-2015
   World Health Organization, 2011, GUID PROGR MAN DRUG
   World Health Organization, 2017, GLOB TUB REP 2017
   World Health Organization, 2013, DEF REP FRAM TUB 201
   Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC
   Yoshiyama T, 2010, INT J TUBERC LUNG D, V14, P1418
   Yuen CM, 2013, PEDIATR INFECT DIS J, V32, pE217, DOI 10.1097/INF.0b013e3182865409
NR 50
TC 32
Z9 33
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2213-2600
J9 LANCET RESP MED
JI Lancet Resp. Med.
PD APR
PY 2018
VL 6
IS 4
BP 265
EP 275
PG 11
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA GA3LQ
UT WOS:000428231000024
PM 29595509
OA Green Accepted
DA 2020-12-15
ER

PT J
AU Rudgard, WE
   das Chagas, NS
   Gayoso, R
   Barreto, ML
   Boccia, D
   Smeeth, L
   Rodrigues, LC
   Lonnroth, K
   Williamson, E
   Maciel, ELN
AF Rudgard, William E.
   das Chagas, Nancy S.
   Gayoso, Regina
   Barreto, Mauricio L.
   Boccia, Delia
   Smeeth, Liam
   Rodrigues, Laura C.
   Lonnroth, Knut
   Williamson, Elizabeth
   Maciel, Ethel L. N.
TI Uptake of governmental social protection and financial hardship during
   drug-resistant tuberculosis treatment in Rio de Janeiro, Brazil
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Editorial Material
ID COSTS; COUNTRIES; PATIENT
C1 [Rudgard, William E.; Boccia, Delia; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
   [das Chagas, Nancy S.; Gayoso, Regina] Fiocruz MS, Escola Nacl Saude ENSP, Ctr Referencia Helio Fraga, Rio De Janeiro, Brazil.
   [Barreto, Mauricio L.] Univ Fed Bahia UFBA, Inst Saude Coletiva, Salvador, BA, Brazil.
   [Barreto, Mauricio L.; Rodrigues, Laura C.] Fiocruz MS, Inst Goncalo Moniz IGM, Ctr Integracao Dados & Conhecimentos Saude CIDACS, Salvador, BA, Brazil.
   [Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England.
   [Lonnroth, Knut] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.
   [Williamson, Elizabeth] London Sch Hyg & Trop Med, Dept Med Stat, London, England.
   [Maciel, Ethel L. N.] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, Brazil.
RP Rudgard, WE (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.
EM willrudgard@hotmail.co.uk
RI Barreto, Mauricio L/B-1752-2008; Lonnroth, Knut/H-5470-2017; Maciel,
   Ethel Leonor LN/G-1027-2012; Smeeth, Liam/X-5862-2018
OI Barreto, Mauricio L/0000-0002-0215-4930; Lonnroth,
   Knut/0000-0001-6944-0256; Maciel, Ethel Leonor LN/0000-0003-4826-3355;
   Smeeth, Liam/0000-0002-9168-6022; rudgard, william/0000-0002-7301-5217
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MR/K006584/1]; Wellcome TrustWellcome Trust [098504/Z/12/Z]
FX Funding was received from the Medical Research Council (MR/K006584/1)
   and the Wellcome Trust (098504/Z/12/Z). Funding information for this
   article has been deposited with the Crossref Funder Registry.
CR [Anonymous], 2017, TUB PAT COST SURV HD
   Gazola Hellmann A., 2015, DOES BOLSA FAMILIA W
   Instituto Nacional Do Seguro Social, 2018, AUX DOENC
   International Labour Organization, 2014, TRANS INF FORM EC
   Lonnroth K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001693
   Madan J, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1138-z
   Medeiros M, 2008, TARGETED CASH TRANSF
   Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717
   Ministerio da Saude, SIST INF TRAT ESP TU
   Ministry of Social Development, WORLD POV
   Morris MD, 2013, INT J TUBERC LUNG D, V17, P954, DOI 10.5588/ijtld.12.0480
   Pichenda K, 2012, INT J TUBERC LUNG D, V16, P828, DOI 10.5588/ijtld.11.0688
   Ramma L, 2015, INT J TUBERC LUNG D, V19, P1513, DOI 10.5588/ijtld.15.0341
   Rouzier VA, 2010, INT J TUBERC LUNG D, V14, P1316
   Rudgard WE, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002418
   Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413
   van den Hof S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1802-x
   Wagstaff A, 2018, LANCET GLOB HEALTH, V6, pE192, DOI 10.1016/S2214-109X(17)30429-1
   Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675
   Wolfe R, 2014, WORKSH EXP ACC HLTH
   World Bank, OFF EXCH RAT
   World Bank, 2015, STAT SOC SAF NETS 20
   World Health Organization, 2009, WHO GUID ID EC CONS
   World Health Organization, 2016, END TB STRAT
NR 24
TC 4
Z9 4
U1 0
U2 0
PU EUROPEAN RESPIRATORY SOC JOURNALS LTD
PI SHEFFIELD
PA 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND
SN 0903-1936
EI 1399-3003
J9 EUR RESPIR J
JI Eur. Resp. J.
PD MAR 1
PY 2018
VL 51
IS 3
AR 1800274
DI 10.1183/13993003.00274-2018
PG 5
WC Respiratory System
SC Respiratory System
GA GB9YD
UT WOS:000429430000040
PM 29567727
OA Green Published, Bronze
DA 2020-12-15
ER

PT J
AU Peres, RL
   Vinhas, SA
   Ribeiro, FKC
   Palaci, M
   do Prado, TN
   Reis-Santos, B
   Zandonade, E
   Suffys, PN
   Golub, JE
   Riley, LW
   Maciel, EL
AF Peres, Renata Lyrio
   Vinhas, Solange Alves
   Correa Ribeiro, Fabiola Karla
   Palaci, Moises
   do Prado, Thiago Nascimento
   Reis-Santos, Barbara
   Zandonade, Eliana
   Suffys, Philip Noel
   Golub, Jonathan E.
   Riley, Lee W.
   Maciel, Ethel Leonor
TI Risk factors associated with cluster size of Mycobacterium tuberculosis
   (Mtb) of different RFLP lineages in Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Tuberculosis; Molecular epidemiology; Transmission; Risk factors;
   Cluster size
ID NEW-YORK-CITY; STRAIN DIFFERENTIATION; EPIDEMIOLOGY; DIVERSITY; MARKERS
AB Background: Tuberculosis (TB) transmission is influenced by patient-related risk, environment and bacteriological factors. We determined the risk factors associated with cluster size of IS6110 RFLP based genotypes of Mycobacterium tuberculosis (Mtb) isolates from Vitoria, Espirito Santo, Brazil.
   Methods: Cross-sectional study of new TB cases identified in the metropolitan area of Vitoria, Brazil between 2000 and 2010. Mtb isolates were genotyped by the IS6110 RFLP, spoligotyping and RDRio. The isolates were classified according to genotype cluster sizes by three genotyping methods and associated patient epidemiologic characteristics. Regression Model was performed to identify factors associated with cluster size.
   Results: Among 959 Mtb isolates, 461 (48%) cases had an isolate that belonged to an RFLP cluster, and six clusters with ten or more isolates were identified. Of the isolates spoligotyped, 448 (52%) were classified as LAM and 412 (48%) as non-LAM. Our regression model found that 6-9 isolates/RFLP cluster were more likely belong to the LAM family, having the RDRio genotype and to be smear-positive (adjusted OR = 1.17, 95% CI 1.08-1.26; adjusted OR = 1. 25, 95% CI 1.14-1.37; crude OR = 2.68, 95% IC 1.13-6.34; respectively) and living in a Serra city neighborhood decrease the risk of being in the 6-9 isolates/RFLP cluster (adjusted OR = 0.29, 95% CI, 0.10-0.84), than in the others groups. Individuals aged 21 to 30, 31 to 40 and > 50 years were less likely of belonging the 2-5 isolates/RFLP cluster than unique patterns compared to individuals < 20 years of age (adjusted OR = 0.49, 95% CI 0.28-0.85, OR = 0.43 95% CI 0. 24-0.77 and OR = 0. 49, 95% CI 0.26-0.91), respectively. The extrapulmonary disease was less likely to occur in those infected with strains in the 2-5 isolates/cluster group (adjustment OR = 0.45, 95% CI 0.24-0.85) than unique patterns.
   Conclusions: We found that a large proportion of new TB infections in Vitoria is caused by prevalent Mtb genotypes belonging to the LAM family and RDRio genotypes. Such information demonstrates that some genotypes are more likely to cause recent transmission. Targeting interventions such as screening in specific areas and social risk groups, should be a priority for reducing transmission.
C1 [Peres, Renata Lyrio; Vinhas, Solange Alves; Correa Ribeiro, Fabiola Karla; Palaci, Moises] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
   [Peres, Renata Lyrio; do Prado, Thiago Nascimento; Reis-Santos, Barbara; Zandonade, Eliana; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Av Marechal Campos 1468 Maruipe, Vitoria, ES, Brazil.
   [Reis-Santos, Barbara] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, Brazil.
   [Suffys, Philip Noel] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Aplicada Micobacterias, Rio De Janeiro, Brazil.
   [Golub, Jonathan E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Av Marechal Campos 1468 Maruipe, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; suffys, philip/E-3009-2013;
   Reis-Santos, Barbara/A-3149-2014
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos,
   Barbara/0000-0001-6952-0352
FU Conselho Nacional de Desenvolvimento Cientifico and Tecnologico-CNPq by
   Edital MCT/CNPq/MS-SCTIE-DECITNational Council for Scientific and
   Technological Development (CNPq) [25/2006]; National Institutes of
   Health on the ICOHRTA grantUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5 U2R TW006883-02];
   CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)CAPES
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico and Tecnologico-CNPq by Edital MCT/CNPq/MS-SCTIE-DECIT No
   25/2006 - Doencas negligenciadas, National Institutes of Health on the
   ICOHRTA grant # 5 U2R TW006883-02 and CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior).
CR ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403
   Baptista IMFD, 2002, MEM I OSWALDO CRUZ, V97, P1147, DOI 10.1590/S0074-02762002000800015
   Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23
   Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004
   Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005
   Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004
   Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07
   Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027
   Gomes T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074517
   Houben RMGJ, 2009, TROP MED INT HEALTH, V14, P892, DOI 10.1111/j.1365-3156.2009.02316.x
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997
   Maciel EL, 2015, REV PANAM SALUD PUBL, V38, P28
   Malhao TA, 2010, EPIDEMIOL SERV SAUDE, V19, P245
   Ministerio da Saude, 2016, INF SAUD TABNET
   Ministerio da Saude (BR), 2016, B EPIDEMIOL, V47, P1
   Moreira Cláudia Maria Marques, 2008, J. bras. pneumol., V34, P225, DOI 10.1590/S1806-37132008000400007
   Nebenzahl-Guimaraes H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097816
   Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08
   Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07
   Perdigao J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42814
   Rhee JT, 2000, INT J TUBERC LUNG D, V4, P1111
   Ribeiro FK, 2015, CLIN INFECT DIS, V5
   SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402
   Suffys PN, 2000, RES MICROBIOL, V151, P343, DOI 10.1016/S0923-2508(00)00157-1
   Teeter LD, 2013, TUBERCULOSIS, V93, pS38, DOI 10.1016/S1472-9792(13)70009-X
   van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930
   VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993
   VANSOOLINGEN D, 1995, EUR RESPIR J, V8, pS649
   VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993
   Varma-Basil M, 2011, MEM I OSWALDO CRUZ, V106, P524, DOI 10.1590/S0074-02762011000500002
   Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747
   Verhagen LM, 2011, J INFECT DIS, V203, P1249, DOI 10.1093/infdis/jir013
   Vinhas SA, 2013, TUBERCULOSIS, V93, P207, DOI 10.1016/j.tube.2012.09.001
   Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003
   Weisenberg SA, 2012, INFECT GENET EVOL, V12, P664, DOI 10.1016/j.meegid.2011.07.018
   World Health Organization, 2016, GLOB TUB REP 2016
NR 36
TC 5
Z9 5
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 8
PY 2018
VL 18
AR 71
DI 10.1186/s12879-018-2969-0
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA FW2RF
UT WOS:000425151300001
PM 29422032
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Maciel, EL
   do Prado, TN
   Andrade, KB
   Golub, JE
AF Maciel, Ethel L.
   do Prado, Thiago N.
   Andrade, Kleydson Bonfim
   Golub, Jonathan E.
TI Is it time for Brazil to prioritize TB preventive therapy for all people
   living with HIV?
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
ID RIO-DE-JANEIRO; TUBERCULOSIS INFECTION; LATENT TUBERCULOSIS; RIFAPENTINE
C1 [Maciel, Ethel L.; do Prado, Thiago N.] Univ Fed Espirito Santo, Lab Epidemiol Lab Epi, Vitoria, ES, Brazil.
   [Andrade, Kleydson Bonfim] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, SP, Brazil.
   [Golub, Jonathan E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol Lab Epi, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR Coordenacao Geral do Programa Nacional de Controle da Tuberculose Secretaria de Vigilancia em Saude Departamento de Vigilancia das Doencas Transmissiveis Ministerio da Saude, 25CGPNCTDEVITSVSMS
   Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7
   Golub JE, 2015, CLIN INFECT DIS, V60, P639, DOI 10.1093/cid/ciu849
   Ministerio da Saude (BR), 2015, MAN INF PEL HIV AT B
   Ministerio da Saude (BR), 2011, MAN REC CONTR TUB BR
   Saraceni V, 2011, BRAZ J INFECT DIS, V15, P249, DOI [10.1590/S1413-86702011000300012, 10.1016/S1413-8670(11)70184-2]
   Schechter M, 2006, AM J RESP CRIT CARE, V173, P922, DOI 10.1164/rccm.200512-1953OC
   Sterling TR, 2016, AIDS, V30, P1607, DOI 10.1097/QAD.0000000000001098
   Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JAN-FEB
PY 2018
VL 22
IS 1
BP 74
EP 75
DI 10.1016/j.bjid.2017.10.001
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA GG4ET
UT WOS:000432647100014
PM 29121486
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Kritski, A
   Andrade, KB
   Galliez, RM
   Maciel, ELN
   Cordeiro-Santos, M
   Miranda, SS
   Villa, TS
   Netto, AR
   Arakaki-Sanchez, D
   Croda, J
AF Kritski, Afranio
   Andrade, Kleydson Bonfim
   Galliez, Rafael Mello
   Noia Maciel, Ethel Leonor
   Cordeiro-Santos, Marcelo
   Miranda, Silvana Spindola
   Villa, Teresa Scatena
   Netto, Antonio Ruffino
   Arakaki-Sanchez, Denise
   Croda, Julio
TI Tuberculosis: renewed challenge in Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Research; Tuberculosis; Strategy; Diagnosis; Prevention; Treatment
ID RIO-DE-JANEIRO; CASH TRANSFER PROGRAM; END-TB-STRATEGY; XPERT MTB/RIF;
   DIAGNOSTIC ALGORITHMS; RANDOMIZED TRIAL; ROLL-OUT; CARE; IMPLEMENTATION;
   FEASIBILITY
AB This article reviews tuberculosis control actions performed over the last decade, at a global level. The perspectives for the fulfillment of the goals of the new Global Tuberculosis Elimination Plan are described, where the insertion of social protection (Pillar 2) and research (Pillar 3) will play an innovative and strategic role, especially in high-burden countries, like Brazil.
C1 [Kritski, Afranio; Galliez, Rafael Mello; Noia Maciel, Ethel Leonor; Cordeiro-Santos, Marcelo; Miranda, Silvana Spindola; Villa, Teresa Scatena; Netto, Antonio Ruffino; Croda, Julio] Rede Brasileira Pesquisa TB, Rede TB, Rio De Janeiro, Brazil.
   [Kritski, Afranio] Univ Fed Rio de Janeiro, Fac Med, Programa Acad TB, Rio De Janeiro, RJ, Brazil.
   [Andrade, Kleydson Bonfim; Arakaki-Sanchez, Denise] Minist Saude, Programa Nacl Controle TB, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Galliez, Rafael Mello] Secretaria Estadual Saude Estado Rio de Janeiro, Inst Estadual Sao Sebastiao, Rio De Janeiro, RJ, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
   [Cordeiro-Santos, Marcelo] Fdn Med Trop Doutor Heitor Vieira Dourado, Secretaria Estadual Estado Saude Amazonas, Manaus, AM, Brazil.
   [Miranda, Silvana Spindola] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Belo Horizonte, MG, Brazil.
   [Villa, Teresa Scatena] Univ Sao Paulo, Escola Enfermagem Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Netto, Antonio Ruffino] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Croda, Julio] Univ Fed Mato Grosso do Sul, Fundacao Oswaldo Cruz, Fac Med, Campo Grande, MS, Brazil.
RP Kritski, A (corresponding author), Rede Brasileira Pesquisa TB, Rede TB, Rio De Janeiro, Brazil.
EM kritskia@gmail.com
RI Galliez, Rafael Mello/AAA-2724-2020; Croda, Julio/I-5172-2013; Maciel,
   Ethel Leonor LN/G-1027-2012; Kritski, Afranio/I-6760-2016
OI Galliez, Rafael Mello/0000-0003-0348-8374; Croda,
   Julio/0000-0002-6665-6825; Maciel, Ethel Leonor LN/0000-0003-4826-3355; 
FU CNPq/Instituto Nacional Ciencia Tecnologia - Tuberculose-INCT-TB
   [465318/2014-2]
FX This work was funded by CNPq/Instituto Nacional Ciencia Tecnologia -
   Tuberculose-INCT-TB) - Process: 465318/2014-2
CR Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016
   Alsdurf H, 2016, LANCET INFECT DIS, V16, P1269, DOI 10.1016/S1473-3099(16)30216-X
   Arakawa T, 2015, CIENC SAUDE COLETIVA, V20, P3877, DOI 10.1590/1413-812320152012.09382014
   Bartholomay P, 2016, REV PANAM SALUD PUBL, V39, P3
   Bertolli Filho C., 2001, HIST SOCIAL TUBERCUL
   Cavalcante SC, 2010, INT J TUBERC LUNG D, V14, P203
   Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X
   Cox HS, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001760
   Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2
   da Costa PA, 2011, J HOSP INFECT, V77, P178, DOI 10.1016/j.jhin.2010.10.002
   Denicolai S, 2016, TECHNOL FORECAST SOC, V104, P57, DOI 10.1016/j.techfore.2015.11.025
   Donoghue HD, 2008, PALEOMICROBIOLOGY
   Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766
   Golub JE, 2015, CLIN INFECT DIS, V60, P639, DOI 10.1093/cid/ciu849
   Kritski A, 2016, I HIG MED TROP, V15, pS35
   Kritski A, 2016, REV SOC BRAS MED TRO, V49, P135, DOI 10.1590/0037-8682-0330-2015
   Kritski A, 2013, BRAZ J INFECT DIS, V17, P211, DOI 10.1016/j.bjid.2013.01.004
   Langley I, 2015, CLIN INFECT DIS, V61, pS126, DOI 10.1093/cid/civ580
   Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOLOGICO, V48, P1
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2017, BRAS LIVR TUB PLAN N
   Naidoo P, 2016, INT J TUBERC LUNG D, V20, P1377, DOI 10.5588/ijtld.16.0081
   Nery JS, 2017, INT J TUBERC LUNG D, V21, P790, DOI 10.5588/ijtld.16.0599
   Netto Antonio Ruffino, 2004, J. bras. pneumol., V30, P307, DOI 10.1590/S1806-37132004000400002
   Ortblad KF, 2015, LANCET, V386, P2354, DOI 10.1016/S0140-6736(15)00324-4
   Prado JC, 2016, CIENC SAUDE COLETIVA, V21, P1491, DOI 10.1590/1413-81232015215.03912016
   Moreira ADR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127588
   Scatena Lúcia Marina, 2009, Rev. Saúde Pública, V43, P389, DOI [10.1590/S0034-89102009005000022, 10.1590/S0034-89102009000300001]
   Sereno AB, 2012, REV PANAM SALUD PUBL, V32, P451, DOI 10.1590/S1020-49892012001400009
   Squire SB, 2011, INT J TUBERC LUNG D, V15, P862, DOI 10.5588/ijtld.11.0161
   Stop TB Partnership and World Health Organization, 2006, GLOB PLAN STOP TB 20
   Sweetland AC, 2017, INT J TUBERC LUNG D, V21, P852, DOI 10.5588/ijtld.16.0584
   Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5
   Torrens AW, 2016, T ROY SOC TROP MED H, V110, P199, DOI 10.1093/trstmh/trw011
   Trajman A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123252
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   Villa TCS, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-241
   Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X
   WHO, WHOHTMTB201602
   WHO, TB ADDR NEEDS VULN P
   World Health Organization, ENGAGE TB APPR INT C
   World Health Organization, 2015, GLOB ACT FRAM TB RES
   World Health Organization, 2016, GLOB TUB REP 2016
   World Health Organization, 2007, US LIQ TB CULT DRUG
   World Health Organization, 2015, MOV RES FIND NEW WHO
   World Health Organization and Stop TB Partnership, 2011, INT ROADM TUB RES
   Wysocki AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155348
NR 47
TC 7
Z9 7
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2018
VL 51
IS 1
BP 2
EP 6
DI 10.1590/0037-8682-0349-2017
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FY6FP
UT WOS:000426938800002
PM 29513837
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Fontenelle, LF
   de Camargo, MBJ
   Bertoldi, AD
   Goncalves, H
   Maciel, ELN
   Barros, AJD
AF Fontenelle, Leonardo Ferreira
   Junqueira de Camargo, Maria Beatriz
   Bertoldi, Andrea Damaso
   Goncalves, Helen
   Noia Maciel, Ethel Leonor
   Barros, Aluisio J. D.
TI Utilization of basic health units of FHS according to private health
   insurance
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Health Services Needs and Demand; Health Centers; Health Services,
   utilization; Supplemental Health; Health Maintenance Organizations,
   utilization; Equity in the Resource Allocation
ID CARE SERVICES; ACCESS; SYSTEM; PATTERNS
AB OBJECTIVE: To describe the utilization of basic health units according to coverage by discount card or private health insurance.
   METHODS: Household survey in the area covered by Family Health Strategy in Pelotas, state of Rio Grande do Sul, Brazil, from December 2007 to February 2008, with persons of all age groups. The frequency of (medical or non-medical) healthcare seeking at the basic health units in the last six months and the prevalence of basic health unit utilization for the last medical consultation (in case it had been performed up to six months before, for a non-routine reason) were analyzed by Poisson regression adjusted for the sampling design.
   RESULTS: Of the 1,423 persons, 75.6% had no discount card or private health insurance. The average frequency of (medical or non-medical) healthcare seeking was 1.6 times in six months (95%CI 1.3-2.0); this frequency was 55.8% lower (p < 0.001) among privately insured persons compared to those with no discount card or private health insurance. Among the last medical consultations, 35.8% (95%CI 25.4-47.7) had been performed at the basic health units; this prevalence was 36.4% lower (p = 0.003) among persons covered by discount card and 87.7% lower (p = 0.007) among privately insured persons compared to those without both coverages.
   CONCLUSIONS: Private health insurance and, to a lesser degree, discount card coverage, are related to lower utilization of basic health units. This can be used to size the population under the accountability of each Family Health Strategy team, to the extent that community health workers are able to differentiate discount card from PHI during family registration.
C1 [Fontenelle, Leonardo Ferreira; Bertoldi, Andrea Damaso; Goncalves, Helen; Barros, Aluisio J. D.] Univ Fed Pelotas, Fac Med, Programa Posgrad Epidemiol, Pelotas, RS, Brazil.
   [Junqueira de Camargo, Maria Beatriz] Univ Fed Pelotas, Fac Odontol, Dept Odontol Social, Pelotas, RS, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Enfermagem, Vitoria, ES, Brazil.
RP Fontenelle, LF (corresponding author), Rua Marechal Deodoro,1160 3 Piso, BR-96020220 Pelotas, RS, Brazil.
EM leonardof@leonardof.med.br
RI Barros, Aluisio JD/A-7417-2008; Goncalves, Helen/M-1603-2017;
   Fontenelle, Leonardo Ferreira/G-3942-2013; Goncalves, Helen/P-2381-2018;
   Maciel, Ethel Leonor LN/G-1027-2012
OI Barros, Aluisio JD/0000-0002-2022-8729; Goncalves,
   Helen/0000-0001-6470-3352; Fontenelle, Leonardo
   Ferreira/0000-0003-4064-433X; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355
FU MCT/CNPq/MS-SCTIE-DECITNational Council for Scientific and Technological
   Development (CNPq) [26]; FAPERGS/MS/CNPq/SESRS [PPSUS/RS 07/0078.2];
   CAPESCAPES [23/2014]
FX Notice MCT/CNPq/MS-SCTIE-DECIT n. 26, 2006. Notice FAPERGS/MS/CNPq/SESRS
   PPSUS/RS 07/0078.2. Notice CAPES n. 23/2014 (Minter/Dinter).
CR [Anonymous], 2016, B INF UT SIST PUBL B
   Ansah EK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-853
   BARRETO JR I. F., 2008, SAO PAULO PERSPECT, V22, P5
   Barros AJD, 2005, REV SAUDE PUBL, V39, P523, DOI [10.1590/S0034-89102005000400002, 10.1590/s0034-89102005000400002]
   Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298
   Bousquat A, 2012, CIENC SAUDE COLETIVA, V17, P2913, DOI 10.1590/S1413-81232012001100008
   Camargo MBJ, 2009, CAD SAUDE PUBLICA, V25, P1894, DOI 10.1590/S0102-311X2009000900004
   da Silva NN, 2000, REV SAUDE PUBL, V34, P44, DOI 10.1590/S0034-89102000000100009
   Bonello AADM, 2014, CIENC SAUDE COLETIVA, V19, P4397, DOI 10.1590/1413-812320141911.13922013
   Santiago Adriana Xavier de, 2014, Rev. bras. epidemiol., V17, P39, DOI 10.1590/1809-4503201400060004
   Dilelio AS, 2014, CAD SAUDE PUBLICA, V30, P2594, DOI 10.1590/0102-311X00118713
   Farias Luís Otávio, 2003, Ciênc. saúde coletiva, V8, P585, DOI 10.1590/S1413-81232003000200019
   Fernandes LCL, 2009, REV SAUDE PUBL, V43, P595, DOI 10.1590/s0034-89102009005000040
   Fontenelle LF, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00141515, 10.1590/0102-311X00141515]
   Garcia-Subirats I, 2014, GAC SANIT, V28, P480, DOI 10.1016/j.gaceta.2014.05.010
   Kloetzel K, 1998, CAD SAUDE PUBLICA, V14, P263, DOI [DOI 10.1590/S0102-311X1998000300020, 10.1590/S0102-311X1998000300020]
   Mendoza-Sassi R, 2003, REV SAUDE PUBL, V37, P372, DOI 10.1590/s0034-89102003000300017
   Ministerio da Saude (BR), 2012, AG NAC SAUD SUPL GLO
   Oliveira LS, 2012, CIENC SAUDE COLETIVA, V17, P3047, DOI 10.1590/S1413-81232012001100021
   Organisation for Economic Co-operation and Development, 2004, PRIV HLTH INS OECD C
   Pereira RJ, 2010, REV MED MINAS GERAIS, V20, P5
   Ribeiro Manoel Carlos Sampaio de Almeida, 2006, Ciênc. saúde coletiva, V11, P1011, DOI 10.1590/S1413-81232006000400022
   Salvatori Rachel Torres, 2012, Organ. Soc., V19, P471, DOI 10.1590/S1984-92302012000300006
   Santos FP, 2008, CIENCIA SAUDE COLETI, V13, P1463, DOI [10.1590/S1413-81232008000500012, DOI 10.1590/S1413-81232008000500012]
   Santos IS, 2008, CIENC SAUDE COLETIVA, V13, P1431, DOI 10.1590/S1413-81232008000500009
   Silva Zilda Pereira da, 2011, Ciênc. saúde coletiva, V16, P3807, DOI 10.1590/S1413-81232011001000016
   Zils AA, 2009, REV BRAS MED COM, V4, P270, DOI [10.5712/rbmfc4(16)233, DOI 10.5712/RBMFC4(16)233]
NR 27
TC 2
Z9 2
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2018
VL 52
AR 55
DI 10.11606/S1518-8787.2018052000383
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GH2QJ
UT WOS:000433246300001
PM 29791678
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU dos Santos, JN
   Sales, CMM
   do Prado, TN
   Maciel, EL
AF dos Santos, Janine Nascimento
   Martins Sales, Carolina Maia
   do Prado, Thiago Nascimento
   Maciel, Ethel Leonor
TI Factors associated with cure when treating tuberculosis in the state of
   Rio de Janeiro, Brazil, 2011-2014
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA Portuguese
DT Article
DE Tuberculosis; Public Policy; Social Vulnerability; Cross-Sectional
   Studies
AB Objective: to analyze factors associated with cure when treating tuberculosis (TB) in the state of Rio de Janeiro, Brazil, from 2011 to 2014. Methods: this was a cross-sectional study with data from the Notifiable Diseases Information System (SINAN); logistic regression was used for data analysis. Results: of the 57,142 cases reported, 49,691 (86.96%) were included in the study; schooling >= 13 years (odds ratio (OR) 3.48; 95%CI 2.74;4.41) and residing in rural areas (OR 2.27; 95%CI 1.38;3.73) were factors associated with a higher chance of cure; being male (OR 0.71; 95%CI 0.66;0.76) and brown skin color/race (OR 0.73;95% CI 0.68;0.78) stood out as factors associated with less chance of cure. Conclusion: social and economic determinants were identified that influence the treatment outcome, evidencing the need for social support and guaranteed access to health services.
C1 [dos Santos, Janine Nascimento] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, RJ, Brazil.
   [Martins Sales, Carolina Maia; do Prado, Thiago Nascimento; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
RP Maciel, EL (corresponding author), Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR Braga JU, 2012, CAD SAUDE COLET RIO, V20, P225
   Brasil. Ministerio da Saude, 2016, B EPIDEMIOL, V47, P1
   Campani STA, 2011, J BRAS PNEUMOL, V37, P776, DOI 10.1590/S1806-37132011000600011
   Reis Dener Carlos dos, 2013, Rev. bras. epidemiol., V16, P592, DOI 10.1590/S1415-790X2013000300004
   Ferreira Silvana Margarida Benevides, 2005, J. bras. pneumol., V31, P427, DOI 10.1590/S1806-37132005000500011
   Giroti SKO, 2010, COGITARE ENFERM, V15, P271
   Gomes T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074517
   Instituto Brasileiro de Geografia e Estatistica, 2016, SER HIST EST
   LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284
   MACIEL E, 2012, PROMOCAO SAUDE DIVER
   Mascarenhas MDM, 2005, EPIDEMIOL SERV SAUDE, V14, P7
   Ministerio da Saude (BR), 2014, B EPIDEMIOLOGICO, V45, P1
   Nichiata LYI, 2008, REV LAT-AM ENFERM, V16, P923, DOI 10.1590/S0104-11692008000500020
   Oliveira DLLC, 2015, REV GAUCHA ENFERM, V36, P247
   Paixao LMM, 2007, REV SAUDE PUBL, V41
   Palaci M, 2007, J CLIN MICROBIOL
   de Albuquerque MDPM, 2007, CAD SAUDE PUBLICA, V23, P1573, DOI 10.1590/S0102-311X2007000700008
   Pinheiro Rejane Sobrino, 2002, Ciênc. saúde coletiva, V7, P687
   Reis-Santos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062604
   San Pedro A, 2013, REV PANAM SALUD PUBL, V33, P294, DOI 10.1590/S1020-49892013000400009
   Santos HLN, 2014, MARANHAO U FEDERAL M
   Santos TMMG, 2012, REV ENFERM UFPI, V1, P8
   Servico Brasileiro de Apoio a Micro e Pequanas Empresas-Sebrae, 2014, OBSERVAT SEBRAE RJ, V28, P1
   Silva CCAV, 2013, EPIDEMIOL SERV SAUDE, V22, P77, DOI DOI 10.5123/S1679-49742013000100008
   Silva PF, CAD SAUDE PUBLICA
   Silva PD, 2014, CAD SAUDE PUBLICA, V30, P1745, DOI 10.1590/0102-311X00124513
   WHO, 2014, GLOB TUB REP 2014
   Wilbur AK, 2006, MEM I OSWALDO CRUZ, V101, P59, DOI 10.1590/S0074-02762006001000011
NR 28
TC 2
Z9 2
U1 0
U2 0
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2018
VL 27
IS 3
AR UNSP e2017464
DI 10.5123/S1679-49742018000300015
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GZ7NJ
UT WOS:000449667500016
PM 30365701
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Sales, CMM
   Bertolde, AI
   Reis-Santos, B
AF Noia Maciel, Ethel Leonor
   Martins Sales, Carolina Maia
   Bertolde, Adelmo Inacio
   Reis-Santos, Barbara
TI Can Brazil achieve the new World Health Organization global targets for
   tuberculosis control?
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA Portuguese
DT Editorial Material
ID COHORT
C1 [Noia Maciel, Ethel Leonor; Martins Sales, Carolina Maia; Reis-Santos, Barbara] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Bertolde, Adelmo Inacio] Univ Fed Espirito Santo, Dept Estat, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29043260 Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR Braga JU, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0820-4
   Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766
   Gomes MGM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1464-8
   Ministerio da Satide (BR), 2015, PLAN NAC MOB INT AC
   Ministerio da Satude (BR), 1999, COORD SAUD COM
   Reis-Santos B, 2015, INT J TUBERC LUNG D, V19, P1188, DOI 10.5588/ijtld.14.0776
   Reis-Santos B, 2013, PLOS ONE, V8
   Torrens AW, 2016, T ROY SOC TROP MED H, V110, P199, DOI 10.1093/trstmh/trw011
   WHO, 2015, THE END TB STRAT
   World Health Organization, 2013, GLOB STRAT TARG TUB
NR 10
TC 1
Z9 1
U1 0
U2 0
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PY 2018
VL 27
IS 2
AR UNSP e0200007
DI 10.5123/S1679-49742018000200007
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GQ6EE
UT WOS:000441795700001
PM 29972471
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Bastos, ML
   Cosme, LB
   Fregona, G
   do Prado, TN
   Bertolde, AI
   Zandonade, E
   Sanchez, MN
   Dalcolmo, MP
   Kritski, A
   Trajman, A
   Maciel, ELN
AF Bastos, Mayara Lisboa
   Cosme, Lorrayne Beliqui
   Fregona, Geisa
   do Prado, Thiago Nascimento
   Bertolde, Adelmo Inacio
   Zandonade, Eliana
   Sanchez, Mauro N.
   Dalcolmo, Margareth Pretti
   Kritski, Afranio
   Trajman, Anete
   Noia Maciel, Ethel Leonor
TI Treatment outcomes of MDR-tuberculosis patients in Brazil: a
   retrospective cohort analysis
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Brazil; Tuberculosis; Multidrug-resistant; Treatment outcomes
ID MULTIDRUG-RESISTANT TUBERCULOSIS; HIV-INFECTION; 1ST
AB Background: Multidrug-resistant tuberculosis (MDR-TB) is a threat for the global TB epidemic control. Despite existing evidence that individualized treatment of MDR-TB is superior to standardized regimens, the latter are recommended in Brazil, mainly because drug-susceptibility tests (DST) are often restricted to first-line drugs in public laboratories. We compared treatment outcomes of MDR-TB patients using standardized versus individualized regimens in Brazil, a high TB-burden, low resistance setting.
   Methods: The 2007-2013 cohort of the national electronic database (SITE-TB), which records all special treatments including drug-resistance, was analysed. Patients classified as MDR-TB in SITE-TB were eligible. Treatment outcomes were classified as successful (cure/treatment completed) or unsuccessful (failure/relapse/death/loss to follow-up). The odds for successful treatment according to type of regimen were controlled for demographic and clinical variables.
   Results: Out of 4029 registered patients, we included 1972 recorded from 2010 to 2012, who had more complete outcome data. The overall success proportion was 60%. Success was more likely in non-HIV patients, sputum-negative at baseline, with unilateral disease and without prior DR-TB. Adjusted for these variables, those receiving standardized regimens had 2.7-fold odds of success compared to those receiving individualized treatments when failure/relapse were considered, and 1.4-fold odds of success when death was included as an unsuccessful outcome. When loss to follow-up was added, no difference between types of treatment was observed. Patients who used levofloxacin instead of ofloxacin had 1.5-fold odds of success.
   Conclusion: In this large cohort of MDR-TB patients with a low proportion of successful outcomes, standardized regimens had superior efficacy than individualized regimens, when adjusted for relevant variables. In addition to the limitations of any retrospective observational study, database quality hampered the analyses. Also, decision on the use of standard or individualized regimens was possibly not random, and may have introduced bias. Efforts were made to reduce classification bias and confounding. Until higher-quality evidence is produced, and DST becomes widely available in the country, our findings support the Brazilian recommendation for the use of standardized instead of individualized regimens for MDR-TB, preferably containing levofloxacin. Better quality surveillance data and DST availability across the country are necessary to improve MDR-TB control in Brazil.
C1 [Bastos, Mayara Lisboa; Trajman, Anete] Univ Estado Rio De Janeiro, Social Med Inst, Rio De Janeiro, RJ, Brazil.
   [Cosme, Lorrayne Beliqui; Fregona, Geisa; do Prado, Thiago Nascimento; Zandonade, Eliana; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Publ Hlth Postgrad Program, Vitoria, ES, Brazil.
   [Bertolde, Adelmo Inacio; Zandonade, Eliana] Univ Fed Espirito Santo, Stat Dept, Vitoria, ES, Brazil.
   [Sanchez, Mauro N.] Brasilia Fed Univ, Publ Hlth Dept, Brasilia, DF, Brazil.
   [Dalcolmo, Margareth Pretti] Fundacao Oswaldo Cruz, Reference Ctr Helio Fraga, Rio De Janeiro, Brazil.
   [Kritski, Afranio] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, Brazil.
   [Kritski, Afranio; Trajman, Anete; Noia Maciel, Ethel Leonor] Brazilian TB Network, Rio De Janeiro, Brazil.
   [Trajman, Anete] McGill Univ, Montreal, PQ, Canada.
   [Trajman, Anete] Rua Macedo Sobrinho 74-203, BR-22271080 Rio De Janeiro, Brazil.
RP Trajman, A (corresponding author), Univ Estado Rio De Janeiro, Social Med Inst, Rio De Janeiro, RJ, Brazil.; Trajman, A (corresponding author), Brazilian TB Network, Rio De Janeiro, Brazil.
EM atrajman@gmail.com
RI Sanchez, Mauro/AAU-2404-2020; Maciel, Ethel Leonor LN/G-1027-2012;
   Trajman, Anete/C-7679-2016; Kritski, Afranio/I-6760-2016
OI Sanchez, Mauro/0000-0002-0472-1804; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Trajman, Anete/0000-0002-4000-4984; Fregona,
   Geisa/0000-0001-5835-8222; kritski, afranio/0000-0002-5900-6007;
   Bertolde, Adelmo Inacio/0000-0002-1747-9957
CR Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300
   Akcakir Y., 2010, THESIS
   Baghaei PT, 2014, EUR RESP J, V44
   Bastos ML, 2014, CLIN INFECT DIS, V59, P1364, DOI 10.1093/cid/ciu619
   Bastos ML, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00803-2016
   Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2015, RED TEST RAP TUB BRA
   Brust JC, PLOS ONE, V6
   Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382
   Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0
   Micheletti VCD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160109
   Duraisamy Karthickeyan, 2014, Ann Am Thorac Soc, V11, P712, DOI 10.1513/AnnalsATS.201312-447OC
   Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436
   Fregona G, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006688, 10.1590/s1518-8787.2017051006688]
   Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC
   Haar CH, 2007, EMERG INFECT DIS, V13, P776, DOI 10.3201/eid1305.060334
   Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008
   Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914
   Karo B, 2016, AIDS, V30, P1089, DOI 10.1097/QAD.0000000000001016
   Koenig SP, 2009, CLIN INFECT DIS, V48, P829, DOI 10.1086/597098
   Kvasnovsky CL, 2011, JAIDS-J ACQ IMM DEF, V57, P146, DOI 10.1097/QAI.0b013e31821190a3
   Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640
   Magee MJ, 2015, INT J TUBERC LUNG D, V19, P685, DOI 10.5588/ijtld.14.0811
   Magee MJK, 2014, PLOS ONE, V9
   Ministerio da Saude, SIST INF TRAT ESP TU
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2011, MAN REC CONTR TUB BR
   Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6
   Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537
   van der Walt M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144249
   World Health Organization, 2015, GLOB TUB REP
   World Health Organization, 2016, TREATM GUID DRUG RES
   Yin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150511
NR 32
TC 13
Z9 13
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 14
PY 2017
VL 17
AR 718
DI 10.1186/s12879-017-2810-1
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA FM6JE
UT WOS:000415156500002
PM 29137626
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Lacerda, TC
   de Souza, FM
   do Prado, TN
   Locatelli, RL
   Fregona, G
   Lima, RDD
   Maciel, EL
AF Lacerda, Thamy Carvalho
   de Souza, Fernanda Mattos
   do Prado, Thiago Nascimento
   Locatelli, Rodrigo Leite
   Fregona, Geisa
   Duarte Lima, Rita de Cassia
   Maciel, Ethel Leonor
TI Tuberculosis infection among primary health care workers
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA English
DT Article
DE Health personnel; Tuberculin test; Latent tuberculosis; Primary health
   care
ID MYCOBACTERIUM-TUBERCULOSIS; ESPIRITO-SANTO; PREVALENCE; STUDENTS; RISK;
   TRANSMISSION; VITORIA
AB Objective: To estimate the prevalence of and determine the risk factors associated with latent Mycobacterium tuberculosis infection (LTBI) among primary health care workers in the city of Vitoria, Brazil. Methods: This was a cross-sectional study with data collected through a survey regarding socio-demographic, occupational, clinical, and exposure characteristics, as well as knowledge about tuberculosis, conducted between 2011 and 2012. All participants underwent a tuberculin skin test (TST), and TSTs were read at 72 h by a trained professional. Results: A total of 218 primary health care workers participated in the study. The prevalence of TST positivity at the >= 10-mm and >= 5-mm cut-off points was, respectively, 39.4% (95% CI: 32.9-45.9) and 54.1% (95% CI: 47.4-60.7). Regarding occupational categories, community health agents had the highest proportion of TST positivity, regardless of the cut-off point (>= 10 mm: 47.5%; and >= 5 mm: 60.5%). Regarding factors associated with TST results, "having had a previous TST" showed a statistically significant association with TST positivity at the > 10-mm and >= 5-mm cut-off points (OR = 2.5 [95% CI: 1.17-5.30] and OR = 2.18 [95% CI: 1.23-3.87], respectively). Conclusions: The prevalence of LTBI was found to be high among the primary health care workers in this sample. Therefore, we recommend the establishment of a periodic screening program for LTBI and implementation of effective biosafety policies for the prevention of this infection among primary health care workers.
C1 [Lacerda, Thamy Carvalho; de Souza, Fernanda Mattos; do Prado, Thiago Nascimento; Locatelli, Rodrigo Leite; Fregona, Geisa; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Ave Marechal Campos 1468, BR-29040090 Vitoria, ES, Brazil.
   [Lacerda, Thamy Carvalho; do Prado, Thiago Nascimento; Locatelli, Rodrigo Leite; Duarte Lima, Rita de Cassia; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
   [Lacerda, Thamy Carvalho; Fregona, Geisa] Univ Fed Espirito Santo, HUCAM, Vitoria, ES, Brazil.
   [do Prado, Thiago Nascimento] Univ Fed Espirito Santo, Programa Posgrad Enfermagem, Vitoria, ES, Brazil.
   [do Prado, Thiago Nascimento; Duarte Lima, Rita de Cassia; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Dept Enfermagem, Vitoria, ES, Brazil.
   [Lacerda, Thamy Carvalho; de Souza, Fernanda Mattos; do Prado, Thiago Nascimento; Locatelli, Rodrigo Leite; Fregona, Geisa; Duarte Lima, Rita de Cassia; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Vitoria, ES, Brazil.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Ave Marechal Campos 1468, BR-29040090 Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq, National Council for Scientific and Technological
   Development)National Council for Scientific and Technological
   Development (CNPq); Brazilian Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (MCT/CNPq/CT-Saude/MS/SCTIE/DECIT) [067/2009];
   Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES, Foundation for
   the Support of Research in the State of Espirito Santo) [59060603/2012]
FX This study received financial support from the Brazilian Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National
   Council for Scientific and Technological Development;
   MCT/CNPq/CT-Saude/MS/SCTIE/DECIT Mandate no. 067/2009) and the Fundacao
   de Amparo a Pesquisa do Espirito Santo (FAPES, Foundation for the
   Support of Research in the State of Espirito Santo; Process no.
   59060603/2012).
CR Borges TS, 2014, BRAZ J HLTH PROMOT, V27, P269
   Brasil. Ministerio da Saude, 2012, POL NAC AT BAS MIN E
   de Souza FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102773
   de Oliveira SMDL, 2007, REV LAT-AM ENFERM, V15, P1120, DOI 10.1590/S0104-11692007000600010
   Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494
   LUNA JAC, 2003, GUIA TUBERCULOSIS ME
   Machado PC, 2014, EPIDEMIOL SERV SAUDE, V23, P675, DOI 10.5123/S1679-49742014000400009
   Maciel ELN, 2005, REV SOC BRAS MED TRO, V38, P469, DOI 10.1590/S0037-86822005000600004
   Menzies D, 2007, INT J TUBERC LUNG D, V11, P593
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2011, MAN REC CONTR TUB BR
   Moreira TR, 2010, REV SAUDE PUBL, V44, P332, DOI [10.1590/S0034-89102010000200014, 10.1590/s0034-89102010000200014]
   Maciel EL, 2007, REV SOC BRAS MED TRO, V40, P397, DOI 10.1590/S0037-86822007000400004
   Oliveira SMVL, 2008, REV BRAS SAUDE OCUP, V33, P72
   Rodrigues PM, 2009, J BRAS PNEUMOL, V35, P351, DOI 10.1590/S1806-37132009000400009
   Rogerio WP, 2015, CAD SAUDE PUBLICA, V31, P2199, DOI 10.1590/0102-311X00152414
   Silva Vania Maria Carneiro da, 2004, J. bras. pneumol., V30, P459, DOI 10.1590/S1806-37132004000500010
   Silva VMC, 2000, INT J TUBERC LUNG D, V4, P420
   Sociedade Brasileira de Pneumologia e Tisiologia, 2004, J BRAS PNEUMOL S1, V30, pS3
   WHO, 2009, WHO POL TB INF CONTR
   WHO, 2015, THE END TB STRATEGY
   World Health Organization, 2015, GUID MAN LAT TUB INF
   World Health Organization, 2009, GLOB TUB CONTR EP ST
   Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180
NR 24
TC 2
Z9 2
U1 0
U2 6
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD NOV-DEC
PY 2017
VL 43
IS 6
BP 416
EP 423
DI 10.1590/S1806-37562016000000211
PG 8
WC Respiratory System
SC Respiratory System
GA FT1FN
UT WOS:000422880900007
PM 29340489
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Macedo, LR
   Maciel, ELN
   Struchiner, CJ
AF Macedo, Laylla Ribeiro
   Noia Maciel, Ethel Leonor
   Struchiner, Claudio Jose
TI Tuberculosis in the Brazilian imprisoned population, 2007-2013
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA Portuguese
DT Article
DE Tuberculosis; Prisons; Epidemiology; Descriptive
ID PRISONS
AB Objective: to describe socio-demographic and clinical characteristics and indicators of tuberculosis (TB) in Brazilian imprisoned population, from 2007 to 2013. Methods: descriptive study with data from the Information System for Notifiable Diseases (Sinan). Results: from 2007 to 2013, 38,083 TB cases were reported in the imprisoned population, equivalent to a TB prevalence of 1,236 cases/100,000 individuals; this prevalence was higher among women (1,693/100,000), indigenous people (2,874/100,000), and in the age group > 60 years (4,093/100,000); there were mainly reports of cases of pulmonary TB (91.5%) and new cases (78.1%); the TB incidence rate in 2013 (904.9/100,000) was higher than 2007 (627.6/100,000), whilst the mortality rate in 2013 (16.0/100,000) was lower than 2007 (18.0/100,000). Conclusion: TB in the imprisoned population presents some specific characteristics and higher occurrence than in the general population; the highest prevalence in women and the highest incidence at the end of the study period stood out.
C1 [Macedo, Laylla Ribeiro; Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, RJ, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Dept Enfermagem, Vitoria, ES, Brazil.
RP Macedo, LR (corresponding author), Rua Prof Hernani Pires de Melo,80,Apto 801, BR-24210130 Niteroi, RJ, Brazil.
EM layllarm@hotmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; Macedo, Laylla
   Ribeiro/AAV-5154-2020; Struchiner, Claudio J/M-9360-2013
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Struchiner, Claudio
   J/0000-0003-2114-847X; Ribeiro Macedo, Laylla/0000-0002-6246-3559
CR [Anonymous], 2013, B EPIDEMIOL, V44, P1
   Basta Paulo Cesar, 2013, Rev Saude Publica, V47, P854, DOI 10.1590/S0034-8910.2013047004628
   Brasil. Ministerio da Saude, 2013, REC MAN COINF TB HIV
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2014, PAN TUB BRAS IND EP
   Belo MTCT, 2010, J BRAS PNEUMOL, V36, P621, DOI 10.1590/S1806-37132010000500015
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96
   Malhao TA, 2010, EPIDEMIOL SERV SAUDE, V19, P245
   Ministerio da Justica, 2015, LEV NAC INF PEN INF
   Ministerio da Justica (BR), 2016, REL EST AN SIST PRIS
   Ministerio da Saude, 2006, DIR OP PACT PEL VID
   Ministerio da Saude (BR), 2016, IND MORB TUB
   Ministerio da Saude (BR), 2016, B EPIDEMIOL, V47, P1
   Ministerio da Saude (BR), 2015, AV GEST PROGR NAC CO
   Ministerio da Saude (BR), 2015, SIT EP TUB NOS EST P
   Ministerio da Saude (BR), 2011, INSTR PREENCH PROGR
   Ministerio da Saude (BR), 2016, SERV INF CID
   Ministerio da Saude (BR), 2011, MAN REC CONTR TUB BR
   Ministerio da Saude (BR), 2012, B EPIDEMIOL, V43, P1
   Ministerio da Saude (BR), 2015, B EPIDEMIOL, V46, P1
   Ministerio da Saude (BR). Secretaria de Vigilancia em Saude, 2014, SUAD BRAS 2013 AN SI
   Ministerio da Saude (BR). Secretaria de Vigilancia em Saude, 2015, TUB POP VULN
   Oliveira AC, 2013, REV ESC ENFERM USP, V47, P113, DOI 10.1590/S0080-62342013000100018
   Pinheiro RS, 2010, SAUDE BRASIL 2010 AN, P175
   Macedo LR, 2013, INT J TUBERC LUNG D, V17, P1427, DOI 10.5588/ijtld.12.0918
   Sacchi FPC, 2015, EMERG INFECT DIS, V21, P452, DOI 10.3201/eid2103.140896
   San Pedro A, 2013, REV PANAM SALUD PUBL, V33, P294, DOI 10.1590/S1020-49892013000400009
   Carbone ADS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0764-8
   World Health Organization, 2015, END TB STRAT
   World Heatlh Organization, 2016, GLOB TUB REP 2016
NR 30
TC 4
Z9 7
U1 0
U2 2
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PD OCT-DEC
PY 2017
VL 26
IS 4
BP 783
EP 794
DI 10.5123/S1679-49742017000400010
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FQ9UI
UT WOS:000418706800010
PM 29211142
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU de Oliveira, SMDL
   Trajman, A
   Paniago, AMM
   Motta-Castro, ARC
   Ruffino-Netto, A
   Maciel, ELN
   Croda, J
   Bonecini-Almeide, MD
AF do Valle Leone de Oliveira, Sandra Maria
   Trajman, Anete
   Miranda Paniago, Anamaria Mello
   Coimbra Motta-Castro, Ana Rita
   Ruffino-Netto, Antonio
   Noia Maciel, Ethel Leonor
   Croda, Julio
   Bonecini-Almeide, Maria da Gloria
TI Frequency of indeterminate results from an interferon-gamma release
   assay among HIV-infected individuals
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA Portuguese
DT Article
ID LATENT TUBERCULOSIS INFECTION; IN-TUBE TEST; SKIN-TEST; QUANTIFERON
C1 [do Valle Leone de Oliveira, Sandra Maria; Miranda Paniago, Anamaria Mello; Coimbra Motta-Castro, Ana Rita] Univ Fed Mato Grosso do Sul, Fac Med, Programa Pos Grad Doencas Infecciosas & Parasitar, Campo Grande, MS, Brazil.
   [do Valle Leone de Oliveira, Sandra Maria; Coimbra Motta-Castro, Ana Rita; Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil.
   [Trajman, Anete] McGill Univ, Montreal Chest Inst, Montreal, PQ, Canada.
   [Trajman, Anete] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, RJ, Brazil.
   [Ruffino-Netto, Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Croda, Julio] Fundacao Univ Fed Grande Dourados, Fac Med, Campo Grande, MS, Brazil.
   [Bonecini-Almeide, Maria da Gloria] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Imunol & Imunogenet Doencas Infecciosas, Rio De Janeiro, RJ, Brazil.
RP de Oliveira, SMDL (corresponding author), Rua Marques Pombal 1889,Apto 3,Bloco A, Campo Grande, MS, Brazil.
EM sandrinhaleone@gmail.com
RI Bonecini-Almeida, Gloria Maria/C-7237-2012; de Oliveira, Sandra Maria do
   Valle Leone/A-1074-2013; Trajman, Anete/C-7679-2016; Maciel, Ethel
   Leonor LN/G-1027-2012; Paniago, Anamaria M M/B-7747-2012; Croda,
   Julio/I-5172-2013; motta-castro, ana rita c/O-2075-2017
OI de Oliveira, Sandra Maria do Valle Leone/0000-0002-8960-6716; Trajman,
   Anete/0000-0002-4000-4984; Maciel, Ethel Leonor LN/0000-0003-4826-3355;
   Paniago, Anamaria M M/0000-0002-8925-7712; Croda,
   Julio/0000-0002-6665-6825; Bonecini-Almeida, Maria da
   Gloria/0000-0001-6030-5576; Motta-Castro, Ana Rita/0000-0003-3070-1337
CR Kussen GMB, 2016, BRAZ J INFECT DIS, V20, P69, DOI 10.1016/j.bjid.2015.10.007
   Brasil. Ministerio daSaucle, 2011, PROGR NAC CONTR TUB
   Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009
   Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab
   Couturier MR, 2014, CLIN INFECT DIS, V59, P1649, DOI 10.1093/cid/ciu644
   Herrera V, 2010, J CLIN MICROBIOL, V48, P2672, DOI 10.1128/JCM.00482-10
   Khawcharoenporn T, 2015, RESPIROLOGY, V20, P340, DOI 10.1111/resp.12442
   Kunst H, 2006, RESP MED, V100, P2098, DOI 10.1016/j.rmed.2006.02.032
   Oni T, 2012, CLIN VACCINE IMMUNOL, V19, P1243, DOI 10.1128/CVI.00166-12
   Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13
   Sauzullo I, 2014, NEW MICROBIOL, V37, P153
   Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803
   Trajman A, 2013, PULM MED, V2013, DOI 10.1155/2013/601737
   Yun JW, 2014, J CLIN MICROBIOL, V52, P90, DOI 10.1128/JCM.01547-13
NR 14
TC 1
Z9 1
U1 1
U2 2
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD MAY-JUN
PY 2017
VL 43
IS 3
BP 215
EP 218
DI 10.1590/S1806-37562016000000125
PG 4
WC Respiratory System
SC Respiratory System
GA EY9NE
UT WOS:000404324500013
PM 28746533
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU do Prado, TN
   Rajan, JV
   Miranda, AE
   Dias, ED
   Cosme, LB
   Possuelo, LG
   Sanchez, MN
   Golub, JE
   Riley, LW
   Maciel, EL
AF do Prado, Thiago Nascimento
   Rajan, Jayant V.
   Miranda, Angelica Espinosa
   Dias, Elias dos Santos
   Cosme, Lorrayne Beliqui
   Possuelo, Lia Goncalves
   Sanchez, Mauro N.
   Golub, Jonathan E.
   Riley, Lee W.
   Maciel, Ethel Leonor
TI Clinical and epidemiological characteristics associated with unfavorable
   tuberculosis treatment outcomes in TB-HIV co-infected patients in
   Brazil: a hierarchical polytomous analysis
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Tuberculosis; HIV; Coinfection; Logistic regression
ID THAILAND; TRENDS
AB Background: TB patients co-infected with HIV have worse treatment outcomes than noncoinfected patients. How clinical characteristics of TB and socioeconomic characteristics influence these outcomes is poorly understood. Here, we use polytomous regression analysis to identify clinical and epidemiological characteristics associated with unfavorable treatment outcomes among TB-HIV co-infected patients in Brazil.
   Methods: TB-HIV cases reported in the Brazilian information system (SINAN) between January 1, 2001 and December 31, 2011 were identified and categorized by TB treatment outcome (cure, default, death, and development of MDR TB). We modeled treatment outcome as a function of clinical characteristics of TB and patient socioeconomic characteristics by polytomous regression analysis. For each treatment outcome, we used cure as the reference outcome.
   Results: Between 2001 and 2011, 990,017 cases of TB were reported in SINAN, of which 93,147 (9.4%) were HIV co-infected. Patients aged 15-19 (OR= 2.86; 95% CI: 2.09-3.91) and 20-39 years old (OR= 2.30; 95% CI: 1.81-2.92) were more likely to default on TB treatment than those aged 0-14 years old. In contrast, patients aged >= 60 years were more likely to die from TB (OR = 2.22; 95% CI: 1.43-3.44) or other causes (OR= 2.86; 95% CI: 2.14-3.83). Black patients were more likely to default on TB treatment (OR= 1.33; 95% CI: 1.22-1.44) and die from TB (OR= 1.50; 95% CI: 1.29-1.74). Finally, alcoholism was associated with all unfavorable outcomes: default (OR= 1.94; 95% CI: 1.73-2.17), death due to TB (OR= 1.46; 95% CI: 1.25-1.71), death due to other causes (OR= 1.38; 95% CI: 1.21-1.57) and MDR-TB (OR = 2.29; 95% CI: 1.46-3.58).
   Conclusions: Socio-economic vulnerability has a significant effect on treatment outcomes among TB-HIV co-infected patients in Brazil. Enhancing social support, incorporation of alcohol abuse screening and counseling into current TB surveillance programs and targeting interventions to specific age groups are interventions that could improve treatment outcomes. (C) 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license.
C1 [do Prado, Thiago Nascimento; Cosme, Lorrayne Beliqui; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [do Prado, Thiago Nascimento; Dias, Elias dos Santos; Cosme, Lorrayne Beliqui; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Dept Enfermagem, Vitoria, ES, Brazil.
   [do Prado, Thiago Nascimento; Miranda, Angelica Espinosa; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Doencas Infecciosas, Vitoria, ES, Brazil.
   [Rajan, Jayant V.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Possuelo, Lia Goncalves] Univ Santa Cruz do Sul, Programa Posgrad Promocao Saude, Santa Cruz Do Sul, RS, Brazil.
   [Sanchez, Mauro N.] Univ Brasilia, Dept Saude Publ, Brasilia, DF, Brazil.
   [Sanchez, Mauro N.] Int Union TB & Lung Dis, Paris, France.
   [Golub, Jonathan E.] Univ Baltimore, Johns Hopkins Sch Med, Ctr TB Res, Baltimore, MD 21201 USA.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.; Maciel, EL (corresponding author), Univ Fed Espirito Santo, Dept Enfermagem, Vitoria, ES, Brazil.; Maciel, EL (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Doencas Infecciosas, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; POSSUELO, LIA/S-7745-2019;
   Possuelo, Lia Goncalves/L-7257-2018; Sanchez, Mauro/AAU-2404-2020
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; POSSUELO,
   LIA/0000-0002-6425-3678; Possuelo, Lia Goncalves/0000-0002-6425-3678;
   Sanchez, Mauro/0000-0002-0472-1804; Miranda,
   Angelica/0000-0002-5556-8379
FU CNPq/BrazilNational Council for Scientific and Technological Development
   (CNPq); U.S. National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [ICOHRTA 5 U2R TW006883-02]; FAPES (Fundacao de Amparo a Pesquisa do
   Espirito Santo)
FX This study was supported by CNPq/Brazil edital Doencas negligenciadas
   2012 and Universal 2010, the U.S. National Institutes of Health, under
   contract ICOHRTA 5 U2R TW006883-02 and FAPES (Fundacao de Amparo a
   Pesquisa do Espirito Santo).
CR Batista Joanna d’Arc Lyra, 2013, Rev. bras. epidemiol., V16, P432, DOI 10.1590/S1415-790X2013000200018
   Biesheuvel CJ, 2008, J CLIN EPIDEMIOL, V61, P125, DOI 10.1016/j.jclinepi.2007.03.002
   Brasil. Ministerio da Saude, 2011, MAN REC CONTR TUB BR
   BRAUN MM, 1993, JAMA-J AM MED ASSOC, V269, P2865, DOI 10.1001/jama.269.22.2865
   Brazilian Ministry of Health, 2011, MON AIDS MON ONL SYS
   Gonzales RIC, 2008, REV LAT-AM ENFERM, V16, P95, DOI 10.1590/S0104-11692008000100015
   Cerqueira ACB, 2008, UFES REV ODONT, V10, P33
   Chan-Yeung M, 2002, INT J TUBERC LUNG D, V6, P771
   Das JK, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-24
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   do Prado TN, 2011, CAD SAUDE PUBLICA, V27, P944, DOI 10.1590/S0102-311X2011000500012
   do Prado TN, 2011, J BRAS PNEUMOL, V37, P93, DOI 10.1590/S1806-37132011000100014
   Franco J, 1998, INT J TUBERC LUNG D, V2, P663
   Gomes T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074517
   Kittikraisak W, 2009, T ROY SOC TROP MED H, V103, P59, DOI 10.1016/j.trstmh.2008.09.003
   Klautau Giselle Burlamaqui, 2005, Braz J Infect Dis, V9, P464, DOI 10.1590/S1413-86702005000600004
   Lee JH, 2005, J KOREAN MED SCI, V20, P784, DOI 10.3346/jkms.2005.20.5.784
   Maciel ELNA, 2012, PROMOCAO SAUDE DETER, P429
   Maciel Ethel Leonor Noia, 2008, J Bras Pneumol, V34, P506, DOI 10.1590/S1806-37132008000700011
   Maruza Magda, 2008, J. bras. pneumol., V34, P394, DOI 10.1590/S1806-37132008000600010
   Maruza M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-351
   Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973
   Nadjane Batista Lacerda Sheylla, 2014, Int Arch Med, V7, P35, DOI 10.1186/1755-7682-7-35
   Ngamvithayapong J, 1997, AIDS, V11, P107, DOI 10.1097/00002030-199701000-00016
   Nik NR, 2011, MALAYS J PUBL HLTH M, V11, P6
   Peltzer K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-699
   Prado TN, 2014, BMC INFECT DIS, V14, P1, DOI [10.1186/1471-2334-14-415, DOI 10.1186/1471-2334-14-415]
   Rabahi Marcelo Fouad, 2002, Braz J Infect Dis, V6, P63, DOI 10.1590/S1413-86702002000200002
   Reis-Santos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062604
   Sanchez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033129
   Villa TCS, 2008, REV ESC ENFERM USP, V42, P98, DOI 10.1590/S0080-62342008000100013
   SCHOEMAN JH, 1994, TUBERCLE LUNG DIS, V75, P371, DOI 10.1016/0962-8479(94)90084-1
   Tanguis HG, 2000, INT J TUBERC LUNG D, V4, P55
   Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197
   World Health Organization, 2010, GLOB TUB CONTR 2010
NR 35
TC 12
Z9 12
U1 0
U2 0
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD MAR-APR
PY 2017
VL 21
IS 2
BP 162
EP 170
DI 10.1016/j.bjid.2016.11.006
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA EQ3HZ
UT WOS:000397963900007
PM 27936379
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Conner, N
   Provedel, A
   Maciel, ELN
AF Conner, Norma
   Provedel, Attilio
   Noia Maciel, Ethel Leonor
TI Ciencia & Saude Coletiva: scientific production analysis and
   collaborative research networks
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Knowledge development; Public health; Partnerships; Computer
   technologies
AB The purpose of this metric and descriptive study was to identify the most productive authors and their collaborative research networks from articles published in Ciencia & Saude Coletiva between, 2005, and 2014. Authors meeting the cutoff criteria of at least 10 articles were considered the most productive authors. VOSviewer and Network Workbench technologies were applied for visual representations of collaborative research networks involving the most productive authors in the period. Initial analysis recovered 2511 distinct articles, with 8920 total authors with an average of 3.55 authors per article. Author analysis revealed 6288 distinct authors, 24 of these authors were identified as the most productive. These 24 authors generated 287 articles with an average of 4.31 authors per article, and represented 8 separate collaborative partnerships, the largest of which had 14 authors, indicating a significant degree of collaboration among these authors. This analysis provides a visual representation of networks of knowledge development in public health and demonstrates the usefulness of VOSviewer and Network Workbench technologies in future research.
C1 [Conner, Norma] Univ Cent Florida, Coll Nursing, 12201 Res Pkwy Suite 300, Orlando, FL 32826 USA.
   [Provedel, Attilio] Univ Fed Espirito Santo, Ctr Ciencias Jurid & Econ, Dept Arquivol, Vitoria, ES, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
RP Conner, N (corresponding author), Univ Cent Florida, Coll Nursing, 12201 Res Pkwy Suite 300, Orlando, FL 32826 USA.
EM norma.conner@ucf.edu
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR Bevc CA, 2015, AM J PUBLIC HEALTH, V105, pS230, DOI 10.2105/AJPH.2014.302256
   Brandes U, 2013, HDB GRAPH DRAWING VI, P517
   Dance A, 2012, NATURE, V489, pS2, DOI 10.1038/489S2a
   Minayo MCD, 2015, CIENC SAUDE COLETIVA, V20, P2013, DOI 10.1590/1413-81232015207.04802015
   Editorial, 1996, CIEN SAUDE COLET, V1, P1
   Garbett D., 2007, HIGHER ED RES DEV, V26, P411, DOI DOI 10.1080/07294360701658617
   Hesse-Biber S, 2016, QUAL HEALTH RES, V26, P649, DOI 10.1177/1049732316634304
   Jain SH, 2011, J GEN INTERN MED, V26, P1513, DOI 10.1007/s11606-011-1754-1
   Meleis A., 2012, THEORETICAL NURSING
   Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100
   Njelesani J, 2013, OCCUP THER INT, V20, P75, DOI 10.1002/oti.1346
   Nunes ED, 2015, CIENC SAUDE COLETIVA, V20, P1975, DOI 10.1590/1413-81232015207.05292015
   NWB Team, 2006, NETW WORKB TOOL
   Riviera E, 2013, J AM SOC INF SCI TEC, V64, P1442, DOI 10.1002/asi.22826
   Sommers MS, 2011, CLIN NURS RES, V20, P115, DOI 10.1177/1054773811403566
   Sunol R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141157
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
NR 17
TC 0
Z9 0
U1 0
U2 6
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD MAR
PY 2017
VL 22
IS 3
BP 987
EP 996
DI 10.1590/1413-81232017223.18992016
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EN9TJ
UT WOS:000396342200031
PM 28301005
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU do Prado, TN
   Riley, LW
   Sanchez, M
   Fregona, G
   Nobrega, RLP
   Possuelo, LG
   Zandonade, E
   Locatelli, RL
   de Souza, FM
   Rajan, JV
   Maciel, ELN
AF do Prado, Thiago Nascimento
   Riley, Lee W.
   Sanchez, Mauro
   Fregona, Geisa
   Peres Nobrega, Renata Lyrio
   Possuelo, Lia Goncalves
   Zandonade, Eliana
   Locatelli, Rodrigo Leite
   de Souza, Fernanda Mattos
   Rajan, Jayant V.
   Noia Maciel, Ethel Leonor
TI Prevalence and risk factors for latent tuberculosis infection among
   primary health care workers in Brazil
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Latent Tuberculosis; Mycobacterium tuberculosis; Health Personnel;
   Occupational Exposure
ID SKIN-TEST POSITIVITY; MYCOBACTERIUM-TUBERCULOSIS; ASSAY; PROFESSIONALS;
   CONVERSION; UNIVERSITY; STUDENTS; SMOKING; IMPACT
AB Health care workers (HCW) are at increased risk of latent tuberculosis infection (LTBI) from occupational exposure to Mycobacterium tuberculosis. The objective was to determine the prevalence of and risk factors for LTBI among primary HCW in five Brazilian cities. We conducted a cross-sectional study, from 2011 to 2013, among primary HCW, using a structured questionnaire and an evaluated for LTBI using the Quantiferon-TB Gold in-tube test. The magnitude of the associations was assessed using hierarchical logistic regression models. Among 708 HCW, the LTBI prevalence was 27% (n = 196; 95% CI: 24%-31%). We found that the following factors were positively associated with LTBI in primary HCW: age > 50 years (OR = 2.94; 95% CI: 1.44-5.99), absence of a BCG scar (OR = 2.10; 95% CI: 1.28-3.43), self-reported ex-smoker status (OR = 1.80; 95% CI: 1.04-3.11), being a nurse (OR = 2.97; 95% CI: 1.13-7.83), being a nurse technician (OR = 3.10; 95% CI: 1.26-7.60), being a community health agent (OR = 2.60; 95% CI: 1.06-6.40), and irregular use of N95 masks (OR = 2.51; 95% CI: 1.11-5.98). In contrast, HCWs who do not work in health care facilities with a TB control program were less likely to have LTBI (OR = 0.66; 95% CI: 0.45-0.97). This study demonstrated a substantial occupational risk of LTBI among primary HCW in Brazil. The Brazilian TB control program, as well as local programs, need to target these high-risk HCW with education, as well as with better personal protective equipment to prevent acquisition of new TB infection.
C1 [do Prado, Thiago Nascimento; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Dept Enfermagem, Vitoria, Brazil.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Sanchez, Mauro] Univ Brasilia, Brasilia, DF, Brazil.
   [Fregona, Geisa; Peres Nobrega, Renata Lyrio; de Souza, Fernanda Mattos] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, Brazil.
   [Fregona, Geisa] Univ Fed Espirito Santo, Hosp Univ Cassiano Antonio Moraes, Vitoria, Brazil.
   [Possuelo, Lia Goncalves] Univ Santa Cruz do Sul, Santa Cruz Do Sul, Brazil.
   [Zandonade, Eliana] Univ Fed Espirito Santo, Dept Estat, Vitoria, Brazil.
   [Locatelli, Rodrigo Leite] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, Brazil.
   [Rajan, Jayant V.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Ctr Biomed, Dept Enfermagem, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI POSSUELO, LIA/S-7745-2019; Maciel, Ethel Leonor LN/G-1027-2012; Sanchez,
   Mauro/AAU-2404-2020
OI POSSUELO, LIA/0000-0002-6425-3678; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Sanchez, Mauro/0000-0002-0472-1804; Fregona,
   Geisa/0000-0001-5835-8222
FU CNPq (Brazilian National Research Council; MCT/CNPq)National Council for
   Scientific and Technological Development (CNPq) [14/2009 - Universal];
   FAPES (Espirito Santo State Research Foundation) [Universal 012/11];
   Capes (Brazilian Graduate Studies Coordinating Board)CAPES; provision of
   a sandwich scholarship at the University of California, Berkely, USA
FX This study was supported by CNPq (Brazilian National Research Council;
   MCT/CNPq n. 14/2009 - Universal), FAPES (Espirito Santo State Research
   Foundation; Universal 012/11), and the Capes (Brazilian Graduate Studies
   Coordinating Board; with the provision of a sandwich scholarship at the
   University of California, Berkely, USA). The funders had no role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947
   Christopher DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010408
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   Cook S, 2003, INFECT CONT HOSP EP, V24, P807, DOI 10.1086/502141
   Costa JT, 2011, INT ARCH OCC ENV HEA, V84, P461, DOI 10.1007/s00420-010-0571-x
   den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924
   Departamento de Vigilancia Epidemiologica Secretaria de Vigilancia em Saude Ministerio da Saude, 2011, MAN REC CONTR TUB BR
   Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048
   de Oliveira SMDL, 2007, REV LAT-AM ENFERM, V15, P1120, DOI 10.1590/S0104-11692007000600010
   Drobniewski F, 2007, PLOS MED, V4, P273, DOI 10.1371/journal.pmed.0040055
   Feng JY, 2014, EUR RESPIR J, V43, P630, DOI 10.1183/09031936.00118313
   Florence CS, 2006, HEALTH SERV RES, V41, P1741, DOI 10.1111/j.1475-6773.2006.00580.x
   Garmendia J, 2012, EUR RESPIR J, V39, P467, DOI 10.1183/09031936.00061911
   Keskiner R, 2004, INFECT CONT HOSP EP, V25, P1067, DOI 10.1086/502345
   KRITSKI AL, 1993, J PNEUMOL, V19, P113
   Lewinsohn DM, 2017, CLIN INFECT DIS, V64, pE1, DOI 10.1093/cid/ciw694
   Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798
   Lopes LKO, 2008, AM J INFECT CONTROL, V36, P148, DOI 10.1016/j.ajic.2007.01.013
   MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206
   Moreira TR, 2010, REV SAUDE PUBL, V44, P332, DOI [10.1590/S0034-89102010000200014, 10.1590/s0034-89102010000200014]
   Nasreen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164034
   Maciel ELN, 2016, EPIDEMIOL SERV SAUDE, V25, P423, DOI [10.5123/s1679-49742016000200021, 10.5123/S1679-49742016000200021]
   Oliveira JS, 2011, REV HCPA FM U FED RI, V31, P13
   Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746
   Severo KGP, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-15
   Petarli GB, 2015, CAD SAUDE PUBLICA, V31, P787, DOI 10.1590/0102-311X00083114
   Plant AJ, 2002, EPIDEMIOL INFECT, V128, P37, DOI 10.1017/S0950268801006434
   Reichman LB, 2008, GUIDELINES DIAGNOSIS
   Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6
   Rogerio WP, 2013, CIENC SAUDE COLETIVA, V18, P1331, DOI 10.1590/S1413-81232013000500018
   Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335
   Schablon A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115322
   Silva Vania Maria Carneiro da, 2004, J. bras. pneumol., V30, P459, DOI 10.1590/S1806-37132004000500010
   Silva VMC, 2002, INFECT CONT HOSP EP, V23, P591, DOI 10.1086/501976
   Souza FM, 2014, PLOS ONE, V9
   Trajman A, 2013, PULM MED, V2013, DOI 10.1155/2013/601737
   World Health Organization, GUID MAN LAT TUB INF
   Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180
NR 38
TC 5
Z9 5
U1 0
U2 2
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2017
VL 33
IS 12
AR e00154916
DI 10.1590/0102-311X00154916
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FQ9AS
UT WOS:000418655200016
PM 29267691
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Fontenelle, LF
   de Camargo, MBJ
   Bertoldi, AD
   Goncalves, H
   Maciel, ELN
   Barros, AJD
AF Fontenelle, Leonardo Ferreira
   Junqueira de Camargo, Maria Beatriz
   Bertoldi, Andrea Damaso
   Goncalves, Helen
   Noia Maciel, Ethel Leonor
   Barros, Aluisio J. D.
TI Coverage by health insurance or discount cards: a household survey in
   the coverage area of the Family Health Strategy
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
ID SOCIOECONOMIC POSITION; BRAZIL; PATTERNS; SYSTEM
AB This study was designed to assess the reasons for health insurance coverage in a population covered by the Family Health Strategy in Brazil. We describe overall health insurance coverage and according to types, and analyze its association with health-related and socio-demographic characteristics. Among the 31.3% of persons (95% CI: 23.8-39.9) who reported "health insurance" coverage, 57.0% (95% CI: 45.2-68.0) were covered only by discount cards, which do not offer any kind of coverage for medical care, but only discounts in pharmacies, clinics, and hospitals. Both for health insurance and discount cards, the most frequently cited reasons for such coverage were "to be on the safe side" and "to receive better care". Both types of coverage were associated statistically with age (+ 65 vs. 15-24 years: adjusted odds ratios, aOR = 2.98, 95% CI: 1.28-6.90; and aOR = 3.67; 95% CI: 2.226.07, respectively) and socioeconomic status (additional standard deviation: aOR = 2.25, 95% CI: 1.62-3.14; and aOR = 1.96, 95% CI: 1.34-2.97). In addition, health insurance coverage was associated with schooling (aOR = 7.59, 95% CI: 4.44-13.00) for complete University Education and aOR = 3.74 (95% CI: 1.61-8.68) for complete Secondary Education, compared to less than complete Primary Education. Meanwhile, neither health insurance nor discount card was associated with health status or number of diagnosed diseases. In conclusion, studies that aim to assess private health insurance should be planned to distinguish between discount cards and formal health insurance.
C1 [Fontenelle, Leonardo Ferreira; Bertoldi, Andrea Damaso; Goncalves, Helen; Barros, Aluisio J. D.] Univ Fed Pelotas, Programa Posgrad Epidemiol, Rua Marechal Deodoro 1160,3 Piso, BR-96020220 Pelotas, RS, Brazil.
   [Junqueira de Camargo, Maria Beatriz] Univ Fed Pelotas, Fac Odontol, Pelotas, RS, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Vitoria, Brazil.
RP Fontenelle, LF (corresponding author), Univ Fed Pelotas, Programa Posgrad Epidemiol, Rua Marechal Deodoro 1160,3 Piso, BR-96020220 Pelotas, RS, Brazil.
EM leonardof@leonardof.med.br
RI Fontenelle, Leonardo Ferreira/G-3942-2013; Goncalves, Helen/M-1603-2017;
   Goncalves, Helen/P-2381-2018; Barros, Aluisio JD/A-7417-2008; Maciel,
   Ethel Leonor LN/G-1027-2012
OI Fontenelle, Leonardo Ferreira/0000-0003-4064-433X; Goncalves,
   Helen/0000-0001-6470-3352; Barros, Aluisio JD/0000-0002-2022-8729;
   Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR Almeida C., 1998, MERCADO PRIVADO SERV, P599
   BAHIA L, 2001, CIENC SAUDE COLETIVA, V6, P329
   Bahia Ligia, 2002, Ciênc. saúde coletiva, V7, P671, DOI 10.1590/S1413-81232002000400006
   Barros AJD, 2005, REV SAUDE PUBL, V39, P523, DOI [10.1590/S0034-89102005000400002, 10.1590/s0034-89102005000400002]
   Barros Marilisa Berti de Azevedo, 2006, Ciênc. saúde coletiva, V11, P911
   Camargo MBJ, 2009, CAD SAUDE PUBLICA, V25, P1894, DOI 10.1590/S0102-311X2009000900004
   Departamento de Atencao Basica, 2012, POL NAC AT BAS E
   Dilelio AS, 2014, CAD SAUDE PUBLICA, V30, P2594, DOI 10.1590/0102-311X00118713
   FARIAS LO, 2001, CIENC SAUDE COLETIVA, V6, P405
   Farias Luís Otávio, 2003, Ciênc. saúde coletiva, V8, P585, DOI 10.1590/S1413-81232003000200019
   Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531
   Hernandes ESC, 2012, REV SAUDE PUBL, V46, P1030, DOI 10.1590/s0034-89102012000600013
   Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037
   Instituto Brasileiro de Geografia e Estatistica, 2008, PAN SAUD BRAS AC UT
   Lima Costa MF, 2004, CIENC SAUDE COLETIVA, V9, P957
   Lima-Costa Maria Fernanda F., 2002, Cad. Saúde Pública, V18, P177, DOI 10.1590/S0102-311X2002000100018
   Machado AF, 2012, CAD SAUDE PUBLICA, V28, P758, DOI 10.1590/S0102-311X2012000400015
   Malta DC, 2011, CIENC SAUDE COLETIVA, V16, P2011, DOI 10.1590/S1413-81232011000300035
   Mendoza-Sassi R, 2003, REV SAUDE PUBL, V37, P372, DOI 10.1590/s0034-89102003000300017
   Ocke-Reis CO, 2000, REV SERVICO PUBLICO, V51, P124
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Pinto Luiz Felipe, 2004, Ciênc. saúde coletiva, V9, P85
   Salvatori Rachel Torres, 2012, Organ. Soc., V19, P471, DOI 10.1590/S1984-92302012000300006
   Santos FP, 2008, CIENCIA SAUDE COLETI, V13, P1463, DOI [10.1590/S1413-81232008000500012, DOI 10.1590/S1413-81232008000500012]
   Travassos Claudia, 2008, Rev. bras. epidemiol., V11, P98, DOI 10.1590/S1415-790X2008000500010
   Viacava Francisco, 2005, Cad. Saúde Pública, V21, pS119, DOI 10.1590/S0102-311X2005000700013
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
NR 27
TC 2
Z9 2
U1 0
U2 1
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2017
VL 33
IS 10
DI 10.1590/0102-311X00141515
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FL4IG
UT WOS:000414192100001
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Fregona, G
   Cosme, LB
   Moreira, CMM
   Bussular, JL
   Dettoni, VD
   Dalcolmo, MP
   Zandonade, E
   Maciel, ELN
AF Fregona, Geisa
   Cosme, Lorrayne Belique
   Marques Moreira, Claudia Maria
   Bussular, Jose Luis
   Dettoni, Valderio do Valle
   Dalcolmo, Margareth Pretti
   Zandonade, Eliana
   Noia Maciel, Ethel Leonor
TI Risk factors associated with multidrug-resistant tuberculosis in
   Espirito Santo, Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Tuberculosis, Multidrug-Resistant, epidemiology; Drug Resistance,
   Multiple, Bacterial; Recurrence; Risk Factors; Socioeconomic Factors
ID SMOKING; EUROPE; STATE
AB OBJECTIVE: To analyze the prevalence and factors associated with multidrug-resistant tuberculosis in Espirito Santo, Brazil.
   METHODS: This is a cross-sectional study of cases of tuberculosis tested for first-line drugs (isoniazid, rifampicin, pyrazinamide, ethambutol, and streptomycin) in Espirito Santo between 2002 and 2012. We have used laboratory data and registration of cases of tuberculosis-from the Sistema Nacional de Agravos de Notificacao and Sistema para Tratamentos Especiais de Tuberculose. Individuals have been classified as resistant and non-resistant and compared in relation to the sociodemographic, clinical, and epidemiological variables. Some variables have been included in a logistic regression model to establish the factors associated with resistance.
   RESULTS: In the study period, 1,669 individuals underwent anti-tuberculosis drug susceptibility testing. Of these individuals, 10.6% showed resistance to any anti-tuberculosis drug. The rate of multidrug resistance observed, that is, to rifampicin and isoniazid, has been 5%. After multiple analysis, we have identified as independent factors associated with resistant tuberculosis: history of previous treatment of tuberculosis [recurrence (OR = 7.72; 95% CI 4.24-14.05) and re-entry after abandonment (OR = 3.91; 95% CI 1.81-8.43)], smoking (OR = 3.93; 95% CI 1.98-7.79), and positive culture for Mycobacterium tuberculosis at the time of notification of the case (OR = 3.22; 95% CI 1.15-8.99).
   CONCLUSION: The partnership between tuberculosis control programs and health teams working in the network of Primary Health Care needs to be strengthened. This would allow the identification and monitoring of individuals with a history of previous treatment of tuberculosis and smoking. Moreover, the expansion of the offer of the culture of tuberculosis and anti-tuberculosis drug susceptibility testing would provide greater diagnostic capacity for the resistant types in Espirito Santo.
C1 [Fregona, Geisa] Univ Fed Espirito Santo, Hosp Univ Cassiano Antonio de Moraes, Programa Posgrad Saude Colet, Vitoria, ES, Spain.
   [Cosme, Lorrayne Belique; Marques Moreira, Claudia Maria] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Spain.
   [Bussular, Jose Luis] Prefeitura Municipal Vila Velha, Lab Micobacteriol, Vila Velha, ES, Spain.
   [Dettoni, Valderio do Valle] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Clin Med, Vitoria, ES, Brazil.
   [Dalcolmo, Margareth Pretti] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Referencia Prof Helio Fraga, Rio De Janeiro, RJ, Brazil.
   [Zandonade, Eliana] Univ Fed Espirito Santo, Dept Estat, Vitoria, ES, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Dept Enfermagem, Vitoria, ES, Brazil.
RP Fregona, G (corresponding author), Care of Borim FSA, UNICAMP, Fac Ciencias Med, Programa Posgrad Gerontol, Ave Tessalia Vieira de Camargo 126, BR-13083887 Campinas, SP, Brazil.
EM flarbex@hotmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Fregona,
   Geisa/0000-0001-5835-8222
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [471890/20, 014/2011/Universal]
FX National Council for Scientific and Technological Development (CNPq -
   Process 471890/20; Notice 014/2011/Universal).
CR Basit A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093206
   Braga JU, 2003, B PNEUMOL SANIT, V11, P76
   Brito RC, 2010, INT J TUBERC LUNG D, V14, P24
   Dalcolmo Margareth Pretti, 2007, Rev. Saúde Pública, V41, P34, DOI [10.1590/s0034-89102007000800006, 10.1590/S0034-89102007000800006]
   Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X
   Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887
   Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963
   Garrido MD, 2015, INT J TUBERC LUNG D, V19, P531, DOI 10.5588/ijtld.14.0291
   Gunther G, 2015, EMERG INFECT DIS, V21, P409, DOI 10.3201/eid2103.141343
   Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020
   Batista JDL, 2008, INT J EPIDEMIOL, V37, P841, DOI 10.1093/ije/dyn113
   Maciel EL, 2013, INT J TUBERC LUNG D, V17, P225, DOI 10.5588/ijtld.12.0426
   Magee MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094890
   Marques M, 2010, J BRAS PNEUMOL, V36, P224, DOI 10.1590/S1806-37132010000200011
   Ministerio de Saude (MS), 2015, B EPIDEMIOL, V46, P1
   Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10
   Mor Z, 2014, INT J TUBERC LUNG D, V18, P1195, DOI 10.5588/ijtld.14.0192
   Palaci M, 2013, INT J TUBERC LUNG D, V17, P782, DOI 10.5588/ijtld.12.0500
   Slam K, 2007, INT J TUBERC LUNG D, V11, P1049
   Souza MB, 2006, J BRAS PNEUMOL, V32, P430
   Coelho AGV, 2012, MEM I OSWALDO CRUZ, V107, P760, DOI 10.1590/S0074-02762012000600009
   Vieira Rafael da Cruz Araújo, 2007, Rev. bras. epidemiol., V10, P56, DOI 10.1590/S1415-790X2007000100007
   Visser ME, 2012, PLOS ONE, V7
   WHO, 2015, GLOB TUB REP 2015
NR 24
TC 12
Z9 13
U1 0
U2 4
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2017
VL 51
AR 41
DI 10.1590/S1518-8787.2017051006688
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ET8MN
UT WOS:000400553600003
PM 28489185
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Nunes, GF
   do Prado, TN
   de Souza, FM
   Possuelo, LG
   Maciel, ELN
AF Nunes, Gabriela Ferreira
   do Prado, Thiago Nascimento
   de Souza, Fernanda Mattos
   Possuelo, Lia Goncalves
   Noia Maciel, Ethel Leonor
TI Analysis of occupational tuberculosis in the brazilian national
   recording system, 2007-2011
SO REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO
LA Portuguese
DT Article
DE Tuberculosis; Occupational Health; Health Information Systems
ID HEALTH-CARE WORKERS; SKIN-TEST; PREVALENCE; CONVERSION; INFECTION; RISK
AB Background and objectives: Health care workers (HCW) are one of the groups at risk of tuberculosis (TB). However, few studies explore this theme in other professions (non-HCW). This manuscript aimed to characterize and analyze factors associated with TB the according to their occupational status, defined as TB acquired at workplace (HCW or non-HCW). Methods: Cross-sectional study utilizing the Brazilian National Surveillance System (SINAN) database, which includes data related to occupational TB transmission. Results: The proportion of TB cases attributable to occupational TB based on data from 2007 to 2011 in Brazil was 1.6%. We analyzed 3,049 subjects, of whom 298 (10%) were TB -HCW and 2,751 (90%) were TB -non-HCW. Among the HCW, were less likely to be male (OR = 0.24 CI 95% 0.18-0.32), to be alcoholism (OR = 0.17, 95% CI 0.05 -0.54), covered under the DOTS program (OR = 0.58, 95% CI 0.43-0.77) and being transferred (OR = 0.34; 95% CI: 0.16-0.70). On the other hand, HCW are more likely to have more than 8 years of schooling (OR = 27.47, 95% CI 16.64 -45.34), have an age of 43 years or more (OR = 1.96, 95% CI 1.37-2.79) and develop extrapulmonary TB (OR = 1.60, 95% CI 1.12-2.28). Conclusions: It highlighted the need for attention to TB as an occupational disease, it is important to strengthen the discussions on the rights of workers, especially for non-HCW and the implementation of public health measures for the prevention and control of disease in both groups.
C1 [Nunes, Gabriela Ferreira; do Prado, Thiago Nascimento; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Vitoria, ES, Brazil.
   [de Souza, Fernanda Mattos] Prefeitura Municipal Campos Goytacazes, Rio De Janeiro, RJ, Brazil.
   [de Souza, Fernanda Mattos] Univ Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
   [Possuelo, Lia Goncalves] Univ Santa Cruz do Sul, Santa Cruz Do Sul, RS, Brazil.
RP do Prado, TN (corresponding author), Univ Fed Espirito Santo, Vitoria, ES, Brazil.
EM thiagonprado@gmail.com
RI Possuelo, Lia Goncalves/L-7257-2018; POSSUELO, LIA/S-7745-2019
OI Possuelo, Lia Goncalves/0000-0002-6425-3678; POSSUELO,
   LIA/0000-0002-6425-3678
CR Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P959, DOI 10.1590/S1806-37132008001100012
   CARNEIRO ANA PAULA SCALIA, 2002, J. Pneumologia, V28, P329, DOI 10.1590/S0102-35862002000600006
   Casas I, 2013, RESP MED, V107, P601, DOI 10.1016/j.rmed.2012.12.008
   COWIE RL, 1994, AM J RESP CRIT CARE, V150, P1460, DOI 10.1164/ajrccm.150.5.7952577
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   Prado Thiago Nascimento do, 2008, J. bras. pneumol., V34, P607, DOI 10.1590/S1806-37132008000800011
   Elkard I, 2016, REV PNEUMOL CLIN, V72, P179, DOI 10.1016/j.pneumo.2015.10.003
   Favero JL, 2012, REV BRAS PESQ SAUDE, V14, P31
   Ferreira S, 2011, J EPIDEMIOL COMMUN H, V65, pA107, DOI 10.1136/jech.2011.142976d.41
   He GX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124097
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494
   Louther J, 1997, AM J RESP CRIT CARE, V156, P201, DOI 10.1164/ajrccm.156.1.9611091
   Macedo LR, 2013, REV BRAS PROMOC SAUD, V26, P216
   MACIEL E, 2012, PROMOCAO SAUDE DIVER
   Malhao TA, 2010, EPIDEMIOL SERV SAUDE, V19, P245
   Ministerio da Saude (BR). Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, MAN REC CONTR TUB BR
   Nasreen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164034
   Nogueira Péricles Alves, 2011, Rev. bras. epidemiol., V14, P486, DOI 10.1590/S1415-790X2011000300013
   Prado TN, 2014, BMC INFECT DIS, V14, P1, DOI [10.1186/1471-2334-14-415, DOI 10.1186/1471-2334-14-415]
   Rogerio WP, 2015, CAD SAUDE PUBLICA, V31, P2199, DOI 10.1590/0102-311X00152414
   Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335
   Sawanyawisuth Kittisak, 2009, J Occup Med Toxicol, V4, P20, DOI 10.1186/1745-6673-4-20
   SEPKOWITZ KA, 1995, CLIN INFECT DIS, V20, P232, DOI 10.1093/clinids/20.2.232
   Souza FM, 2014, PLOS ONE, V9
   Torres-Gonzalez P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002177
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   World Health Organization, 2016, GLOB TUB REP
   World Health Organization, 2016, WHO GLOB TUB REP
NR 28
TC 0
Z9 0
U1 0
U2 4
PU UNIV SANTA CRUZ DO SUL
PI SANTA CRUZ DO SUL
PA AV INDEPENDENCIA, 2293, BAIRRO UNIVERSITARIO, SANTA CRUZ DO SUL,
   96815-900, BRAZIL
SN 2238-3360
J9 REV EPIDEMIOL CONTRO
JI Rev. Epidemiol. Control. Infecc.
PY 2017
VL 7
IS 1
DI 10.17058/reci.v7i1.7411
PG 17
WC Infectious Diseases
SC Infectious Diseases
GA EO4WR
UT WOS:000396695500006
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Snyder, RE
   Marlow, MA
   Phuphanich, ME
   Riley, LW
   Maciel, ELN
AF Snyder, Robert E.
   Marlow, Mariel A.
   Phuphanich, Melissa E.
   Riley, Lee W.
   Noia Maciel, Ethel Leonor
TI Risk factors for differential outcome following directly observed
   treatment (DOT) of slum and non-slum tuberculosis patients: a
   retrospective cohort study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Tuberculosis treatment outcome; Directly observed treatment;
   Tuberculosis cure; Urban poverty; Slum
ID PREDICTORS
AB Background: Brazil's National Tuberculosis Control Program seeks to improve tuberculosis (TB) treatment in vulnerable populations. Slum residents are more vulnerable to TB due to a variety of factors, including their overcrowded living conditions, substandard infrastructure, and limited access to healthcare compared to their non-slum dwelling counterparts. Directly observed treatment (DOT) has been suggested to improve TB treatment outcomes among vulnerable populations, but the program's differential effectiveness among urban slum and non-slum residents is not known.
   Methods: We retrospectively compared the impact of DOT on TB treatment outcome in residents of slum and non-slum census tracts in Rio de Janeiro reported to the Brazilian Notifiable Disease Database in 2010. Patient residential addresses were geocoded to census tracts from the 2010 Brazilian Census, which were identified as slum (aglomerados subnormais -AGSN) and non-slum (non-AGSN) by the Census Bureau. Homeless and incarcerated cases as well as those geocoded outside the city's limits were excluded from analysis.
   Results: In 2010, 6,601 TB cases were geocoded within Rio de Janeiro; 1,874 (27.4 %) were residents of AGSN, and 4,794 (72.6 %) did not reside in an AGSN area. DOT coverage among AGSN cases was 35.2 % (n = 638), while the coverage in non-AGSN cases was 26.2 % (n = 1,234). Clinical characteristics, treatment, follow-up, cure, death and abandonment were similar in both AGSN and non-AGSN TB patients. After adjusting for covariates, AGSN TB cases on DOT had 1.67 (95 % CI: 1.17, 2.4) times the risk of cure, 0.61 (95 % CI: 0.41, 0.90) times the risk of abandonment, and 0.1 (95 % CI: 0.01, 0.77) times the risk of death from TB compared to non-AGSN TB cases not on DOT.
   Conclusion: While DOT coverage was low among TB cases in both AGSN and non-AGSN communities, it had a greater impact on TB cure rate in AGSN than in non-AGSN populations in the city of Rio de Janeiro.
C1 [Snyder, Robert E.; Marlow, Mariel A.; Riley, Lee W.] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Snyder, Robert E.; Marlow, Mariel A.; Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.
   [Phuphanich, Melissa E.; Noia Maciel, Ethel Leonor] Rush Med Coll, 600 S Paulina St, Chicago, IL 60612 USA.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Ave Marechal Campos, BR-1468 Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Ave Marechal Campos, BR-1468 Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU US Student Fulbright Program; NIH - Fogarty International CenterUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [R25 TW009338];
   Office of AIDS Research at the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA; NIH/USAUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U2RTW006885 ICOHRTA];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of
   BrazilNational Council for Scientific and Technological Development
   (CNPq); FOGARTY INTERNATIONAL CENTERUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, U2RTW006885,
   R25TW009338, R25TW009338, U2RTW006885, R25TW009338, R25TW009338,
   R25TW009338, U2RTW006885, R25TW009338, R25TW009338, U2RTW006885,
   U2RTW006885, U2RTW006885, R25TW009338, U2RTW006885, U2RTW006885,
   U2RTW006885, R25TW009338, R25TW009338, U2RTW006885, R25TW009338] Funding
   Source: NIH RePORTER
FX RES was supported by the US Student Fulbright Program. MAM was supported
   by NIH Research Training Grant # R25 TW009338 funded by the Fogarty
   International Center and the Office of AIDS Research at the National
   Institutes of Health. ELNM was supported by Grant # U2RTW006885 ICOHRTA
   from NIH/USA and the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) of Brazil.
CR Barreira Draurio, 2007, Rev. Saúde Pública, V41, P4, DOI 10.1590/S0034-89102007000800002
   Brasil. Ministerio da Saude, 2009, GUIA VIGILANCIA EPID
   Cavalcante SC, 2007, INT J TUBERC LUNG D, V11, P544
   Choi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-360
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4
   Marlow MA, 2015, J URBAN HEALTH, V92, P622, DOI 10.1007/s11524-015-9957-0
   Orofino RD, 2012, J BRAS PNEUMOL, V38, P88, DOI 10.1590/S1806-37132012000100013
   Pinheiro RS, 2012, CAD SAUDE PUBLICA, V28, P1559, DOI 10.1590/S0102-311X2012000800014
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Scatena LM, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005548
   Snyder RE, 2014, J URBAN HEALTH, V91, P432, DOI 10.1007/s11524-013-9848-1
   Ukwaja Kingsley N, 2016, World J Methodol, V6, P118, DOI 10.5662/wjm.v6.i1.118
   Unger A, 2007, PLOS MED, V4, P1561, DOI 10.1371/journal.pmed.0040295
   Uplekar M, 2006, STOP TB STRATEGY BUI
   VanderWeele TJ, 2016, EPIDEMIOL METHOD, V3, P1
   Wang R, 2013, PREV SCI, V14, P111, DOI 10.1007/s11121-011-0221-x
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
NR 18
TC 4
Z9 4
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD SEP 20
PY 2016
VL 16
AR 494
DI 10.1186/s12879-016-1835-1
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA DW5AR
UT WOS:000383654900001
PM 27647383
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Maciel, ELN
AF Noia Maciel, Ethel Leonor
TI Post-2015 agenda strategies for tuberculosis control in Brazil:
   challenges and opportunities
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA English
DT Editorial Material
C1 [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, Es, Brazil.
RP Maciel, ELN (corresponding author), Av Marechal Campos,1468,Maruipe, BR-29043900 Vitoria, Es, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR Freire DN, 2007, EPIDEMIOL SERV SAUDE, V16, P155
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   Hartwig Shaiana Vilella, 2008, J. bras. pneumol., V34, P298, DOI 10.1590/S1806-37132008000500009
   Kritski A, 2016, REV SOC BRAS MED TRO, V49, P135, DOI 10.1590/0037-8682-0330-2015
   London School of Hygiene and Tropical Medicine, 2012, ANN S ACT SOC DET TU
   Maciel ELNA, 2012, PROMOCAO SAUDE DETER, P429
   Pereira SM, 2007, REV SAUDE PUBL, V41, DOI 10.1590/S0034-89102007000800009
   Rede TB: rede brasileira de pesquisas em tuberculose, 2016, REDE BRASILEIRA PESQ
   WHO, 2015, GLOB TUB REP 2015
   WHO, 2013, EL CAT EC BURD TB UN
   World Health Organization, 2013, GLOB STRAT TARG TUB
   World Health Organization, 2013, 13 M 2013 JUN 11 12
   Young KH, 2016, MMWR-MORBID MORTAL W, V64, P1369, DOI 10.15585/mmwr.mm6450a1
NR 13
TC 4
Z9 7
U1 0
U2 0
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PD APR-JUN
PY 2016
VL 25
IS 2
BP 423
EP 426
DI 10.5123/S1679-49742016000200021
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FE2RB
UT WOS:000408062300021
PM 27869960
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Torrens, AW
   Rasella, D
   Boccia, D
   Maciel, ELN
   Nery, JS
   Olson, ZD
   Barreira, DCN
   Sanchez, MN
AF Torrens, Ana W.
   Rasella, Davide
   Boccia, Delia
   Maciel, Ethel L. N.
   Nery, Joilda S.
   Olson, Zachary D.
   Barreira, Draurio C. N.
   Sanchez, Mauro N.
TI Effectiveness of a conditional cash transfer programme on TB cure rate:
   a retrospective cohort study in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Adherence; Conditional cash transfer; Social protection; Tuberculosis
ID TUBERCULOSIS TREATMENT OUTCOMES; RANDOMIZED CONTROLLED-TRIAL;
   MIDDLE-INCOME COUNTRIES; ECONOMIC SUPPORT; SOUTH-AFRICA; HEALTH;
   MUNICIPALITIES; INTERVENTIONS; DETERMINANTS
AB Background: Despite the efforts of the National Tuberculosis Programme, TB cure rates in Brazil are sub-optimal. The End TB Strategy for post-2015 identifies conditional cash transfer interventions as powerful tools to improve TB control indicators, including TB cure rate. This study aims to inform the new policy by evaluating the role of the Bolsa Familia Programme (BFP), one of the largest conditional cash transfer programmes in the world, on TB cure rates in Brazil.
   Methods: We undertook a retrospective cohort study, based on an unprecedented record linkage of socioeconomic and health data, to compare cases of patients newly diagnosed with TB in 2010 receiving BFP cash benefits (n = 5788) with those who did not (n = 1467) during TB treatment. We used Poisson regression with robust variance to estimate the relative risks for TB cure adjusted for known confounders.
   Results: The cure rate among patients exposed to BFP during TB treatment was 82.1% (4752/5788), 5.2% higher than among those not exposed. This was confirmed after controlling for TB type, diabetes mellitus, HIV status and other relevant clinical and socioeconomic covariates (RR = 1.07, 95% CI 1.04 to 1.11 for cure rates among BFP beneficiaries). This association seemed higher for patients not under directly observed treatment (RR = 1.11; 95% CI 1.05 to 1.16).
   Conclusions: Although further research is needed, this study suggests that conditional cash transfer programmes can contribute to improve TB cure rate in Brazil.
C1 [Torrens, Ana W.] Univ Brasilia, Trop Med Dept, Brasilia, DF, Brazil.
   [Rasella, Davide] Oswaldo Cruz Fdn FIOCRUZ, Brasilia, DF, Brazil.
   [Boccia, Delia] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.
   [Maciel, Ethel L. N.] Univ Fed Espirito Santo, Vitoria, DF, Brazil.
   [Nery, Joilda S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Olson, Zachary D.] Univ Calif Berkeley, Berkeley, CA 94720 USA.
   [Barreira, Draurio C. N.] Minist Hlth Brazil, Natl TB Program, Brasilia, DF, Brazil.
   [Sanchez, Mauro N.] Fed Univ Brasilia, Brasilia, DF, Brazil.
RP Torrens, AW (corresponding author), Univ Brasilia, Trop Med Dept, Brasilia, DF, Brazil.
EM aninhawt@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; Sanchez, Mauro/AAU-2404-2020;
   Rasella, Davide/ABG-4182-2020
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Sanchez,
   Mauro/0000-0002-0472-1804; Rasella, Davide/0000-0002-7260-4386
FU Wellcome TrustWellcome Trust [104473] Funding Source: Medline
CR Adato M., 2008, REV EVIDENCE IMPACTS
   Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438
   Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824
   Buse K, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0098-8
   Coordenacao-Geral do Programa Nacional de Controle da Tuberculose. Secretaria de Vigilancia em Saude - Ministerio da Saude, 2012, EP B TUB, V43
   Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655
   de Oliveira NF, 2013, REV LAT-AM ENFERM, V21, P507, DOI 10.1590/S0104-11692013000200006
   Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453
   Ferreira HD, 2014, CIENC SAUDE COLETIVA, V19, P1533, DOI 10.1590/1413-81232014195.06122013
   Gaarder MM, 2010, J DEV EFFECT, V2, P6, DOI 10.1080/19439341003646188
   Gopalan SS, 2014, SOC SCI MED, V100, P72, DOI 10.1016/j.socscimed.2013.10.030
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   Heise L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18615
   Hoddinott J, 2009, 09 UN FAO
   Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900
   Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137
   Lindert Kathy, 2007, 0709 WORLD BANK
   Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014
   Lutge E, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-236
   Lutge E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-154
   McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074
   Ministerio da Saude. Secretaria de Vigilancia em Saude - Ministerio da Saude, 2014, CONTR TUB BRAZ ADV I, V44
   Ministerio do Desenvolvimento Social e Combate a Fome, BPC CAD UN
   de Andrade LOM, 2015, LANCET, V385, P1343, DOI 10.1016/S0140-6736(14)61494-X
   Nery JS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003357
   Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533
   Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1
   Rocha C, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P50, DOI 10.5588/ijtld.10.0447
   Schnell R, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-41
   Shei A, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-10
   Soaeres FV, 2007, EVALUATING IMPACT BR
   Soares TS, 2012, 89 INT POL CTR INCL
   Sripad A, 2014, INT J TUBERC LUNG D, V18, P44, DOI 10.5588/ijtld.13.0253
   UNDP, 2014, CASH TRANSF HIV PREV
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   WHO, 2015, GLOB TUB REP 2015
   Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675
NR 37
TC 41
Z9 43
U1 0
U2 22
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR
PY 2016
VL 110
IS 3
SI SI
BP 199
EP 206
DI 10.1093/trstmh/trw011
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DF5WC
UT WOS:000371422300013
PM 26884501
OA Green Accepted
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Sales, CMM
AF Noia Maciel, Ethel Leonor
   Martins Sales, Carolina Maia
TI Epidemiological surveillance of tuberculosis in Brazil: How can more
   progress be made?
SO EPIDEMIOLOGIA E SERVICOS DE SAUDE
LA Portuguese
DT Editorial Material
ID SPATIAL-ANALYSIS; ESPIRITO-SANTO; TRANSMISSION; COMMUNITY; VITORIA;
   STATE
C1 [Noia Maciel, Ethel Leonor; Martins Sales, Carolina Maia] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, LabEPI, Av Marechal Campos 1468, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR [Anonymous], 2011, GUIA PRAT MATR SAUD
   Vieira RDA, 2008, REV SOC BRAS MED TRO, V41, P82, DOI 10.1590/S0037-86822008000100017
   Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136
   Ribeiro FKC, 2015, CLIN INFECT DIS, V61, P758, DOI 10.1093/cid/civ365
   Fok A, 2008, INT J TUBERC LUNG D, V12, P480
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395
   MADICO G, 1995, LANCET, V345, P416, DOI 10.1016/S0140-6736(95)90401-8
   Sales CMM, 2010, REV SOC BRAS MED TRO, V43, P435, DOI 10.1590/S0037-86822010000400020
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2011, MAN REC CONTR TUB BR
   Mota Fábio Frias, 2003, Cad. Saúde Pública, V19, P915, DOI 10.1590/S0102-311X2003000400014
   SANTOS M., 1996, NATUREZA ESPACO TECN
   Sebek M, 2000, INT J TUBERC LUNG D, V4, pS45
   SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402
   WHO, 2015, GLOB TUB REP 2015
NR 14
TC 7
Z9 9
U1 0
U2 1
PU MINISTERIO DA SAUDE
PI BRASILIA
PA ESPLANADA MINISTERIOS, BLOCO G, BRASILIA, DF 70058-900, BRAZIL
SN 1679-4974
EI 2237-9622
J9 EPIDEMIOL SERV SAUDE
JI Epidemiol. Serv. Saude
PD JAN-MAR
PY 2016
VL 25
IS 1
BP 175
EP 178
DI 10.5123/S1679-49742016000100018
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FD9MH
UT WOS:000407846000018
PM 27861690
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Kritski, A
   Barreira, D
   Junqueira-Kipnis, AP
   Moraes, MO
   Campos, MM
   Degrave, WM
   Miranda, SS
   Krieger, MA
   Chimara, E
   Morel, C
   Dalcolmo, MP
   Maciel, ELN
   Evangelista, MDN
   Villa, TS
   Sanchez, M
   Costa, FD
   Queiroz, I
   Oliveira, MM
   Souza, R
   Silva, JRLE
   Ruffino-Netto, A
AF Kritski, Afranio
   Barreira, Draurio
   Junqueira-Kipnis, Ana Paula
   Moraes, Milton Ozorio
   Campos, Maria Martha
   Degrave, Wim Mauritz
   Miranda, Silvana Spindola
   Krieger, Marco Aurelio
   Chimara, Erica
   Morel, Carlos
   Dalcolmo, Margareth Pretti
   Noia Maciel, Ethel Leonor
   Nantua Evangelista, Maria do Socorro
   Villa, Teresa Scatena
   Sanchez, Mauro
   Costa, Fernanda Dockhorn
   Queiroz, Inacio
   Oliveira, Martha Maria
   Souza Junior, Ruy
   Lapa e Silva, Jose Roberto
   Ruffino-Netto, Antonio
TI Brazilian Response to Global End TB Strategy: The National Tuberculosis
   Research Agenda
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
C1 [Kritski, Afranio; Junqueira-Kipnis, Ana Paula; Campos, Maria Martha; Miranda, Silvana Spindola; Krieger, Marco Aurelio; Chimara, Erica; Dalcolmo, Margareth Pretti; Noia Maciel, Ethel Leonor; Villa, Teresa Scatena; Sanchez, Mauro; Oliveira, Martha Maria; Lapa e Silva, Jose Roberto; Ruffino-Netto, Antonio] Rede Brasileira Pesquisa TB Rede TB, Rio De Janeiro, RJ, Brazil.
   [Kritski, Afranio; Lapa e Silva, Jose Roberto] Univ Fed Rio de Janeiro, Fac Med, Programa Acad TB, Rio De Janeiro, RJ, Brazil.
   [Barreira, Draurio; Nantua Evangelista, Maria do Socorro; Costa, Fernanda Dockhorn; Souza Junior, Ruy] Minist Saude, Secretaria Vigilancia Saude, Programa Nacl Controle TB, Brasilia, DF, Brazil.
   [Junqueira-Kipnis, Ana Paula] Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Imunopatol Doencas Infecciosas, Goiania, Go, Brazil.
   [Moraes, Milton Ozorio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil.
   [Campos, Maria Martha] Pontificia Univ Catolica Rio Grande do Sul, Inst Toxicol & Farmacol, Porto Alegre, RS, Brazil.
   [Degrave, Wim Mauritz] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, Rio De Janeiro, RJ, Brazil.
   [Miranda, Silvana Spindola] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Belo Horizonte, MG, Brazil.
   [Krieger, Marco Aurelio] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Genom Func, Curitiba, Parana, Brazil.
   [Chimara, Erica] Adolfo Lutz Inst, Lab Micobacterias, Sao Paulo, SP, Brazil.
   [Morel, Carlos; Oliveira, Martha Maria] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, RJ, Brazil.
   [Dalcolmo, Margareth Pretti] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Spain.
   [Nantua Evangelista, Maria do Socorro] Univ Brasilia, Fac Ciencias Saude, Dept Enfermagem, Brasilia, DF, Brazil.
   [Villa, Teresa Scatena] Univ Sao Paulo, Escola Enfermagem Ribeirao Preto, Sao Paulo, Brazil.
   [Sanchez, Mauro] Univ Brasilia, Fac Ciencias Saude, Dept Saude Publ, Brasilia, DF, Brazil.
   [Queiroz, Inacio] Grp Pela Vidda, Rio De Janeiro, Brazil.
   [Ruffino-Netto, Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
RP Kritski, A (corresponding author), Rede Brasileira Pesquisa TB Rede TB, Rio De Janeiro, RJ, Brazil.; Kritski, A (corresponding author), Univ Fed Rio de Janeiro, Fac Med, Programa Acad TB, Rio De Janeiro, RJ, Brazil.
EM kritskia@gmail.com
RI Campos, Maria Martha M/J-8829-2015; Krieger, Marco/AAE-8611-2020;
   Chimara, Erica/U-4381-2019; Morel, Carlos/Q-9657-2019; Sanchez,
   Mauro/AAU-2404-2020; Morel, Carlos M/B-4079-2009; Moraes, Milton
   Ozorio/G-9753-2011; Kritski, Afranio/I-6760-2016; Junqueira-Kipnis, Ana
   Paula/I-5534-2012; Lapa e Silva, Jose R./AAS-4793-2020; Maciel, Ethel
   Leonor LN/G-1027-2012; Villa, Tereza Cristina Scatena/K-7891-2013
OI Campos, Maria Martha M/0000-0002-1153-3633; Morel,
   Carlos/0000-0003-2752-0009; Sanchez, Mauro/0000-0002-0472-1804; Morel,
   Carlos M/0000-0003-2752-0009; Moraes, Milton Ozorio/0000-0003-2653-0037;
   Lapa e Silva, Jose R./0000-0003-3116-0253; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Villa, Tereza Cristina
   Scatena/0000-0001-8927-2624; Campos, Maria/0000-0001-7738-9892; kritski,
   afranio/0000-0002-5900-6007
FU CNPq/INCTNational Council for Scientific and Technological Development
   (CNPq) [573548/2008-0]; ICOHRTA AIDS/TB [5 U2R TW006883-10]
FX This work was funded by CNPq/INCT - Process: 573548/2008-0 and by the
   ICOHRTA AIDS/TB grant # 5 U2R TW006883-10.
CR BRICS Health Ministers, 2014, COMM 4 M
   Dirlikov E, 2015, ANN INTERN MED, V163, P52, DOI 10.7326/M14-2210
   Kritski Afranio, 2010, Rev Port Pneumol, V16SA, pS67, DOI 10.1016/S0873-2159(15)30095-7
   Kritski AL, 2007, REV SAUDE PUBL, V41
   Lienhardt C, 2014, NATURE, V507, P401, DOI 10.1038/507401a
   MS-Ministerio da Saude, 2011, MAN REC CONTR TUB BR
   Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   WHO, 2015, GLOB TUB REP 2015
   World Health Organization (WHO), 2015, GLOB PLAN STOP ENG T
NR 11
TC 11
Z9 11
U1 0
U2 6
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2016
VL 49
IS 1
BP 135
EP 145
DI 10.1590/0037-8682-0330-2015
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DH5RA
UT WOS:000372848300023
PM 27163579
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Rogerio, WP
   do Prado, TN
   de Souza, FM
   Pinheiro, JD
   Rodrigues, PM
   Sant'anna, APDN
   de Jesus, KG
   Cerutti, C
   Lima, RDD
   Maciel, ELN
AF Rogerio, Wesley Pereira
   do Prado, Thiago Nascimento
   de Souza, Fernanda Mattos
   Pinheiro, Jair dos Santos
   Rodrigues, Patrcia Marques
   do Nascimento Sant'anna, Amanda Pissinate
   de Jesus, Kassia Gomes
   Cerutti Junior, Crispim
   Duarte Lima, Rita de Cassia
   Noia Maciel, Ethel Leonor
TI Prevalence of infection with Mycobacterium tuberculosis and associated
   factors in community health workers in Brazil based on the tuberculin
   skin test
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Tuberculin Test; Tuberculosis; Mycobacterium tuberculosis; Community
   Health Workers
ID CARE WORKERS; RISK; CONVERSION; STUDENTS; VITORIA; STATE
AB This article aimed to determine the prevalence of latent Mycobacterium tuberculosis infection and associated factors in community health workers (CHW) in Brazil, using two cutoff points for the tuberculin skin test (5mm and 10mm). This was a cross-sectional study with data on gender, age, BCG scar, working in a primary care unit (PCU), having a household contact with tuberculosis (TB), alcohol consumption, previous tuberculin skin test (TST), smoking, time on the job as CHW, and comorbidities. Logistic regression was used to estimate odds ratios (OR) and to control for confounding. TST was applied and read after 48-72 hours. Prevalence rates were 57.88% and 37.3%, respectively, for the 5mm and 10mm TST cutoffs. Variables that remained associated with positive TST using the 10mm cutoff were working in a primary care unit that had implemented a Tuberculosis Control Program (TCP) and history of household contact with TB. Variables associated with the 5mm cutoff were working in a primary care unit with a TCP. Necessary actions at the local level include awareness-raising and strengthening of continuing education.
C1 [Rogerio, Wesley Pereira; do Prado, Thiago Nascimento; de Souza, Fernanda Mattos; Rodrigues, Patrcia Marques; do Nascimento Sant'anna, Amanda Pissinate; de Jesus, Kassia Gomes; Cerutti Junior, Crispim; Duarte Lima, Rita de Cassia; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
   [Pinheiro, Jair dos Santos] Secretaria Municipal Saude Manaus, Dept Vigilancia Ambiental & Epidemiol, Manaus, Amazonas, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Enfermagem, Ave Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Pinheiro, Jair/AAE-5785-2019; Cerutti, Crispim/C-4529-2011; Maciel,
   Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Pereira Rogerio,
   Wesley/0000-0001-9068-7827
CR [Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]
   [Anonymous], 2007, GLOB TUB CONTR SURV
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   Brasil. Departamento de Vigilancia Epidemiologica Secretaria de Vigila^ncia em Saude Ministerio da oes Saude, 2011, MAN REC CONTR TUB BR
   Cailleaux-Cezar M, 2009, INT J TUBERC LUNG D, V13, P190
   Chermont AB, 11 C MED PNEUM TIS R
   Coelho Magna Adaci de Quadros, 2009, Rev. bras. educ. med., V33, P535, DOI 10.1590/S0100-55022009000400004
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   Coordenacao Geral do Programa Nacional de Controle da Tuberculose Secretaria de Vigilancia em Saude Departamento de Vigilancia das Doencas Transmissiveis Ministerio da Saude, 25CGPNCTDEVITSVSMS
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   Do AN, 1999, INT J TUBERC LUNG D, V3, P377
   Prado Thiago Nascimento do, 2008, J. bras. pneumol., V34, P607, DOI 10.1590/S1806-37132008000800011
   de Oliveira SMDL, 2007, REV LAT-AM ENFERM, V15, P1120, DOI 10.1590/S0104-11692007000600010
   Ferreira FM, 1998, THESIS
   FRANCO C, 2004, ARQ CI SAUDE, V11, P244
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494
   Kassim S, 2000, INT J TUBERC LUNG D, V4, P321
   Larsen NM, 2002, CLIN INFECT DIS, V35, P796, DOI 10.1086/342333
   Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798
   Maciel EL, 2012, QUESTOES AMBIENTAIS, P39
   Maciel ELN, 2005, REV SOC BRAS MED TRO, V38, P469, DOI 10.1590/S0037-86822005000600004
   Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740
   Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120
   Minayo MC, 1990, PROGRAMA AGENTE COMU
   Ministerio da Saude, 2002, MAN NORM CONTR TUB
   Ministerio da Saude, 2001, B ALERTA, V7
   Moreira TR, 2010, REV SAUDE PUBL, V44, P332, DOI [10.1590/S0034-89102010000200014, 10.1590/s0034-89102010000200014]
   Moreno S, 2001, ARCH INTERN MED, V161, P1760, DOI 10.1001/archinte.161.14.1760
   Muniz J N, 1999, B PNEUMOL SANIT, V7, P33
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P1377, DOI 10.1590/S0102-311X2008000600018
   Maciel EL, 2007, REV SOC BRAS MED TRO, V40, P397, DOI 10.1590/S0037-86822007000400004
   Maciel ELN, 2009, J BRAS PNEUMOL, V35, P83, DOI 10.1590/S1806-37132009000100012
   Nunes Mônica de Oliveira, 2002, Cad. Saúde Pública, V18, P1639, DOI 10.1590/S0102-311X2002000600018
   Oliveira JS, 2011, REV HCPA FM U FED RI, V31, P13
   Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13
   Pereira AL, 2007, MED CUTAN IBER LAT A, V35, P35
   Pôrto Ângela, 2007, Rev. Saúde Pública, V41, P43, DOI 10.1590/s0034-89102007000800007
   Rodrigues PM, 2009, J BRAS PNEUMOL, V35, P351, DOI 10.1590/S1806-37132009000400009
   Rogerio WP, 2013, CIENC SAUDE COLETIVA, V18, P1331, DOI 10.1590/S1413-81232013000500018
   Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335
   Schwartzman K, 1996, AM J RESP CRIT CARE, V154, P1006, DOI 10.1164/ajrccm.154.4.8887599
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2013, TUB AL COM SOC AF CO, V44
   Silva Vania Maria Carneiro da, 2004, J. bras. pneumol., V30, P459, DOI 10.1590/S1806-37132004000500010
   Silva VMC, 2001, J BRAS PNEUMOL, V27, P77
   Silva-Junior JS, 2001, THESIS
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   WHO, 2009, WHO POL TB INF CONTR
   [World Health Organization WHO HTM TB], 2008, IMPL STOP TB STRAT H
   Yushiara EV, 2013, THESIS
NR 50
TC 5
Z9 5
U1 0
U2 1
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD NOV
PY 2015
VL 31
IS 10
BP 2199
EP 2210
DI 10.1590/0102-311X00152414
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DA3ZA
UT WOS:000367738700023
PM 26735386
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Dias, ED
   do Prado, TN
   Guimaraes, ALD
   Ramos, MC
   Sales, CMM
   Lima, EDA
   Sant'Anna, CC
   Sanchez, M
   Maciel, EL
AF dos Santos Dias, E.
   do Prado, T. N.
   da Silva Guimaraes, A. L.
   Ramos, M. C.
   Sales, C. M. M.
   de Fatima Almeida Lima, E.
   Sant'Anna, C. C.
   Sanchez, M.
   Maciel, E. L.
TI Childhood tuberculosis and human immunodeficiency virus status in
   Brazil: a hierarchical analysis
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE coinfection; HIV/AIDS; child health
ID RIO-DE-JANEIRO; PULMONARY TUBERCULOSIS; HIV COINFECTION; CHILDREN;
   SPUTUM; MODEL
AB SETTING: Human immunodeficiency virus (HIV) infection may impact tuberculosis (TB) diagnosis, clinical presentation and treatment outcomes in children as the signs and symptoms of both diseases overlap.
   OBJECTIVE: To compare the sociodemographic and clinical profiles of childhood TB according to HIV status in Brazil.
   METHODS: This was a cross-sectional study of data on subjects aged <15 years retrieved from the Brazilian National Electronic Disease Registry (Sistema de Informacao de Agravos de Notificacao) database on TB to compare TB-HIV coinfected patients and patients with TB only registered between 2007 and 2011. A hierarchical logistic regression model was applied.
   RESULTS: Of 6091 cases analysed, 780(12%) were TB-HIV patients, while 5311 (87%) presented with TB only. TB-HIV patients were more likely to be institutionalised (OR 2.22, 95%CI 1.43-3.46), to present with relapsed TB (OR 5.03, 95%CI 2.02-12.5) and be readmitted after treatment default (OR 16.7, 95%CI 4.34-64.46). They were also more likely to have unfavourable outcomes, including default (OR 2.85, 95%CI 1.81-4.49), death due to TB (OR 2.76, 95%CI 1.27-6.03) and death from other causes (OR 5.59, 95%CI 2.63-11.8).
   CONCLUSION: Our study highlights the challenges of using national registers for research into childhood TB.
C1 [dos Santos Dias, E.; do Prado, T. N.; da Silva Guimaraes, A. L.; Sales, C. M. M.; Maciel, E. L.] Univ Fed Espirito Santo, Lab Epidemiol, BR-29040091 Vitoria, ES, Brazil.
   [dos Santos Dias, E.; do Prado, T. N.; da Silva Guimaraes, A. L.; Ramos, M. C.; Sales, C. M. M.; de Fatima Almeida Lima, E.; Maciel, E. L.] Univ Fed Espirito Santo, Sch Nursing, BR-29040091 Vitoria, ES, Brazil.
   [do Prado, T. N.; Sales, C. M. M.; Maciel, E. L.] Univ Fed Espirito Santo, Postgrad Programme Infect Dis, BR-29040091 Vitoria, ES, Brazil.
   [Sant'Anna, C. C.] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, RJ, Brazil.
   [Sanchez, M.] Univ Brasilia, Dept Publ Hlth, Brasilia, DF, Brazil.
   [Maciel, E. L.] Univ Fed Espirito Santo, Postgrad Program Publ Hlth, BR-29040091 Vitoria, ES, Brazil.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Av Marechal Campos,1468 Maruipe, BR-29040091 Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; Sanchez, Mauro/AAU-2404-2020; Anna,
   Clemax Sant/H-7923-2019
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Sanchez,
   Mauro/0000-0002-0472-1804; Anna, Clemax Sant/0000-0001-8732-8065
CR Alves R, 2003, INT J TUBERC LUNG D, V7, P198
   Brazilian Ministry of Health, 2011, MON AIDS MON ONL SYS
   Brazilian Ministry of Health, 2010, MAN REC CONTR TUB BR
   Brazilian Ministry of Health, 2002, TB EP SURV GUID PREP
   Cerqueira ACB, 2008, UFES REV ODONT, V10, P33
   Coovadia HM, 1998, INT J TUBERC LUNG D, V2, P844
   Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009
   DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   do Prado TN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-415
   Fuchs SC, 1996, REV SAUDE PUBL, V30, P168, DOI 10.1590/S0034-89101996000200009
   Gomes T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-9
   Maciel E L., 2012, DETERMINANTES SOCIAI
   Marais BJ, 2007, J INFECT DIS, V196, pS76, DOI 10.1086/518659
   Matos TP, 2012, J PEDIAT-BRAZIL, V88, P335, DOI 10.2223/JPED.2207
   Ministry of Health, 2004, BRAZ INF SYST NOT DI
   Ministry of Health Brazil Secretaria de Vigilancia em Saude Departamento de DST Aids e Hepatites Virais, 2013, B EP AIDS DST
   Miranda AE, 2011, J TROP PEDIATRICS, V57, P296, DOI 10.1093/tropej/fmq087
   Moore HA, 2011, INT J TUBERC LUNG D, V15, P1185, DOI 10.5588/ijtld.10.0681
   Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07
   Pan American Health Organization Regional office of the World Health Organization, 2011, TUB REG AM REG REP 2
   Reis-Santos B, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-61
   Sanchez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033129
   Sant'Anna Clemax Couto, 2002, J Pediatr (Rio J), V78 Suppl 2, pS205
   Villa TCS, 2008, REV ESC ENFERM USP, V42, P98, DOI 10.1590/S0080-62342008000100013
   Venturini E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S5
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   *WHO, 2004, WHOHTMTB2004330
   World Health Organization, 2007, WHOHTMTB2007381
   World Health Organization, 2011, GLOB HIV AIDS RESP
   World Health Organization, 2013, GLOB TUB REP
   World Health Organization, 2014, WHOHTMTB2006371
   Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2
NR 33
TC 4
Z9 4
U1 0
U2 5
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD NOV
PY 2015
VL 19
IS 11
BP 1305
EP 1311
DI 10.5588/ijtld.14.0619
PG 7
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA CV4XQ
UT WOS:000364270200008
PM 26467582
DA 2020-12-15
ER

PT J
AU Reis-Santos, B
   Pellacani-Posses, I
   Macedo, LR
   Golub, JE
   Riley, LW
   Maciel, EL
AF Reis-Santos, B.
   Pellacani-Posses, I.
   Macedo, L. R.
   Golub, J. E.
   Riley, L. W.
   Maciel, E. L.
TI Directly observed therapy of tuberculosis in Brazil: associated
   determinants and impact on treatment outcome
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE surveillance system; vulnerable populations; conceptual models; logistic
   models; health impact assessment
ID EXTRAPULMONARY TUBERCULOSIS; SOCIOECONOMIC-STATUS; INTERVENTIONS;
   DISEASES; NEEDS
AB SETTING: All Brazilian states.
   OBJECTIVES: To assess the determinants of tuberculosis (TB) in patients undergoing directly observed therapy (DOT) and the impact of DOT on treatment outcomes.
   DESIGN: This is a cross-sectional study among TB patients aged 18 years conducted in 2011. The primary outcome was the status of DOT received, while the secondary was the outcome of anti-tuberculosis treatment.
   RESULTS: In 2011, 35 775 (38.3%) subjects received DOT. The odds of receiving DOT were higher in patients with the following characteristics: brown/mestizo patients (OR 1.18, 95%CI 1.14-1.22) and those of other ethnic groups (OR 2.01, 95%CI 1.79-2.27) compared to Whites, alcohol users (OR 1.37, 95%CI 1.28-1.47) and those with mental disorders (OR 1.88, 95%CI 1.54-2.29). The odds of receiving DOT were lower in human immunodeficiency virus positive patients (OR 0.64, 95%CI 0.60-0.68). Patients who did not receive DOT were more likely to default from anti-tuberculosis treatment (OR 0.62, 95%CI 0.57-0.66), die due to TB (OR 0.68, 95%CI 0.61-0.77) and to have unknown treatment outcomes (OR 0.71, 95%CI 0.66-0.76). The adjusted preventable fraction of DOT in the reduction of unfavorable outcomes was 25%.
   CONCLUSION: Sociodemographic and clinical characteristics are determinants of anti-tuberculosis treatment outcomes in patients undergoing DOT; DOT use led to a 25% reduction in unfavorable outcomes.
C1 [Reis-Santos, B.; Pellacani-Posses, I.; Macedo, L. R.; Maciel, E. L.] Univ Fed Espirito Santo, Lab Epi Lab Epidemiol, Vitoria, Espirito Santo, Brazil.
   [Golub, J. E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Riley, L. W.] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Sch Publ Hlth, Berkeley, CA 94720 USA.
RP Reis-Santos, B (corresponding author), Univ Fed Espirito Santo, Lab Epi Lab Epidemiol, Av Marechal Campos,1468 Maruipe Vitoria, BR-29040091 Espirito Santo, Brazil.
EM reissantos.barbara@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; Macedo, Laylla
   Ribeiro/AAV-5154-2020; Reis-Santos, Barbara/A-3149-2014
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos,
   Barbara/0000-0001-6952-0352; Ribeiro Macedo, Laylla/0000-0002-6246-3559;
   Pellacani Pereira das Posses, Isabela/0000-0001-5822-9789
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil
   Doencas Negligenciadas; International Clinical, Operational and Health
   Services Research and Training Award [5 U2R TW006883-02]
FX The study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico/Brazil Doencas Negligenciadas-2012 and
   International Clinical, Operational and Health Services Research and
   Training Award 5 U2R TW006883-02.
CR Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007
   Andrade R L, 2005, SMAD, V1, P1
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Bergel FS, 2005, REV SAUDE PUBL, V39, P898, DOI 10.1590/S0034-89102005000600005
   Brazil Ministerio da Saude, 2011, MAN REC CONTR TUB, P284
   Buchillet, 1998, Cad Saude Publica, V14, P181, DOI 10.1590/S0102-311X1998000100026
   Ferreira Silvana Margarida Benevides, 2005, J. bras. pneumol., V31, P427, DOI 10.1590/S1806-37132005000500011
   Gomes T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-9
   Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3
   Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395
   Maciel ELNA, 2012, PROMOCAO SAUDE DETER, P429
   Maciel Ethel Leonor Noia, 2008, J Bras Pneumol, V34, P506, DOI 10.1590/S1806-37132008000700011
   Ministerio da Saude Brazil, 2004, SIST INF AGR NOT
   Ministerio da Saude Brazil, 2011, MUN PRIOR CONTR TUB
   Muniz J N, 1999, B PNEUMOL SANIT, V7, P33
   Sanchez AIM, 2009, REV LAT-AM ENFERM, V17, P689, DOI 10.1590/S0104-11692009000500015
   Naing C, 2013, LUNG, V191, P27, DOI 10.1007/s00408-012-9440-6
   Paixão Lúcia Miana M., 2007, Rev. Saúde Pública, V41, P205, DOI 10.1590/s0034-89102007000200006
   Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2
   Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15
   Rothman KJ, 2011, EPIDEMIOLOGIA MODERN
   Sa LD, 2007, ENFERMAGEM, V16, P712
   Stop TB Partnership, 2006, STOP TB PARTN GLOB P
   Stop TB Partnership World Health Organization, 2006, WHOHTMSTB200637
   Terra MF, 2008, REV LAT-AM ENFERM, V16, P659, DOI 10.1590/S0104-11692008000400002
   Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Vieira Amadeu Antonio, 2008, J. bras. pneumol., V34, P159, DOI 10.1590/S1806-37132008000300006
   Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2
   Wells WA, 2013, LANCET INFECT DIS, V13, P449, DOI 10.1016/S1473-3099(13)70025-2
   World Health Organization, 2012, WHOHTMTB20126
   World Health Organization, 2014, WHOHTMTB201408
NR 33
TC 9
Z9 12
U1 0
U2 11
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD OCT
PY 2015
VL 19
IS 10
BP 1188
EP 1193
DI 10.5588/ijtld.14.0776
PG 6
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA CS5YR
UT WOS:000362154700011
PM 26459531
DA 2020-12-15
ER

PT J
AU Ribeiro, FKC
   Pan, W
   Bertolde, A
   Vinhas, SA
   Peres, RL
   Riley, L
   Palaci, M
   Maciel, EL
AF Correa Ribeiro, Fabiola Karla
   Pan, William
   Bertolde, Adelmo
   Vinhas, Solange Alves
   Peres, Renata Lyrio
   Riley, Lee
   Palaci, Moises
   Maciel, Ethel Leonor
TI Genotypic and Spatial Analysis of Mycobacterium tuberculosis
   Transmission in a High-Incidence Urban Setting
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE tuberculosis; molecular epidemiology; transmission; spatial analysis
ID HIGH-INCIDENCE AREA; MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS;
   SAN-FRANCISCO; RISK-FACTORS; PATTERNS; COMMUNITY; BRAZIL; METAANALYSIS;
   INFECTIONS
AB Background. Genotyping Mycobacterium tuberculosis isolates allows study of dynamics of tuberculosis transmission, while geoprocessing allows spatial analysis of clinical and epidemiological data. Here, genotyping data and spatial analysis were combined to characterize tuberculosis transmission in Vitoria, Brazil, to identify distinct neighborhoods and risk factors associated with recent tuberculosis transmission.
   Methods. From 2003 to 2007, 503 isolates were genotyped by IS6110 restriction fragment length polymorphism (RFLP) and spoligotyping. The analysis included kernel density estimation, K-function analysis, and a t test distance analysis. Mycobacterium tuberculosis isolates belonging to identical RFLP patterns (clusters) were considered to represent recent tuberculosis infection (cases).
   Results. Of 503 genotyped isolates, 242 (48%) were categorized into 70 distinct clusters belonging to 12 RFLP families. The proportion of recent transmission was 34.2%. Kernel density maps indicated 3 areas of intense concentration of cases. K-function analysis of the largest RFLP clusters and families showed they co-localized in space. The distance analysis confirmed these results and demonstrated that unique strain patterns (controls) randomly distributed in space. A logit model identified young age, positive smear test, and lower Index of Quality of Urban Municipality as risk factors for recent transmission. The predicted probabilities for each neighborhood were mapped and identified neighborhoods with high risk for recent transmission.
   Conclusions. Spatial and genotypic clustering of M. tuberculosis isolates revealed ongoing active transmission of tuberculosis caused by a small subset of strains in specific neighborhoods of the city. Such information provides an opportunity to target tuberculosis transmission control, such as through rigorous and more focused contact investigation programs.
C1 [Correa Ribeiro, Fabiola Karla; Vinhas, Solange Alves; Peres, Renata Lyrio; Palaci, Moises] Univ Fed Espirito Santo, Grad Program Infect Dis, Vitoria, Brazil.
   [Pan, William] Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
   [Pan, William] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.
   [Bertolde, Adelmo] Univ Fed Espirito Santo, Dept Stat, Vitoria, Brazil.
   [Riley, Lee] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Maciel, Ethel Leonor] Univ Fed Espirito Santo, Grad Program Publ Hlth, Vitoria, Brazil.
RP Ribeiro, FKC (corresponding author), Lab Micobacteriol, Av Marechal Campos, BR-1468 Vitoria, Espirito Santo, Brazil.
EM fabiolarib@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Bertolde, Adelmo
   Inacio/0000-0002-1747-9957
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) by
   Edital Ministerio da Ciencia, Tecnologia e Inovacao/CNPq/MS-SCTIE-DECIT
   [25/2006]; National institute of Health on the International Clinical,
   Operational and Health Services Research Training Award [5 U2R
   TW006883-02, ENSP-011-LIV-10-2-3]; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883] Funding Source: NIH RePORTER
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) by Edital Ministerio da Ciencia,
   Tecnologia e Inovacao/CNPq/MS-SCTIE-DECIT No. 25/2006 and the National
   institute of Health on the International Clinical, Operational and
   Health Services Research Training Award (grant number 5 U2R TW006883-02
   and ENSP-011-LIV-10-2-3). Travel support for W. P. was provided by the
   Duke Brazil Initiative.
CR Baddeley AJ, 2000, STAT NEERL, V54, P329, DOI 10.1111/1467-9574.00144
   Barnes PF, 1997, JAMA-J AM MED ASSOC, V278, P1159, DOI 10.1001/jama.278.14.1159
   Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679
   Brasil. Ministerio da Saude, SAL AP GEST ESTR
   Chan-Yeung M, 2005, INT J TUBERC LUNG D, V9, P1320
   Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   de Boer AS, 1999, J INFECT DIS, V180, P1238, DOI 10.1086/314979
   de Vries G, 2008, J CLIN MICROBIOL, V46, P3924, DOI 10.1128/JCM.00793-08
   Emch M, 2012, ANN ASSOC AM GEOGR, V102, P1004, DOI 10.1080/00045608.2012.671129
   Ferrazoli L, 2000, INT J TUBERC LUNG D, V4, P18
   Fok A, 2008, INT J TUBERC LUNG D, V12, P480
   Giebultowicz S, 2011, HEALTH PLACE, V17, P490, DOI 10.1016/j.healthplace.2010.12.004
   Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517
   Haase I, 2007, INT J TUBERC LUNG D, V11, P632
   Houben RMGJ, 2009, TROP MED INT HEALTH, V14, P892, DOI 10.1111/j.1365-3156.2009.02316.x
   Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997
   KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404
   Klovdahl AS, 2001, SOC SCI MED, V52, P681, DOI 10.1016/S0277-9536(00)00170-2
   Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7
   Lopez Leonardo, 2014, BMC Res Notes, V7, P234, DOI 10.1186/1756-0500-7-234
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1403
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395
   Maher D, 2006, INT J TUBERC LUNG D, V10, P240
   McNabb SJN, 2004, AM J EPIDEMIOL, V160, P589, DOI 10.1093/aje/kwh253
   Ministerio da Saude, 2002, GUIA TRAT TUB PROGR
   Munch Z, 2003, INT J TUBERC LUNG D, V7, P271
   Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17
   SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402
   Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426
   Tessema B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-131
   van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930
   van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x
   VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993
   VANSOOLINGEN D, 1995, EUR RESPIR J, V8, pS649
   Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021
   Warren RM, 2002, J CLIN MICROBIOL, V40, P1705, DOI 10.1128/JCM.40.5.1705-1708.2002
   WHO, 2014, GLOB TUB REP 2013
NR 39
TC 24
Z9 28
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 1
PY 2015
VL 61
IS 5
BP 758
EP 766
DI 10.1093/cid/civ365
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CR6PD
UT WOS:000361468700013
PM 25948063
OA Green Published, Bronze
DA 2020-12-15
ER

PT J
AU Marlow, MA
   Maciel, ELN
   Sales, CMM
   Gomes, T
   Snyder, RE
   Daumas, RP
   Riley, LW
AF Marlow, Mariel A.
   Noia Maciel, Ethel Leonor
   Martins Sales, Carolina Maia
   Gomes, Teresa
   Snyder, Robert E.
   Daumas, Regina Paiva
   Riley, Lee W.
TI Tuberculosis DALY-Gap: Spatial and Quantitative Comparison of Disease
   Burden Across Urban Slum and Non-slum Census Tracts
SO JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
LA English
DT Article
DE Disease burden; DALY; Disability-adjusted life years; DALY-gap; Urban
   informal settlements; Slums; Tuberculosis
ID GLOBAL BURDEN; ETHNIC DISPARITIES; DISABILITY WEIGHTS; HEALTH; BRAZIL;
   INJURY; DETERMINANTS; METRICS
AB To quantitatively assess disease burden due to tuberculosis between populations residing in and outside of urban informal settlements in Rio de Janeiro, Brazil, we compared disability-adjusted life years (DALYs), or "DALY-gap." Using the 2010 Brazilian census definition of informal settlements as aglomerados subnormais (AGSN), we allocated tuberculosis (TB) DALYs to AGSN vs non-AGSN census tracts based on geocoded addresses of TB cases reported to the Brazilian Information System for Notifiable Diseases in 2005 and 2010. DALYs were calculated based on the 2010 Global Burden of Disease methodology. DALY-gap was calculated as the difference between age-adjusted DALYs/100,000 population between AGSN and non-AGSN. Total TB DALY in Rio in 2010 was 16,731 (266 DALYs/100,000). DALYs were higher in AGSN census tracts (306 vs 236 DALYs/100,000), yielding a DALY-gap of 70 DALYs/100,000. Attributable DALY fraction for living in an AGSN was 25.4 %. DALY-gap was highest for males 40-59 years of age (501 DALYs/100,000) and in census tracts with < 60 % electricity (12,327 DALYs/100,000). DALY-gap comparison revealed spatial and quantitative differences in TB burden between slum vs non-slum census tracts that were not apparent using traditional measures of incidence and mortality. This metric could be applied to compare TB burden or burden for other diseases in mega-cities with large informal settlements for more targeted resource allocation and evaluation of intervention programs.
C1 [Marlow, Mariel A.; Snyder, Robert E.; Riley, Lee W.] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Noia Maciel, Ethel Leonor; Martins Sales, Carolina Maia; Gomes, Teresa] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Daumas, Regina Paiva] Oswaldo Cruz Fdn FIOCRUZ, Germano Sinval Faria Teaching Primary Care Ctr, Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
RP Marlow, MA (corresponding author), Univ Calif Berkeley, Div Infect Dis & Vaccinol, Sch Publ Hlth, 530E Li Ka Shing Hlth Ctr, Berkeley, CA 94720 USA.
EM mmarlow3@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; DAUMAS, REGINA/M-9387-2013; Snyder,
   Robert E./AAD-4433-2020
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; DAUMAS,
   REGINA/0000-0002-8923-7711; Snyder, Robert E./0000-0001-9743-0872
FU NIH - Fogarty International CenterUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338]; Office of AIDS Research at the
   National Institutes of Health; Secretariat of Health
   Surveillance/Ministry of Health of Brazil [U2RTW006885 ICOHRTA]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, U2RTW006885,
   U2RTW006885, U2RTW006885, R25TW009338, U2RTW006885, U2RTW006885,
   R25TW009338, U2RTW006885, R25TW009338, R25TW009338, U2RTW006885,
   U2RTW006885, R25TW009338, R25TW009338, U2RTW006885, R25TW009338,
   R25TW009338, U2RTW006885, R25TW009338, R25TW009338, R25TW009338] Funding
   Source: NIH RePORTER
FX Funding MM was supported by NIH Research Training Grant #R25TW009338
   (Global Health Equity Scholars Program) funded by the Fogarty
   International Center and the Office of AIDS Research at the National
   Institutes of Health. ELNM, CMMS, and TG were supported by Grant
   #U2RTW006885 ICOHRTA from the Secretariat of Health
   Surveillance/Ministry of Health of Brazil.
CR Adhikari M, 2009, SEMIN FETAL NEONAT M, V14, P234, DOI 10.1016/j.siny.2009.02.001
   Aragon TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-116
   Costilla R, 2013, AUST NZ J PUBL HEAL, V37, P218, DOI 10.1111/1753-6405.12062
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   Emina J, 2011, J URBAN HEALTH, V88, P200, DOI 10.1007/s11524-011-9594-1
   Government of India, 2010, REP COMM SLUM STAT C
   Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008
   Hossain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044980
   Instituto Brasileiro de Geografia e Estatistica, 2011, 2010 DEM CENS SUBN S
   Instituto Brasileiro de Geografia e Estatistica, 2010, 2010 CENS
   Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7
   Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1
   Leite IC, 2013, LANCET, V381, P83
   Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807
   Maciel ELN, 2012, HLTH PROMOTION HUMAN, P429
   Ministerio da Saude Brasil, 2010, TUB INC RAT
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6
   Nord E, 2013, HEALTH POLICY, V111, P99, DOI 10.1016/j.healthpol.2013.03.019
   Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-45
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
   Snyder RE, 2014, J URBAN HEALTH, V91, P432, DOI 10.1007/s11524-013-9848-1
   Szwarcwald CL, 2011, AM J PUBLIC HEALTH, V101, P517, DOI 10.2105/AJPH.2010.195453
   UN-HABITAT, 2003, CHALL SLUMS GLOB REP
   Unger A, 2007, PLOS MED, V4, P1561, DOI 10.1371/journal.pmed.0040295
   Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240
NR 27
TC 4
Z9 4
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1099-3460
EI 1468-2869
J9 J URBAN HEALTH
JI J. Urban Health
PD AUG
PY 2015
VL 92
IS 4
BP 622
EP 634
DI 10.1007/s11524-015-9957-0
PG 13
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA CO2DS
UT WOS:000358966100003
PM 25840553
OA Green Published
DA 2020-12-15
ER

PT J
AU Maciel, EL
   Reis-Santos, B
AF Maciel, Ethel Leonor
   Reis-Santos, Barbara
TI Determinants of tuberculosis in Brazil: from conceptual framework to
   practical application
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Tuberculosis; epidemiology; health surveillance; data analysis;
   multivariate analysis; social determinants of health; Brazil
ID TREATMENT OUTCOMES; NATURAL-HISTORY; CITY; RESPONSES; CAXIAS; DUQUE
AB Objective. To leverage a conceptual analytical model for TB determination to identify factors that influence emergence of new cases of tuberculosis (TB) and poor TB treatment outcomes in Brazil.
   Methods. This was a cross-sectional study based on data from Brazil's Notifiable Disease Surveillance System database (SINAN). It included all confirmed, incident TB cases reported in Brazil in 2007 - 2011: a total of 432 958 TB cases, of which 318 465 cases with complete data on treatment outcomes were included. Analysis to explain the causal network that influences TB treatment outcomes was based on a theoretical model for determining TB. Adjusted analyses were used to assess the model fit. Hierarchical logistic regression was used to model the dichotomous TB outcome; hierarchical polytomous regression was used for multinomial TB outcome.
   Results. Of the 318 465 TB cases included, 222 186 (69.8%) were classified as "cured" and 96 279 (30.2%) as "treatment failure." Among the latter, 37 604 (11.8%) abandoned treatment; 13 193 (4.1%) died due to TB; 15 440 (4.8%) died due to causes other than TB; 28 848 (9.1%) were transferred to another municipality; and 1 194 (0.4%) developed multidrug-resistant TB. The dichotomous models were more likely to show spurious associations when compared with the polytomous model. In the polytomous model, individuals assigned to Directly Observed Treatment Short-course were more likely to be cured than others.
   Conclusions. Theoretical models are dynamic structures that need ongoing re-evaluation according to new findings; therefore, this is not a definitive proposal for a TB determination model or analysis plan, but rather a proposal that, at present, is adequate in Brazil and has the potential to be extrapolated or adapted to other areas.
C1 [Maciel, Ethel Leonor; Reis-Santos, Barbara] Univ Fed Espirito Santo, Epidemiol Lab, Vitoria, Espirito Santo, Brazil.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Epidemiol Lab, Vitoria, Espirito Santo, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; Reis-Santos, Barbara/A-3149-2014
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos,
   Barbara/0000-0001-6952-0352
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brasilia,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); International Clinical, Operational and Health Services Research
   Training Award (ICOHRTA) from the National Institutes of Health
   (Bethesda, Maryland, United States) [5 U2R TW006883-02]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883] Funding
   Source: NIH RePORTER
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (Brasilia, Brazil) and an International
   Clinical, Operational and Health Services Research Training Award
   (ICOHRTA grant: 5 U2R TW006883-02) from the National Institutes of
   Health (Bethesda, Maryland, United States).
CR Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323
   Antoine D, 2013, EUROSURVEILLANCE, V18, P26
   Ayres JRCM, 2003, PROMOCAO SAUDE CONCE, P117
   Bastos João Luiz Dornelles, 2007, Ciênc. saúde coletiva, V12, P1611, DOI 10.1590/S1413-81232007000600022
   Belo MTCT, 2011, INT J TUBERC LUNG D, V15, P978, DOI 10.5588/ijtld.10.0706
   Biesheuvel CJ, 2008, J CLIN EPIDEMIOL, V61, P125, DOI 10.1016/j.jclinepi.2007.03.002
   BROOKMEYER R, 1990, ENVIRON HEALTH PERSP, V87, P43, DOI 10.2307/3431004
   BURNET F M, 1948, Med J Aust, V1, P57
   Cantalice JP, 2009, J BRAS PNEUMOL, V35, P992, DOI 10.1590/S1806-37132009001000008
   Belo MTCT, 2010, J BRAS PNEUMOL, V36, P621, DOI 10.1590/S1806-37132010000500015
   Mafra ACCN, 2010, CAD SAUDE PUBLICA, V26, P451, DOI 10.1590/S0102-311X2010000300003
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   Escobar A L, 2001, Cad Saude Publica, V17, P285, DOI 10.1590/S0102-311X2001000200004
   Facchini LA, 1995, TEORIA TRABALHO MATE, P23
   Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   Hernández-Girón Carlos, 2012, Rev. salud pública, V14, P315, DOI 10.1590/S0124-00642012000200012
   Hosking J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-695
   Kleinbaum D.G., 2010, LOGISTIC REGRESSION, P429, DOI DOI 10.1007/978-1-4419-1742-3_12
   LAGUARDIA J, 2004, EPIDEMIOL SERV SAUDE, V13, P135
   Maciel ELNA, 2012, PROMOCAO SAUDE DETER, P429
   Mazzei AMA, 2003, BOL PNEUMOL SANIT, V11, P41
   Medeiros D, 2012, CAD SAUDE COLET RIO, V20, P146
   Ministerio da Saude do Brasil, 2011, MAN REC CONTR TUB BR, P284
   Ministry of Health of Brazil, SIST INF AGR NOT BRA
   Monroe AA, 2008, REV ESC ENFERM USP, V42, P262, DOI 10.1590/S0080-62342008000200008
   MYERS JA, 1965, J AMER MED ASSOC, V194, P1086, DOI 10.1001/jama.194.10.1086
   Picon PD, 2011, J BRAS PNEUMOL, V37, P504, DOI 10.1590/S1806-37132011000400013
   Sanchez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033129
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Weekes AA, 2012, ENVIRON MANAGE, V50, P982, DOI 10.1007/s00267-012-9957-8
NR 31
TC 15
Z9 17
U1 0
U2 4
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PD JUL
PY 2015
VL 38
IS 1
BP 28
EP 34
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CU9MR
UT WOS:000363869100005
PM 26506318
DA 2020-12-15
ER

PT J
AU Lima, EDA
   Sousa, AI
   Primo, CC
   Leite, FMC
   Lima, RDD
   Maciel, ELN
AF Almeida Lima, Eliane de Fatima
   Sousa, Ana Ines
   Primo, Candida Canicali
   Costa Leite, Francielie Marabotti
   Duarte Lima, Rita de Cassia
   Noia Maciel, Ethel Leonor
TI An assessment of primary care attributes from the perspective of female
   healthcare users
SO REVISTA LATINO-AMERICANA DE ENFERMAGEM
LA English
DT Article
DE Primary Health Care; Family Healthcare; Healthcare Services Evaluation;
   Nursing
ID SERVICES; CHILDREN
AB Objective: this study sought to assess the quality of the Family Health Strategy (FHS) and investigated the association between primary care attributes (PCAs) and the sociodemographic characteristics of users. Method: a total of 215 female FHS users were interviewed for this descriptive and cross-sectional study. The Primary Care Assessment Tool (PCATool), Adult Edition was used, and the results were analyzed using Fisher's exact tests, Pearson's chisquare tests and logistic regressions. Results: the lowest average score corresponded to the dimension "accessibility" (1.80), and the highest score corresponded to "access" (8.76). The results corresponding to the attributes "longitudinality", "coordination", "comprehensiveness", and "orientation" were not significant. No association was found between the participants' sociodemographic characteristics and the essential, derivative, and general attributes (p>0.05). Conclusion: several attributes must be improved across all the investigated services from the perspective of female FHS users.
C1 [Almeida Lima, Eliane de Fatima; Primo, Candida Canicali; Costa Leite, Francielie Marabotti; Duarte Lima, Rita de Cassia; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Dept Enfermagem, BR-29040090 Vitoria, ES, Brazil.
   [Sousa, Ana Ines; Primo, Candida Canicali] Univ Fed Rio de Janeiro, Escola Enfermagem Anna Nery, Rio De Janeiro, RJ, Brazil.
   [Costa Leite, Francielie Marabotti] Univ Fed Pelotas, Dept Epidemiol, Pelotas, RS, Brazil.
RP Lima, EDA (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Enfermagem, Ave Marechal Campos 1468, BR-29040090 Vitoria, ES, Brazil.
EM elianelima66@gmail.com
RI Primo, Candida C/O-7572-2015; Sousa, Ana Ines/W-3845-2017; Maciel, Ethel
   Leonor LN/G-1027-2012
OI Primo, Candida C/0000-0001-5141-2898; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355
CR de Araujo LUA, 2014, CIENC SAUDE COLETIVA, V19, P3521, DOI 10.1590/1413-81232014198.21862013
   Brandao ALDBD, 2013, CIENC SAUDE COLETIVA, V18, P103, DOI 10.1590/S1413-81232013000100012
   Benazzi LEB, 2010, CIENC SAUDE COLETIVA, V15, P861, DOI 10.1590/S1413-81232010000300029
   Carneiro Maria do Socorro Melo, 2014, Saúde debate, V38, P279, DOI 10.5935/0103-1104.2014S021
   de Alencar MN, 2014, CIENC SAUDE COLETIVA, V19, P353, DOI 10.1590/1413-81232014192.08522012
   Furtado MCD, 2013, REV LAT-AM ENFERM, V21, P554, DOI 10.1590/S0104-11692013000200012
   Silva CSDE, 2014, CIENC SAUDE COLETIVA, V19, P4407, DOI 10.1590/1413-812320141911.14122013
   Escorel S, 2007, REV PANAM SALUD PUBL, V21, P164
   Gervas J, 2006, MED CLIN-BARCELONA, V126, P658, DOI 10.1157/13087852
   Giovanella L, 2002, SAUDE DEBATE, V26, P37
   Harzheim E, 2013, REV BRAS MED FAM COM, V8, P274, DOI DOI 10.5712/RBMFC8(29)829
   Ibañez Nelson, 2006, Ciênc. saúde coletiva, V11, P683, DOI 10.1590/S1413-81232006000300016
   Leão Claudia Danyella Alves, 2011, Rev. Bras. Saude Mater. Infant., V11, P323, DOI 10.1590/S1519-38292011000300013
   Mesquita M, 2014, CIENC SAUDE COLETIVA, V19, P2033, DOI 10.1590/1413-81232014197.17322013
   Mishima SM, 2010, REV LAT-AM ENFERM, V18, P148
   Moraes José Rodrigo de, 2011, Ciênc. saúde coletiva, V16, P3769, DOI 10.1590/S1413-81232011001000013
   Patton MQ, 2001, AM J EVAL, V22, P329, DOI 10.1016/S1098-2140(01)00147-3
   Pereira M., 2011, P IEEE TRONDH POWERT, P1, DOI DOI 10.1109/PTC.2011.6019245
   Reis RS, 2013, CIENC SAUDE COLETIVA, V18, P3321, DOI 10.1590/S1413-81232013001100022
   Rocha PD, 2008, CAD SAUDE PUBLICA, V24, pS69, DOI 10.1590/S0102-311X2008001300012
   Sala A, 2011, SAUDE SOC-SAO PAULO, V20, P948, DOI 10.1590/S0104-12902011000400012
   SILVA LG, 2008, REV APS, V11, P74
   Starfield B, 2002, ATENCAO PRIMARIA EQU
   Terraza Núñez Rebeca, 2006, Gac Sanit, V20, P485
   van Stralen CJ, 2008, CAD SAUDE PUBLICA, V24, pS148, DOI 10.1590/S0102-311X2008001300019
NR 25
TC 11
Z9 16
U1 0
U2 6
PU UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO
PI RIBEIRAO PRETO
PA AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL
SN 1518-8345
J9 REV LAT-AM ENFERM
JI Rev. Latino-Am. Enfermagem
PD MAY-JUN
PY 2015
VL 23
IS 3
BP 553
EP 559
DI 10.1590/0104-1169.0496.2587
PG 7
WC Nursing
SC Nursing
GA CP9EL
UT WOS:000360196400025
PM 26155006
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU de Souza, FM
   do Prado, TN
   Pinheiro, JD
   Peres, RL
   Lacerda, TC
   Loureiro, RB
   Carvalho, JA
   Fregona, G
   Dias, ES
   Cosme, LB
   Rodrigues, RR
   Riley, LW
   Maciel, ELN
AF de Souza, Fernanda Mattos
   do Prado, Thiago Nascimento
   Pinheiro, Jair dos Santos
   Peres, Renata Lyrio
   Lacerda, Thamy Carvalho
   Loureiro, Rafaela Borge
   Carvalho, Jose Americo
   Fregona, Geisa
   Dias, Elias Santos
   Cosme, Lorrayne Beliqui
   Rodrigues, Rodrigo Ribeiro
   Riley, Lee Wood
   Noia Maciel, Ethel Leonor
TI Comparison of Interferon-gamma Release Assay to Two Cut-Off Points of
   Tuberculin Skin Test to Detect Latent Mycobacterium tuberculosis
   Infection in Primary Health Care Workers
SO PLOS ONE
LA English
DT Article
ID QUANTIFERON-TB-GOLD; HOUSEHOLD CONTACTS; TEST POSITIVITY; TUBE ASSAY;
   RISK; DIAGNOSIS; CONVERSIONS; DISCORDANCE; PREDICTORS; DISEASE
AB Background: An interferon-gamma release assay, QuantiFERON-TB (QFT) test, has been introduced an alternative test for the diagnosis of latent Mycobacterium tuberculosis infection LTBI). Here, we compared the performance of QFT with tuberculin skin test (TST) measured at two different cut-off points among primary health care work (HCW) in Brazil.
   Methods: A cross-sectional study was carried out among HCWs in four Brazilian cities with a known history of high incidence of TB. Results of the QFT were compared to TST results based on both >= 5 mm and >= 10 mm as cut-off points.
   Results: We enrolled 632 HCWs. When the cut-off value of >= 10 mm was used, agreement between QFT and TST was 69% (k = 0.31), and when the cut-off of >= 5 mm was chosen, the agreement was 57% (k = 0.22). We investigated possible factors of discordance of TST vs QFT. Compared to the TST2/QFT2 group, risk factors for discordance in the TST+/QFT2 group with TST cut-off of $ 5 mm included age between 41-45 years [OR = 2.70; CI 95%: 1.32-5.51] and 46-64 years [OR = 2.04; CI 95%: 1.05-3.93], BCG scar [OR = 2.72; CI 95%: 1.40-5.25], and having worked only in primary health care [OR = 2.30; CI 95%: 1.09-4.86]. On the other hand, for the cut-off of $ 10 mm, BCG scar [OR = 2.26; CI 95%: 1.03-4.91], being a household contact of a TB patient [OR = 1.72; CI 95%: 1.01-2.92] and having had a previous TST [OR = 1.66; CI 95%: 1.05-2.62], were significantly associated with the TST+/QFT2 group. No statistically significant associations were found among the TST2/QFT+ discordant group with either TST cut-off value.
   Conclusions: Although we identified BCG vaccination to contribute to the discordance at both TST cut-off measures, the current Brazilian recommendation for the initiation of LTBI treatment, based on information gathered from medical history, TST, chest radiograph and physical examination, should not be changed.
C1 [de Souza, Fernanda Mattos; do Prado, Thiago Nascimento; Peres, Renata Lyrio; Lacerda, Thamy Carvalho; Loureiro, Rafaela Borge; Fregona, Geisa; Dias, Elias Santos; Cosme, Lorrayne Beliqui; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [de Souza, Fernanda Mattos; do Prado, Thiago Nascimento; Peres, Renata Lyrio; Rodrigues, Rodrigo Ribeiro] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
   [Lacerda, Thamy Carvalho; Fregona, Geisa; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
   [Carvalho, Jose Americo; Fregona, Geisa] Univ Fed Espirito Santo, Hosp Univ Cassiano Antonio Moraes, Programa Controle TB, Vitoria, ES, Brazil.
   [Riley, Lee Wood] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Pinheiro, Jair dos Santos] Secretaria Municipal Saude, Nucleo Controle TB, Manaus, Amazonas, Brazil.
   [Loureiro, Rafaela Borge] Univ Estado Rio de Janeiro, Inst Social Med, Dept Epidemiol, BR-20550011 Rio De Janeiro, Brazil.
   [Dias, Elias Santos; Cosme, Lorrayne Beliqui] Univ Fed Espirito Santo, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Rodrigues, Rodrigo Ribeiro/AAY-7820-2020; Pinheiro, Jair/AAE-5785-2019;
   Maciel, Ethel Leonor LN/G-1027-2012
OI Rodrigues, Rodrigo Ribeiro/0000-0002-0675-110X; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
   MCT/CNPq - UniversalNational Council for Scientific and Technological
   Development (CNPq) [14/2009]; FAPES (Fundacao de Amparo a Pesquisa do
   Espirito Santo) [012/11]
FX This study was supported by CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) MCT/CNPq No. 14/2009 - Universal and the FAPES
   (Fundacao de Amparo a Pesquisa do Espirito Santo) according to the
   Universal 012/11. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Altman D., 1990, PRACTICAL STAT MED R
   BASS JB, 1990, AM REV RESPIR DIS, V142, P725
   Brasil. Ministerio da Saude, 2011, MAN REC CONTR TUB BR
   Canada, 2010, RECOMMENDATIONS INTE
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   Cook S, 2003, INFECT CONT HOSP EP, V24, P807, DOI 10.1086/502141
   del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257
   Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x
   Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110
   Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048
   de Oliveira SMDL, 2007, REV LAT-AM ENFERM, V15, P1120, DOI 10.1590/S0104-11692007000600010
   Florence CS, 2006, HEALTH SERV RES, V41, P1741, DOI 10.1111/j.1475-6773.2006.00580.x
   FRANCO C, 2004, ARQ CI SAUDE, V11, P244
   Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494
   Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756
   Lee SW, 2011, EUR RESPIR J, V37, P1447, DOI 10.1183/09031936.00089510
   Machado A, 2009, INT J TUBERC LUNG D, V13, P446
   Menzies D, 2007, INT J TUBERC LUNG D, V11, P593
   Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC
   Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513
   Moreira TR, 2010, REV SAUDE PUBL, V44, P332, DOI [10.1590/S0034-89102010000200014, 10.1590/s0034-89102010000200014]
   Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P1377, DOI 10.1590/S0102-311X2008000600018
   Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746
   Pai M, 2009, INT J TUBERC LUNG D, V13, P84
   Pai M, 2007, AM J RESP CRIT CARE, V175, P529, DOI 10.1164/rccm.200701-024ED
   Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC
   Park JS, 2012, CHEST, V142, P1461, DOI 10.1378/chest.11-3299
   Pollock NR, 2008, INFECT CONT HOSP EP, V29, P878, DOI 10.1086/590262
   Reichman LB, 2008, GUIDELINES DIAGNOSIS
   Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220
   Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335
   Saleiro Sandra, 2007, Rev Port Pneumol, V13, P789
   Shanaube K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018206
   Silva Vania Maria Carneiro da, 2004, J. bras. pneumol., V30, P459, DOI 10.1590/S1806-37132004000500010
   Sociedade Brasileira de Pneumologia e Tisiologia, 2004, J BRAS PNEUMOL, V30, P86
   TRAJMAN A, 2013, PULMONARY MED, V2013, P1
   Tuuminen T, 2013, CLIN VACCINE IMMUNOL, V20, P1778, DOI 10.1128/CVI.00476-13
   United States of America, 2010, UPD GUID US INT GAMM
   Wang L, 2003, THORAX, V58, P188
   Weinfurter P, 2011, INT J TUBERC LUNG D, V15, P1056, DOI 10.5588/ijtld.10.0650
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   Zhao XR, 2009, AM J CLIN PATHOL, V132, P678, DOI 10.1309/AJCPUHC34NBDGKKL
   Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180
NR 45
TC 11
Z9 12
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 19
PY 2014
VL 9
IS 8
AR e102773
DI 10.1371/journal.pone.0102773
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN6XM
UT WOS:000340742100004
PM 25137040
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU do Prado, TN
   Miranda, AE
   de Souza, FM
   Dias, ED
   Sousa, LKF
   Arakaki-Sanchez, D
   Sanchez, MN
   Golub, JE
   Maciel, EL
AF do Prado, Thiago Nascimento
   Miranda, Angelica Espinosa
   de Souza, Fernanda Mattos
   Dias, Elias dos Santos
   Fernandes Sousa, Lorena Kellen
   Arakaki-Sanchez, Denise
   Sanchez, Mauro N.
   Golub, Jonathan E.
   Maciel, Ethel Leonor
TI Factors associated with tuberculosis by HIV status in the Brazilian
   national surveillance system: a cross sectional study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Tuberculosis; HIV; Coinfection; Logistic regression
ID ACQUIRED-IMMUNODEFICIENCY-SYNDROME; TRENDS; AIDS; COINFECTION
AB Background: Over the last decade tuberculosis (TB) incidence and mortality in Brazil have been steadily declining. However, this downward trend has not been observed among HIV-infected patients. We describe the epidemiological and clinical profile of TB patients by HIV status using the Brazilian National Surveillance System.
   Methods: All TB diagnoses with HIV status information between January 1, 2007 and December 31, 2011 were categorized as either HIV or non-HIV at time of TB diagnosis. Co-infected patients (TB-HIV) were compared to TB patients with no HIV-infection using a hierarchical logistic regression model using Stata 13.0.
   Results: The prevalence of TB-HIV co-infection was 19% among adults >= 15 years of age. We analyzed data from 243,676 individuals, of whom 46,466 were TB-HIV and 197,210 were only TB cases. The following factors increased risk of co-infection: male sex (OR: 1.06, 95% CI 1.03-1.10), 20 to 39 years of age (OR = 4.82, 95% CI 4.34-5.36), black (OR = 1.08, 95% CI 1.04-1.13), 4-7 years of education (OR = 1.13, 95% CI 1.19-1.28), diagnosed following default (OR = 2.65, 95% CI 1.13-6.25), presenting with pulmonary and extra-pulmonary forms of TB simultaneously (OR = 2.80, 95% CI 1.56-5.02), presenting with histopathologic examination suggestive of TB (OR = 2.15, 95% CI 1.13-4.07). Co-infected patients were less likely to live in rural areas (OR = 0.45, 95% CI 0.42-0.48), have diabetes (OR = 0.45, 95% CI 0.40-0.50) and be smear positive (OR = 0.55, 95% CI 0.32-0.95), and co-infected patients had higher risk of default (OR = 2.96, 95% CI 2.36-3.71) and death from TB (OR = 5.16, 95% CI 43.04-5.77).
   Conclusions: The prevalence of co-infection with HIV among TB patients is 19% in Brazil. By identifying predictors of co-infection targeted interventions can be developed to prevent both TB and HIV, and to diagnose each disease earlier and ultimately decrease poor treatment outcomes and death.
C1 [do Prado, Thiago Nascimento; de Souza, Fernanda Mattos; Dias, Elias dos Santos; Fernandes Sousa, Lorena Kellen; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epi, Lab Epidemiol, Vitoria, ES, Brazil.
   [do Prado, Thiago Nascimento; Dias, Elias dos Santos; Fernandes Sousa, Lorena Kellen; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Sch Nursing, Espirito Santo, Brazil.
   [do Prado, Thiago Nascimento; Miranda, Angelica Espinosa; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Post Grad Program Infect Dis, Espirito Santo, Brazil.
   [Miranda, Angelica Espinosa; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Post Grad Program Publ Hlth, Espirito Santo, Brazil.
   [Arakaki-Sanchez, Denise] Pan Amer Hlth Org, Sao Paulo, Brazil.
   [Sanchez, Mauro N.] Univ Brasilia, Dept Publ Hlth, BR-70910900 Brasilia, DF, Brazil.
   [Golub, Jonathan E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epi, Lab Epidemiol, Av Marechal Campos 1468 Maruipe, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; Sanchez, Mauro/AAU-2404-2020
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Sanchez,
   Mauro/0000-0002-0472-1804; Miranda, Angelica/0000-0002-5556-8379
FU CNPq/BrazilNational Council for Scientific and Technological Development
   (CNPq); U.S. National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [ICOHRTA 5 U2R TW006883-02]; FAPES (Fundacao de Amparo a Pesquisa do
   Espirito Santo); FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883] Funding Source: NIH RePORTER
FX This study was supported by CNPq/Brazil edital Doencas
   negligenciadas2012 and Universal 2010, the U.S. National Institutes of
   Health, undercontract ICOHRTA 5 U2R TW006883-02, and FAPES (Fundacao de
   Amparo a Pesquisa do Espirito Santo).
CR Aerts D, 2004, INT J TUBERC LUNG D, V8, P785
   Rodrigues ILA, 2010, REV ESC ENFERM USP, V44, P380
   BRAUN MM, 1993, JAMA-J AM MED ASSOC, V269, P2865, DOI 10.1001/jama.269.22.2865
   Cerqueira ACB, 2008, UFES REV ODONT, V10, P33
   Coimbra I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095828
   Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009
   DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404
   Carvalho Luiz Gustavo Miranda de, 2006, J. bras. pneumol., V32, P424, DOI 10.1590/S1806-37132006000500009
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   Neves LAD, 2010, REV ESC ENFERM USP, V44, P1129
   do Prado TN, 2011, J BRAS PNEUMOL, V37, P93, DOI 10.1590/S1806-37132011000100014
   Fenner L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034186
   Fuchs SC, 1996, REV SAUDE PUBL, V30, P168, DOI 10.1590/S0034-89101996000200009
   Guimaraes RM, 2012, J BRAS PNEUMOL, V38, P511, DOI 10.1590/S1806-37132012000400014
   Lazarus JV, 2008, HIV MED, V9, P406, DOI 10.1111/j.1468-1293.2008.00567.x
   Maciel E L., 2012, DETERMINANTES SOCIAI
   Ministerio da Saude, 2004, SIST INF AGR NOT
   Muniz Jordana Nogueira, 2006, J. bras. pneumol., V32, P529, DOI 10.1590/S1806-37132006000600010
   Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464
   Reis-Santos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062604
   RIEDER HL, 1989, ARCH INTERN MED, V149, P1268, DOI 10.1001/archinte.149.6.1268
   Sanchez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033129
   Santos Filho ET, 2007, REV SAUDE PUBL, V41, P111
   Silveira Jussara Maria, 2006, J. bras. pneumol., V32, P48, DOI 10.1590/S1806-37132006000100011
   Santos MDSG, 2009, REV LAT-AM ENFERM, V17, P683, DOI 10.1590/S0104-11692009000500014
   SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   World Health Organization, 2011, GLOB TUB CONTR 2011
NR 28
TC 16
Z9 16
U1 1
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUL 28
PY 2014
VL 14
AR 415
DI 10.1186/1471-2334-14-415
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA AM1UD
UT WOS:000339633000001
PM 25066655
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Reis-Santos, B
   Gomes, T
   Locatelli, R
   de Oliveira, ER
   Sanchez, MN
   Horta, BL
   Riley, LW
   Maciel, EL
AF Reis-Santos, Barbara
   Gomes, Teresa
   Locatelli, Rodrigo
   de Oliveira, Elizabete R.
   Sanchez, Mauro N.
   Horta, Bernardo L.
   Riley, Lee W.
   Maciel, Ethel L.
TI Treatment Outcomes in Tuberculosis Patients with Diabetes: A Polytomous
   Analysis Using Brazilian Surveillance System
SO PLOS ONE
LA English
DT Article
ID COUNTRIES; MELLITUS; IMPACT; CITY
AB Background: The impact of non-communicable diseases on tuberculosis incidence has received significant attention. It has been suggested that the risk of tuberculosis is higher among subjects with diabetes and these subjects also has poor TB treatment outcomes. This study was aimed at assessing the socio-demographic and clinical factors that may influence different outcome of TB in patients with DM (TB-DM) identified in the Brazilian national database from 2001 to 2011.
   Methods: TB-DM cases reported in the Brazilian information system were identified and compared. Covariates associated with the outcomes of interest (cure, default, deaths, and development of TB MDR) were included in a hierarchical regression model.
   Results: TB-DM cases increased from 380/100,000/year in 2001 to 6,150/100,000/year in 2011. Some of the main associations found are pointed. The odds of default was higher among those in the age group 20-39 years (OR = 2.07, 95% CI 1.32-3.24); alcoholics (OR = 2.17, 95% CI 1.86-2.54), and HIV/AIDS (OR = 2.16, 95% CI 1.70-2.74); positive monitoring smear (OR = 1.94, 95% CI 1.55-2.43); prior default (OR = 5.41, 95% CI 4.47-6.54), and unknown type of treatment (OR = 3.33, 95% CI 1.54-7.22). The odds of death was greater for subjects >= 60 years old (OR = 2.74, 95% CI 1.74-4.29); institutionalized in shelter (OR = 2.69, 95% CI 1.07-6.77); alcoholics (OR = 2.70, 95% CI 2.27-3.22); HIV/AIDS (OR = 2.87, 95% CI 2.13-3.86); pulmonary+extrapulmonary TB (OR = 2.49, 95% CI 1.79-3.46); with unknown type of treatment (OR = 14.12, 95% CI 7.04-28.32). Development of MDR TB was more related to relapse (OR = 9.60, 95% CI 6.07-15.14); previous default (OR = 17.13, 95% CI 9.58-30.63); and transfer of treatment center (OR = 7.87, 95% CI 4.74-13.07).
   Conclusions: Older subjects and those with comorbidities and with a previous treatment of TB had poorest outcomes. TB control program in Brazil will need to expand efforts to focus on treatment of TB-DM patients to improve their cure rates in order to achieve the goals of tuberculosis elimination.
C1 [Reis-Santos, Barbara; Gomes, Teresa; Locatelli, Rodrigo; Maciel, Ethel L.] Univ Fed Espirito Santo, Lab Epi UFES Lab Epidemiol, Vitoria, ES, Brazil.
   [Reis-Santos, Barbara; Horta, Bernardo L.] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, RS, Brazil.
   [de Oliveira, Elizabete R.; Maciel, Ethel L.] Univ Fed Espirito Santo, Postgrad Programme Saude Colet, Ctr Ciencias Saude, Vitoria, ES, Brazil.
   [Sanchez, Mauro N.] Univ Brasilia, Fac Ciencias Saude, Dept Publ Hlth, Brasilia, DF, Brazil.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epi UFES Lab Epidemiol, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Sanchez, Mauro/AAU-2404-2020; Horta, Bernardo/A-7604-2008; Maciel, Ethel
   Leonor LN/G-1027-2012; Reis-Santos, Barbara/A-3149-2014
OI Sanchez, Mauro/0000-0002-0472-1804; Horta, Bernardo/0000-0001-9843-412X;
   Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos,
   Barbara/0000-0001-6952-0352
FU National Council for Scientific and Technological Development of
   BrazilNational Council for Scientific and Technological Development
   (CNPq) [40/2012]; National Institute of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [U2RTW006885 ICOHRTA]
FX This work was supported by the National Council for Scientific and
   Technological Development of Brazil [Decit 40/2012] and the National
   Institute of Health [U2RTW006885 ICOHRTA]. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abdi H, 2010, ENCY RES DESIGN
   Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81
   Batista Luís Eduardo, 2005, Ciênc. saúde coletiva, V10, P71, DOI 10.1590/S1413-81232005000100013
   Biesheuvel CJ, 2008, J CLIN EPIDEMIOL, V61, P125, DOI 10.1016/j.jclinepi.2007.03.002
   Brasil, 2012, TUBERCULOSE CAS CONF
   Brasil, 2008, SIST INF AGR NOT
   Brasil, 2010, DOENC INF PAR GUIA B
   [Brasil Epidemiologica DdV], 2011, EP DDV, P284
   [Brasil MdS Epidemiologica SdVeSDdV], 2008, EP SDVESDDV
   BROOKMEYER R, 1990, BIOMETRICS, V46, P1151, DOI 10.2307/2532455
   Chan-Yeung M, 2002, INT J TUBERC LUNG D, V6, P771
   de Oliveira HB, 2000, REV SAUDE PUBL, V34, P437, DOI 10.1590/S0034-89102000000500002
   Dooley KE, 2009, AM J TROP MED HYG, V80, P634, DOI 10.4269/ajtmh.2009.80.634
   Fatiregun AA, 2009, ANN AFR MED, V8, P100, DOI 10.4103/1596-3519.56237
   Faurholt-Jepsen D, 2012, INT J TUBERC LUNG D, V16, P1680, DOI 10.5588/ijtld.12.0360
   Fullilove M T, 1993, J Law Med Ethics, V21, P324, DOI 10.1111/j.1748-720X.1993.tb01257.x
   Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238
   Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152
   Jimenez-Corona ME, 2012, THORAX
   Kapur A, 2013, DIABETES RES CLIN PR
   Kourbatova EV, 2006, EUR J EPIDEMIOL, V21, P715, DOI 10.1007/s10654-006-9060-7
   Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3
   McCullagh P., 1989, GEN LINEAR MODELS
   NigatuHaregu T, 2012, INT J DIABETES RES, V1, P81
   Pinheiro R S, 2011, MELHORIA QUALIDADE S
   Prata P. R., 1992, Cadernos de Saude Publica, V8, P168, DOI 10.1590/S0102-311X1992000200008
   RASTOGI N, 1993, RES MICROBIOL, V144, P133, DOI 10.1016/0923-2508(93)90028-Z
   Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2
   Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450
   Reis-Santos B, 2013, J BRAS PNEU IN PRESS, V39
   Reis-Santos B, 2013, PLOS ONE, V8
   Remais JV, 2013, INT J EPIDEMIOL, V42, P221, DOI 10.1093/ije/dys135
   Sanchez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033129
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Coelho AGV, 2009, J BRAS PNEUMOL, V35, P998, DOI 10.1590/S1806-37132009001000009
   Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367
   WHO, 2005, GLOB TUB PROGR GLOB, P108
   World Health Organization, 2011, WHO FRAM TARG TUB DI
NR 38
TC 14
Z9 16
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 8
PY 2014
VL 9
IS 7
AR e100082
DI 10.1371/journal.pone.0100082
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AL6KZ
UT WOS:000339242700004
PM 25003346
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Loureiro, RB
   Villa, TCS
   Ruffino-Netto, A
   Peres, RL
   Braga, JU
   Zandonade, E
   Maciel, ELN
AF Loureiro, Rafaela Borges
   Scatena Villa, Tereza Cristina
   Ruffino-Netto, Antonio
   Peres, Renata Lyrio
   Braga, Jose Ueleres
   Zandonade, Eliana
   Noia Maciel, Ethel Leonor
TI Access to the diagnosis of tuberculosis in health services in the
   municipality of Vitoria, state of Espirito Santo, Brazil
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Tuberculosis; Access; Accessibility; Health Services; Diagnosis; Primary
   health care
ID PULMONARY TUBERCULOSIS; TREATMENT DELAY; CARE; BARRIERS; CLINICS
AB This study sought to assess the accessibility to the diagnosis of tuberculosis in health services in Victoria, state of Espirito Santo. It featured a cross-sectional study conducted in 2009 of patients with tuberculosis using the Primary Care Assessment Tool and statistical analysis with the Chi-square test (p < 0,05). In relation to initial access to care, it was seen that the health service of first access most sought was Primary Care (37.6%), with most diagnoses occurring in the Tuberculosis Control Program Reference Units (61.3%). There was evidence of association between first health service accessed and the factors of time delay in: obtaining consultation at the first health service sought (p = 0.0182); diagnosis made by the first health service sought (p = 0.0001); request for sputum exam (p = 0,0003); request for X-ray exams (p = 0.0159); referral for X-rays at another institution (p = 0.0001); diagnosis by the same health service (p = 0.0001); exams conducted by the same health service that initially diagnosed tuberculosis (p = 0.0018); and proximity to the home (p = 0.0001). Therefore, the identification of important gaps in accessibility to diagnosis of tuberculosis seems to be related to the operational difficulties of organization of health care.
C1 [Loureiro, Rafaela Borges; Peres, Renata Lyrio; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, BR-29040091 Vitoria, ES, Brazil.
   [Scatena Villa, Tereza Cristina] Univ Sao Paulo, Dept Enfermagem Saude Publ, Escola Enfermagem Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Ruffino-Netto, Antonio] Univ Sao Paulo, Dept Med Social, Fac Med Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Braga, Jose Ueleres] Univ Estado Rio de Janeiro, Dept Epidemiol, Inst Med Social, Rio De Janeiro, Brazil.
   [Zandonade, Eliana] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, Spain.
RP Loureiro, RB (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM rafaelabloureiro@gmail.com
RI Villa, Tereza Cristina Scatena/K-7891-2013; Maciel, Ethel Leonor
   LN/G-1027-2012
OI Villa, Tereza Cristina Scatena/0000-0001-8927-2624; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355
CR de Jesus WLA, 2010, CIENC SAUDE COLETIVA, V15, P161, DOI 10.1590/S1413-81232010000100022
   Almeida C, 2006, VALIDACAO METODOLOGI
   Carr-Hill R, 1994, FORMULA DISTRIBUTING
   Cerqueira MB, 2009, REV BAIANA SAUDE PUB, V33
   Diez M, 2005, EUR J PUBLIC HEALTH, V15, P343, DOI 10.1093/eurpub/cki010
   Dimitrova B, 2006, HEALTH POLICY PLANN, V21, P265, DOI 10.1093/heapol/czl014
   Donabedian A., 1973, ASPECTS MED CARE ADM
   dos Santos MAPS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-25
   Fekete MC, 1997, ESTUDO ACESSIBILIDAD, VI
   Fekete MC, 1992, ESTUDO ACESSIBILIDAD
   Figueiredo Tânia Maria Ribeiro Monteiro de, 2009, Rev. Saúde Pública, V43, P825, DOI 10.1590/s0034-89102009005000054
   Fishbein M, 1975, BELIEF ATTITUDE INTE
   Frenk J, 1985, Salud Publica Mex, V27, P438
   Goddard M, 2001, SOC SCI MED, V53, P1149, DOI 10.1016/S0277-9536(00)00415-9
   Harter J, 2010, UTILIZACAO BACILOSCO
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2009, EST POP RES EM 1 JUL
   Jaiswal A, 2003, TROP MED INT HEALTH, V8, P625, DOI 10.1046/j.1365-3156.2003.01061.x
   Leung Eric C. C., 2007, Hong Kong Medical Journal, V13, P221
   Marcolino Alinne Beserra Lucena, 2009, Rev. bras. epidemiol., V12, P144, DOI 10.1590/S1415-790X2009000200005
   Moreira CMM, 2010, CAD SAUDE PUBLICA, V26, P1619, DOI 10.1590/S0102-311X2010000800015
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P1377, DOI 10.1590/S0102-311X2008000600018
   Oliveira Mayra Fernanda de, 2011, Rev. esc. enferm. USP, V45, P898, DOI 10.1590/S0080-62342011000400015
   Oliveira MF, 2009, THESIS U SAO PAULO R
   Paixão Lúcia Miana M., 2007, Rev. Saúde Pública, V41, P205, DOI 10.1590/s0034-89102007000200006
   Palermo PU., 2005, THESIS U FEDERAL RIO
   Ribeiro Manoel Carlos Sampaio de Almeida, 2006, Ciênc. saúde coletiva, V11, P1011, DOI 10.1590/S1413-81232006000400022
   Villa TCS, 2009, J BRAS PNEUMOL, V35, P610, DOI 10.1590/S1806-37132009000600014
   Starfield B, 2002, ATENCAO PRIMARIA EQU
   Travassos C, 2008, POLITICAS SISTEMA SA, P215
   Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190
   Unglert C V, 1990, Rev Saude Publica, V24, P445, DOI 10.1590/S0034-89101990000600002
   Viacava Francisco, 2004, Ciênc. saúde coletiva, V9, P711, DOI 10.1590/S1413-81232004000300021
   Vieira E. M., 2005, FUNDAMENTOS EPIDEMIO, P337
   Wang WB, 2007, EUR J PUBLIC HEALTH, V17, P419, DOI 10.1093/eurpub/ckm029
   Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112
NR 35
TC 6
Z9 11
U1 0
U2 4
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD APR
PY 2014
VL 19
IS 4
BP 1233
EP 1244
DI 10.1590/1413-81232014194.01002013
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AH3TY
UT WOS:000336049700024
PM 24820606
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Gomes, T
   Reis-Santos, B
   Bertolde, A
   Johnson, JL
   Riley, LW
   Maciel, EL
AF Gomes, Teresa
   Reis-Santos, Barbara
   Bertolde, Adelmo
   Johnson, John L.
   Riley, Lee W.
   Maciel, Ethel Leonor
TI Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical
   model
SO BMC INFECTIOUS DISEASES
LA English
DT Article
ID PROPOSAL; AIDS
AB Background: Although extrapulmonary tuberculosis (EPTB) is less frequent than Pulmonary Tuberculosis (PTB) and is a secondary target for national TB control programs, its significance has increased worldwide during the HIV epidemic. The objective of this study was to examine the epidemiology of EPTB in Brazil between 2007 and 2011.
   Methods: Cross-sectional study involving all cases of TB reported to the Brazilian Notifiable Diseases Surveillance System (Sistema de Informacoes de Agravo de Notificacao - SINAN) in Brazil between 2007 and 2011. Sociodemographic and clinical characteristics of patients with exclusively PTB and exclusively EPTB were compared. Following analysis with Pearson's chi-square test, variables with p < 0.05 were included in a hierarchical regression model. Variables with p < 0.05 in the corresponding level were kept in the model.
   Results: A total of 427,548 cases of TB were included. Of these, 356,342 cases (83.35%; 95% confidence interval (CI) 83.23% - 83.45%) were PTB, 57,217 (13.37%; 95% CI 13.28% - 13.48%) were EPTB, 13,989 (3.27%; 95% CI 3.21% - 3.32%) were concurrent pulmonary and extrapulmonary TB. Patients with EPTB were mainly white (16.7%), and most (29.1%) patients had five to eight years of education. Among comorbidities, HIV infection was prominent (OR 2.15; 95% CI 2.09 - 2.21), although the proportion of cases awaiting test results or untested was high (39%). Ethanol use (OR 0.45; 95% CI 0.43 - 0.46), diabetes mellitus (OR 0.54; 95% CI 0.51 - 0.57) and mental illness (OR 0.88; 95% CI 0.82 - 0.95) were associated with PTB.
   Conclusions: Thirteen percent of patients diagnosed with TB in Brazil have only EPTB. More effective diagnostic strategies and control measures are needed to reduce the number of cases of extrapulmonary TB in Brazil.
C1 [Gomes, Teresa; Reis-Santos, Barbara; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
   [Bertolde, Adelmo] Univ Fed Espirito Santo, Dept Stat, Vitoria, ES, Brazil.
   [Johnson, John L.] Case Western Reserve Univ, Dept Med, Div Infect Dis, TB Res Unit, Cleveland, OH 44106 USA.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; Reis-Santos, Barbara/A-3149-2014
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos,
   Barbara/0000-0001-6952-0352
FU CNPq/BrazilNational Council for Scientific and Technological Development
   (CNPq); U.S. National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [ICOHRTA 5 U2R TW006883-02]; FAPES (Fundacao de Amparo a Pesquisa do
   Espirito Santo)
FX This study was supported by CNPq/Brazil edital Doencas negligenciadas
   2012 and Universal 2010, the U.S. National Institutes of Health, under
   contract ICOHRTA 5 U2R TW006883-02, and FAPES (Fundacao de Amparo a
   Pesquisa do Espirito Santo).
CR Abraham BK, 2012, J IMMIGR MINOR HEALT, V15, P381
   [Anonymous], 2012, SECR VIG SAUD, V43, P2
   Barbosa IR, 2012, HYGIEA, V8, P232
   Bierrenbach Ana Luiza, 2007, Rev. Saúde Pública, V41, P67, DOI [10.1590/S0034-89102007000800010, 10.1590/s0034-89102007000800010]
   Boffo Maria Marta Santos, 2004, J. bras. pneumol., V30, P140, DOI 10.1590/S1806-37132004000200011
   Braga JU GG, 1992, J BRAS PNEUMOL, V18, P119
   Carvalho CN, 2011, REV SAUDE PUBL, V45, P548, DOI [10.1590/S0034-89102011005000021, 10.1590/s0034-89102011000300013]
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   Coutinho LASA, 2012, REV BRAS CIENCIAS SA, V16, P35, DOI DOI 10.4034/RBCS.2012.16.01.06
   de Oliveira Gisele Pinto, 2012, Rev Bras Epidemiol, V15, P468, DOI 10.1590/S1415-790X2012000300003
   Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607
   Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005
   Fuchs SC, 1996, REV SAUDE PUBL, V30, P168, DOI 10.1590/S0034-89101996000200009
   Golden MP, 2005, AM FAM PHYSICIAN, V72, P1761
   Gomes T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074517
   Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10
   Hoa NT, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-6
   MACIEL E, 2012, PROMOCAO SAUDE DIVER
   Mascarenhas MDM, 2005, EPIDEMIOL SERV SAUDE, V14, P7
   Naing C, 2013, LUNG, V191, P27, DOI 10.1007/s00408-012-9440-6
   Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448
   Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559
   Portillo-Gomez L, 2000, INT J TUBERC LUNG D, V4, P361
   Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213
   Rowinska-Zakrzewska Ewa, 2011, Pneumonol Alergol Pol, V79, P377
   Saita NM, 2012, REV LAT-AM ENFERM, V20, P769, DOI 10.1590/S0104-11692012000400018
   Sankar MM, 2013, TUBERCULOSIS, V93, P75, DOI 10.1016/j.tube.2012.10.005
   Seiscento M, 2009, J BRAS PNEUMOL, V35, P548, DOI 10.1590/S1806-37132009000600008
   Selig L, 2010, REV SAUDE PUBL, V44, P1072, DOI 10.1590/s0034-89102010000600012
   Silva A, 2011, REV BRAS CLIN MED, V9, P11
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   World Health Organization, 2012, WHOHTMTB20126
   World Health Organization, TUB COUNTR PROF
   Yone EWP, 2013, SCAND J INFECT DIS, V45, P104, DOI 10.3109/00365548.2012.714905
NR 34
TC 35
Z9 40
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 8
PY 2014
VL 14
AR 9
DI 10.1186/1471-2334-14-9
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA 294NE
UT WOS:000330052600001
PM 24400848
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Sampaio, PB
   Bertolde, AI
   Maciel, ELN
   Zandonade, E
AF Sampaio, Poliane Barbosa
   Bertolde, Adelmo Inacio
   Noia Maciel, Ethel Leonor
   Zandonade, Eliana
TI Correlation between the spatial distribution of leprosy and
   socioeconomic indicators in the city of Vitoria, State of ES, Brazil
SO LEPROSY REVIEW
LA English
DT Article
ID DISEASE; RISK; STATISTICS; PATTERNS
AB Introduction: Leprosy is a disease that is directly linked to poverty. The number of cases in Vitoria, the capital city of Espirito Santo, has been decreasing in recent years, but the disease remains highly endemic. This research aimed to identify relationships between the epidemiological status of leprosy and socioeconomic indicators during the period from 2005 to 2009.
   Methods: An ecological study was performed based on the spatial distribution of leprosy in Vitoria, Espirito Santo, between 2005 and 2009. The source data used were records available at the Secretary of State for Health of the Espirito Santo. We used the Urban Quality Index (IQU) as the leprosy-associated socioeconomic variable. The data were analysed with covariate and spatial effects by the WinBugs programme (Version 1.4) and R (Version 2.12).
   Results: The spatial distribution of leprosy in the district is not uniform. By studying the geographic distribution of leprosy cases, and the risks estimated by the complete Bayesian model, it was possible to gain further insight into the distribution of leprosy cases. It was noted that neighbourhoods with a low IQU have a higher leprosy case detection rate than neighbourhoods with a higher IQU. This result reinforced the theory that a low IQU is associated with the emergence of leprosy.
   Conclusion: The model methodology adopted enabled the verification of the effect of the influence of covariates related to the social determinants of health as well as the spatial structure, in contrast to the gross rate method that does not aggregate this information. The results obtained suggest that leprosy control may be promoted by improving the socioeconomic indicators of neighbourhoods, and highlights the need for implementation of health policies aimed at. people who live in areas where they are at greatest risk of getting sick.
C1 [Sampaio, Poliane Barbosa; Noia Maciel, Ethel Leonor; Zandonade, Eliana] Univ Fed Espirito Santo, Univ Fed Espirito Santo, Grad Program Publ Hlth, Vitoria, ES, Brazil.
   [Bertolde, Adelmo Inacio] Univ Fed Espirito Santo, Exact Sci Ctr, Vitoria, ES, Brazil.
RP Sampaio, PB (corresponding author), Rua Maria Eleonora Pereira 605-302 B115 Ed Fenix, BR-29060180 Vitoria, ES, Brazil.
EM polianebsampaio@hotmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU Ministry of Health (MS); Ministry of Science and Technology (MCT);
   National Council for Science and Technological Development (CNPq)
   through Edict MCT/CNPq/CT - Saude/MS/SCTIE DECIT [034/2008]
FX This study was financially supported by the Ministry of Health (MS), the
   Ministry of Science and Technology (MCT), and the National Council for
   Science and Technological Development (CNPq) through Edict MCT/CNPq/CT -
   Saude/MS/SCTIE DECIT No. 034/2008, along with additional studies to
   assist in interventions for leprosy control in cluster No. 4
   municipalities (States of Espirito Santo, Bahia and Minas Gerais).
CR Assuncao R M, 1998, Cad Saude Publica, V14, P713, DOI 10.1590/S0102-311X1998000400013
   Bakker MJ, 2006, LEPROSY REV, V77, P170
   Barbosa AC, 2011, REV SAUDE PUBL, V45, P644
   Imbiriba ENB, 2009, REV SAUDE PUBL, V43, P656, DOI 10.1590/s0034-89102009005000046
   BERNARDINELLI L, 1992, STAT MED, V11, P983, DOI 10.1002/sim.4780110802
   Brasil. Ministerio da Sadde. Secretaria de Vigilancia em Smide. Programa Nacional de Controle da Hanseniase, 2009, HANS BRAS DAD IND SE
   Brasil. Ministerio da Saude, 2006, SAUD BRAS 2005 AN SI
   Brasil. Ministerio da Saude. Secretaria de Politicas de Saude. Departamento de Atencao Basica. Area Tecnica de Dermatologia Sanitaria, 1994, AR TECN DERM SAN HAN
   Carvalho Marilia Sá, 2005, Cad. Saúde Pública, V21, P361, DOI 10.1590/S0102-311X2005000200003
   da Silva AR, 2010, REV SOC BRAS MED TRO, V43, P691, DOI 10.1590/S0037-86822010000600018
   Cury MRDO, 2012, REV SAUDE PUBL, V46, P110, DOI 10.1590/S0034-89102011005000086
   Declercq E, 2011, LEPROSY REV, V82, P87
   do Prado RR, 2009, REV SOC BRAS MED TRO, V42, P537, DOI 10.1590/S0037-86822009000500011
   Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735
   Fundacao Instituto Brasileiro de Geografia e Estatistica, 2009, CENS DEM 2009 AGR SE
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Kato SK, 2009, CAD SAUDE PUBLICA, V25, P1501, DOI 10.1590/S0102-311X2009000700008
   Lockwood DNJ, 2005, B WORLD HEALTH ORGAN, V83, P230
   LOMBARDI, 1990, HANSENIASE EPIDEMIOL, P13
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395
   Marshall RJ, 1991, APPL STAT, V40, P28
   Marzliak M. L. C., 2008, Hansenologia Internationalis, V33, P39
   Organizacion Panamericana de La Salud (OPS), 1996, B EPIDEMIOLOGICO, V17
   Penna MLF, 2009, EMERG INFECT DIS, V15, P650, DOI 10.3201/eid1504.081378
   Prefeitura Municipal Vitoria ES, 2004, IND QUAL URB IQU BAI
   Queiroz JW, 2010, AM J TROP MED HYG, V82, P306, DOI 10.4269/ajtmh.2010.08-0675
   Sampaio PB, 2012, REV SOC BRAS MED TRO, V43, P691
   Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Teixeira JC, 2011, ENG SANIT AMBIENT, V16, P197, DOI 10.1590/S1413-41522011000200014
   WHO, 2012, WHO WEEKLY EPIDEMIOL
   World Health Organization (WHO), 2010, FIN REP
NR 31
TC 2
Z9 2
U1 0
U2 3
PU LEPRA
PI COLCHESTER
PA 28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND
SN 0305-7518
EI 2162-8807
J9 LEPROSY REV
JI Lepr. Rev.
PD DEC
PY 2013
VL 84
IS 4
BP 256
EP 265
PG 10
WC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
SC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
GA AF3ZF
UT WOS:000334650500002
PM 24745125
DA 2020-12-15
ER

PT J
AU Macedo, LR
   Reis-Santos, B
   Riley, LW
   Maciel, EL
AF Ribeiro Macedo, L.
   Reis-Santos, B.
   Riley, L. W.
   Maciel, E. L.
TI Treatment outcomes of tuberculosis patients in Brazilian prisons: a
   polytomous regression analysis
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE cure; treatment; prisoners
ID REGION; HIV
AB SETTING: Tuberculosis (TB) is a major public health problem and an important cause of infectious disease-related death in young adults. TB rates are higher in vulnerable populations, including prisoners.
   OBJECTIVE: TO describe the clinical and epidemiological characteristics associated with anti-tuberculosis treatment outcomes in the Brazilian prison population.
   DESIGN: The study population consisted of prisoners diagnosed with TB identified through the Sistema de Informacao de Agravos de Notificacao (Information System for Notifiable Diseases) between January 2007 and December 2011. Pearson's chi(2) test was used to compare the proportions and covariates associated with the outcome of interest. These variables were further analysed using the polytomous regression model.
   RESULTS: Compared to those who completed anti-tuberculosis treatment, prisoners who defaulted from treatment were younger (P < 0.001), less educated (P < 0.001) and more likely to be alcoholic (P < 0.001); they were more likely to have recurrent or relapse TB (P < 0.001) and they were not under directly observed treatment (P < 0.001). Those who died from TB tended to be older (P < 0.001) and alcoholic (P < 0.001); they were also more likely to have received treatment of unknown type (P < 0.001) and to have both pulmonary and extra-pulmonary TB (EPTB). Prisoners who developed multidrug-resistant TB were more likely to experience TB recurrence, return to treatment after default, change treatment centres and have EPTB.
   CONCLUSION: Our results highlight the need to improve TB control and policies in correctional facilities. Improving treatment outcomes of prisoners will also prevent transmission to other prisoners, their family members, and health professionals.
C1 [Ribeiro Macedo, L.; Maciel, E. L.] Univ Fed Espirito Santo, Postgrad Programme Doencas Infecciosas, BR-29040091 Vitoria, ES, Brazil.
   [Ribeiro Macedo, L.; Reis-Santos, B.; Maciel, E. L.] Univ Fed Espirito Santo, Lab Epidemiol, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
   [Riley, L. W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Macedo, LR (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Ave Maruipe Bairro Santos Dumont, BR-29040091 Vitoria, ES, Brazil.
EM layllarm@hotmail.com
RI Macedo, Laylla Ribeiro/AAV-5154-2020; Maciel, Ethel Leonor
   LN/G-1027-2012; Reis-Santos, Barbara/A-3149-2014
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos,
   Barbara/0000-0001-6952-0352; Ribeiro Macedo, Laylla/0000-0002-6246-3559
FU Edital Doencas Negligenciadas, Conselho Nacional de Pesquisa, Brasilia,
   Brazil; Edital ICHORTA [5U2R TW006883-02]; International Clinical
   Operational and Health Services Research and Training Award; National
   Institutes of Health, Bethesda, MD, USAUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883] Funding
   Source: NIH RePORTER
FX The study was supported by the Edital Doencas Negligenciadas, Conselho
   Nacional de Pesquisa, Brasilia, Brazil; and the Edital ICHORTA 5U2R
   TW006883-02, International Clinical Operational and Health Services
   Research and Training Award, National Institutes of Health, Bethesda,
   MD, USA.
CR Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81
   Balabanova Y, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-44
   Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381
   Berhe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-537
   Bierrenbach AL, 2007, REV SAUDE PUBL, V41
   Biesheuvel CJ, 2008, J CLIN EPIDEMIOL, V61, P125, DOI 10.1016/j.jclinepi.2007.03.002
   Brasil. Ministerio da Saude, 2011, MAN REC CONTR TUB BR
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2008, MAN NAC VIG LAB TUB
   BRAUN MM, 1990, ARCH INTERN MED, V150, P1913, DOI 10.1001/archinte.150.9.1913
   Gonzales RIC, 2008, REV ESC ENFERM USP, V42, P627, DOI 10.1590/S0080-62342008000400003
   Coelho HC, 2007, CAD SAUDE PUBLICA, V23, P2197, DOI 10.1590/S0102-311X2007000900027
   Das SK, 2012, INDIAN J MED MICROBI, V30, P364, DOI 10.4103/0255-0857.99509
   Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8
   Jurgens R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-26
   Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3
   Lopes AJ, 2006, PULMAO RJ, V15, P253
   Malhao TA, 2010, EPIDEMIOL SERV SAUDE, V19, P245
   Medeiros D, 2012, CAD SAUDE COLET RIO, V20, P146
   Ministerio da Saude (BR), 2012, B EP ESP TUB
   Moreira Cláudia Maria Marques, 2008, J. bras. pneumol., V34, P225, DOI 10.1590/S1806-37132008000400007
   MORSE RM, 1992, JAMA-J AM MED ASSOC, V268, P1012, DOI 10.1001/jama.268.8.1012
   Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973
   Nik NR, 2011, MALAYS J PUBL HLTH M, V11, P6
   Nogueira PA, 2012, REV SAUDE PUBL, V46, P119, DOI 10.1590/S0034-89102011005000080
   Orofino RD, 2012, J BRAS PNEUMOL, V38, P88, DOI 10.1590/S1806-37132012000100013
   Pedro H S P, 2010, REV PATOLOGIA TROPIC, V39, P273
   Pinheiro R S, 2011, MELHORIA QUALIDADE S
   Sanchez A, 2009, INT J TUBERC LUNG D, V13, P1247
   Sanchez A I M, 2007, TRATAMENTO DIRETAMEN
   Sanchez AR, 2010, CAD SAUDE PUBLICA, V26, P851, DOI 10.1590/S0102-311X2010000500001
   Talay F, 2008, JPN J INFECT DIS, V61, P25
   WHO, 2011, WHOHTMTB201116
   World Health Organization, 2012, TUB PRIS
   Zhang XY, 2011, AM J TROP MED HYG, V85, P285, DOI 10.4269/ajtmh.2011.10-0630
NR 34
TC 15
Z9 16
U1 0
U2 9
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD NOV
PY 2013
VL 17
IS 11
BP 1427
EP 1434
DI 10.5588/ijtld.12.0918
PG 8
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 244YK
UT WOS:000326425900012
PM 24125446
DA 2020-12-15
ER

PT J
AU Gomes, T
   Vinhas, SA
   Reis-Santos, B
   Palaci, M
   Peres, RL
   Aguiar, PP
   Ribeiro, FKC
   Marques, HS
   Dettoni, VD
   Johnson, JL
   Riley, LW
   Maciel, EL
AF Gomes, Teresa
   Vinhas, Solange Alves
   Reis-Santos, Barbara
   Palaci, Moises
   Peres, Renata Lyrio
   Aguiar, Paola P.
   Correa Ribeiro, Fabiola Karla
   Marques, Hebert Silva
   Dettoni, Valderio do Valle
   Johnson, John L.
   Riley, Lee W.
   Maciel, Ethel Leonor
TI Extrapulmonary Tuberculosis: Mycobacterium tuberculosis Strains and Host
   Risk Factors in a Large Urban Setting in Brazil
SO PLOS ONE
LA English
DT Article
ID IDENTIFICATION; EPIDEMIOLOGY; PULMONARY; LINEAGE
AB Background: Factors related to the development of extrapulmonary forms of tuberculosis (EPTB) are still poorly understood, particularly in high-endemic countries like Brazil. The objective of the paper is to determine host and Mycobacterium tuberculosis (MTB) strain-related factors associated with the development of EPTB in Espirito Santo state, Brazil.
   Methods and Findings: We conducted a retrospective laboratory-based surveillance study of new tuberculosis (TB) cases diagnosed in Espirito Santo state, Brazil between 1998 and 2007. We genotyped 612 isolates of MTB from 606 TB patients using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) typing and compared sociodemographic and clinical characteristics of patients with pulmonary TB (PTB) and EPTB. Among 606 patients, 464 (77%) had PTB, 79 (13%) had EPTB, 51 (8%) had both, and 12 (2%) had miliary TB. The IS6110 RFLP analysis demonstrated that 250 (41%) isolates belonged to clustered RFLP patterns, 27 (11%) of which were from EPTB. We identified 73 clusters including 35 (48%) composed of 2 isolates each. By spoligotyping, 506 (83%) MTB isolates fell into known patterns and 106 (17%) fell into patterns with no family assignment; 297 (48%) isolates belonged to the Latin-American Mediterranean family. Higher school level (4-7 years OR: 0.16 95% CI 0.34-0.73 and > 8 years of education, OR 0.06 95% CI 0.009-0.50) white ethnicity (OR: 2.54 95% CI 1.03-6.25) and HIV infection (OR: 16.83 95% CI 5.23-54.18) were associated with EPTB. No specific strain lineage or percentage of clustering was associated with EPTB.
   Conclusions: These results demonstrate that risk factors for EPTB are related more to host than to MTB strain lineage characteristics.
C1 [Gomes, Teresa; Vinhas, Solange Alves; Reis-Santos, Barbara; Palaci, Moises; Peres, Renata Lyrio; Aguiar, Paola P.; Correa Ribeiro, Fabiola Karla; Marques, Hebert Silva; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Grad Program Infect Dis, Vitoria, Brazil.
   [Dettoni, Valderio do Valle] Univ Fed Espirito Santo, TB Control Program, Vitoria, Brazil.
   [Johnson, John L.] Case Western Reserve Univ, Dept Med, Div Infect Dis, TB Res Unit, Cleveland, OH 44106 USA.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Maciel, Ethel Leonor] Univ Fed Espirito Santo, Grad Program Publ Hlth, Vitoria, Brazil.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Grad Program Infect Dis, Vitoria, Brazil.
EM ethel.maciel@gmail.com
RI Tuberculose, Inct/K-2302-2013; Maciel, Ethel Leonor LN/G-1027-2012;
   Reis-Santos, Barbara/A-3149-2014
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos,
   Barbara/0000-0001-6952-0352
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Espirito Santo (Fapes);
   Tuberculosis Research Unit at Case Western Reserve University; United
   States National Institutes of Allergy and Infectious Diseases, National
   Institutes of Health and Human ServicesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)NIH National
   Human Genome Research Institute (NHGRI) [NO1-AI95383,
   HHSN266200700022C/NO1-AI-70022, ICOHRTA 5 U2R TW006883-02]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [N01AI095383, N01AI095383, N01AI095383,
   N01AI095383, N01AI095383, N01AI095383] Funding Source: NIH RePORTER
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Brazil and Fundacao de Amparo a
   Pesquisa do Espirito Santo (Fapes). The laboratory work for this study
   was supported, in part, by the Tuberculosis Research Unit at Case
   Western Reserve University, established with funds from the United
   States National Institutes of Allergy and Infectious Diseases, National
   Institutes of Health and Human Services, under contract NO1-AI95383 and
   HHSN266200700022C/NO1-AI-70022 and ICOHRTA 5 U2R TW006883-02. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Benedetti A, 2010, AM J EPIDEMIOL, V172, P318, DOI 10.1093/aje/kwq124
   Borgdorff MW, 2011, AM J EPIDEMIOL, V174, P243, DOI 10.1093/aje/kwr061
   Brasil. Ministerio da Saude, 2012, B EP ESP TUB, P43
   Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23
   *CDC, 2012, REP TUB US
   Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004
   da Roza DL, 2012, REV SOC BRAS MED TRO, V45, P607, DOI 10.1590/S0037-86822012000500013
   Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004
   DEVIEDMA DG, 2005, J INFECT DIS, V192, P2059, DOI DOI 10.1086/498245.PUBMED:16288368
   *EP MDSSDVESDDV, 2008, MAN NAC VIG LAB TUB
   Fiske CT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-16
   Fok A, 2008, INT J TUBERC LUNG D, V12, P480
   Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005
   Gibson JF, 2010, MOL PHYLOGENET EVOL, V56, P1126, DOI 10.1016/j.ympev.2010.05.005
   GOMES T, 2013, THESIS U FEDERAL ESP
   Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10
   JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997
   Kingkaew N, 2009, INT J INFECT DIS, V13, P722, DOI 10.1016/j.ijid.2008.11.013
   Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x
   MACIEL E, 2012, PROMOCAO SAUDE DIVER
   Mazza-Stalder J, 2012, REV MAL RESPIR, V29, P566, DOI 10.1016/j.rmr.2011.05.021
   *MIN PLAN, 2012, CONT POP
   *MIN SAUD, 2011, MAN REC CONTR TUB BR, P32
   *MIN SAUD, 2012, SER HIST TAX MORT TU
   Nicol MP, 2005, J CLIN MICROBIOL, V43, P5779, DOI 10.1128/JCM.43.11.5779-5781.2005
   Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07
   Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448
   Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464
   Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559
   Razanamparany VR, 2002, J CLIN MICROBIOL, V40, P3964, DOI 10.1128/JCM.40.11.3964-3969.2002
   RIEDER HL, 1990, AM REV RESPIR DIS, V141, P347, DOI 10.1164/ajrccm/141.2.347
   Sankar MM, 2013, TUBERCULOSIS, V93, P75, DOI 10.1016/j.tube.2012.10.005
   Seiscento M, 2009, J BRAS PNEUMOL, V35, P548, DOI 10.1590/S1806-37132009000600008
   Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779
   VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993
   VINHAS SP, 2012, TUBERCULOSI IN PRESS
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   *WHO, 2011, GLOB TB CONTR
   *WHO, 2012, TUB COUNTR PROF
   Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644
   2011, SISTEMA NACL VIGILAN, P5
NR 44
TC 23
Z9 24
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 2
PY 2013
VL 8
IS 10
AR e74517
DI 10.1371/journal.pone.0074517
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 231RG
UT WOS:000325434500012
PM 24098337
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Reis-Santos, B
   Gomes, T
   Horta, BL
   Maciel, ELN
AF Reis-Santos, Barbara
   Gomes, Teresa
   Horta, Bernardo Lessa
   Noia Maciel, Ethel Leonor
TI The outcome of tuberculosis treatment in subjects with chronic kidney
   disease in Brazil: a multinomial analysis
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA Portuguese
DT Article
DE Tuberculosis/epidemiology; Renal insufficiency, chronic/epidemiology;
   Risk factors; Logistic models
ID CHRONIC-RENAL-FAILURE; TRANSPLANTATION; INTERVENTIONS; POPULATION;
   HEALTH; DEATH
AB Objective: To analyze the association between clinical/epidemiological characteristics and outcomes of tuberculosis treatment in patients with concomitant tuberculosis and chronic kidney disease (CKD) in Brazil. Methods: We used the Brazilian Ministry of Health National Case Registry Database to identify patients with tuberculosis and CKD, treated between 2007 and 2011. The tuberculosis treatment outcomes were compared with epidemiological and clinical characteristics of the subjects using a hierarchical multinomial logistic regression model, in which cure was the reference outcome. Results: The prevalence of CKD among patients with tuberculosis was 0.4% (95% CI: 0.37-0.42%). The sample comprised 1,077 subjects. The outcomes were cure, in 58%; treatment abandonment, in 7%; death from tuberculosis, in 13%; and death from other causes, in 22%. The characteristics that differentiated the ORs for treatment abandonment or death were age; alcoholism; AIDS; previous noncompliance with treatment; transfer to another facility; suspected tuberculosis on chest X-ray; positive results in the first smear microscopy; and indications for/use of directly observed treatment, short-course strategy. Conclusions: Our data indicate the importance of sociodemographic characteristics for the diagnosis of tuberculosis in patients with CKD and underscore the need for tuberculosis control strategies targeting patients with chronic noncommunicable diseases, such as CKD.
C1 [Reis-Santos, Barbara; Gomes, Teresa; Horta, Bernardo Lessa; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Ave Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Horta, Bernardo/A-7604-2008; Maciel, Ethel Leonor LN/G-1027-2012;
   Reis-Santos, Barbara/A-3149-2014
OI Horta, Bernardo/0000-0001-9843-412X; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Reis-Santos, Barbara/0000-0001-6952-0352
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [U2R TW006883] Funding Source: Medline
CR Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Baussano I, 2010, PLOS MED, V7, DOI DOI 10.1371/J0URNAL.PMED.I000381
   Bedendo J, 2011, PROG TRANSPLANT, V21, P249, DOI 10.7182/prtr.21.3.n83l123j66062615
   Biesheuvel CJ, 2008, J CLIN EPIDEMIOL, V61, P125, DOI 10.1016/j.jclinepi.2007.03.002
   Costa e Silva FV, 2008, J BRAS NEFROL, V30, P83
   Barros MBD, 2011, CIENC SAUDE COLETIVA, V16, P3755
   de Oliveira GP, 2013, BRAZ J INFECT DIS, V17, P218, DOI 10.1016/j.bjid.2013.01.005
   DONNELLY PK, 1983, P EUR DIAL TRANS, V20, P297
   Eggers PW, 2009, SEMIN NEPHROL, V29, P551, DOI 10.1016/j.semnephrol.2009.07.001
   Khan FA, 2012, CLIN INFECT DIS, V55, P1154, DOI 10.1093/cid/cis630
   KHAN MA, 1981, ARCH INTERN MED, V141, P1554, DOI 10.1001/archinte.141.11.1554
   LAGUARDIA J, 2004, EPIDEMIOL SERV SAUDE, V13, P135
   Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3
   Lezaic V, 2001, RENAL FAILURE, V23, P97, DOI 10.1081/JDI-100001289
   Maciel E L., 2012, DETERMINANTES SOCIAI
   Malhao TA, 2010, EPIDEMIOL SERV SAUDE, V19, P245
   Medeiros D, 2012, CAD SAUDE COLET, V20, P146
   Oliveira H B, 2000, Rev Saude Publica, V34, P437
   Perez-Guzman C, 2011, LUNG INDIA, V28, P191, DOI 10.4103/0970-2113.83976
   Portillo-Gomez L, 2000, INT J TUBERC LUNG D, V4, P361
   Raviglione M, 2012, LANCET, V379, P2242
   Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2
   Reyes H, 1997, BRIT MED J, V315, P1447, DOI 10.1136/bmj.315.7120.1447
   Saran R, 2010, ADV CHRONIC KIDNEY D, V17, P213, DOI 10.1053/j.ackd.2010.03.009
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   Selig L, 2010, REV SAUDE PUBL, V44, P1072, DOI 10.1590/s0034-89102010000600012
   Venkata RKC, 2007, CLIN NEPHROL, V67, P217
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2
   Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352
   Zhang XY, 2011, AM J TROP MED HYG, V85, P285, DOI 10.4269/ajtmh.2011.10-0630
NR 31
TC 10
Z9 10
U1 0
U2 3
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD SEP-OCT
PY 2013
VL 39
IS 5
BP 585
EP 594
DI 10.1590/S1806-37132013000500009
PG 10
WC Respiratory System
SC Respiratory System
GA 278FW
UT WOS:000328875600009
PM 24310632
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Reis-Santos, B
   Gomes, T
   Macedo, LR
   Horta, BL
   Riley, LW
   Maciel, EL
AF Reis-Santos, Barbara
   Gomes, Teresa
   Macedo, Laylla R.
   Horta, Bernardo L.
   Riley, Lee W.
   Maciel, Ethel L.
TI Prevalence and patterns of multimorbidity among tuberculosis patients in
   Brazil: a cross-sectional study
SO INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH
LA English
DT Article
DE Tuberculosis; Multimorbidities; Inequity; Social determinants;
   Hierarchical models
ID TREATMENT OUTCOMES; RISK-FACTORS; HIV STATUS; EPIDEMIOLOGY;
   DETERMINANTS; COMORBIDITY; PROPOSAL; IMPACT; CARE
AB Introduction: The number of subjects with tuberculosis (TB) presenting with co-occurrence of multiple chronic medical conditions, or multimorbidity (MM) is increasing in Brazil. This manuscript aimed to characterize subjects with TB, according to their MM status and to analyse factors associated with TB treatment outcomes.
   Methods: This is a cross-sectional study that included 39,881 TB subjects reported in Brazil, in 2011. MM were defined as any (two or more) occurrence of chronic medical conditions in a TB patient (TB-MM). Data analysis was performed by hierarchical logistic regression models comparing TBMM with those with only TB.
   Results: Of the reported TB cases in 2011, 454 (1.14%) had MM. The subjects in the age group 40-59 years (OR: 17.89; 95% CI, 5.71-56.03) and those >= 60 years (OR: 44.11; 95% CI, 14.09-138.06) were more likely to develop TB-MM. The TB-MM subjects were less likely to be male (OR: 0.63; 95% CI, 0.52-0.76), institutionalized (OR: 0.59; 95% CI, 0.23-0.80) and live in rural areas (OR: 0.63; 95% CI, 0.42-0.95). Death from causes other than TB was higher among TB-MM subjects (OR: 1.76; 95% CI, 1.36-2.28). Of 454 TB-MM subjects 302 (66.5%) were cured and 152 (33.5%) were not cured. The odds of not being cured was 1.55 (95% CI, 1.04-2.32) among males, 2.85 (95% CI, 1.12-7.28) among institutionalized subjects, and 3.93 (IC 95%, 1.86-8.30) among those who were infected with HIV. TB retreatment after previous abandonment (OR: 7.53; 95% CI, 2.58-21.97) and transfer from a treatment site (OR: 2.76; 95% CI, 1.20-6.38) were higher for subjects not cured compared to those who were cured.
   Conclusions: While TB is well recognized to be a disease engendered by social inequity, we found that even among TB patients, those who have MM have greater inequity in terms of socioeconomic status and adverse clinical outcomes. Addressing the problem of TB and TB-MM requires a multisectorial approach that includes health and social service organizations.
C1 [Reis-Santos, Barbara; Gomes, Teresa; Macedo, Laylla R.; Maciel, Ethel L.] Univ Fed Espirito Santo, Lab Epi UFES Lab Epidemioly, Vitoria, ES, Brazil.
   [Reis-Santos, Barbara; Horta, Bernardo L.] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, Brazil.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epi UFES Lab Epidemioly, Av Marechal Campos 1468 Maruipe, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012; Macedo, Laylla
   Ribeiro/AAV-5154-2020; Horta, Bernardo/A-7604-2008; Reis-Santos,
   Barbara/A-3149-2014
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Horta,
   Bernardo/0000-0001-9843-412X; Ribeiro Macedo,
   Laylla/0000-0002-6246-3559; Reis-Santos, Barbara/0000-0001-6952-0352
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883] Funding
   Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [5 U2R TW006883-02] Funding Source: Medline
CR Anderson RT, 1997, EPIDEMIOLOGY, V8, P42, DOI 10.1097/00001648-199701000-00007
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   BRASIL GF, 2011, PLAN BRAS SEM MIS
   Brasil. Ministerio. da Saude, 2011, PROGR NAC CONTR TUB
   Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x
   BUSKIN SE, 1994, AM J PUBLIC HEALTH, V84, P1750, DOI 10.2105/AJPH.84.11.1750
   Chan-Yeung M, 2002, INT J TUBERC LUNG D, V6, P771
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   Coninx R, 2000, BRIT MED J, V320, P440, DOI 10.1136/bmj.320.7232.440
   de Oliveira Gisele Pinto, 2012, Rev Bras Epidemiol, V15, P468, DOI 10.1590/S1415-790X2012000300003
   Dooley KE, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/874083
   Fatiregun AA, 2009, ANN AFR MED, V8, P100, DOI 10.4103/1596-3519.56237
   Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337
   Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111
   Fuchs SC, 1996, REV SAUDE PUBL, V30, P168, DOI 10.1590/S0034-89101996000200009
   Garrido MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039134
   Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2
   Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3
   Maciel ELNA, 2012, PROMOCAO SAUDE DETER, P429
   Mori T, 2010, INFECT DIS CLIN N AM, V24, P751, DOI 10.1016/j.idc.2010.04.011
   Reis-Santos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062604
   Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929
   Selig L, 2010, REV SAUDE PUBL, V44, P1072, DOI 10.1590/s0034-89102010000600012
   Suhadev M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019485
   Swaminathan S, 2008, J BIOSCIENCES, V33, P527, DOI 10.1007/s12038-008-0071-2
   Takarinda KC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-124
   Teixeira E. C., 2011, Revista de Economia, V37, P106
   Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093
   van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5
   van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI DOI 10.3109/13814789609162146
   WHO, 2005, GLOB TUB PROGR GLOB, P108
   Yone EWP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-190
   Zhang XY, 2011, AM J TROP MED HYG, V85, P285, DOI 10.4269/ajtmh.2011.10-0630
NR 35
TC 9
Z9 9
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-9276
J9 INT J EQUITY HEALTH
JI Int. J. Equity Health
PD AUG 20
PY 2013
VL 12
AR 61
DI 10.1186/1475-9276-12-61
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 206MQ
UT WOS:000323526100001
PM 23962018
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Rogerio, WP
   Baraona, CMO
   do Prado, TN
   Lacerda, TC
   Carlesso, GF
   Maciel, ELN
AF Rogerio, Wesley Pereira
   Oliveira Baraona, Catarina Maria
   do Prado, Thiago Nascimento
   Lacerda, Thamy Carvalho
   Carlesso, Geisa Fregona
   Noia Maciel, Ethel Leonor
TI Prevalence of latent infection of mycobacterium tuberculosis among
   healthcare students in a public university in Vitoria, state of Espirito
   Santo, Brazil
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Students; Nursing Students; Medical Students; Tuberculosis; Tuberculin
   Test
ID INTERFERON-GAMMA ASSAY; DIAGNOSIS; SCHOOLS
AB This article seeks to determine the prevalence of Mycobacterium tuberculosis infection in medical and nursing students of the Federal University of Espirito Santo (UFES) This is a cross-sectional study in which data were collected through a questionnaire assessing personal characteristics, information about tuberculosis, use of preventive measures, etc. This was followed by the application of the tuberculin skin test, with readings after 72 hours by trained nurses, the positive cutoff point for the TST being 10 mm of induration in the 72-hour reading. Participants in the study included 225 volunteers, namely 98 Medical students and 127 Nursing students. A positive tuberculin skin test was found in 54 students of both courses, resulting in a prevalence of 24%. Among Nursing Students the result of a positive TST was obtained in 24% and in 23%, of Medical Students, such that this difference was not statistically significant. It is necessary to carry out a routine program of tuberculin testing, for confirmation, combined with interventions to reduce the risk of nosocomial transmission in the workplace, as well as further studies to evaluate the effectiveness of new tests to detect latent tuberculosis infection.
C1 [Rogerio, Wesley Pereira; Oliveira Baraona, Catarina Maria; do Prado, Thiago Nascimento; Lacerda, Thamy Carvalho; Carlesso, Geisa Fregona; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Biomed, Programa Posgrad Saude Colet, BR-29040091 Vitoria, ES, Brazil.
RP Rogerio, WP (corresponding author), Univ Fed Espirito Santo, Ctr Biomed, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM wesley_enfufes@hotmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Fregona,
   Geisa/0000-0001-5835-8222; Pereira Rogerio, Wesley/0000-0001-9068-7827
CR Caglayan V, 2011, TUBERK TORAK, V59, P43, DOI 10.5578/tt.1129
   Coelho Magna Adaci de Quadros, 2009, Rev. bras. educ. med., V33, P535, DOI 10.1590/S0100-55022009000400004
   Prado Thiago Nascimento do, 2008, J. bras. pneumol., V34, P607, DOI 10.1590/S1806-37132008000800011
   Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002
   EVBF Penteado, 1999, THESIS ESCOLA NACL S
   Fernandes MHT, 2009, THESIS U BEIRA INTER
   Ferreira FM, 1998, THESIS U FEDERAL RIO
   Figueredo RM, 2006, REV CIENC MED, V15, P333
   Fregona G, 2007, THESIS U FEDERAL ESP
   Teixeira EG, 2011, J HOSP INFECT, V77, P80, DOI 10.1016/j.jhin.2010.07.021
   Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756
   Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1403
   Maciel EL, 1999, THESIS U FEDERAL RIO
   Maciel ELN, 2005, REV SOC BRAS MED TRO, V38, P469, DOI 10.1590/S0037-86822005000600004
   Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740
   Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006
   Moreira Cláudia Maria Marques, 2008, J. bras. pneumol., V34, P601, DOI 10.1590/S1806-37132008000800010
   Moreira MAC, 2007, REV ENF UERJ, V15, P387
   MS - Ministerio da Saude Brasil, 2010, MAN REC CONTR TUB BR
   Maciel EL, 2007, REV SOC BRAS MED TRO, V40, P397, DOI 10.1590/S0037-86822007000400004
   Trajman A, 2007, INT J TUBERC LUNG D, V11, P703
   Villa TCS, 2006, INT J TUBERC LUNG D, V10, P323
   World Health Organization, 2011, GLOB TUB CONTR SURV
NR 24
TC 5
Z9 5
U1 1
U2 5
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD MAY
PY 2013
VL 18
IS 5
BP 1331
EP 1339
DI 10.1590/S1413-81232013000500018
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 158WL
UT WOS:000320004600018
PM 23670461
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Reis-Santos, B
   Locatelli, R
   Horta, BL
   Faerstein, E
   Sanchez, MN
   Riley, LW
   Maciel, EL
AF Reis-Santos, Barbara
   Locatelli, Rodrigo
   Horta, Bernardo L.
   Faerstein, Eduardo
   Sanchez, Mauro N.
   Riley, Lee W.
   Maciel, Ethel Leonor
TI Socio-Demographic and Clinical Differences in Subjects with Tuberculosis
   with and without Diabetes Mellitus in Brazil - A Multivariate Analysis
SO PLOS ONE
LA English
DT Article
ID PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; RISK-FACTORS; PREVALENCE;
   COHORT; PREDICTORS; FAILURE; IMPACT; DEATH
AB Background: Several studies have evaluated the relationship between diabetes mellitus (DM) and tuberculosis (TB), but the nature of this relationship is not fully understood. TB incidence may be influenced by immunosuppression from DM, but this association may be confounded by other clinical and socioeconomic factors. We aimed to assess socio-demographic and clinical differences in TB patients with and without DM.
   Methods: Using the Brazilian national surveillance system (SINAN), we compared 1,797 subjects with TB and DM with 29,275 subjects diagnosed with TB only in 2009. We performed multivariate analysis to identify factors associated with the presence of DM among TB patients.
   Results: Subjects with TB - DM were older; have initial positive sputum smear test (OR = 1.42, 95% CI 1.26-1.60), and were more likely to die from TB (OR = 1.44, 95% CI 1.03-2.01). They were less likely to have been institutionalized [ in prison, shelter, orphanage, psychiatric hospital (OR = 0.74, 95% CI 0.60-0.93)]; developed extra pulmonary TB (OR = 0.62, 95% CI 0.51-0.75) and to return to TB treatment after abandonment (OR = 0.66, 95% CI 0.51-0.86).
   Conclusions: Prevalence of NCD continues to rise in developing countries, especially with the rise of elderly population, the prevention and treatment of infectious diseases will be urgent. DM and TB represent a critical intersection between communicable and non-communicable diseases in these countries and the effect of DM on TB incidence and outcomes provide numerous opportunities for collaboration and management of these complex diseases in the national public health programs.
C1 [Reis-Santos, Barbara; Locatelli, Rodrigo; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Lab Epi UFES, Vitoria, ES, Brazil.
   [Horta, Bernardo L.] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, RS, Brazil.
   [Faerstein, Eduardo] Univ Estado Rio de Janeiro, Inst Social Med, Postgrad Programme Saude Colet, Rio De Janeiro, Brazil.
   [Sanchez, Mauro N.] Univ Brasilia, Fac Ciencies Saude, Dept Saude Colet, Brasilia, DF, Brazil.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Lab Epi UFES, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Sanchez, Mauro/AAU-2404-2020; Horta, Bernardo/A-7604-2008; Maciel, Ethel
   Leonor LN/G-1027-2012; Reis-Santos, Barbara/A-3149-2014
OI Sanchez, Mauro/0000-0002-0472-1804; Horta, Bernardo/0000-0001-9843-412X;
   Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos,
   Barbara/0000-0001-6952-0352
FU CNPq/BrazilNational Council for Scientific and Technological Development
   (CNPq); United States National Institutes of Allergy and Infectious
   Diseases, National Institutes of Health and Human ServicesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH
   National Human Genome Research Institute (NHGRI) [NO1-AI95383,
   HHSN266200700022C/NO1-AI-70022];  [ICOHRTA 5 U2R TW006883-02]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006885, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006883,
   U2RTW006885, U2RTW006885, U2RTW006883, U2RTW006885, U2RTW006883,
   U2RTW006885, U2RTW006885, U2RTW006883, U2RTW006883, U2RTW006885,
   U2RTW006885, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006885] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [N01AI095383, N01AI095383, N01AI095383,
   N01AI095383, N01AI095383, N01AI095383] Funding Source: NIH RePORTER
FX This study was supported by CNPq/Brazil edital Doencas
   negligenciadas-2006 and Universal-2009. The United States National
   Institutes of Allergy and Infectious Diseases, National Institutes of
   Health and Human Services, under contract NO1-AI95383 and
   HHSN266200700022C/NO1-AI-70022 and was also supported by ICOHRTA 5 U2R
   TW006883-02. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841
   Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81
   Banerjee D, 2011, ADV CLIN CHEM, V53, P139, DOI 10.1016/S0065-2423(11)53006-9
   Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0
   Belo MTCT, 2011, INT J TUBERC LUNG D, V15, P978, DOI 10.5588/ijtld.10.0706
   Brasil MdS, 2008, MAN NAC VIG LAB TUB
   Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8
   Dyck RF, 2007, CAN J PUBLIC HEALTH, V98, P55, DOI 10.1007/BF03405386
   Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161
   Faurholt-Jepsen D, 2012, INT J TUBERC LUNG D, V16, P1680, DOI 10.5588/ijtld.12.0360
   Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114
   Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238
   Gupta Soham, 2011, J Infect Public Health, V4, P140, DOI 10.1016/j.jiph.2011.03.005
   Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x
   Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152
   Jimenez-Corona ME, 2012, THORAX
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Laguardia J, 2004, EPIDEMIOL SERV SAUDE, V13, P135, DOI DOI 10.5123/S1679-49742004000300002
   Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3
   Machado A, 2009, INT J TUBERC LUNG D, V13, P719
   Malhao TA, 2010, EPIDEMIOL SERV SAUDE, V19, P245
   Medeiros D, 2012, CAD SAUDE COLET, V20
   Ministerio da Saude, 2004, SIST INF AGR NOT
   Moreira Cláudia Maria Marques, 2008, J. bras. pneumol., V34, P225, DOI 10.1590/S1806-37132008000400007
   MUGUSI F, 1990, TUBERCLE, V71, P271, DOI 10.1016/0041-3879(90)90040-F
   Maciel ELN, 2009, J BRAS PNEUMOL, V35, P884, DOI 10.1590/S1806-37132009000900010
   Orofino RD, 2012, J BRAS PNEUMOL, V38, P88, DOI 10.1590/S1806-37132012000100013
   Pajankar Sumant, 2008, Oman Med J, V23, P263
   Perez-Guzman C, 2011, LUNG INDIA, V28, P191, DOI 10.4103/0970-2113.83976
   de Albuquerque MDPM, 2007, CAD SAUDE PUBLICA, V23, P1573, DOI 10.1590/S0102-311X2007000700008
   Pinheiro R S, 2011, MELHORIA QUALIDADE S
   Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584
   Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2
   Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935
   Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738
   Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x
   Selig L, 2010, REV SAUDE PUBL, V44, P1072, DOI 10.1590/s0034-89102010000600012
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   SILWER H, 1958, Acta Med Scand Suppl, V335, P1
   Singla R, 2006, INT J TUBERC LUNG D, V10, P74
   Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0
   Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234
   *STOP TB PARTN, 2006, STOP TB STRAT BUILD
   Stop TB Partnership and World Health Organization, 2006, GLOB PLAN STOP TB 20
   Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269
   Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304
   van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088
   Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291
   Wang C.-H., 1999, Tubercle and Lung Disease, V79, P235, DOI 10.1054/tuld.1998.0167
   Wang JY, 2009, RESPIROLOGY, V14, P1012, DOI 10.1111/j.1440-1843.2009.01598.x
   WHO, 2011, TUB DIAB COLL FRAM C
   World Health Organization, 2011, WHO FRAM TARG TUB DI
NR 54
TC 32
Z9 34
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 24
PY 2013
VL 8
IS 4
AR e62604
DI 10.1371/journal.pone.0062604
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 136DE
UT WOS:000318340400117
PM 23638123
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Vinhas, SA
   Palaci, M
   Marques, HS
   de Aguiar, PPL
   Ribeiro, FK
   Peres, RL
   Dietze, R
   Gomes, HM
   Suffys, PN
   Golub, JE
   Riley, LW
   Maciel, ELN
AF Vinhas, Solange Alves
   Palaci, Moises
   Marques, Hebert Silva
   Lobo de Aguiar, Paola Poloni
   Ribeiro, Fabola Karla
   Peres, Renata Lyrio
   Dietze, Reynaldo
   Gomes, Harrison Magdinier
   Suffys, Philip Noel
   Golub, Jonathan E.
   Riley, Lee W.
   Noia Maciel, Ethel Leonor
TI Mycobacterium tuberculosis DNA fingerprint clusters and its relationship
   with RDRio genotype in Brazil
SO TUBERCULOSIS
LA English
DT Article
DE Tuberculosis; DNA fingerprinting; Mycobacterium tuberculosis;
   Epidemiologic surveillance; RDRio
ID NEW-YORK-CITY; GENETIC DIVERSITY; EPIDEMIOLOGY; PATTERNS; DATABASE;
   VITORIA
AB Mycobacterium tuberculosis (Mtb) strains designated as RDRio are responsible for a large cluster of new cases of tuberculosis (TB) in Rio de Janeiro. They were previously shown to be associated with severe manifestations of TB. Here, we used three genotyping methods (IS6110 RFLP, spoligotyping, and multiplex PCR) to characterize RDRio and non-RDRio strains from the metropolitan area of Vitoria, State of Espirito Santo in southeast Brazil to determine strain diversity and transmission patterns. Strains with identical IS6110 RFLP patterns were considered to belong to a cluster indicative of recent transmission. Between 2000 and 2010, we identified 5470 new TB patients and genotyped 981 Mtb strains. Of these, 376 (38%) were RDRio. By RFLP, 180 (48%) of 376 RDRio strains and 235 (40%) of 593 non-RDRio strains belonged to RFLP cluster pattern groups (p = 0.023). Simpson's diversity index based on RFLP patterns was 0.96 for RDRio and 0.98 for non-RDRio strains. Thus, although RDRio strains appear to be comprised of a fewer number of RFLP genotypes, they represent a heterogeneous group. While TB cases caused by RDRio appear more likely to be due to recent transmission than cases caused by non-RDRio strains, the difference is small. These observations suggest that factors other than inherent biological characteristic of RDRio lineages are more important in determining recent transmission, and that public health measures to interrupt new transmissions need to be emphasized for TB control in Vitoria. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Vinhas, Solange Alves; Palaci, Moises; Marques, Hebert Silva; Lobo de Aguiar, Paola Poloni; Ribeiro, Fabola Karla; Peres, Renata Lyrio; Dietze, Reynaldo; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, BR-1468 Vitoria, ES, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, BR-1468 Vitoria, ES, Brazil.
   [Gomes, Harrison Magdinier; Suffys, Philip Noel] Inst Oswaldo Cruz FioCruz, Lab Biol Mol Aplicada Micobacterias, Rio De Janeiro, Brazil.
   [Golub, Jonathan E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Av Marechal Campos, BR-1468 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Gomes, Harrison M/E-2942-2013; Maciel, Ethel Leonor LN/G-1027-2012;
   suffys, philip/E-3009-2013
OI Gomes, Harrison M/0000-0002-6489-8003; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Dietze, Reynaldo/0000-0002-6995-8001
FU National institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5 U2R TW006883-02,
   ENSP-011-LIV-10-2-3]; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [U2RTW006885, U2RTW006885,
   U2RTW006885, U2RTW006885, U2RTW006885, U2RTW006885, U2RTW006885,
   U2RTW006885, U2RTW006885, U2RTW006885] Funding Source: NIH RePORTER
FX We would like to acknowledge the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPq by Edital MCT/CNPq/MS-SCTIE-DECIT No
   25/2006 - Doencas negligenciadas, National institute of Health on the
   ICHORTA grant # 5 U2R TW006883-02 and ENSP-011-LIV-10-2-3. We thank Dr.
   Valderio do Valle Dettoni for helping with the medical files. We are
   also grateful to Joao Batista Pereira da Silva for technical laboratory
   support.
CR ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403
   Vieira RDA, 2008, REV SOC BRAS MED TRO, V41, P82, DOI 10.1590/S0037-86822008000100017
   Behr MA, 1999, LANCET, V353, P1714
   BRASIL, 2008, MAN NAC VIG LAB TUB
   Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23
   Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004
   Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004
   Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07
   HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988
   Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997
   Lari N, 2007, J CLIN MICROBIOL, V45, P1851, DOI 10.1128/JCM.00170-07
   Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395
   Ministerio da Saude, 2002, GUIA TRAT TUB PROGR
   Niemann S, 1999, J CLIN MICROBIOL, V37, P3078, DOI 10.1128/JCM.37.2.409-412.1999
   Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08
   Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07
   Perez-Lago L, 2011, J CLIN MICROBIOL, V49, P3771, DOI 10.1128/JCM.01285-11
   SHAW JB, 1954, AM REV TUBERC PULM, V69, P724
   SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402
   Van Loon Frederik P. L., 1995, Morbidity and Mortality Weekly Report, V44, P1
   van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930
   VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993
   Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003
   Weisenberg SA, 2012, INFECT GENET EVOL, V12, P664, DOI 10.1016/j.meegid.2011.07.018
   *WHO, 2011, GLOB TB CONTR
NR 25
TC 11
Z9 11
U1 0
U2 8
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1472-9792
J9 TUBERCULOSIS
JI Tuberculosis
PD MAR
PY 2013
VL 93
IS 2
BP 207
EP 212
DI 10.1016/j.tube.2012.09.001
PG 6
WC Immunology; Microbiology; Respiratory System
SC Immunology; Microbiology; Respiratory System
GA 114IJ
UT WOS:000316734000013
PM 23232111
OA Green Accepted, Green Published
DA 2020-12-15
ER

PT J
AU Kaiser, TDL
   Pereira, EM
   dos Santos, KRN
   Maciel, ELN
   Schuenck, RP
   Nunes, APF
AF Lemos Kaiser, Thais Dias
   Pereira, Eliezer Menezes
   Netto dos Santos, Katia Regina
   Noia Maciel, Ethel Leonor
   Schuenck, Ricardo Pinto
   Ferreira Nunes, Ana Paula
TI Modification of the Congo red agar method to detect biofilm production
   by Staphylococcus epidermidis
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE S. epidermidis; Biofilm; Congo red agar; Vancomycin; icaAB gene
ID SLIME PRODUCTION; PLATE TEST; VANCOMYCIN; RESISTANCE; ADHERENCE; STRAINS
AB Staphylococcus epidermidis in immunocompromised patients can cause bacteremia related to the use of catheter due to biofilm production. There are different phenotypic methods to detect biofilm formation. One method is based on culture in brain heart infusion agar (BHIA) containing sucrose and red Congo dye (original Congo red agar). Our group created a new CRA formula and we have confirmed its capacity to detect biofilm production in 210 S. epidermidis strains, including 76 (36.2%) icaAB gene-positive strains. Other parameters were also evaluated. The new CRA formula that gave the best results was BHIA with sucrose (5%), Congo red (0.08%), NaCl (1.5%), glucose (2%), and vancomycin (0.5 mg/mL) (vancomycin-modified CRA-CRAmod). The CRAmod plus vancomycin may be a promising tool and can help to determine the real participation of S. epidermidis in the infectious process. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Lemos Kaiser, Thais Dias; Schuenck, Ricardo Pinto; Ferreira Nunes, Ana Paula] Univ Fed Espirito Santo, RESBAC, Dept Patol, Lab Resistencia Bacteriana, BR-29043900 Maruipe, ES, Brazil.
   [Lemos Kaiser, Thais Dias; Schuenck, Ricardo Pinto; Ferreira Nunes, Ana Paula] Univ Fed Espirito Santo, Programa Posgrad Doengcas Infecciosas, BR-29043900 Maruipe, ES, Brazil.
   [Pereira, Eliezer Menezes] Inst Fed Educ Ciencia & Tecnol Rio de Janeiro, Lab Microbiol Aplicada & Proc Fermentat Prof Deni, Rio De Janeiro, Brazil.
   [Netto dos Santos, Katia Regina] Univ Fed Rio de Janeiro, Inst Microbiol, Lab Infeccoes Hosp, BR-21941 Rio De Janeiro, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Dept Enfermagem, BR-29043900 Maruipe, ES, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Doengas Infecciosas, BR-29043900 Maruipe, ES, Brazil.
RP Nunes, APF (corresponding author), Univ Fed Espirito Santo, RESBAC, Ctr Ciencia Saude, Lab Resistencia Bacteriana,Dept Patol, Av Marechal Campos S-No, BR-29043900 Maruipe, ES, Brazil.
EM anastron@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES) [38906007/2007];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [479294/2010-0]; Coordenacao de Aperfeicoamento Pessoal de Nivel
   Superior (CAPES)CAPES
FX This study was supported by grants from Fundacao de Amparo a Pesquisa do
   Espirito Santo (FAPES) (no. 38906007/2007), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (no. 479294/2010-0), and
   Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES).
CR Akpolat NO, 2003, FOLIA MICROBIOL, V48, P649, DOI 10.1007/BF02993473
   Aparna MSPBD, 2008, BRAZ J INFECT DIS, V12, P526, DOI 10.1590/S1413-86702008000600016
   Arciola CR, 2002, BIOMATERIALS, V23, P4233, DOI 10.1016/S0142-9612(02)00171-0
   Cargill JS, 2009, J CLIN PATHOL, V62, P1112, DOI 10.1136/jcp.2009.069021
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318, DOI 10.1128/IAI.37.1.318-326.1982
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985
   Cotter JJ, 2009, APPL ENVIRON MICROB, V75, P261, DOI 10.1128/AEM.00261-08
   Falagas ME, 2008, J MED MICROBIOL, V57, P1, DOI 10.1099/jmm.0.47432-0
   Nunes APF, 2006, INT J ANTIMICROB AG, V27, P307, DOI 10.1016/j.ijantimicag.2005.11.013
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Fitzpatrick F, 2005, CLIN MICROBIOL INFEC, V11, P967, DOI 10.1111/j.1469-0691.2005.01274.x
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   Gazzola S, 2008, MICROBIOL-SGM, V154, P3224, DOI 10.1099/mic.0.2008/021154-0
   Hassan A, 2011, BRAZ J INFECT DIS, V15, P305, DOI 10.1590/S1413-86702011000400002
   Iorio NLP, 2011, INT MICROBIOL, V14, P13, DOI 10.2436/20.1501.01.130
   Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Liberto MC, 2007, MICROBIOL RES
   Los R, 2010, FEMS MICROBIOL LETT, V310, P97, DOI 10.1111/j.1574-6968.2010.02050.x
   Mariana NS, 2009, AFR J MICROBIOL RES, V3, P330
   Mathur T, 2006, Indian J Med Microbiol, V24, P25
   Monzon M, 2002, DIAGN MICR INFEC DIS, V44, P319, DOI 10.1016/S0732-8893(02)00464-9
   Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640
   Iorio NLP, 2011, MICROBIOL IMMUNOL, V55, P28, DOI 10.1111/j.1348-0421.2010.00288.x
   Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001
   Schuenck RP, 2008, FEMS IMMUNOL MED MIC, V52, P431, DOI 10.1111/j.1574-695X.2008.00387.x
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6
   Stepanovic S, 2003, CLIN MICROBIOL INFEC, V9, P955, DOI 10.1046/j.1469-0691.2003.00676.x
NR 30
TC 41
Z9 44
U1 0
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD MAR
PY 2013
VL 75
IS 3
BP 235
EP 239
DI 10.1016/j.diagmicrobio.2012.11.014
PG 5
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 095FC
UT WOS:000315319100002
PM 23313084
DA 2020-12-15
ER

PT J
AU Maciel, EL
   Brioschi, AP
   Peres, RL
   Guidoni, LM
   Ribeiro, FK
   Hadad, DJ
   Vinhas, SA
   Zandonade, E
   Palaci, M
   Dietze, R
   Johnson, JL
AF Maciel, E. L.
   Brioschi, A. P.
   Peres, R. L.
   Guidoni, L. M.
   Ribeiro, F. K.
   Hadad, D. J.
   Vinhas, S. A.
   Zandonade, E.
   Palaci, M.
   Dietze, R.
   Johnson, J. L.
TI Smoking and 2-month culture conversion during anti-tuberculosis
   treatment
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE pulmonary tuberculosis; smoking; culture conversion
ID SPUTUM SMEAR CONVERSION; PULMONARY TUBERCULOSIS; CIGARETTE-SMOKING;
   ADULTS
AB OBJECTIVE: To investigate risk factors for delayed sputum culture conversion to negative during anti-tuberculosis treatment, with an emphasis on smoking.
   DESIGN: Nested case-control study of adults with non-cavitary, culture-confirmed pulmonary tuberculosis (TB) participating in an anti-tuberculosis treatment trial in Brazil. A case of delayed culture conversion was a patient who remained culture-positive after 2 months of treatment. Odds ratios with 95% confidence intervals were calculated.
   RESULTS: Fifty-three cases and 240 control patients were analyzed. Smokers had three-fold greater odds of remaining culture-positive after 2 months of treatment (P = 0.007) than non-smokers, while smokers and ex-smokers who smoked >20 cigarettes a day had two-fold greater odds of remaining culture-positive after 2 months of treatment (P = 0.045).
   CONCLUSION: Cigarette smoking adversely affects culture conversion during anti-tuberculosis treatment. Support for smoking cessation should be considered to improve outcomes in TB control programs.
C1 [Maciel, E. L.; Brioschi, A. P.; Peres, R. L.; Guidoni, L. M.; Ribeiro, F. K.; Hadad, D. J.; Vinhas, S. A.; Palaci, M.; Dietze, R.] Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
   [Maciel, E. L.; Brioschi, A. P.; Guidoni, L. M.; Zandonade, E.] Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
   [Johnson, J. L.] Case Western Reserve Univ, Dept Med, Div Infect Dis, TB Res Unit, Cleveland, OH 44106 USA.
RP Maciel, EL (corresponding author), Lab Epidemiol, Av Marechal Campos,1468 Maruipe, Vitoria, ES, Brazil.
EM ethel.maciel@gmail.com
RI Tuberculose, Inct/K-2302-2013; Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Dietze,
   Reynaldo/0000-0002-6995-8001
FU Tuberculosis Research Unit at Case Western Reserve University; United
   States National Institutes of Allergy and Infectious Diseases, National
   Institutes of Health and Human ServicesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)NIH National
   Human Genome Research Institute (NHGRI) [NO1-AI95383,
   HHSN266200700022C/NO1-AI-70022]; ICOHRTA [5 U2R TW006883-02]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006885, U2RTW006883, U2RTW006885,
   U2RTW006885, U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006885,
   U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006883, U2RTW006885,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006885, U2RTW006885, U2RTW006883, U2RTW006883, U2RTW006885] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [N01AI095383, N01AI095383, N01AI095383,
   N01AI095383, N01AI095383, N01AI095383] Funding Source: NIH RePORTER
FX The authors thank C M Bark for critical review of the manuscript. This
   study was supported by the Tuberculosis Research Unit at Case Western
   Reserve University, established with funds from the United States
   National Institutes of Allergy and Infectious Diseases, National
   Institutes of Health and Human Services, under contract NO1-AI95383 and
   HHSN266200700022C/NO1-AI-70022. ELNM was also supported by ICOHRTA 5 U2R
   TW006883-02.
CR Abal AT, 2005, RESP MED, V99, P415, DOI 10.1016/j.rmed.2004.08.016
   Davies PDO, 2006, T ROY SOC TROP MED H, V100, P291, DOI 10.1016/j.trstmh.2005.06.034
   Dietze R, 2008, AM J RESP CRIT CARE, V178, P1180, DOI 10.1164/rccm.200806-892OC
   FALK A, 1969, DIAGNOSTIC STANDARDS, P68
   Blanco JAG, 2007, MED CLIN-BARCELONA, V128, P565
   Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC
   Batista JDL, 2008, INT J EPIDEMIOL, V37, P841, DOI 10.1093/ije/dyn113
   MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062
   Onyebujoh PC, 1999, LANCET, V354, P116
   Singla R, 2003, INT J TUBERC LUNG D, V7, P58
   Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772
   Wang JM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-292
   World Health Organization, 2011, WHONMHTFI113
   World Health Organization/International Union Against Tuberculosis and Lung Disease, 2007, WHOHTMTB2007390
NR 14
TC 38
Z9 40
U1 0
U2 7
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD FEB
PY 2013
VL 17
IS 2
BP 225
EP 228
DI 10.5588/ijtld.12.0426
PG 4
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 081MW
UT WOS:000314327300016
PM 23317958
OA Green Accepted
DA 2020-12-15
ER

PT J
AU Sarti, TD
   Campos, CEA
   Zandonade, E
   Ruschi, GEC
   Maciel, ELN
AF Sarti, Thiago Dias
   Aguilera Campos, Carlos Eduardo
   Zandonade, Eliana
   Cabral Ruschi, Gustavo Enrico
   Noia Maciel, Ethel Leonor
TI Evaluation of health planning activities by family health teams
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Family Health; Health Planning; Health Evaluation; Quality of Health
   Care
ID PRIMARY-CARE; INFANT-MORTALITY; PROGRAM; STRATEGY; IMPACT; BRAZIL;
   ORGANIZATION; CHALLENGES; MANAGEMENT; MODEL
AB Evaluation of health planning activities adapted to the local context is an essential part of daily work in the Family Health Strategy (FHS). This study aimed to evaluate the planning activities conducted by family health teams in Espirito Santo State, Brazil. This was an ecological study based on secondary data from 241 health teams in 46 municipalities (counties) in the State that use the Evaluation for Quality Improvement in the Family Health Strategy (AMQ-ESF) form. Criteria were set for evaluating the responses by health professionals to the quality standards in the AMQ-ESF forms, and health planning indicators were listed. The responses were stratified according to the municipality's population size and time since implementation of the FHS and population coverage. The study mostly showed low adequacy rates in the teams' work processes in relation to the AMQ quality standards, and stratification of the variables had no influence on the local planning practices. Specific measures are needed to upgrade the work processes in the FHS.
C1 [Sarti, Thiago Dias] Univ Fed Espirito Santo, Dept Social Med, Ctr Ciencias Saude, BR-29090041 Vitoria, ES, Brazil.
   [Aguilera Campos, Carlos Eduardo] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, Brazil.
   [Zandonade, Eliana; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, BR-29090041 Vitoria, ES, Brazil.
   [Cabral Ruschi, Gustavo Enrico] Ctr Univ Vila Velha, Programa Interacao Serv Ensino & Comunidade, Vila Velha, Brazil.
RP Sarti, TD (corresponding author), Univ Fed Espirito Santo, Dept Social Med, Ctr Ciencias Saude, Av Marechal Campos 1468, BR-29090041 Vitoria, ES, Brazil.
EM thiagosarti@yahoo.com.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Sarti,
   Thiago/0000-0002-1545-6276
CR Alves VS, 2006, INTERFACE-BOTUCATU, V10, P131, DOI 10.1590/S1414-32832006000100010
   Aquino R, 2009, AM J PUBLIC HEALTH, V99, P87, DOI 10.2105/AJPH.2007.127480
   Black N, 2005, UNDERSTANDING HLTH S
   Trad LAB, 2009, INTERFACE-BOTUCATU, V13, P557, DOI 10.1590/S1414-32832009000500008
   Brasil. Ministerio da Saude, 1997, SAUD FAM ESTR REOR M
   Caetano Rosângela, 2002, Physis, V12, P11, DOI 10.1590/S0103-73312002000100002
   Campos Francisco Eduardo de, 2002, Physis, V12, P47, DOI 10.1590/S0103-73312002000100004
   Conill EM, 2008, CAD SAUDE PUBLICA, V24, pS7, DOI 10.1590/S0102-311X2008001300002
   Crevelim Maria Angélica, 2005, Ciênc. saúde coletiva, V10, P323, DOI 10.1590/S1413-81232005000200010
   Departament of Health Office of Public Health Practice, 2007, COMM HLTH ASS ACT PL
   Colome ICD, 2008, REV ESC ENFERM USP, V42, P256, DOI 10.1590/S0080-62342008000200007
   Elias Paulo Eduardo, 2006, Ciênc. saúde coletiva, V11, P633, DOI 10.1590/S1413-81232006000300012
   ESCOREL S, 2002, AVALIACAO IMPLEMENTA
   Goldbaum M, 2005, REV SAUDE PUBL, V39, P90, DOI 10.1590/s0034-89102005000100012
   Gomes KD, 2009, CIENC SAUDE COLETIVA, V14, P1473
   Kell MDG, 2010, CIENC SAUDE COLETIVA, V15, P1533, DOI 10.1590/S1413-81232010000700065
   Guanais F, 2009, J AMBUL CARE MANAG, V32, P115, DOI 10.1097/JAC.0b013e31819942e51
   Harzheim E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-156
   Ibañez Nelson, 2006, Ciênc. saúde coletiva, V11, P683, DOI 10.1590/S1413-81232006000300016
   Kawata LS, 2009, TEXTO CONTEXTO ENFER, V18, P313, DOI 10.1590/S0104-07072009000200015
   Lacerda William Almeida de, 2007, Rev. katálysis, V10, P197, DOI 10.1590/S1414-49802007000200007
   Lightburn A., 2006, HDB COMMUNITY BASED, P19
   Machado CV, 2008, CAD SAUDE PUBLICA, V24, pS42, DOI 10.1590/S0102-311X2008001300010
   Macinko J, 2006, J EPIDEMIOL COMMUN H, V60, P13, DOI 10.1136/jech.2005.038323
   Macinko J, 2007, SOC SCI MED, V65, P2070, DOI 10.1016/j.socscimed.2007.06.028
   Marin MJS, 2007, REV LAT-AM ENFERM, V15, P1065, DOI 10.1590/S0104-11692007000600002
   *MIN SAUD, 1994, PROGR SAUD FAM
   Ministerio da Saude, 2005, AV MELH QUAL ESTR SA
   Ministerio da Saude, 2006, SAUD FAM BRAS AN IND
   Ministerio da Saude, 2006, POL NAC AT BAS, V2006
   Ministerio da Saude, 2008, POL NAC CIENC TECN I
   Mishima SM, 2003, THESIS U SAO PAULO R
   Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI 10.1590/s0034-89102009000100005
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   Sarti TD, 2004, THESIS U FEDERAL ESP
   Schimith Maria Denise, 2004, Cad. Saúde Pública, V20, P1487, DOI 10.1590/S0102-311X2004000600005
   Schwartz TD, 2010, CIENC SAUDE COLETIVA, V15, P2145, DOI 10.1590/S1413-81232010000400028
   Shimizu HE, 2009, REV BRAS ENFERM, V62, P424, DOI 10.1590/S0034-71672009000300014
   Silva Anderson Soares da, 2005, Cad. Saúde Pública, V21, P1821, DOI 10.1590/S0102-311X2005000600031
   Silva KL, 2010, REV BRAS ENFERM, V63, P762, DOI 10.1590/S0034-71672010000500011
   Sousa Maria Fátima de, 2009, Ciênc. saúde coletiva, V14, P1325, DOI 10.1590/S1413-81232009000800002
   van Weel C, 2008, LANCET, V372, P871, DOI 10.1016/S0140-6736(08)61376-8
   Viana Ana Luiza d'Ávila, 2006, Ciênc. saúde coletiva, V11, P577, DOI 10.1590/S1413-81232006000300009
   Xavier AJ, 2008, CIENC SAUDE COLETIVA, V13, P1543, DOI 10.1590/S1413-81232008000500019
NR 44
TC 11
Z9 19
U1 0
U2 1
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAR
PY 2012
VL 28
IS 3
BP 537
EP 548
DI 10.1590/S0102-311X2012000300014
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 907ZN
UT WOS:000301459700014
PM 22415186
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU de Castro, CBA
   da Costa, PA
   Ruffino-Netto, A
   Maciel, ELN
   Kritski, AL
AF Alves de Castro, Cristiano Bel
   da Costa, Paulo Albuquerque
   Ruffino-Netto, Antonio
   Noia Maciel, Ethel Leonor
   Kritski, Afranio Lineu
TI Assessment of a clinical score for screening suspected pulmonary
   tuberculosis cases
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Tuberculosis, Pulmonary, diagnosis; Clinical Diagnosis; Diagnostic
   Techniques and Procedures; Triage; Sensitivity and Specificity
ID HEALTH; INFECTION
AB OBJECTIVE: To assess the accuracy (sensitivity) of a clinical score for presumptive pulmonary tuberculosis cases during screening.
   METHODS: Descriptive cross-sectional study comprising 1,365 patients attending the department of lung diseases at a secondary care outpatient clinic in the city of Rio de Janeiro, Southeastern Brazil, during 2006 and 2007. All respondents answered a standardized questionnaire administered by the clinic's nursing staff. Information on age, weight and clinical symptoms were collected. The presumptive diagnosis of pulmonary tuberculosis was made by summing up the scores of the data collected. The diagnosis of active tuberculosis was based on bacteriological findings and medical criteria. There were estimated sensitivity, specificity, positive predictive value and negative predictive value for a set prevalence, and 95% confidence intervals for different score cutoffs. The score performance was assessed using the receiver operating characteristic (ROC) curve.
   RESULTS: For the diagnosis of tuberculosis, cough for more than one week and cough for more than three weeks showed a sensitivity of 88.2% (86.2, 90.2) and 61.1% (57.93, 64.3), specificity 19.2% (16.6, 21.8) and 51.3% (48.1, 54.5), respectively. The clinical score of 8 had a sensitivity of 83.13% (77.8, 87.6), specificity of 51.8% (48.5, 55.1), positive predictive value of 91.6% (90.0, 83.2) and negative predictive value of 32.9% (30.1, 35.7).
   CONCLUSIONS: Cough for more than three weeks showed low sensitivity and specificity. A highly sensitive clinical score can be an alternative tool for screening pulmonary tuberculosis as it allows early care of suspected cases and standard nursing care approach.
C1 [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Nucleo Doencas Infecciosas, Programa Posgrad Saude Colet, BR-29040091 Vitoria, ES, Brazil.
   [Alves de Castro, Cristiano Bel] Univ Fed Rio de Janeiro, Programa Posgrad Clin Med, Rio De Janeiro, Brazil.
   [da Costa, Paulo Albuquerque] Univ Fed Rio de Janeiro, Inst Doencas Torax, Rio de Janeiro, Brazil.
   [Ruffino-Netto, Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Kritski, Afranio Lineu] Univ Fed Rio de Janeiro, Fac Med, Dept Clin Med, Rio de Janeiro, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Nucleo Doencas Infecciosas, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012; Kritski, Afranio/I-6760-2016
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; 
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [410538/2006-0]; TB-Adapt-European Union [037919]; International
   Clinical, Operational and Health Services Research Training Award for
   AIDS and Tuberculosis (ICOHRTA AIDS/TB) [5 U2R TW006883-02]
FX Research funded by the National Council for Scientific and Technological
   Development (CNPq-Decit Notice - Process No. 410538/2006-0),
   TB-Adapt-European Union (Process No. 037919), International Clinical,
   Operational and Health Services Research Training Award for AIDS and
   Tuberculosis (ICOHRTA AIDS/TB - Grant #5 U2R TW006883-02).
CR Bastos LGV, 2007, INT J TUBERC LUNG D, V11, P156
   Castells Maria Alicia, 2005, Rev. Bras. Psiquiatr., V27, P54, DOI 10.1590/S1516-44462005000100012
   Chaimowicz F, 2001, REV SAUDE PUBL, V35, P81, DOI 10.1590/S0034-89102001000100012
   Job JRPP, 1998, REV SAUDE PUBL, V32, P596, DOI 10.1590/S0034-89101998000600014
   Johnson R.A., 1982, APPL MULTIVARIATE ST
   Macedo LG, 1992, J PNEUMOL, V18, P118
   Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5
   Moreira CMM, 2010, CAD SAUDE PUBLICA, V26, P1619, DOI 10.1590/S0102-311X2010000800015
   Miller LG, 2000, CLIN INFECT DIS, V30, P293, DOI 10.1086/313651
   Moreira TR, 2010, REV SAUDE PUBL, V44, P332, DOI [10.1590/S0034-89102010000200014, 10.1590/s0034-89102010000200014]
   Rodrigues PM, 2009, J BRAS PNEUMOL, V35, P351, DOI 10.1590/S1806-37132009000400009
   Ruffino-Netto Antonio, 2002, Rev. Soc. Bras. Med. Trop., V35, P51, DOI 10.1590/S0037-86822002000100010
   Santos AM, 2007, STAT IND TECHNOL, P275, DOI 10.1007/978-0-8176-4542-7_18
   Santos JWA, 2006, REV AMRIGS, V46, P25
   Vendramini SHF, 2006, INT J TUBERC LUNG D, V10, P1231
   *WHO, 2009, WHOSTMTB2009411
NR 16
TC 0
Z9 0
U1 0
U2 2
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD DEC
PY 2011
VL 45
IS 6
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 858MO
UT WOS:000297802600013
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Miranda, AE
   Dietze, R
   Maciel, EL
   Prado, TN
   Caus, AL
   Silva, MM
   Golub, JE
AF Miranda, Angelica E.
   Dietze, Reynaldo
   Maciel, Ethel L.
   Prado, Thiago N.
   Caus, Antonio L.
   Silva, Murilo M.
   Golub, Jonathan E.
TI Tuberculosis and AIDS Co-Morbidity in Children: Linkage of Databases
   from Espirito Santo State, Brazil
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Article
DE tuberculosis; AIDS; co-infection; children
AB We assessed the prevalence of AIDS among children diagnosed with active tuberculosis (TB) in Espirito Santo State, Brazil, by linking TB and AIDS surveillance databases using Reclink software and SPSS. Among 411 pediatric TB cases from 2000 to 2006, 27 (7%) were co-infected with AIDS. Most children were unable to provide a sputum specimen; co-infected patients were more likely to be smear negative for acid-fast bacilli (83% vs 46%; p = 0.07) and culture positive for Mycobacterium tuberculosis (44% vs 19%; p < 0.001). In all, 57% of co-infected patients did not react to tuberculin skin test compared with 17% of TB patients (p < 0.001). This report emphasizes the significance of AIDS in pediatric TB cases and highlights the importance of evaluating surveillance databases for gaining a better understanding of the burden of co-infection.
C1 [Miranda, Angelica E.; Dietze, Reynaldo; Maciel, Ethel L.; Prado, Thiago N.; Caus, Antonio L.; Silva, Murilo M.] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas NDI, BR-2904091 Vitoria, Brazil.
   [Golub, Jonathan E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA.
RP Miranda, AE (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas NDI, Av Marechal Campos 1468, BR-2904091 Vitoria, Brazil.
EM espinosa@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Miranda,
   Angelica/0000-0002-5556-8379; Dietze, Reynaldo/0000-0002-6995-8001
FU Innovative approaches for tuberculosis control in Brazil [5
   U2RTW006883-02]; National Institute of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [K01-AI066994]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [U2RTW006885, U2RTW006885,
   U2RTW006885, U2RTW006885, U2RTW006885, U2RTW006885, U2RTW006885,
   U2RTW006885, U2RTW006885, U2RTW006885] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [K01AI066994, K01AI066994, K01AI066994, K01AI066994, K01AI066994]
   Funding Source: NIH RePORTER
FX Innovative approaches for tuberculosis control in Brazil. Grant #5
   U2RTW006883-02; National Institute of Health K01-AI066994.
CR Alves R, 2003, INT J TUBERC LUNG D, V7, P198
   Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1
   *BRAS MIN SAUD, PROGR NAC DST AIDS C
   *FUND NAC SAUD, 2002, TUB GUIA VIG EP BRAS
   Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012
   MACIEL ELN, 2006, CAD SAUDE COLET, V14, P81
   Marais BJ, 2007, J INFECT DIS, V196, pS76, DOI 10.1086/518659
   SANTANNA CC, 2002, J PEDIAT RIO J, V78, P205, DOI DOI 10.1590/S0021-75572002000800011
   World Health Organization, 2007, RES AG CHILDH TUB IM
NR 9
TC 5
Z9 5
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
EI 1465-3664
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD AUG
PY 2011
VL 57
IS 4
BP 296
EP 298
DI 10.1093/tropej/fmq087
PG 3
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA 800CX
UT WOS:000293338000014
PM 20876684
OA Bronze, Green Published
DA 2020-12-15
ER

PT J
AU Peres, RL
   Palaci, M
   Loureiro, RB
   Dietze, R
   Johnson, JL
   Golub, JE
   Ruffino-Netto, A
   Maciel, EL
AF Peres, Renata L.
   Palaci, Moises
   Loureiro, Rafaela B.
   Dietze, Reynaldo
   Johnson, John L.
   Golub, Jonathan E.
   Ruffino-Netto, A.
   Maciel, Ethel L.
TI Evaluation of Oral Antiseptic Rinsing before Sputum Collection To Reduce
   Contamination of Mycobacterial Cultures
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID TUBERCULOSIS; DECONTAMINATION; DISINFECTANTS; RESISTANCE; DIAGNOSIS;
   CHLORIDE
AB To assess whether rinsing with oral antiseptics before sputum collection would reduce contamination of mycobacterial cultures, 120 patients with suspected tuberculosis were randomly assigned to rinse with chlorhexidine or cetylpyridinium mouthwash before collection. The culture contamination rate was significantly lower after rinsing with chlorhexidine before collection, especially for cultures grown in MGIT medium.
C1 [Maciel, Ethel L.] Univ Fed Espirito Santo, Ctr Infect Dis, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
   [Johnson, John L.] Case Western Reserve Univ, Sch Med, Univ Hosp Case Med Ctr, Cleveland, OH USA.
   [Golub, Jonathan E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA.
   [Golub, Jonathan E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Ruffino-Netto, A.] Univ Sao Paulo, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Ctr Infect Dis, Ctr Ciencias Saude, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Borge Loureiro,
   Rafaela/0000-0002-5173-6160; Dietze, Reynaldo/0000-0002-6995-8001
FU Fundo de Apoio a Ciencia e Tecnologia do Municipio de Vitoria (FACITEC);
   International Clinical Operational and Health Services Research and
   Training Award; Edital ICHORTA [5U2R TW006883-02]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006883, U2RTW006885,
   U2RTW006883, U2RTW006885, U2RTW006885, U2RTW006885, U2RTW006883,
   U2RTW006885, U2RTW006885, U2RTW006883, U2RTW006885, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006883,
   U2RTW006885, U2RTW006883, U2RTW006883] Funding Source: NIH RePORTER
FX This study was supported by the Fundo de Apoio a Ciencia e Tecnologia do
   Municipio de Vitoria (FACITEC) and an International Clinical Operational
   and Health Services Research and Training Award, Edital ICHORTA 5U2R
   TW006883-02.
CR Alisjahbana B, 2005, INT J TUBERC LUNG D, V9, P814
   BARROS VMR, 1998, REV ODONTOL U S PAUL, V12, P201
   DENTON GW, 1991, DISINFECTION STERILI, P274
   GROSSMAN E, 1986, J PERIODONTAL RES, V21, P33, DOI 10.1111/j.1600-0765.1986.tb01513.x
   Kent P T, 1985, PUBLIC HLTH MYCOBACT
   Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7
   KUDOH S, 1974, B WORLD HEALTH ORGAN, V51, P71
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147
   Muzanye G, 2009, AFR HEALTH SCI, V9, P200
   Maciel ELN, 2009, J BRAS PNEUMOL, V35, P460, DOI 10.1590/S1806-37132009000500012
   Pardini M, 2005, J CLIN MICROBIOL, V43, P442, DOI 10.1128/JCM.43.1.442-444.2005
   Peres RL, 2009, INT J TUBERC LUNG D, V13, P1572
   Roldan S, 2004, J CLIN PERIODONTOL, V31, P1128, DOI 10.1111/j.1600-051X.2004.00621.x
   Russell AD, 1996, J APPL BACTERIOL, V81, pS87, DOI 10.1111/j.1365-2672.1996.tb04602.x
   RUSSELL AD, 1986, J HOSP INFECT, V7, P213, DOI 10.1016/0195-6701(86)90071-X
   RUSSELL AD, 1982, J ANTIMICROB CHEMOTH, V9, P445, DOI 10.1093/jac/9.6.445
   SMITHWICK RW, 1975, J CLIN MICROBIOL, V1, P411, DOI 10.1128/JCM.1.5.411-413.1975
NR 17
TC 8
Z9 8
U1 2
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD AUG
PY 2011
VL 49
IS 8
BP 3058
EP 3060
DI 10.1128/JCM.00541-11
PG 3
WC Microbiology
SC Microbiology
GA 798PE
UT WOS:000293221900053
PM 21677070
OA Green Published, Bronze
DA 2020-12-15
ER

PT J
AU Vieira, ACBC
   Miranda, AE
   de Vargas, PRM
   Maciel, ELN
AF Barbosa Cerqueira Vieira, Anne Caroline
   Miranda, Angelica Espinosa
   Mercon de Vargas, Paulo Roberto
   Noia Maciel, Ethel Leonor
TI HIV prevalence in pregnant women and vertical transmission in according
   to socioeconomic status, Southeastern Brazil
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Pregnant Women; HIV Infections, epidemiology; Infectious Disease
   Transmission, Vertical, prevention & control
ID TO-CHILD TRANSMISSION; AIDS EPIDEMIC; VITORIA; HOSPITALS; CARE
AB OBJECTIVE: To describe HIV prevalence in pregnant women and the rate of vertical transmission according to socioeconomic status of residential neighborhoods.
   METHODS: Ecological exploratory study, which used the Information System of Notifiable Diseases database on HIV-positive pregnant women and AIDS in children, reported from 2000 to 2006, in Vitoria, Southeastern Brazil. For analysis of socioeconomic data the Urban Quality Index was utilized The HIV prevalence rate in pregnant women and vertical transmission rate were calculated. Spatial distribution was carried out by Terraview 3.2.0. To verify the association between urban quality and HIV prevalence in pregnant women, Poisson regression was used.
   RESULTS: A total of 137 HIV-positive women and 14 children infected by vertical transmission was reported. Seven children matched to HIV-positive mothers without notification in the period analyzed. HIV prevalence among pregnant women in the period was 0.44%, and the vertical transmission rate was 9.7%.
   CONCLUSIONS: The prevalence of HIV infection among pregnant women and vertical transmission were associated with the urban quality of residential neighborhood. Neighborhoods with lower urban quality should be prioritized in actions to reduce vertical transmission.
C1 [Barbosa Cerqueira Vieira, Anne Caroline] UFES, Ctr Univ Norte Espirito Santo, Dept Ciencias Saude, Sao Mateus, RS, Brazil.
   [Miranda, Angelica Espinosa; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
   [Mercon de Vargas, Paulo Roberto] Univ Fed Espirito Santo, Dept Patol, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Av Marechal Campos,1468 Maruipe, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Miranda,
   Angelica/0000-0002-5556-8379
CR Barcellos, 1996, Cad Saude Publica, V12, P389
   Barcellos C, 2006, REV SAUDE PUBL, V40, P928, DOI [10.1590/S0034-89102006005000007, 10.1590/S0034-89102006000600025]
   Barcellos C, 2008, EPIDEMIOL SERV SAUDE, V17, P59
   Bastos F I, 2000, Cad Saude Publica, V16, P65, DOI 10.1590/S0102-311X2000000700006
   Bastos Márcia de Jesus Rocha Pereira, 2009, Rev. Saúde Pública, V43, P123, DOI 10.1590/S0034-89102009000100016
   Cardoso Antônio José Costa, 2007, Rev. Saúde Pública, V41, P101, DOI 10.1590/s0034-89102007000900016
   CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801
   Succi RCD, 2007, CAD SAUDE PUBLICA, V23, pS379, DOI 10.1590/S0102-311X2007001500006
   de Souza PRB, 2004, REV SAUDE PUBL, V38, P764, DOI 10.1590/S0034-89102004000600003
   de Lemos LMD, 2005, REV BRAS GINECOL OBS, V27, P32, DOI 10.1590/S0100-72032005000100007
   Fernandes Regina Célia de Souza Campos, 2005, Cad. Saúde Pública, V21, P1153, DOI 10.1590/S0102-311X2005000400017
   Fonseca M G, 2000, Cad Saude Publica, V16, P77
   Fonseca MGP, 2007, CAD SAUDE PUBLICA, V23, pS333, DOI 10.1590/S0102-311X2007001500002
   Fonseca MGP, 2002, REV SAUDE PUBL, V36, P678, DOI 10.1590/S0034-89102002000700004
   Miranda AE, 2005, AIDS CARE, V17, P721, DOI 10.1080/09540120500038033
   Miranda AE, 2010, WOMEN HEALTH, V50, P229, DOI 10.1080/03630242.2010.480904
   Miranda AE, 2009, REV SOC BRAS MED TRO, V42, P386, DOI 10.1590/S0037-86822009000400006
   Nishimoto Teresa Maria Isaac, 2005, Rev. Assoc. Med. Bras., V51, P54, DOI 10.1590/S0104-42302005000100021
   Tess BH, 1998, AIDS, V12, P513, DOI 10.1097/00002030-199805000-00013
   Tomazelli Jeane, 2003, Cad. Saúde Pública, V19, P1049, DOI 10.1590/S0102-311X2003000400027
   Vasconcelos Ana Lucia Ribeiro de, 2005, Rev. Bras. Saude Mater. Infant., V5, P483, DOI 10.1590/S1519-38292005000400012
NR 21
TC 10
Z9 12
U1 0
U2 4
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD AUG
PY 2011
VL 45
IS 4
BP 644
EP 651
DI 10.1590/S0034-89102011005000041
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 794XM
UT WOS:000292934600002
PM 21739080
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU do Prado, TN
   Wada, N
   Guidoni, LM
   Golub, JE
   Dietze, R
   Maciel, ELN
AF do Prado, Thiago Nascimento
   Wada, Nikolas
   Guidoni, Leticia Molino
   Golub, Jonathan E.
   Dietze, Reynaldo
   Noia Maciel, Ethel Leonor
TI Cost-effectiveness of community health worker versus home-based
   guardians for directly observed treatment of tuberculosis in Vitoria,
   Espirito Santo State, Brazil
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Tuberculosis; Cost-Benefit Analysis; Effectiveness
ID RANDOMIZED CONTROLLED-TRIAL; CARE FACILITY INVOLVEMENT; PULMONARY
   TUBERCULOSIS; DISTRICT; DOT; MEMBERS
AB The objective of this study was to compare the costs and outcomes associated with guardian-supervised directly observed treatment relative to the standard of care Directly Observed Therapy, Short Course (DOTS) provided by community health workers (CHW). New cases of culture-positive pulmonary tuberculosis (TB) treated in Vitoria, Espirito Santo State, Brazil, between January 2005 and December 2006 were interviewed and chose their preferred treatment strategy. Costs incurred by providers and patients (and patients' families) were estimated, and cost-effectiveness was assessed by comparing costs per successfully treated patient. 130 patients were included in the study; 84 chose CHW-supervised DOTS and 46 chose guardian-supervised DOTS. 45 of 46 (98%) patients treated with guardian-supervised DOTS were cured or completed treatment compared to 70/84 (83%) of the CHW-supervised patients (p = 0.01). Logistic regression showed only the strategy of supervision to be a significant association with treatment outcome, with guardian-supervised care strongly protective. Cost per patient treated with guardian-supervised DOTS was US$398,compared to US$548 for CHW-supervised DOTS. The guardian-supervised DOTS is an attractive option to complement CHW-supervised DOTS.
C1 [do Prado, Thiago Nascimento] Univ Fed Espirito Santo, Lab Epidemiol, Nucl Doencas Infecciosas, BR-29040091 Vitoria, ES, Brazil.
   [Wada, Nikolas; Golub, Jonathan E.] Johns Hopkins Univ, Baltimore, MD USA.
RP do Prado, TN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Nucl Doencas Infecciosas, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM tiagufes@yahoo.com.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU ICOHRTA AIDS/TB [2 U2R TW006883-06]; Edital CTSAUDE/Edital
   MCT/CNPq/CT-Saude/MS/SCTIE/DECITNational Council for Scientific and
   Technological Development (CNPq) [67/2009 - REBRATS]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006885, U2RTW006885, U2RTW006885,
   U2RTW006885, U2RTW006885, U2RTW006885, U2RTW006885, U2RTW006885,
   U2RTW006885, U2RTW006885] Funding Source: NIH RePORTER
FX To ICOHRTA AIDS/TB (project 2 U2R TW006883-06) and Edital CTSAUDE/Edital
   MCT/CNPq/CT-Saude/MS/SCTIE/DECIT no 67/2009 - REBRATS.
CR Akkslip S, 1999, INT J TUBERC LUNG D, V3, P1061
   Chowdhury AMR, 1997, LANCET, V350, P169, DOI 10.1016/S0140-6736(96)11311-8
   Ferraz Lucimare, 2005, Ciênc. saúde coletiva, V10, P347, DOI 10.1590/S1413-81232005000200012
   Floyd K, 2003, INT J TUBERC LUNG D, V7, pS29
   Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4
   Johannesson M, 1997, J HEALTH ECON, V16, P249, DOI 10.1016/S0167-6296(97)00006-4
   Kamolratanakul P, 1999, T ROY SOC TROP MED H, V93, P552, DOI 10.1016/S0035-9203(99)90379-6
   Khan MA, 2002, HEALTH POLICY PLANN, V17, P178, DOI 10.1093/heapol/17.2.178
   Lwilla F, 2003, TROP MED INT HEALTH, V8, P204, DOI 10.1046/j.1365-3156.2003.00999.x
   Maciel Ethel Leonor Noia, 2008, J Bras Pneumol, V34, P506, DOI 10.1590/S1806-37132008000700011
   *MIN SAUD, 2001, PROGR AG COM SAUD
   Muennig PKK, 2002, DESIGNING CONDUCTING
   MURRAY CJL, 1991, LANCET, V338, P1305, DOI 10.1016/0140-6736(91)92600-7
   Needham DM, 1998, INT J TUBERC LUNG D, V2, P811
   Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3
   Nganda B, 2003, INT J TUBERC LUNG D, V7, pS14
   Maciel ELN, 2010, REV SAUDE PUBL, V44, P339, DOI 10.1590/S0034-89102010000200015
   Okanurak K, 2007, INT J TUBERC LUNG D, V11, P762
   *STOP TB DEP, 2003, WHOCDSTB2003312 STOP
   Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2
   Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5
   Wandwalo E, 2004, INT J TUBERC LUNG D, V8, P1248
   *WHO, 2006, GLOB TUB CONTR SURV
   WHO, 2002, GUID COST COST EFF A
   WILKINSON D, 1994, LANCET, V343, P647, DOI 10.1016/S0140-6736(94)92640-9
   World Bank, 1993, WORLD DEV REP 1993 I
   Wyss K, 2001, TROP MED INT HEALTH, V6, P60, DOI 10.1046/j.1365-3156.2001.00677.x
   Zhao FZ, 1996, LANCET, V347, P358
   Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7
NR 29
TC 19
Z9 21
U1 0
U2 5
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2011
VL 27
IS 5
BP 944
EP 952
DI 10.1590/S0102-311X2011000500012
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 773QE
UT WOS:000291321400012
PM 21655845
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Peres, RL
   Palaci, M
   Loureiro, RB
   Dietze, R
   Johnson, JL
   Maciel, EL
AF Peres, R. L.
   Palaci, M.
   Loureiro, R. B.
   Dietze, R.
   Johnson, J. L.
   Maciel, E. L.
TI Reduction of contamination of mycobacterial growth indicator tubes using
   increased PANTA concentration
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE tuberculosis; diagnosis; culture contamination rate; PANTA; MGIT medium
ID ACID-FAST BACILLI; CLINICAL SPECIMENS; RECOVERY; CULTURE; MGIT;
   MULTICENTER; SYSTEMS
AB We assessed the effect of a double concentration of supplemental polymyxin B, amphotericin B, nalidixic acid, trimethoprim and azlocillin (PANTA) added to the Mycobacterial Growth Indicator Tube (MGIT) on contamination and positivity rates in 216 sputum cultures. Contamination rates were respectively 12.9% and 5.5% for samples processed using standard and double PANTA concentrations (P = 0.0001, McNemar's test). Thirty-five per cent of cultures performed using standard PANTA and 36.5% of those performed using two-fold PANTA concentrations were positive for Mycobacterium tuberculosis, compared to 25.9% of cultures inoculated on Ogawa medium. These results suggest that the use of MGIT with 2 x PANTA may be useful in reducing culture contamination without reducing the diagnostic yield.
C1 [Peres, R. L.; Palaci, M.; Loureiro, R. B.; Dietze, R.; Maciel, E. L.] Univ Fed Espirito Santo, Ctr Infect Dis, Vitoria, Brazil.
   [Johnson, J. L.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Av Marechal Campos,1468 Maruipe, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU Fundo de Apoio a Ciencia e Tecnologia do Municipio de Vitoria;
   International Clinical Operational and Health Services Research and
   Training Award [Edital ICHORTA 5U2R TW006883-02]
FX The authors thank the patients and staff of the TB clinic of the Centro
   de Saude de Maruipe and Serra and the Nucleo de Doencas Infecciosas of
   the Federal University of Espirito Santo for their assistance with the
   study. This study was supported by the Fundo de Apoio a Ciencia e
   Tecnologia do Municipio de Vitoria and the International Clinical
   Operational and Health Services Research and Training Award: Edital
   ICHORTA 5U2R TW006883-02.
CR Chang CL, 2002, J CLIN MICROBIOL, V40, P3845, DOI 10.1128/JCM.40.10.3845-3847.2002
   Cornfield DB, 1997, J CLIN MICROBIOL, V35, P2068, DOI 10.1128/JCM.35.8.2068-2071.1997
   Kent P T, 1985, PUBLIC HLTH MYCOBACT
   Leitritz L, 2001, J CLIN MICROBIOL, V39, P3764, DOI 10.1128/JCM.39.10.3764-3767.2001
   Metchock B G, 1999, MANUAL CLIN MICROBIO, P399
   MITCHISON DA, 1972, J MED MICROBIOL, V5, P165, DOI 10.1099/00222615-5-2-165
   Peres RL, 2009, INT J TUBERC LUNG D, V13, P1572
   Pfyffer GE, 1997, J CLIN MICROBIOL, V35, P364, DOI 10.1128/JCM.35.2.364-368.1997
   Piersimoni C, 1999, DIAGN MICR INFEC DIS, V34, P293, DOI 10.1016/S0732-8893(99)00029-2
   Tortoli E, 1999, J CLIN MICROBIOL, V37, P3578, DOI 10.1128/JCM.37.11.3578-3582.1999
NR 10
TC 9
Z9 9
U1 0
U2 2
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD FEB
PY 2011
VL 15
IS 2
BP 281
EP 283
PG 3
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 716ZH
UT WOS:000287011500025
PM 21219695
DA 2020-12-15
ER

PT J
AU Galavote, HS
   do Prado, TN
   Maciel, ELN
   Lima, RDD
AF Galavote, Heleticia Scabelo
   do Prado, Thiago Nascimento
   Noia Maciel, Ethel Leonor
   Duarte Lima, Rita de Cassia
TI Disclosing the work processes of the community health agents on the
   Family Health Strategy in Vitoria (ES, Brazil)
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Family Health Strategy; Community health agent; Work process; Basic
   health care
AB The community health agent (CHA) has a singular role as a "link" between the community and the health service. The main purpose of this descriptive/qualitative study is to evaluate the production of the CHA work processes in the Family Health Strategy in the county of Vitoria (ES, Brazil). The research was developed in the health region of Maruipe, a district in the county of Vitoria. The researchers invited 14 CHAs to use a half structured interview based on a guide script containing 24 questions. The process of work in health was considered as "a prevention and promotion of health", and the domiciliary visits were considered as being an everyday basic activity. The CHAs withhold several interpretations concerning to the work process and associated to the concept of unit the team has. It is also possible to notice a kind of idealism of the competences concerning to the CHA work, thus, causing a feeling of impotence and limitation when facing the challenges imposed by it. It is possible to conclude that the CHA needs tools and abilities that overcome their technical knowledge in order to act in a social scope and also to deal with the health needs of each user.
C1 [Galavote, Heleticia Scabelo; do Prado, Thiago Nascimento; Noia Maciel, Ethel Leonor; Duarte Lima, Rita de Cassia] Unidade Saude Familia Frade Praias, BR-23900000 Angra Dos Reis, RJ, Brazil.
RP Galavote, HS (corresponding author), Unidade Saude Familia Frade Praias, Rua Paulo Sodre Nobrega 130B, BR-23900000 Angra Dos Reis, RJ, Brazil.
EM heleticiagalavote@yahoo.com.br
OI Maciel, Ethel Leonor/0000-0003-4826-3355
CR ALMEIDA MC, 2006, INTERFACE COMUNIC SA
   Casate Juliana Cristina, 2005, Rev. Latino-Am. Enfermagem, V13, P105, DOI 10.1590/S0104-11692005000100017
   Contandriopoulos André-Pierre, 2006, Ciênc. saúde coletiva, V11, P705, DOI 10.1590/S1413-81232006000300017
   Crevelim Maria Angélica, 2005, Ciênc. saúde coletiva, V10, P323, DOI 10.1590/S1413-81232005000200010
   Ferraz Lucimare, 2005, Ciênc. saúde coletiva, V10, P347, DOI 10.1590/S1413-81232005000200012
   INAYO MCS, 2001, PESQUISA SOCIAL TEOR
   Lima RCD, 2001, ENFERMEIRA PROTAGONI
   LUNARDELO SR, 2004, THESIS SAO PAULO
   Merhy E, 2003, TRABALHO SAUDE OLHAN
   NOGUEIRA R, 2000, SUI GENERIS
   OLIVEIRA RG, 2003, ACTA SCI HLTH SCI, V25
   PEDUZZI M, 1998, THESIS U CAPINAS
   Peduzzi M, 2007, TRABALHO EQUIPE SOB, P161
   SANTOS S.B., 2007, TRABALHADOR SAUDE PR
   Schimith Maria Denise, 2004, Cad. Saúde Pública, V20, P1487, DOI 10.1590/S0102-311X2004000600005
   SILVA JA, 2006, INTERFACE COMUNIC SA, V10
   SILVA MJ, 2000, REV ELECT ENFERMAGEM, V2
   TOMAZ JBC, 2006, INTERFACE COMMUNIC S, V10
NR 18
TC 14
Z9 27
U1 0
U2 1
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD JAN
PY 2011
VL 16
IS 1
BP 231
EP 240
DI 10.1590/S1413-81232011000100026
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 697JU
UT WOS:000285510600026
PM 21180831
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU do Prado, TN
   Caus, AL
   Marques, M
   Maciel, EL
   Golub, JE
   Miranda, AE
AF do Prado, Thiago Nascimento
   Caus, Antonio Luiz
   Marques, Murilo
   Maciel, Ethel Leonor
   Golub, Jonathan E.
   Miranda, Angelica Espinosa
TI Epidemiological profile of adult patients with tuberculosis and AIDS in
   the state of Espirito Santo, Brazil: Cross-referencing tuberculosis and
   AIDS databases
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA English
DT Article
DE Tuberculosis; Acquired immunodeficiency syndrome; Brazil
ID ACQUIRED-IMMUNODEFICIENCY-SYNDROME; TRENDS; MORTALITY; IMPACT; VIRUS;
   SPAIN
AB Objective: To evaluate the epidemiological profile of patients with tuberculosis (TB) only and that of patients with TB/AIDS in the state of Espirito Santo, Brazil, between 2000 and 2006. Methods: For the patients of interest, we collected demographic and clinical data from the Epidemiological Surveillance Center (TB database), Brazilian Case Registry Database, and Brazilian National Mortality Database, as well as the Brazilian National CD4+/CD8+ T Lymphocyte Count and Viral Load Network Laboratory Test Control System and the Logistic Medication Monitoring System (HIV/AIDS databases). All of the compiled data were cross-referenced. Results: During the study period, we identified 9,543 TB patients > 15 years of age, 437 of whom (4.6%) had AIDS. The median age did not differ between TB/AIDS and TB-only patients (35 years vs. 38 years). Of the 437 TB/AIDS patients, 298 (68.2%) were male, and 156 (35.8%) were in the 30-39 age bracket. In terms of TB treatment outcome, 79.0% were cured, 9.7% were referred to other facilities, 6.0% died, 5.2% abandoned treatment, and 0.2% developed multidrug-resistant TB. Death was 4.75 times more common in patients with TB/AIDS than in those with TB only. Pulmonary TB accounted for 82.4% of the cases. The combination of pulmonary and extrapulmonary TB was 8.2 times more common in the TB/AIDS patients than in the TB-only patients (95% Cl: 6.2-10.8). Conclusions: Our results emphasize the significance of AIDS among TB patients in Brazil, as well as the importance of evaluating secondary data in order 10 improve their quality and develop public health interventions.
C1 [do Prado, Thiago Nascimento; Caus, Antonio Luiz; Marques, Murilo; Maciel, Ethel Leonor; Golub, Jonathan E.; Miranda, Angelica Espinosa] Univ Fed Espirito Santo, Vitoria, Brazil.
RP Miranda, AE (corresponding author), Ctr Ciencias Saude, Ave Marechal Campos,1468 Maruipe, BR-29040090 Vitoria, ES, Brazil.
EM espinosa@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Miranda,
   Angelica/0000-0002-5556-8379
FU World BankThe World Bank India; International Clinical Operational and
   Health Services Research and Training Award (ICOHRTA) [5 U2R
   TW006883-02]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [U2RTW006885, U2RTW006883,
   U2RTW006885, U2RTW006885, U2RTW006885, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006885, U2RTW006883, U2RTW006885, U2RTW006883,
   U2RTW006883, U2RTW006885, U2RTW006883, U2RTW006883, U2RTW006885,
   U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006883, U2RTW006885,
   U2RTW006883] Funding Source: NIH RePORTER
FX The study received financial support from the World Bank Reaching the
   Poor Program and from the International Clinical Operational and Health
   Services Research and Training Award (ICOHRTA; AIDS/TB grant no. 5 U2R
   TW006883-02).
CR Aerts D, 2004, INT J TUBERC LUNG D, V8, P785
   Boerma JT, 1998, AIDS, V12, pS3
   BRAUN MM, 1993, JAMA-J AM MED ASSOC, V269, P2865, DOI 10.1001/jama.269.22.2865
   BRUDNEY K, 1991, AM REV RESPIR DIS, V144, P745, DOI 10.1164/ajrccm/144.4.745
   Camargo K R Jr, 2000, Cad Saude Publica, V16, P439
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009
   DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404
   David AM, 2007, J URBAN HEALTH, V84, pI65, DOI 10.1007/s11524-007-9183-5
   de Oliveira HB, 2004, REV SAUDE PUBL, V38, P503, DOI 10.1590/S0034-89102004000400004
   Diez M, 2002, INT J TUBERC LUNG D, V6, P295
   Franco J, 1998, INT J TUBERC LUNG D, V2, P663
   Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4
   Lazaridis EN, 1997, ANN INTERN MED, V127, P696, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00052
   *MIN SAUD, 2008, B EP MIN SAUD, V1
   Muniz Jordana Nogueira, 2006, J. bras. pneumol., V32, P529, DOI 10.1590/S1806-37132006000600010
   Picon P, 1993, TUBERCULOSE EPIDEMIO
   RIEDER HL, 1989, ARCH INTERN MED, V149, P1268, DOI 10.1001/archinte.149.6.1268
   SANTOS ET, 2006, POLITICA TB BRASIL P
   Silveira Jussara Maria, 2006, J. bras. pneumol., V32, P48, DOI 10.1590/S1806-37132006000100011
   Song Alice Tung Wan, 2003, Rev. Hosp. Clin., V58, P207, DOI 10.1590/S0041-87812003000400004
   SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362
   Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020
   *WHO, 1996, TB HIV MAN CLIN BRAS
   World Health Organization, 2009, GLOB TUB CONTR EP ST
NR 25
TC 18
Z9 22
U1 0
U2 4
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD JAN-FEB
PY 2011
VL 37
IS 1
BP 93
EP 99
DI 10.1590/S1806-37132011000100014
PG 7
WC Respiratory System
SC Respiratory System
GA 725WU
UT WOS:000287678400014
PM 21390437
OA DOAJ Gold, Green Accepted
DA 2020-12-15
ER

PT J
AU Maciel, EL
   Peres, RL
   do Prado, TN
   Macedo, CR
   Palaci, M
   Vinhas, SA
   Dietze, R
   Johnson, JL
   Struchiner, CJ
AF Maciel, Ethel Leonor
   Peres, Renata Lyrio
   do Prado, Thiago Nascimento
   Macedo, Cristina Ribeiro
   Palaci, Moises
   Vinhas, Solange Alves
   Dietze, Reynaldo
   Johnson, John L.
   Struchiner, Claudio Jose
TI Saline Nebulization before Gastric Lavage in the Diagnosis of Pulmonary
   Tuberculosis in Children and Adolescents
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Letter
DE tuberculosis; diagnosis; gastric lavage; child
ID BRONCHOALVEOLAR LAVAGE
AB The main objective is to assess whether nebulization before gastric lavage (GL) improves its sensitivity for the diagnosis of childhood tuberculosis (TB). Children and adolescents suspected of pulmonary TB were randomly assigned (1 : 2) to nebulization with hypertonic saline 30 min before GL (Neb group; n = 36) or GL without prior nebulization (controls; n = 68). The proportion of positive GL smears was greater in Neb group than in the control group; however, no statistical significance was observed (36.3% vs. 22.2%; p = 0.4). Inhalation of nebulized hypertonic saline before GL did not improve TB diagnosis in this study. Nevertheless, the validation of our data will require large longitudinal studies.
C1 [Maciel, Ethel Leonor; Peres, Renata Lyrio; do Prado, Thiago Nascimento; Palaci, Moises; Vinhas, Solange Alves; Dietze, Reynaldo] NDI Univ Fed Espirito Santo, BR-29040090 Maruipe Vitoria, ES, Brazil.
   [Macedo, Cristina Ribeiro] Hosp Nossa Senhora da Gloria, Vitoria, ES, Brazil.
   [Johnson, John L.] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA.
   [Struchiner, Claudio Jose] Oswaldo Cruz Fdn FIOCRUZ, Sergio Arrouca Arouca Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
RP Maciel, EL (corresponding author), NDI Univ Fed Espirito Santo, Av Marechal Campos 1468, BR-29040090 Maruipe Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Struchiner, Claudio J/M-9360-2013; Maciel, Ethel Leonor LN/G-1027-2012
OI Struchiner, Claudio J/0000-0003-2114-847X; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Dietze, Reynaldo/0000-0002-6995-8001
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [N01-AI-70022, N01-AI95383] Funding Source:
   Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [N01AI095383, N01AI095383, N01AI095383, N01AI095383,
   N01AI095383, N01AI095383] Funding Source: NIH RePORTER
CR ABADCO DL, 1992, PEDIATR INFECT DIS J, V11, P735, DOI 10.1097/00006454-199209000-00013
   BASS JB, 1990, AM REV RESPIR DIS, V142, P725
   Kent P T, 1985, PUBLIC HLTH MYCOBACT
   MACIEL ELN, 2006, CAD SAUDE COLET, V14, P81
   Maciel Ethel Leonor Noia, 2008, J. bras. pneumol., V34, P404, DOI 10.1590/S1806-37132008000600011
   *MIN HLTH, 2002, TUB CONTR PROGR INT
   Sant'Anna Clemax Couto, 2002, J Pediatr (Rio J), V78 Suppl 2, pS205
   SOMU N, 1995, TUBERCLE LUNG DIS, V76, P295, DOI 10.1016/S0962-8479(05)80027-9
   STARKE JR, 1992, J PEDIATR-US, V120, P839, DOI 10.1016/S0022-3476(05)81949-3
   STARKE JR, 1993, CHEST, V104, P329, DOI 10.1378/chest.104.2.329
   Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2
NR 11
TC 2
Z9 2
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD DEC
PY 2010
VL 56
IS 6
BP 458
EP 459
DI 10.1093/tropej/fmq015
PG 3
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA 685RF
UT WOS:000284645100020
PM 20207695
OA Green Published
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Pan, W
   Dietze, R
   Peres, RL
   Vinhas, SA
   Ribeiro, FK
   Palaci, M
   Rodrigues, RR
   Zandonade, E
   Golub, JE
AF Maciel, E. L. N.
   Pan, W.
   Dietze, R.
   Peres, R. L.
   Vinhas, S. A.
   Ribeiro, F. K.
   Palaci, M.
   Rodrigues, R. R.
   Zandonade, E.
   Golub, J. E.
TI Spatial patterns of pulmonary tuberculosis incidence and their
   relationship to socio-economic status in Vitoria, Brazil
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE tuberculosis; prevention control; epidemiologic surveillance; spatial
   distribution
ID TRANSMISSION; COMMUNITY; RISKS
AB OBJECTIVE: To investigate spatial patterns of the incidence of pulmonary tuberculosis (TB) and its relationship with socio-economic status in Vitoria, Espirito Santo, Brazil.
   DESIGN: In a 4-year, retrospective, territory-based surveillance study of all new pulmonary TB cases conducted in Vitoria between 2002 and 2006, spatial patterns of disease incidence were compared using spatial clustering statistics (Anselin's local indicators of spatial association [LISA] and Getis-Ord Gi* statistics), smoothed empirical Bayes estimates and model-predicted incidence rates. Spatial Poisson models were fit to examine the relationship between socio-economic status and TB incidence.
   RESULTS: A total of 651 TB cases were reported across 78 neighborhoods, with rates ranging from 0 to 129 cases per 100 000 population. Moran's I indicated strong spatial autocorrelation among incidence rates (0.399, P < 0.0001), and four areas of high incidence were identified by LISA and Gi* statistics. Smoothed spatial empirical Bayes estimates demonstrate that two of these areas range from 70 to 90 cases/100 000, while the other two range from 40 to 70 cases/100 000. TB incidence and socioeconomic status had a significant curvilinear relationship (P = 0.02).
   CONCLUSIONS: Data derived from these spatial statistical tools will help TB control programs to allocate TB resources to those populations most at risk of increasing TB rates and to target areas where TB control efforts need to be concentrated.
C1 [Maciel, E. L. N.; Dietze, R.; Peres, R. L.; Vinhas, S. A.; Ribeiro, F. K.; Palaci, M.; Rodrigues, R. R.] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
   [Maciel, E. L. N.; Zandonade, E.] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
   [Pan, W.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA.
   [Golub, J. E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Av Marechal Campos,1468 Maruipe, Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012; Rodrigues, Rodrigo
   Ribeiro/AAY-7820-2020
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Rodrigues, Rodrigo
   Ribeiro/0000-0002-0675-110X; Pan, William/0000-0002-7407-7399
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5 U2R TW006883-02];
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006883, U2RTW006885, U2RTW006883,
   U2RTW006885, U2RTW006885, U2RTW006883, U2RTW006885, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006885, U2RTW006883,
   U2RTW006885, U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006883,
   U2RTW006883, U2RTW006885, U2RTW006883, U2RTW006885, U2RTW006883] Funding
   Source: NIH RePORTER
FX The authors thank W M Ramalho from the Minister of Health in Brazil who
   contributed towards the study by teaching the use of the Terraview
   application; the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) by Edital MCT/CNPq/MS-SCTIE-DECIT No 25/2006 Doencas
   negligenciadas and National Institute of Health on the ICHORTA Grant No,
   5 U2R TW006883-02.
CR ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Vieira RDA, 2008, REV SOC BRAS MED TRO, V41, P82, DOI 10.1590/S0037-86822008000100017
   Assuncao R M, 1998, Cad Saude Publica, V14, P713, DOI 10.1590/S0102-311X1998000400013
   Bailey T., 1995, INTERACTIVE SPATIAL
   Bailey T. C., 2001, Cadernos de Saude Publica, V17, P1083
   Barr RG, 2001, AM J PUBLIC HEALTH, V91, P1487, DOI 10.2105/AJPH.91.9.1487
   Bastos JL, 2009, CAD SAUDE PUBLICA, V25, P2111, DOI 10.1590/S0102-311X2009001000003
   Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679
   Cantwell MF, 1998, AM J RESP CRIT CARE, V157, P1016, DOI 10.1164/ajrccm.157.4.9704036
   Carlin Bradley P, 2000, C&H TEXT STAT SCI
   Cavalcante SC, 2010, INT J TUBERC LUNG D, V14, P203
   CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   De Fede AL, 2008, INT J TUBERC LUNG D, V12, P1425
   Druck S, 2004, ANALISE ESPACIAL DAD
   Gazetta CE, 2008, REV LAT-AM ENFERM, V16, P306, DOI 10.1590/S0104-11692008000200021
   Gazetta Cláudia Eli, 2006, J. bras. pneumol., V32, P559, DOI 10.1590/S1806-37132006000600014
   GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x
   Kistemann T, 2002, SOC SCI MED, V55, P7, DOI 10.1016/S0277-9536(01)00216-7
   Lemos Antonio Carlos, 2004, Braz J Infect Dis, V8, P424, DOI 10.1590/S1413-86702004000600006
   Liestol K, 2009, INT J EPIDEMIOL, V38, P427, DOI 10.1093/ije/dyn347
   Littell R.C., 2006, SAS MIXED MODELS
   McConkey SJ, 2002, CLIN INFECT DIS, V34, P612, DOI 10.1086/338785
   Militino AF, 2001, STAT MED, V20, P2035, DOI 10.1002/sim.821
   *MIN SAUD, 1980, SER HIST DOEN NOT CO
   Ministerio da Saude, 2002, GUIA TRAT TUB PROGR
   Ministerio da Saude. Secretaria Executiva. Departamento de Informatica do SUS, 2006, SIST INF MORT
   Pinheiro JC, 2006, J COMPUT GRAPH STAT, V15, P58, DOI 10.1198/106186006X96962
   *PREF MUN, 2004, IND QUAL URB BAIRR V
   ROM WN, 1995, TUBERCULOSIS, P953
   Ruffino-Netto Antonio, 2002, Rev. Soc. Bras. Med. Trop., V35, P51, DOI 10.1590/S0037-86822002000100010
   Souza WV, 2005, REV SAUDE PUBL, V39, P82, DOI [10.1590/S0034-89102005000100011, 10.1590/s0034-89102005000100011]
   Van Loon Frederik P. L., 1995, Morbidity and Mortality Weekly Report, V44, P1
   Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021
   Waaler HT, 2002, INT J TUBERC LUNG D, V6, P745
   Yang ZH, 2001, INT J TUBERC LUNG D, V5, P313
NR 36
TC 45
Z9 54
U1 1
U2 11
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD NOV
PY 2010
VL 14
IS 11
BP 1395
EP 1402
PG 8
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 675KV
UT WOS:000283830500007
PM 20937178
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Golub, JE
   Peres, RL
   Hadad, DJ
   Favero, JL
   Molino, LP
   Bae, JW
   Moreira, CM
   Detoni, VD
   Vinhas, SA
   Palaci, M
   Dietze, R
AF Maciel, E. L. N.
   Golub, J. E.
   Peres, R. L.
   Hadad, D. J.
   Favero, J. L.
   Molino, L. P.
   Bae, J. W.
   Moreira, C. M.
   Detoni, V. do V.
   Vinhas, S. A.
   Palaci, M.
   Dietze, R.
TI Delay in diagnosis of pulmonary tuberculosis at a primary health clinic
   in Vitoria, Brazil
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE tuberculosis; epidemiology; delayed diagnosis
ID CARE-SYSTEM DELAYS; SEEKING BEHAVIOR; PATIENT; PREVALENCE; MORTALITY;
   KNOWLEDGE; THAILAND; COUNTRY; STATE; TIME
AB SETTING: Primary health clinics in Vitoria, Espirito Santo, Brazil.
   OBJECTIVE: To identify risk factors associated with patient and health care delays among patients seeking care at primary health clinics.
   METHODS: A prospective study among tuberculosis (TB) patients diagnosed in Vitoria between 1 January 2003 and 30 December 2007. A questionnaire ascertained the date of onset and duration of TB symptoms and medical records were reviewed. Between-group distributions of delay were compared and multivariate logistic regression was performed.
   RESULTS: Of 304 patients, 296 (97%) reported at least one TB symptom presenting for the first time to a qualified health service; 244 (80%) reported cough > 3 weeks. Median health care delay was 30 days (range 5-68), and median total delay was 110 days (range 26-784). Multivariate analysis revealed any cough (ORadi 7.35, 95% CI 2.40-22.5) and weight at TB diagnosis < 60 kg (ORadi 5.92, 95% CI 1.83-19.1) to be associated with patient delay of >= 30 days. Factors increasing risk of prolonged delay (>= 90 days) were age >= 30 years (ORadi 1.93, 95% CI 1.09-3.43) and chest pain (ORadi 2.42, 95% CI 1.29-4.53).
   CONCLUSION: Improving health care workers' education regarding TB symptoms and implementing active case finding in targeted populations may reduce delays.
C1 [Maciel, E. L. N.; Peres, R. L.; Hadad, D. J.; Favero, J. L.; Molino, L. P.; Vinhas, S. A.; Palaci, M.; Dietze, R.] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
   [Golub, J. E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Bae, J. W.] Yale Univ, Sch Med, New Haven, CT USA.
   [Moreira, C. M.] TB Control Program Vitoria City Secretary Hlth, TB Control Program, Vitoria, ES, Brazil.
   [Detoni, V. do V.] Hosp Univ Cassiano Antonio Moraes, TB Control Program, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Av Marechal Campos,1468 Maruipe, Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Gutierrez, Fredy R.S./C-3911-2009; Guedes, Paulo/Y-2546-2018; Maciel,
   Ethel Leonor LN/G-1027-2012; Silva, Joao S/A-4484-2008
OI Gutierrez, Fredy R.S./0000-0001-9873-8342; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Silva, Joao S/0000-0002-3410-3927
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI066994]; Harvard
   College Office of Career Services; MCT/CNPq/MS-SCTIE-DECITNational
   Council for Scientific and Technological Development (CNPq); ICOHRTA [5
   U2R TW006883-02]; FOGARTY INTERNATIONAL CENTERUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [U2RTW006883, U2RTW006883,
   U2RTW006885, U2RTW006885, U2RTW006885, U2RTW006883, U2RTW006885,
   U2RTW006885, U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006883,
   U2RTW006883, U2RTW006885, U2RTW006883, U2RTW006883, U2RTW006885,
   U2RTW006885, U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006883,
   U2RTW006883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [K01AI066994, K01AI066994,
   K01AI066994, K01AI066994, K01AI066994] Funding Source: NIH RePORTER
FX Edital MCT/CNPq/MS-SCTIE-DECIT 25/2006- Estudo de Doencas Negligenciadas
   and ICOHRTA 5 U2R TW006883-02. JEG was supported by the National
   Institutes of Health grant AI066994. JB was supported by Alex G Booth
   Fellowship from Harvard College Office of Career Services.
CR Bastos LGV, 2007, INT J TUBERC LUNG D, V11, P156
   Bjune G, 2005, NORSK EPIDEMIOLOGI, V15, P133
   Brazil, 2004, PROGR NAC CONTR TUB
   Calder L, 2000, NEW ZEAL MED J, V113, P483
   dos Santos MAPS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-25
   Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677
   El-Sony AI, 2003, INT J TUBERC LUNG D, V7, P445
   ENARSON DA, 1978, CAN MED ASSOC J, V118, P1520
   Epstein MD, 1998, CHEST, V113, P379, DOI 10.1378/chest.113.2.379
   Farah MG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-33
   Godfrey-Faussett R, 2002, INT J TUBERC LUNG D, V6, P796
   Golub JE, 2006, INT J TUBERC LUNG D, V10, P24
   Golub JE, 2005, INT J TUBERC LUNG D, V9, P992
   Gomez MNA, 2003, ARCH BRONCONEUMOL, V39, P146
   Hooi L N, 1994, Med J Malaysia, V49, P223
   Huong NT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-110
   Kent P T, 1985, PUBLIC HLTH MYCOBACT
   Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122
   Lambert ML, 2005, TROP MED INT HEALTH, V10, P945, DOI 10.1111/j.1365-3156.2005.01485.x
   Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233
   Long NH, 1999, INT J TUBERC LUNG D, V3, P388
   Lonnroth K, 1999, INT J TUBERC LUNG D, V3, P992
   MADEBO T, 1999, MED GEN MED, pE6
   MORAN GJ, 1995, ANN EMERG MED, V26, P290, DOI 10.1016/S0196-0644(95)70074-9
   Ngamvithayapong J, 2001, INT J TUBERC LUNG D, V5, P1013
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P1377, DOI 10.1590/S0102-311X2008000600018
   Maciel ELN, 2009, CIENC SAUDE COLETIVA, V14, P1395, DOI 10.1590/S1413-81232009000800012
   Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07
   Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619
   Rodger A, 2003, BRIT MED J, V326, P909, DOI 10.1136/bmj.326.7395.909
   Rojpibulstit M, 2006, INT J TUBERC LUNG D, V10, P422
   RUFFINONETTO A, 2007, TUBERCULOSIS TREATME
   Sherman LF, 1999, INT J TUBERC LUNG D, V3, P1088
   Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91
   Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15
   Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P133
   Ward J, 2001, INT J TUBERC LUNG D, V5, P1021
   *WHO, 2004, WHOHTMTB2004331
   *WHO, 1998, WHOTB98258
   Yamasaki-Nakagawa M, 2001, INT J TUBERC LUNG D, V5, P24
NR 40
TC 31
Z9 35
U1 0
U2 1
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD NOV
PY 2010
VL 14
IS 11
BP 1403
EP 1410
PG 8
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 675KV
UT WOS:000283830500008
PM 20937179
DA 2020-12-15
ER

PT J
AU Moreira, CMM
   Zandonade, E
   Lacerda, T
   Maciel, ELN
AF Marques Moreira, Claudia Maria
   Zandonade, Eliana
   Lacerda, Thamy
   Noia Maciel, Ethel Leonor
TI Respiratory symptomatics among patients at primary health clinics in
   Vitoria, Espirito Santo State, Brazil
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Tuberculosis; Respiratory Signs and Symptoms; Primary Health Care
ID TUBERCULOSIS
AB The aim of this study was to estimate the rate of positive respiratory symptomatics among patients seeking treatment at primary health clinics in Vitoria, Espirito Santo State, Brazil. This cross-sectional study included 603 individuals that answered a questionnaire with socio-demographic data and a question on cough in the previous three weeks. The prevalence ratio was calculated with 5% significance. The proportion of patients with positive respiratory symptoms in the municipality was 4%, varying from 1.6 to 11.7% between regions. The majority (71%) did not report cough as the reason for coming to the health clinic. Variables significantly associated with respiratory symptoms were: shortness of breath (PR = 6.29; 95%CI: 2.22-21.81) and lack of appetite (PR = 2.75; 95% CI: 1.08-6.82). Among patients with respiratory symptoms, cough was the principal reason for seeking treatment. This condition was only associated with two variables, thus demonstrating the need to adopt different strategies to identify these individuals among the daily patient flow in primary health clinics.
C1 [Marques Moreira, Claudia Maria; Zandonade, Eliana; Lacerda, Thamy; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, BR-29040901 Vitoria, ES, Brazil.
   [Marques Moreira, Claudia Maria] Secretaria Municipal Saude Vitoria, Vitoria, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, BR-29040901 Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29040901 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR [Anonymous], 2012, GLOB TUB CONTR SURV
   Vieira RDA, 2008, REV SOC BRAS MED TRO, V41, P82, DOI 10.1590/S0037-86822008000100017
   ARMENGOL R, 1992, GAC MED CARACAS, V100, P121
   Bastos LGV, 2007, INT J TUBERC LUNG D, V11, P156
   BRASIL. Ministerio da Saude  Ministerio da Saude, 2005, SAUD BRAS 2005 AN SI
   Ducati RG, 2006, MEM I OSWALDO CRUZ, V101, P697, DOI 10.1590/S0074-02762006000700001
   GABARDO BMA, 2008, AN 3 ENC NAT TUB, pR21
   MARIN MAV, 1999, REV I NAC ENFERMEDAD, V12, P29
   *MIN SAUD, 2002, TUB GUIA VIG EP
   *MIN SAUD SECR VIG, 2004, PROGR NAC CONTR TUB
   MOTA MRT, 2004, B PNEUMOL SANIT, V12, P85
   Muniz Jordana Nogueira, 2005, Ciênc. saúde coletiva, V10, P315, DOI 10.1590/S1413-81232005000200009
   NAGPAUL D R, 1985, Revista Argentina de Tuberculosis Enfermedades Pulmonares y Salud Publica, V46, P5
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P1377, DOI 10.1590/S0102-311X2008000600018
   OLIVEIRA MF, 2006, THESIS U SAO PAULO
   RODRIGUES ILA, 2008, AN 3 ENC NAC TUB BRA, pR33
   Santha T, 2005, INT J TUBERC LUNG D, V9, P61
   *SECR DES CID, HIST BAIRR
   *SECR MUN SAUDE, 2000, MAN AT BAS MUN VIT P
   *SOC BRAS PNEUM TI, 2006, J BRAS PNEUMOL S6, V32, P403
   *WHO, 2007, TRAIN MOD MAN TB RAT
NR 21
TC 6
Z9 10
U1 0
U2 5
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD AUG
PY 2010
VL 26
IS 8
BP 1619
EP 1626
DI 10.1590/S0102-311X2010000800015
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 648KD
UT WOS:000281691600015
PM 21229220
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU do Nascimento, FG
   do Prado, TN
   Galavote, HS
   Maciel, PA
   Lima, RDD
   Maciel, ELN
AF do Nascimento, Fernanda Gomes
   do Prado, Thiago Nascimento
   Galavote, Heleticia Scabelo
   Maciel, Paulete Ambrosio
   Duarte Lima, Rita de Cassia
   Noia Maciel, Ethel Leonor
TI Applicability of the risk scale to the organization of the work process
   with families in a health care unit in the city of Vitoria, Espirito
   Santo State
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Family Health Strategy; Coelho scale; Work process
AB The objective of this study was to evaluate the applicability of Coelho's scale (CS) and to determine its adaptation to the reality observed in the families accompanied in the Maria Rangel Passos health care unit (USFMRP) in the city of Vitoria, Espirito Santo State. This is a cross-sectional exploratory, descriptive study developed in the area of health of Greater Maruipe. First, it was made the classification of the families according to CS and the results were presented for a discussion group that proposed changes and possible alterations in CS, being the new tool denominated as "UFES criterium". In order to verify the applicability of that instrument and to accomplish a comparison with the obtained results of the classification for CS, thirty families assisted in USFMRP were randomly selected and visited, including by the HCA. This new scale allowed to identify a larger number of families of minimum risk and to guide the several actions accomplished daily in a health care unit, aiming to define priorities and to reorient the practices exercised by the professionals heading for the consolidation of a more even and integral attendance, centered in the service of the real social needs in health of the families assisted in the extent of the Family Health Strategy (FHS).
C1 [do Nascimento, Fernanda Gomes; Galavote, Heleticia Scabelo; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, BR-29040091 Vitoria, ES, Brazil.
   [do Prado, Thiago Nascimento] Univ Fed Espirito Santo, Lab Epidemiol, BR-29040091 Vitoria, ES, Brazil.
   [Maciel, Paulete Ambrosio; Duarte Lima, Rita de Cassia] Univ Fed Espirito Santo, Dept Enfermagem, BR-29040091 Vitoria, ES, Brazil.
RP do Nascimento, FG (corresponding author), Univ Fed Espirito Santo, Av Marechal Campos 1-468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR ALEIXO JLM, 2002, REV MINEIRA SAUDE PU, V1, P1
   Ayres JRCM, 2003, PROMOCAO SAUDE CONCE, P117
   Buss PM, 2004, PROMOCAO SAUDE CONCE, P15
   Campos T P, 2000, Rev Panam Salud Publica, V8, P164, DOI 10.1590/S1020-49892000000800003
   CARVALHO YM, 2006, TRATADO SAUDE COLETI, P149
   CASTIEL LD, 1996, HIST CIENC SAUDE-MAN, V3, P237
   COELHO FLG, 2003, 1 C MIN MED FAM COM
   LEVCOVITZ E, 2002, CIENC SAUDE COLETIVA, V6, P269
   Martinez L, 1998, J PHOTOCH PHOTOBIO B, V45, P51, DOI 10.1016/S1011-1344(98)00160-2
   Monteiro CA, 2005, REV SAUDE PUBL, V39, P47, DOI [10.1590/S0034-89102005000100007, 10.1590/s0034-89102005000100007]
   Prietsch Silvio O. M., 2003, Rev Panam Salud Publica, V13, P303, DOI 10.1590/S1020-49892003000400005
   Sabry MOD, 1999, J PNEUMOL, V25, P313
   SOARES BM, 1997, THESIS I U PESQUISAS
   Soares N. T., 2001, Revista de Nutricao, V14, P103, DOI 10.1590/S1415-52732001000200003
NR 14
TC 3
Z9 5
U1 0
U2 0
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD AUG
PY 2010
VL 15
IS 5
BP 2465
EP 2472
DI 10.1590/S1413-81232010000500021
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 645CU
UT WOS:000281429300022
PM 20802879
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Brotto, LDD
   Sales, CMM
   Zandonade, E
   Sant'Anna, CC
AF Noia Maciel, Ethel Leonor
   de Aguiar Brotto, Leia Damasceno
   Martins Sales, Carolina Maia
   Zandonade, Eliana
   Sant'Anna, Clemax Couto
TI Gastric lavage in the diagnosis of pulmonary tuberculosis in children: a
   systematic review
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Gastric Lavage, methods; Tuberculosis, diagnosis; Diagnostic Techniques,
   Respiratory System; Systematic review
ID YOUNG-CHILDREN; SCORING SYSTEM; CHILDHOOD; HEALTH; INFANTS; SPUTUM
AB OBJECTIVE: To analyze standardization of gastric lavage protocols in the diagnosis of pulmonary tuberculosis in children.
   METHODS:A systematic review was conducted for the period between 1968 and 2008 in the following databases: LILACS, SciELO and MEDLINE. The search strategy included the following terms: "gastric lavage and tuberculosis" or "gastric washing and tuberculosis" with the restriction of "children aged up to 15 years;" "gastric lavage and tuberculosis and childhood" or "gastric washing and tuberculosis and childhood." There were retrieved 80 articles and their analysis was based on information on the gastric lavage protocol for the diagnosis of pulmonary tuberculosis in children: preparation of children and fasting; time of gastric aspiration; aspiration of gastric residues; total volume of aspirate; solution used for aspiration of gastric contents; decontaminant solution; buffer solution; and time for forwarding samples to the laboratory. After a thorough analysis, 14 articles were selected.
   RESULTS: No article detailed the whole procedure. Some articles had missing information on: amount of gastric aspirate; aspiration before or after solution injection; solution used for gastric aspiration; buffer solution used; and waiting time between specimen collection and laboratory processing. These results showed inconsistencies of gastric lavage protocols.
   CONCLUSIONS: Although gastric lavage is a secondary diagnostic approach used only in special cases that did not reach the diagnostic scoring as recommended by the Brazilian Ministry of Health, there is a need to standardize gastric lavage protocols for the diagnosis of pulmonary tuberculosis in children.
C1 [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Nucl Doencas Infecciosas, Dept Enfermagem, CCS, BR-3040091 Vitoria, ES, Brazil.
   [Noia Maciel, Ethel Leonor; Zandonade, Eliana] CCS UFES, Programa Posgrad Saude Coletiva, Vitoria, Es, Brazil.
   [Sant'Anna, Clemax Couto] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Fac Med, Rio De Janeiro, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Nucl Doencas Infecciosas, Dept Enfermagem, CCS, Av Marechal Campos,1468 Maruipe, BR-3040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Anna, Clemax Sant/H-7923-2019; Maciel, Ethel Leonor LN/G-1027-2012
OI Anna, Clemax Sant/0000-0001-8732-8065; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355
CR ABACICO DL, 1992, PEDIATR INFECT DIS J, V11, P735
   Alves R, 2000, REV SAUDE PUBL, V34, P409, DOI 10.1590/S0034-89102000000400015
   Bhandari B, 1971, Indian J Pediatr, V38, P349, DOI 10.1007/BF02806119
   CASTELO F, 2004, J BRAS PNEUMOL, V30, P57, DOI DOI 10.1590/S1806-37132004000700002
   Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011
   Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377
   GIAMMONA ST, 1969, AM J DIS CHILD, V117, P198, DOI 10.1001/archpedi.1969.02100030200014
   Hatherill M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000021
   Houwert KAF, 1998, EUR RESPIR J, V11, P1116, DOI 10.1183/09031936.98.11051116
   Jeena PM, 2002, INT J TUBERC LUNG D, V6, P672
   Lloyd A V, 1968, East Afr Med J, V45, P140
   Lobato MN, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e40
   MACIEL ELN, 2001, CAD SAUDE COLET RIO, V14, P81
   Maciel Ethel Leonor Noia, 2008, J. bras. pneumol., V34, P404, DOI 10.1590/S1806-37132008000600011
   Marais BJ, 2006, PEDIATRICS, V118, pE1350, DOI 10.1542/peds.2006-0519
   MIGLIORI GB, 1992, TUBERCLE LUNG DIS, V73, P145, DOI 10.1016/0962-8479(92)90148-D
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P402, DOI 10.1590/S0102-311X2008000200019
   Okutan O, 2003, YONSEI MED J, V44, P242, DOI 10.3349/ymj.2003.44.2.242
   Pedrozo C, 2009, INT J TUBERC LUNG D, V13, P413
   Sant'Anna C, 2009, INT J TUBERC LUNG D, V13, P1566
   Sant'Anna CC, 2002, TUBERCULOSE INFANCIA
   Sant'Anna Clemax Couto, 2004, Braz J Infect Dis, V8, P305, DOI 10.1590/S1413-86702004000400006
   Sant'Anna Clemax Couto, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P103, DOI 10.1590/S0036-46652003000200010
   SANTANNA CC, 2002, J PEDIAT RIO J, V78, P205, DOI DOI 10.1590/S0021-75572002000800011
   Sequeira MD, 2000, MEDICINA-BUENOS AIRE, V60, P170
   Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967
   Singh M, 2005, ARCH DIS CHILD, V90, P624, DOI 10.1136/adc.2003.044255
   Singh M, 2000, Indian Pediatr, V37, P947
   SOMU N, 1995, TUBERCLE LUNG DIS, V76, P295, DOI 10.1016/S0962-8479(05)80027-9
   STARKE JR, 1992, J PEDIATR-US, V120, P839, DOI 10.1016/S0022-3476(05)81949-3
   STARKE JR, 1993, CHEST, V104, P329, DOI 10.1378/chest.104.2.329
   Zar HJ, 2005, LANCET, V365, P130, DOI 10.1016/S0140-6736(05)17702-2
   Zar HJ, 2000, ARCH DIS CHILD, V82, P305, DOI 10.1136/adc.82.4.305
NR 33
TC 8
Z9 9
U1 0
U2 6
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD AUG
PY 2010
VL 44
IS 4
BP 735
EP 742
DI 10.1590/S0034-89102010005000019
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 640LW
UT WOS:000281054000018
PM 20585739
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Figueiredo, PF
   do Prado, TN
   Galavote, HS
   Ramos, MC
   de Araujo, MD
   Lima, RDD
AF Noia Maciel, Ethel Leonor
   Figueiredo, Pryscilla Formiga
   do Prado, Thiago Nascimento
   Galavote, Heleticia Scabelo
   Ramos, Maria Cristina
   de Araujo, Maristela Dalbello
   Duarte Lima, Rita de Cassia
TI Evaluation of egressing students of the specialization course on Family
   Care Health in Espirito Santo State, Brazil
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Egressing students; Continued education; Health service
AB The purpose of this study was to evaluate the contribution of the specialization course on Family Health Care (PG-PSF), in Espirito Santo State, for the reorientation of the practices in health. It is a cross-sectional study with a population of 47 egressing students of the PG-PSF course in 2007. It was used a semi-structured questionnaire for data collection data. The analysis of the generated contributions showed some reports regarding the changes in the work actions after the acquired knowledge during the course. The majority of the students declared that the acquired knowledge have applicability in their daily work. They also declared that can plan their actions based in the epidemic profile of the area where worked. The relevance of this course was verified for the egressing students, with the perspective of a constant adaptation of the contents and improvement of the didactic-pedagogic process, through a system of continuous education or permanent education, as well as the attendance processes and supervision in service.
C1 [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Nucleos Estudos Saude Colet, BR-29040091 Vitoria, ES, Brazil.
   [Figueiredo, Pryscilla Formiga] Univ Fed Espirito Santo, Ctr Biomed, BR-29040091 Vitoria, ES, Brazil.
   [do Prado, Thiago Nascimento] Univ Fed Espirito Santo, Lab Epidemiol, Nucleo Doencas Infecciosas, BR-29040091 Vitoria, ES, Brazil.
   [Ramos, Maria Cristina] Univ Fed Espirito Santo, Dept Enfermagem, BR-29040091 Vitoria, ES, Brazil.
   [de Araujo, Maristela Dalbello; Duarte Lima, Rita de Cassia] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, BR-29040091 Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Nucleos Estudos Saude Colet, Av Marechal Campos 1-468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR AKERMAN M, 2004, ACOMPANHAMENTO AVALI, V1, P42
   BRITO JC, 2005, CAD SAUDE PUBLICA, V21, P1612
   COTTA TC, 1998, REV SERV PUB, V49, P32
   ESCOREL S, 2002, AVALIACAO IMPLEMENTA
   FINGER AP, 1989, EVALUACION ACAD I U, P88
   FRANCO T. B., 2003, TRABALHO SAUDE OLHAN, P37
   Gil Célia Regina Rodrigues, 2005, Cad. Saúde Pública, V21, P490, DOI 10.1590/S0102-311X2005000200015
   GIRARDI SN, 2002, RECURSOS HUMANOS SAU, P221
   Hartz ZMA, 1997, AVALIACAO SAUDE MODE
   PAIM JS, 1992, CAD SAUDE PUBLICA, V8, P262
   Paschoal AS, 2007, REV ESC ENFERM USP, V41, P478, DOI 10.1590/S0080-62342007000300019
NR 11
TC 3
Z9 7
U1 0
U2 2
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD JUL
PY 2010
VL 15
IS 4
BP 2021
EP 2028
DI 10.1590/S1413-81232010000400016
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 662MP
UT WOS:000282811700016
PM 20694324
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Schwartz, TD
   Ferreira, JTB
   Maciel, ELN
   Lima, RDD
AF Schwartz, Talita Dourado
   Bertulozo Ferreira, Josilda Terezinha
   Noia Maciel, Ethel Leonor
   Duarte Lima, Rita de Cassia
TI Family Health Strategy: evaluating the access to SUS from the perception
   of the users of the health unit Resistencia, in the region of Sao Pedro,
   Vitoria, Espirito Santo State
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Access; Family Health Strategy; Basic attention; User
AB Family Health is a re-orientation strategy of the assistance model. One of its guiding principles is the establishment of a link between the health teams and the SUS users. The purpose of this research is to evaluate user access to the Family Health Unit (FHU) and the local problems faced. It is an exploratory, qualitative research, developed at the FHU Resistencia of Sao Pedro, located in the Greater Vitoria, Espirito Santo State, with data collected individually through a semi-structured survey. It was found that the main needs of the population are incorporated in the services provided by the FHU, and the users face many difficulties with access. The main criticism is related to access to the specialized services. The majority of the participants of the survey showed satisfaction with the access to the services, and were not intimidated to express the difficulties faced. The work developed by the Family Heath Strategy (FHS) at FHU Resistencia has been contributing to the improvement of the quality of the services offered by FHS to the users served, although many problems have been identified, which demonstrates the great challenge in redefining the assistance model, as proposed by this public policy.
C1 [Schwartz, Talita Dourado; Noia Maciel, Ethel Leonor; Duarte Lima, Rita de Cassia] Univ Fed Espirito Santo, Dept Enfermagem, Vitoria 29040090, ES, Spain.
RP Schwartz, TD (corresponding author), Univ Fed Espirito Santo, Dept Enfermagem, Av Marechal Campos 1-468, Vitoria 29040090, ES, Spain.
EM talitaschwartz@gmail.com
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR AGUIAR A. C. S., 2004, REV BRASILEIRA PROMO, V17, P163
   ANJOS LA, 1992, CAD SAUDE PUBLICA, V8, P50
   Araújo Maria Alix Leite, 2005, Cad. Saúde Pública, V21, P396, DOI 10.1590/S0102-311X2005000200006
   Bardin L., 1979, ANALISE CONTEUDO
   *BRAS SECR ESP POL, 2008, RETR DES GEN RAC
   Cecilio L. C. O., 2001, SENTIDOS INTEGRALIDA, P113
   Araujo MBD, 2007, CIENC SAUDE COLETIVA, V12, P455, DOI 10.1590/S1413-81232007000200022
   Franco TB, 2003, TRABALHO SAUDE OLHAN, P55
   *I BRAS GEOGR EST, 2005, PESQ NAC AM DOM AC
   Lima RCD, 2001, ENFERMEIRA PROTAGONI
   Magalhães Rosana, 2007, Ciênc. saúde coletiva, V12, P1415, DOI 10.1590/S1413-81232007000600002
   Marques GQ, 2007, REV LAT-AM ENFERM, V15, P13, DOI 10.1590/S0104-11692007000100003
   MINAYO M, 1994, PESQUISA SOCIAL TEOR
   Nascimento Maristella Santos, 2005, Ciênc. saúde coletiva, V10, P333, DOI 10.1590/S1413-81232005000200011
   Nogueira-Martins Maria Cezira Fantini, 2004, Saude soc., V13, P44, DOI 10.1590/S0104-12902004000300006
   Pasche D. F., 2008, SEM HUM SUS DEB VIT
   POBREZA FS, 2007, CIENC SAUDE COLETIVA, V12, P1422
   Queiroz Maria Veraci Oliveira, 2007, Texto contexto - enferm., V16, P479, DOI 10.1590/S0104-07072007000300014
   Ramos Donatela Dourado, 2003, Cad. Saúde Pública, V19, P27, DOI 10.1590/S0102-311X2003000100004
   SANTOS NR, 2006, SAUDE DEBATE, V30, P120
   Starfield B, 2002, ATENCAO PRIMARIA EQU
   TAVARES FL, 2003, SAUDE DEBATE, V27, P405
   Telles V. da Silva, 1994, ANOS 90 POLITICA SOC, P91
   Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190
   UNGLERT CVD, 1987, REV SAUDE PUBL, V21, P439
   *VIT SECR MUN SAUD, RED MUN SAUD
NR 26
TC 13
Z9 23
U1 0
U2 0
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD JUL
PY 2010
VL 15
IS 4
BP 2145
EP 2154
DI 10.1590/S1413-81232010000400028
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 662MP
UT WOS:000282811700028
PM 20694336
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Sales, CMM
   de Figueiredo, TAM
   Zandonade, E
   Maciel, ELN
AF Martins Sales, Carolina Maia
   Martins de Figueiredo, Tulio Alberto
   Zandonade, Eliana
   Noia Maciel, Ethel Leonor
TI Spatial analysis on childhood tuberculosis in the State of Espirito
   Santo, Brazil, 2000 to 2007
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Article
DE Childhood tuberculosis; Spatial analysis; Transmission
ID DIAGNOSIS; CRITERIA; HEALTH
AB Introduction: Childhood tuberculosis is responsible for 15% of case notifications. The focus of Tuberculosis Control National Program is on identifying tuberculosis in adults, while leaving children under 15 years of age on the margins of studies, diagnoses and treatment. Spatial analysis quantifies the exposition to the illness and displays the main causes relating to geographical space. The objective of this study was to analyze the spatial distribution of childhood tuberculosis in Espirito Santo, between 2000 and 2007, according to the municipality of notification. Methods: An ecological study was conducted on 515 cases of childhood tuberculosis that occurred between 2000 and 2007. The Local Empirical Bayesian Method was used to measure the risk. The Moran Local Index was calculated in order to evaluate autocorrelations between threshold districts. Results: High incidence rates were found in the Metropolitan Region of Vitoria and the northeastern region, and lower rates were found in the southeastern region. Similar data were observed in a study on endemic tuberculosis among adults in Espirito Santo. This is possibly related to contacts within the home. Conclusions: This study identified possible areas of recent transmission of the disease. It is important to emphasize that knowledge of the high priority areas for tuberculosis control may help public administrators to diminish healthcare iniquities and enable improvement of resources and teams for controlling childhood tuberculosis.
C1 [Martins Sales, Carolina Maia; Martins de Figueiredo, Tulio Alberto; Zandonade, Eliana; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Programa Posgrad Saude Coletiva, Vitoria, ES, Brazil.
   [Martins Sales, Carolina Maia; Martins de Figueiredo, Tulio Alberto; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Dept Enfermagem, Vitoria, ES, Brazil.
   [Zandonade, Eliana] Univ Fed Espirito Santo, Dept Estatist, Vitoria, ES, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, NDI, Marechal Campos 1468, BR-29040090 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883] Funding
   Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [5 U2R TW006883-02] Funding Source: Medline
CR ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Bailey T., 1995, INTERACTIVE SPATIAL
   COSTA MCN, 1999, CAD SAUDE PUBLICA, V5, P271
   Fourie PB, 1998, INT J TUBERC LUNG D, V2, P116
   Houwert KAF, 1998, EUR RESPIR J, V11, P1116, DOI 10.1183/09031936.98.11051116
   MACIEL ELN, 2006, CAD SAUDE COLET, V14, P81
   MIGLIORI GB, 1992, TUBERCLE LUNG DIS, V73, P145, DOI 10.1016/0962-8479(92)90148-D
   *MIN SAUD, 2002, CONTR TUB PROP INT E
   *MIN SAUD, 2005, SIST NAC VIG SAUD RE
   Mota Fábio Frias, 2003, Cad. Saúde Pública, V19, P915, DOI 10.1590/S0102-311X2003000400014
   Nair P H, 1981, Indian Pediatr, V18, P299
   Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P402, DOI 10.1590/S0102-311X2008000200019
   PINEDA NI, 2004, J BRAS PNEUMOL, V30, P485
   SANTANNA CC, 2002, J PEDIAT RIO J, V78, P205, DOI DOI 10.1590/S0021-75572002000800011
   STARKE JR, 1992, J PEDIATR-US, V120, P839, DOI 10.1016/S0022-3476(05)81949-3
   VIEIRA RC, 2006, THESIS U FEDERAL ESP
   *WHO, 2008, WHO REP 208 GLOB TUB
   GEOBASES ESPIRITO SA
NR 19
TC 11
Z9 14
U1 0
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2010
VL 43
IS 4
BP 435
EP 439
DI 10.1590/S0037-86822010000400020
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 645BO
UT WOS:000281426100020
PM 20802946
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Toledo, LDG
   Maciel, ELN
   Rodrigues, LCDM
   Tristao-Sa, R
   Fregona, G
AF Gouvea Toledo, Lidiane da Silveira
   Noia Maciel, Ethel Leonor
   de Melo Rodrigues, Livia Carla
   Tristao-Sa, Ricardo
   Fregona, Geisa
TI Features and trend of AIDS, among the elderly in the State of Espirito
   Santo
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Article
DE Public health; Epidemiology; Aging; AIDS
ID OLDER-ADULTS; MORTALITY
AB Introduction: AIDS among older adults is a public health problem emerging. This study compared the demographic and epidemiological profile and the evolution and trend of the epidemic among men and women aged 50 years and older and 20 to 39 years affected by AIDS in the State of Espirito Santo, Brazil. Methods: We conducted a time serie study with secondary data from SINAN/AIDS for the period January 1991 to December 2006. Results: In this period were 3,382 reported cases of AIDS in individuals aged 20 to 39 years and 551 cases among individuals with 50 years or older. In both age groups most affected are men. There are differences related to race or color, where the majority of the older is white (45.3% - p-value = 0.044) and the young brown (44.7%, p = 0.003). Illiteracy prevails among the older (17.7% - p-value = 0.001). More than half (80%) of the notifications occurred in cities of medium to large. The main risk factor was heterosexual in both the age groups more frequently to the group of 50 or more (77.3% - p = 0.0001). The cumulative incidence is higher for the age group 20 to 39 years (R-2 = 0.68), but is increasing proportionally between the two bands over the years, with a significant upward trend for both (p<0.01). Conclusions: The AIDS epidemic among the elderly can be seen growing among older on the Espirito Santo State.
C1 [Noia Maciel, Ethel Leonor] UFES, NDI, Programa Posgrad Saude Coletiva, Vitoria 29040091, Spain.
   [Gouvea Toledo, Lidiane da Silveira; de Melo Rodrigues, Livia Carla; Fregona, Geisa] Fac Novo Milenio, Vila Velha, Spain.
   [Noia Maciel, Ethel Leonor; Fregona, Geisa] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, Spain.
   [Tristao-Sa, Ricardo] Escola Med Santa Casa Misericordia, Rio De Janeiro, Brazil.
RP Maciel, ELN (corresponding author), UFES, NDI, Programa Posgrad Saude Coletiva, Av Marechal Campos 1468, Vitoria 29040091, Spain.
EM emaciel@ndi.ufes.br
RI Toledo, Lidiane/AAT-5838-2020; Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR ADLER WH, 1994, DRUG AGING, V4, P410, DOI 10.2165/00002512-199404050-00006
   [Anonymous], 2004, ATL DES HUM BRAS
   ARAUJO VLB, 2007, BRASIL REV BRAS EPID, V10, P544
   BOUDES P, 1991, Comprehensive Therapy, V17, P39
   Brito A M, 2001, Rev Soc Bras Med Trop, V34, P207, DOI 10.1590/S0037-86822001000200010
   Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866
   ELSADR W, 1995, ARCH INTERN MED, V155, P184, DOI 10.1001/archinte.155.2.184
   *ESP SANT SECR EST, 2007, B EP
   Ferreira RCSL, 2008, ARQ CATARINENSES MED, V37, P19
   Fonseca MGP, 2002, REV SAUDE PUBL, V36, P678, DOI 10.1590/S0034-89102002000700004
   Fry PH, 2007, CAD SAUDE PUBLICA, V23, P497, DOI 10.1590/S0102-311X2007000300002
   Gordis L, 2004, EPIDEMIOLOGY, P48
   Inelmen EM, 2005, GERIATRICS-US, V60, P26
   KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P932, DOI 10.2105/AJPH.84.6.932
   Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423
   LINLEY L, 2007, NAT HIV PREV C ATL D
   Linsk N L, 2000, AIDS Read, V10, P430
   Mack KA, 2003, JAIDS-J ACQ IMM DEF, V33, pS68, DOI 10.1097/00126334-200306012-00003
   Mack KA, 1999, GERONTOLOGIST, V39, P687, DOI 10.1093/geront/39.6.687
   *MIN SAUD SECR VIG, 2008, PROGR NAC DST AIDS B
   Nguyen N, 2008, CLIN INTERV AGING, V3, P453
   POTTES FA, 1990, REV BRAS EPIDEMIOL, V338, P2000
   Siegel K, 1999, RES AGING, V21, P595, DOI 10.1177/0164027599214004
   SORLIE PD, 1995, AM J PUBLIC HEALTH, V85, P949, DOI 10.2105/AJPH.85.7.949
   SOUSA JL, 1990, REV BRAS GERIATRIA G, V203, P2003
   VENTURA AAC, 2007, FAC MED U FED PERNAM, V2, P122
   WALLACE JI, 1993, GERIATRICS, V48, P61
   *WHO, 2008, JOINT UN PROGR HIV A
NR 28
TC 7
Z9 10
U1 0
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2010
VL 43
IS 3
BP 264
EP 267
DI 10.1590/S0037-86822010000300010
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 613VR
UT WOS:000279011700010
PM 20563493
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Moreira, TR
   Zandonade, E
   Maciel, ELN
AF Moreira, Tiago Ricardo
   Zandonade, Eliana
   Noia Maciel, Ethel Leonor
TI Risk of tuberculosis infection among community health agents
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Tuberculosis, nursing; Caregivers; Exposure to Biological Agents;
   Occupational Exposure; Occupational Risks; Community Health Centers
ID STUDENTS; TRANSMISSION; WORKERS; VITORIA
AB OBJECTIVE: To estimate the risk of tuberculosis infection among community health agents involved in disease control.
   METHODS: A prospective cohort was followed up from April 2007 to May 2008 in the municipality of Cachoeiro de Itapemirim, Southeastern Brazil. The cohort was composed of 61 community agents, divided between unexposed individuals (n = 37) and exposed individuals (who were following up tuberculosis patients; n = 24). Over the 12-month follow-up, the tuberculin test was performed, using the tuberculin PPD RT23. The relative risk and 95% confidence interval were calculated, and the correlation between tuberculin response and the agents' occupational history was evaluated by means of Pearson's correlation.
   RESULTS: The incidence of the response was 41.7% in the exposed group and 13.5% in the unexposed group. The annual risk of infection was 52.8% in the exposed group and 14.4% in the unexposed group (p = 0.013). An association between tuberculin response and exposure to patients with tuberculosis was observed (RR = 3.08; 95% CI: 1.201; 7.914).
   CONCLUSIONS: The agents who followed up tuberculosis patients during their routine work presented a greater risk of infection than did those who were not following up such patients. Implementation of routine administrative biosafety measures, among which the tuberculin test, should be prioritized, given the high risk of acquiring tuberculous infection among community health agents.
C1 [Zandonade, Eliana; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
   [Moreira, Tiago Ricardo] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Moreira, Tiago/AAJ-6236-2020; Maciel, Ethel Leonor LN/G-1027-2012
OI Moreira, Tiago/0000-0002-6606-4942; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355
CR Centers for Disease Control and Prevention, 1994, MMWR-MORBID MORTAL W, V43, P1
   de Oliveira SMDL, 2007, REV LAT-AM ENFERM, V15, P1120, DOI 10.1590/S0104-11692007000600010
   Fox W, 1999, INT J TUBERC LUNG D, V3, pS231
   FRANCO C, 2004, ARQ CI SAUDE, V11, P244
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494
   Kusano Maria do Socorro Evangelista, 2005, Rev. bras. epidemiol., V8, P262, DOI 10.1590/S1415-790X2005000300008
   Maciel ELN, 2005, REV SOC BRAS MED TRO, V38, P469, DOI 10.1590/S0037-86822005000600004
   MINAYO MCS, 1990, PROGRAMA AGENTES SAU
   Muniz Jordana Nogueira, 2005, Ciênc. saúde coletiva, V10, P315, DOI 10.1590/S1413-81232005000200009
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P1377, DOI 10.1590/S0102-311X2008000600018
   Maciel EL, 2007, REV SOC BRAS MED TRO, V40, P397, DOI 10.1590/S0037-86822007000400004
   Maciel ELN, 2009, J BRAS PNEUMOL, V35, P83, DOI 10.1590/S1806-37132009000100012
   Nunes Mônica de Oliveira, 2002, Cad. Saúde Pública, V18, P1639, DOI 10.1590/S0102-311X2002000600018
   Rodrigues PM, 2009, J BRAS PNEUMOL, V35, P351, DOI 10.1590/S1806-37132009000400009
   Ruffino-Netto A, 1977, Rev Saude Publica, V11, P188, DOI 10.1590/S0034-89101977000200004
   SEPKOWITZ KA, 1996, TUBERCULOSIS, P935
   Silva Vania Maria Carneiro da, 2004, J. bras. pneumol., V30, P459, DOI 10.1590/S1806-37132004000500010
   Silva VMC, 2000, INT J TUBERC LUNG D, V4, P420
   *SOC BRAS PNEUM TI, 2004, J BRAS PNEUMOL, V30, P86
   WHO, 2007, WHOHTMTB2007376
NR 20
TC 15
Z9 18
U1 0
U2 3
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD APR
PY 2010
VL 44
IS 2
BP 332
EP 338
DI 10.1590/S0034-89102010000200014
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 575SW
UT WOS:000276089500014
PM 20339633
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Guidoni, LM
   Brioshi, AP
   do Prado, TN
   Fregona, G
   Hadad, DJ
   Molino, LP
   Palaci, M
   Johnson, JL
   Dietze, R
AF Noia Maciel, Ethel Leonor
   Guidoni, Leticia Molino
   Brioshi, Ana Paula
   do Prado, Thiago Nascimento
   Fregona, Geisa
   Hadad, David Jamil
   Molino, Lucilia Pereira
   Palaci, Moises
   Johnson, John L.
   Dietze, Reynaldo
TI Household members and health care workers as supervisors of tuberculosis
   treatment
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Tuberculosis, nursing; Homebound Persons; Family Nursing; Caregivers;
   Home Nursing; Medication Therapy Management; Treatment Outcome; Cohort
   Studies
ID RANDOMIZED CONTROLLED-TRIAL; ADHERENCE; THAILAND; DOTS
AB OBJECTIVE: To compare tuberculosis cure rates among patients supervised by household members or health care workers.
   METHODS: Prospective cohort study of 171 patients treated by the program in Vitoria, Southeastern Brazil, from 2004 to 2007. Each patient was followed-up for six months until the end of the treatment. Of the patients studied, a household member supervised 59 patients and healthcare workers supervised 112 patients. Patients' sociodemographic and clinic data were analyzed. Differences between groups were assessed using chi-square test or Student's t-test. Significance level was set at 5%.
   RESULTS: Most patients had smear positive, culture confirmed pulmonary tuberculosis. Two patients were HIV-positive. There were more illiterate patients in the healthcare-supervised group, in comparison to those supervised by their families (p = 0.01). All patients supervised by a household member were cured compared to 90% of the patients supervised by health care workers (p = 0.024).
   CONCLUSIONS: Successful tuberculosis treatment was more frequent when supervised by household members.
C1 [Noia Maciel, Ethel Leonor; Fregona, Geisa; Hadad, David Jamil; Molino, Lucilia Pereira; Palaci, Moises; Dietze, Reynaldo] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
   [Guidoni, Leticia Molino; Brioshi, Ana Paula; Johnson, John L.] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
   [Noia Maciel, Ethel Leonor; do Prado, Thiago Nascimento] Univ Fed Espirito Santo, Programa Posgrad Doencas Infecciosas, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
   Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
OI Fregona, Geisa/0000-0001-5835-8222
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [N01-AI95383, N01-AI-70022] Funding Source:
   Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [N01AI095383, N01AI095383, N01AI095383, N01AI095383,
   N01AI095383, N01AI095383] Funding Source: NIH RePORTER
CR Akkslip S, 1999, INT J TUBERC LUNG D, V3, P1061
   Gonzales RIC, 2008, REV LAT-AM ENFERM, V16, P95, DOI 10.1590/S0104-11692008000100015
   HIJJAR MA, 2001, B PNEUMOLOGIA SANITA, V9, P9
   Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4
   Kent P T, 1985, PUBLIC HLTH MYCOBACT
   Lima M. B. de, 2001, Cadernos de Saude Publica, V17, P877, DOI 10.1590/S0102-311X2001000400021
   Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8
   Maciel Ethel Leonor Noia, 2008, J Bras Pneumol, V34, P506, DOI 10.1590/S1806-37132008000700011
   Manders AJE, 2001, INT J TUBERC LUNG D, V5, P838
   Muniz JN, 2002, B PNEUMOL SANITARIA, V10, P49
   Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238
   Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3
   Okanurak K, 2007, INT J TUBERC LUNG D, V11, P762
   Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07
   Radilla-Chavez P, 2007, INT J TUBERC LUNG D, V11, P289
   RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220
   SILVA JB, 2004, J BRAS PNEUMOL S1, V30, pS57, DOI DOI 10.1590/S1806-37132004000700003
   Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380
NR 18
TC 5
Z9 6
U1 0
U2 4
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD APR
PY 2010
VL 44
IS 2
BP 339
EP 343
DI 10.1590/S0034-89102010000200015
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 575SW
UT WOS:000276089500015
PM 20339634
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Oliveira, CB
   Frechiani, JM
   Sales, CMM
   Brotto, LDD
   Araujo, MD
AF Noia Maciel, Ethel Leonor
   Oliveira, Carla Braga
   Frechiani, Janaina Menezes
   Martins Sales, Carolina Maia
   de Aguiar Brotto, Leia Damasceno
   Araujo, Maristela Dalbello
TI Project Learning Health in School: the experience of positive impact on
   the quality of life and health determinants of members of a community
   school in Vitoria, Espirito Santo State
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Health promotion; School health; Children's health
AB A descriptive study, using a quantitative approach to evaluate the strategies carried through by nurses in a school environment of a Municipal Center of Children Education, through the Project of Extension Learning Health in the School, and still to analyze the profile of the children attended. The research was carried through with a sample of 350 nursing attendances. We verify that in 10 pupils had been found suggestive corporal lesions of family violence/negligence. They were registered educative activities, involving the following subjects: dengue, personal hygiene, parasitosis and the destination of the solid residues. We evidence that 4.6% of the children attended were unfed, and that 6.4% were in nutritional risk, and that 80% of children did not presented an adequate oral hygiene, demonstrated through the presence of caries. In the evaluation of the professors about the performance of the project it was possible to identify stories on the reduction of the episodes of domestic violence against the child. The Project has provided to the action of the Interdisciplinary work favoring the health promotion activities having the school as a space of the Basic Attention, and need to be understood as a motivator nucleus of the participatory performance of the health professionals in the pertaining to school community.
C1 [Noia Maciel, Ethel Leonor; Oliveira, Carla Braga; Frechiani, Janaina Menezes] Univ Fed Espirito Santo, Dept Enfermagem, Programa Iniciacao Docencia, BR-29040090 Vitoria, ES, Brazil.
   [Noia Maciel, Ethel Leonor; Martins Sales, Carolina Maia] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, BR-29040090 Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Dept Enfermagem, Programa Iniciacao Docencia, Av Marechal Campos 1468, BR-29040090 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
OI Maciel, Ethel Leonor/0000-0003-4826-3355
CR BASTOS JRM, 1996, REV PAUL ODONTOL, V18, P38
   *BRAS MIN SAUD, 2002, CART PROM SAUD
   *BRAS MIN SAUD, 2004, INV SAUD BUC PASS 84
   CAUAS RC, 2006, REV BRAS SAUDE MAT I, V6, P1
   FEITOSA LMR, 2006, REV BRAS SAUDE MAT I, V6, P1
   GONCALVES HS, 2002, CAD SAUDE PUBLICA, V18, P1
   HARADA J, 2003, ESCOLA PROMOTORA SAU
   *HUCAM, 2000, DIAGN SIT BAIRR BONF
   IPOLLITOSHEPERD J, 2003, ESCOLA PROMOTORA SAU
   Moura João Batista Vianey Silveira, 2007, Hist. cienc. saude-Manguinhos, V14, P489, DOI 10.1590/S0104-59702007000200006
   NASCIMENTO CCC, 2006, REV BRAS SAUDE MAT I, V6, P8
   *PREF MUN VIT SECR, 2003, PROT SAUD CRIANC
   Queiroz MV, 2006, INTERFACE-BOTUCATU, V10, P117, DOI 10.1590/S1414-32832006000100009
   REICHENHEIM ME, 1999, CIEN SAUDE COLET, V4, P1
NR 14
TC 8
Z9 12
U1 0
U2 8
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD MAR
PY 2010
VL 15
IS 2
BP 389
EP 396
DI 10.1590/S1413-81232010000200014
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 594XJ
UT WOS:000277574100014
PM 20414605
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Guidoni, LM
   Favero, JL
   Hadad, DJ
   Molino, LP
   Jonhson, JL
   Dietze, R
AF Noia Maciel, Ethel Leonor
   Guidoni, Leticia Molino
   Favero, Juliana Lopes
   Hadad, David Jamil
   Molino, Lucilia Pereira
   Jonhson, John L.
   Dietze, Reynaldo
TI Adverse effects of the new tuberculosis treatment regimen recommended by
   the Brazilian Ministry of Health
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA Portuguese
DT Article
DE Treatment outcome, Tuberculosis; Antitubercular agents, Adverse drug
   reaction reporting systems
ID ANTITUBERCULOSIS DRUGS; RISK-FACTORS; RIFAMPIN; PYRAZINAMIDE; HEPATITIS;
   HEPATOTOXICITY
AB Objective: To determine the principal adverse effects of the tuberculosis treatment regimen recommended by the Brazilian Ministry of Health. Methods: A prospective descriptive study involving 79 tuberculosis patients treated at the Clinical Research Center of the Cassiano Antonio Moraes University Hospital, in the city of Vitoria, Brazil, between 2003 and 2006 The treatment regimen consisted of isoniazid, rifampicin, pyrazinamide and ethambutol for four months, followed by rifampicin and isoniazid for two months. During the treatment period, the patients were clinically evaluated every week and had a monthly medical visit. Results: The overall incidence of adverse effects was 83.54%. Articular/bone/muscle involvement was the most common, followed by skin involvement (24.94% and 22.09%, respectively). Adverse effects were more common in the second month of treatment (41.59%). Modification of the treatment regimen was unnecessary One patient required concomitant medication to counter the adverse effects. The cure rate was 100%. Conclusions: The overall incidence of adverse effects related to the new treatment regimen recommended by the Brazilian Ministry of Health was high However, none of those effects demanded a change in the regimen, which was effective in the patients evaluated.
C1 [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, BR-29040091 Vitoria, ES, Brazil.
   [Molino, Lucilia Pereira] Hosp Univ Cassiano Antonio Moraes, Pesquisa Clin, Med Ctr, Vitoria, ES, Brazil.
   [Jonhson, John L.] Case Western Reserve Univ, Sch Med, Dept Med, TB Res Unit, Cleveland, OH 44106 USA.
   [Jonhson, John L.] Univ Hosp Case Med Ctr, Cleveland, OH USA.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Ave Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
OI Maciel, Ethel Leonor/0000-0003-4826-3355
CR Bartacek A, 2009, INT J TUBERC LUNG D, V13, P760
   Bisaglia J. B., 2003, B PNEUMOLOGIA SANITA, V11, P53
   *BRAS MIN SAUD SEC, 2002, 6 BRAS MIN SAUD DEP
   Breen RAM, 2006, THORAX, V61, P791, DOI 10.1136/thx.2006.058867
   DURAND F, 1995, HEPATOLOGY, V21, P929, DOI 10.1016/0270-9139(95)90236-8
   FRANKS AL, 1989, PUBLIC HEALTH REP, V104, P151
   Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC
   KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991
   Lee AM, 2002, INT J TUBERC LUNG D, V6, P995
   LEIBOLD JE, 1966, ANN NY ACAD SCI, V135, P904, DOI 10.1111/j.1749-6632.1966.tb45532.x
   Marra F, 2007, INT J TUBERC LUNG D, V11, P868
   Ministerio da Saude, 2009, PORT SAUD
   MONTANER LJG, 1982, TUBERCLE, V63, P291, DOI 10.1016/S0041-3879(82)80018-4
   Oliveira H B, 2000, Rev Saude Publica, V34, P437
   PATEL AM, 1995, DRUG SAFETY, V12, P1, DOI 10.2165/00002018-199512010-00001
   Salles CLG, 2004, INT J TUBERC LUNG D, V8, P318
   Schaberg T, 1996, EUR RESPIR J, V9, P2026, DOI 10.1183/09031936.96.09102026
   *SOC BRAS PNEUM TI, 2004, J BRAS PNEUMOL S1, V30, pS5
   *SOC BRAS PNEUM TI, 1997, J PNEUMOL, V23, P281
   STEELE MA, 1991, CHEST, V99, P465, DOI 10.1378/chest.99.2.465
   VANDENBRANDE P, 1995, AM J RESP CRIT CARE, V152, P1705, DOI 10.1164/ajrccm.152.5.7582317
   Vieira Denise Eri Onodera, 2008, J Bras Pneumol, V34, P1049
   Williams GM, 2002, TOXICOL PATHOL, V30, P41, DOI 10.1080/01926230252824699
   Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC
NR 24
TC 20
Z9 23
U1 0
U2 2
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD MAR-APR
PY 2010
VL 36
IS 2
BP 232
EP 238
DI 10.1590/S1806-37132010000200012
PG 7
WC Respiratory System
SC Respiratory System
GA 588JU
UT WOS:000277066700012
PM 20485945
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Peres, RL
   Maciel, EL
   Morais, CG
   Ribeiro, FCK
   Vinhas, SA
   Pinheiro, C
   Dietze, R
   Johnson, JL
   Eisenach, K
   Palaci, M
AF Peres, R. L.
   Maciel, E. L.
   Morais, C. G.
   Ribeiro, F. C. K.
   Vinhas, S. A.
   Pinheiro, C.
   Dietze, R.
   Johnson, J. L.
   Eisenach, K.
   Palaci, M.
TI Comparison of two concentrations of NALC-NaOH for decontamination of
   sputum for mycobacterial culture
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE tuberculosis; diagnosis; decontamination methods; NaOH-N-acetyl cysteine
ID CLINICAL SPECIMENS; SODIUM HYDROXIDE; RECOVERY; MULTICENTER; CYSTEINE;
   SYSTEM
AB This study compared the effect of using two different concentrations of sodium hydroxide (NaOH) in the N-acetyl-L-cysteine-sodium hydroxide (NA-LC-NaOH) method for sputum decontamination on smear and culture positivity and the proportion of contaminated cultures: 14% of cultures were contaminated using the standard final 1% NaOH concentration during processing compared to 11% contaminated cultures using a final 1.25% NaOH concentration (P < 0.008). The proportion of cultures positive for mycobacteria decreased from 21 % to 11 % for sputum processed with 1 % and 1.25% final NaOH concentrations, respectively (P < 0.001). Our findings suggest that a small reduction in culture contamination did not justify the considerable loss of positive cultures.
C1 [Maciel, E. L.] Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, BR-29040091 Vitoria, ES, Brazil.
   [Johnson, J. L.] Case Western Reserve Univ, Sch Med, Case Med Ctr, Cleveland, OH USA.
   [Johnson, J. L.] Univ Hosp Cleveland, Cleveland, OH 44106 USA.
   [Eisenach, K.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA.
   [Eisenach, K.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.
RP Maciel, EL (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Av Marechal Campos,1468 Maruipe Vitoria, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU United States National Institutes of Allergy and Infectious Diseases,
   National Institutes of Health and Human ServicesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)NIH National
   Human Genome Research Institute (NHGRI) [NO1-AI95383,
   HHSN266200700022CNO1-AI-70022]; Edital MCT/CNPq/MS-DAB/SAS
   ndegrees49/2005National Council for Scientific and Technological
   Development (CNPq); CNPqNational Council for Scientific and
   Technological Development (CNPq); Rede Brasileira de Pesquisa em
   Tuberculose (REDE-TB); NIH ICHORTA [5 U2R TWO06L883-02]; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [N01AI095383, N01AI095383, N01AI095383, N01AI095383, N01AI095383,
   N01AI095383] Funding Source: NIH RePORTER
FX The laboratory work for this study was funded in part by the United
   States National Institutes of Allergy and Infectious Diseases, National
   Institutes of Health and Human Services, under Contract No. NO1-AI95383
   and HHSN266200700022CNO1-AI-70022 and by funding from Edital
   MCT/CNPq/MS-DAB/SAS n degrees 49/2005, Pesquisas Avaliativas em Atencao
   Basica a Saude from CNPq and Rede Brasileira de Pesquisa em Tuberculose
   (REDE-TB). ELM was Supported by NIH ICHORTA grant # 5 U2R TWO06L883-02.
CR Buijtels PCA, 2005, J MICROBIOL METH, V62, P83, DOI 10.1016/j.mimet.2005.01.010
   CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204
   Ganoza CA, 2008, J MED MICROBIOL, V57, P1094, DOI 10.1099/jmm.0.2008/001339-0
   Grandjean L, 2008, J CLIN MICROBIOL, V46, P2339, DOI 10.1128/JCM.02476-07
   Hanna BA, 1999, J CLIN MICROBIOL, V37, P748, DOI 10.1128/JCM.37.3.748-752.1999
   Kent P T, 1985, PUBLIC HLTH MYCOBACT
   Kubica G.P., 1963, AM REV RESPIR DIS, V89, P284
   MARTIN ME, 1968, APPL MICROBIOL, V16, P506, DOI 10.1128/AEM.16.3.506-508.1968
   Piersimoni C, 2001, J CLIN MICROBIOL, V39, P651, DOI 10.1128/JCM.39.2.651-657.2001
   RATNAM S, 1987, J CLIN MICROBIOL, V25, P1428, DOI 10.1128/JCM.25.8.1428-1432.1987
   RINALDI JN, 2008, TROP DOCT, V38, P97
   YAJKO DM, 1993, J CLIN MICROBIOL, V31, P302, DOI 10.1128/JCM.31.2.302-306.1993
NR 12
TC 33
Z9 33
U1 0
U2 2
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD DEC
PY 2009
VL 13
IS 12
BP 1572
EP 1575
PG 4
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 532DY
UT WOS:000272726800024
PM 19919781
DA 2020-12-15
ER

PT J
AU Macedo, CR
   Frauches, DD
   Macedo, LR
   Moreira-Silva, SF
   Nader, PRD
   Lima, APNB
   Maciel, ELN
AF Macedo, Cristina Ribeiro
   Frauches, Diana de Oliveira
   Macedo, Laylla Ribeiro
   Moreira-Silva, Sandra Fagundes
   de Araujo Nader, Priscila Rocha
   Neves Burian Lima, Ana Paula
   Noia Maciel, Ethel Leonor
TI Predictors of changes in drug regimens for treating AIDS in children
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Article
DE Aids; Children; Treatment; Failure; Adherence
ID ANTIRETROVIRAL THERAPY; DISCONTINUATION; ADHERENCE; HAART
AB To identify the causes of changes in therapeutic regimens for treating AIDS in children infected through vertical transmission. This was a case-control study in which the control group consisted of 49 children who had not had any changes to their antiretroviral regimen and the case group consisted of 62 children who had had changes between January 2000 and December 2005. Data from the patients' medical files and a semistructured interview were used. The data analysis was carried out using the SPSS software, and the chi-square test and logistic regression were applied. The main causes of changes in treatment were: increased viral load (48.4%), poor immunological response (46.6%) and clinical worsening (35.5%) of the patients. The adjustment of the data through logistic regression analysis showed that drug intolerance was the variable that contributed most to the change in medication ((adjusted) OR: 79.94; 95% CI: 6.28-1034.55). Adherence was not shown to be responsible for changes in the anti-retroviral therapy, and this was attributable to the organization of the service and actions of the interdisciplinary team.
C1 [Macedo, Cristina Ribeiro; Frauches, Diana de Oliveira; Moreira-Silva, Sandra Fagundes; Neves Burian Lima, Ana Paula] Hosp Infantil Nossa Senhora Gloria, Serv Infectol, BR-29056030 Vitoria, ES, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
   [Macedo, Cristina Ribeiro; Frauches, Diana de Oliveira; Moreira-Silva, Sandra Fagundes; de Araujo Nader, Priscila Rocha] Escola Super Ciencias Santa Casa Misericordia Vit, Vitoria, ES, Brazil.
RP Macedo, CR (corresponding author), Hosp Infantil Nossa Senhora Gloria, Serv Infectol, Alameda Mary Ubirajara 205, BR-29056030 Vitoria, ES, Brazil.
EM cristinarmacedo@gmail.com
RI Macedo, Laylla Ribeiro/AAV-5154-2020; Maciel, Ethel Leonor
   LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Ribeiro Macedo,
   Laylla/0000-0002-6246-3559
CR Brasil Ministerio da Saude, 2003, REC TER ANT AD AD IN
   Brogly S, 2005, JAMA-J AM MED ASSOC, V293, P2213, DOI 10.1001/jama.293.18.2213
   DARMINIO MA, 2005, J ACQ IMMUN DEF SYND, V38, P407
   DELLANEGRA M, 1997, MANEJO CLIN AIDS PED
   Garcia Rosa, 2005, Braz J Infect Dis, V9, P494, DOI 10.1590/S1413-86702005000600007
   Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2
   HADDAD M, 2000, COCHRANE DB SYST REV, V3
   LAMBERT JS, 2001, MANUAL ACOMPANHAMENT
   Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320
   Lignani L, 2001, REV SAUDE PUBL, V35, P495, DOI 10.1590/S0034-89102001000600001
   Marhefka SL, 2008, AIDS PATIENT CARE ST, V22, P637, DOI 10.1089/apc.2007.0110
   Medronho RA, 2004, EPIDEMIOLOGIA
   *MIN SAUD, 2004, GUIA TRAT CLIN INF P
   Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007
   Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005
   O'Brien ME, 2003, JAIDS-J ACQ IMM DEF, V34, P407, DOI 10.1097/00126334-200312010-00008
   Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100
   Wachholz NIR, 2007, CAD SAUDE PUBLICA, V23, pS424, DOI 10.1590/S0102-311X2007001500010
   Riddler SA, 2007, ANTIVIR THER, V12, P531
   Selinger-Leneman H, 2008, JAIDS-J ACQ IMM DEF, V47, P206, DOI 10.1097/QAI.0b013e31815aca91
   Shibuyama S, 2006, CURR PHARM DESIGN, V12, P1075, DOI 10.2174/138161206776055796
   Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232
   Van Dyke RB, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e61
   van Roon EN, 1999, J ACQ IMMUN DEF SYND, V20, P290, DOI 10.1097/00042560-199903010-00012
   Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325
NR 25
TC 2
Z9 3
U1 0
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2009
VL 42
IS 6
BP 666
EP 671
DI 10.1590/S0037-86822009000600011
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 544HO
UT WOS:000273645500011
PM 20209352
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Johnson, JL
   Hadad, DJ
   Dietze, R
   Maciel, ELN
   Sewali, B
   Gitta, P
   Okwera, A
   Mugerwa, RD
   Alcaneses, MR
   Quelapio, MI
   Tupasi, TE
   Horter, L
   Debanne, SM
   Eisenach, KD
   Boom, WH
AF Johnson, John L.
   Hadad, David Jamil
   Dietze, Reynaldo
   Noia Maciel, Ethel Leonor
   Sewali, Barrett
   Gitta, Phineas
   Okwera, Alphonse
   Mugerwa, Roy D.
   Alcaneses, Mary Rose
   Quelapio, Maria Imelda
   Tupasi, Thelma E.
   Horter, Libby
   Debanne, Sara M.
   Eisenach, Kathleen D.
   Boom, W. Henry
TI Shortening Treatment in Adults with Noncavitary Tuberculosis and 2-Month
   Culture Conversion
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Article
DE tuberculosis; antitubercular agents; isoniazid; rifampin
ID NEGATIVE PULMONARY TUBERCULOSIS; SHORT-COURSE CHEMOTHERAPY;
   MYCOBACTERIUM-TUBERCULOSIS; IN-VITRO; REGIMENS; 4-MONTH; RELAPSE;
   BACILLI; 3-MONTH; DISEASE
AB Rationale Cavitary disease and delayed culture conversion have been associated with relapse. Combining patient characteristics and measures of bacteriologic response might allow treatment shortening with current drugs in some patients.
   Objectives: To assess whether treatment could be shortened from 6 to 4 months in patients with noncavitary tuberculosis whose sputum cultures converted to negative after 2 months.
   Methods: This study was a randomized, open-label equivalence trial. HIV-uninfected adults with noncavitary tuberculosis were treated daily with isoniazid, rifampin, pyrazinamide, and ethambutol for 2 months, followed by 2 months of isoniazid and rifampin. After 4 months, patients with drug-susceptible TB whose sputum cultures on solid media were negative after 8 weeks of treatment were randomly assigned to continue treatment for 2 more months or to stop treatment. Patients were followed for relapse for 30 months after beginning treatment.
   Measurements and Main Results: Enrollment was stopped by the safety monitoring committee after 394 patients were enrolled due to apparent increased risk for relapse in the 4-month arm. A total of 370 patients were eligible for per protocol analysis. Thirteen patients in the 4-month arm relapsed, compared with three subjects in the 6-month arm (7.0 vs. 1.6%; risk difference, 0.054; 95% confidence interval with Hauck-Anderson correction, 0.01-0.10).
   Conclusion: Shortening treatment from 6 to 4 months in adults with noncavitary disease and culture conversion after 2 months using current drugs resulted in a greater relapse rate. The combination of noncavitary disease and 2-month culture conversion was insufficient to identify patients with decreased risk for relapse.
C1 [Johnson, John L.] Univ Hosp Case Med Ctr, Div Infect Dis, Cleveland, OH 44106 USA.
   [Johnson, John L.; Horter, Libby; Boom, W. Henry] Case Western Reserve Univ, Sch Med, Dept Med, TB Res Unit, Cleveland, OH 44106 USA.
   [Hadad, David Jamil; Dietze, Reynaldo; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Vitoria, Brazil.
   [Sewali, Barrett; Gitta, Phineas; Okwera, Alphonse; Mugerwa, Roy D.] Makerere Univ, Coll Hlth Sci, Mulago Hosp, Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda.
   [Okwera, Alphonse] Ugandan Natl TB & Leprosy Programme, Kampala, Uganda.
   [Alcaneses, Mary Rose; Quelapio, Maria Imelda; Tupasi, Thelma E.] Trop Dis Fdn, Makati, Philippines.
   [Debanne, Sara M.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.
   [Eisenach, Kathleen D.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA.
RP Johnson, JL (corresponding author), Univ Hosp Case Med Ctr, Div Infect Dis, Room 406 Foley Bldg,Mailstop Foley 5083,11100 Euc, Cleveland, OH 44106 USA.
EM jlj@case.edu
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Dietze,
   Reynaldo/0000-0002-6995-8001; MUGERWA, MICHEAL/0000-0001-8591-7544
FU Tuberculosis Research Unit at Case Western Reserve University; United
   States National Institutes of Allergy and Infectious DiseasesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID); National Institutes of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)
   [NO1-AI95383, HHSN266200700022C/NO1-AI-70022]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [N01AI095383,
   N01AI095383, N01AI095383, N01AI095383, N01AI095383, N01AI095383] Funding
   Source: NIH RePORTER
FX Supported by the Tuberculosis Research Unit at Case Western Reserve
   University, established with funds from the United States National
   Institutes of Allergy and Infectious Diseases, National Institutes of
   Health and Human Services, under Contract No. NO1-AI95383 and
   HHSN266200700022C/NO1-AI-70022.
CR Andreu J, 2004, EUR J RADIOL, V51, P139, DOI 10.1016/j.ejrad.2004.03.009
   BALASUBRAMANIAN R, 1990, TUBERCLE, V71, P253, DOI 10.1016/0041-3879(90)90037-9
   Benator D, 2002, LANCET, V360, P528
   Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065
   *BRIT MED RES COUN, 1981, AM REV RESPIR DIS, V124, P138
   *BRIT MED RES COUN, 1976, AM REV RESPIR DIS, V114, P471
   *BRIT THOR ASS, 1981, BR J DIS CHEST, V75, P141
   COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407
   COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397
   Dick T, 2001, J ANTIMICROB CHEMOTH, V47, P117, DOI 10.1093/jac/47.1.117
   DUTT AK, 1989, AM REV RESPIR DIS, V139, P867, DOI 10.1164/ajrccm/139.4.867
   Epstein MD, 1998, CHEST, V113, P379, DOI 10.1378/chest.113.2.379
   FALK A, 1969, CLASSIFICATION PULMO, pCH6
   GIRLING DJ, 1991, AM REV RESPIR DIS, V143, P262
   GIRLING DJ, 1989, AM REV RESPIR DIS, V139, P871
   GOMES N, 2003, REV INST MED TROP SP, V45, P275
   HAUCK WW, 1986, AM STAT, V40, P318, DOI 10.2307/2684618
   Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884
   Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466
   Matsuoka S, 2004, CLIN IMAG, V28, P119, DOI 10.1016/S0899-7071(03)00148-7
   MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6
   MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062
   MITCHISON DA, 1992, J ANTIMICROB CHEMOTH, V29, P477, DOI 10.1093/jac/29.5.477
   Nettles RE, 2004, CLIN INFECT DIS, V38, P731, DOI 10.1086/381675
   Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07
   Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5
   Teo SK, 2002, ANN ACAD MED SINGAP, V31, P175
   TRIPATHY S. P., 1981, Indian Journal of Tuberculosis, V28, P45
   TU D, 1997, DRUG INF J, V31, P1291
   Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8
   Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996
   Wilcke JTR, 1998, RESP MED, V92, P493, DOI 10.1016/S0954-6111(98)90297-9
   Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744
   ZIERSKI M, 1980, AM REV RESPIR DIS, V122, P879
NR 34
TC 90
Z9 91
U1 0
U2 5
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1073-449X
EI 1535-4970
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PD SEP 15
PY 2009
VL 180
IS 6
BP 558
EP 563
DI 10.1164/rccm.200904-0536OC
PG 6
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA 496TV
UT WOS:000270002600012
PM 19542476
OA Green Published
DA 2020-12-15
ER

PT J
AU McGee, B
   Dietze, R
   Hadad, DJ
   Molino, LPD
   Maciel, ELN
   Boom, WH
   Palaci, M
   Johnson, JL
   Peloquin, CA
AF McGee, Bryan
   Dietze, Reynaldo
   Hadad, David Jamil
   Dutra Molino, Lucilia Pereira
   Noia Maciel, Ethel Leonor
   Boom, W. Henry
   Palaci, Moises
   Johnson, John L.
   Peloquin, Charles A.
TI Population Pharmacokinetics of Linezolid in Adults with Pulmonary
   Tuberculosis
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS;
   OXAZOLIDINONES; EFFICACY
AB Nineteen adults with pulmonary tuberculosis received linezolid (600 mg) once or twice daily in an early bactericidal activity trial. A one-compartment population model produced median values for the absorption rate constant, volume of distribution, and elimination rate constant of 1.5 h(-1), 29.6 liters, and 0.25 h(-1) (once daily) and 2.7 h(-1), 32.1 liters, and 0.15 h(-1) (twice daily). Linezolid administered twice daily produced higher values for free drug area under the concentration-time curve (AUC)/MIC and time above MIC. Both regimens achieved free AUC/MIC ratios > 100. Median times above the MIC for free drug were 100% (twice daily) and 63% (once daily).
C1 [McGee, Bryan; Peloquin, Charles A.] Natl Jewish Hlth, Infect Dis Pharmacokinet Lab, Denver, CO USA.
   [McGee, Bryan; Peloquin, Charles A.] Univ Colorado, Sch Med, Denver, CO USA.
   [Dietze, Reynaldo; Hadad, David Jamil; Dutra Molino, Lucilia Pereira; Noia Maciel, Ethel Leonor; Palaci, Moises] Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Vitoria, Brazil.
   [Boom, W. Henry; Johnson, John L.] Case Western Reserve Univ, Sch Med, Dept Med, TB Res Unit, Cleveland, OH 44106 USA.
   [Boom, W. Henry; Johnson, John L.] Univ Hosp Case Med Ctr, Cleveland, OH USA.
RP Peloquin, CA (corresponding author), Univ Florida, Coll Pharm, Gainesville, FL 32610 USA.
EM peloquin@cop.ufl.edu
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Dietze,
   Reynaldo/0000-0002-6995-8001
FU U.S. National Institute of Allergy and Infectious Diseases, National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [NO1-AI95383,
   HHSN266200700022C/NO1-AI-70022]; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [N01AI095383, N01AI095383,
   N01AI095383, N01AI095383, N01AI095383, N01AI095383] Funding Source: NIH
   RePORTER
FX This work was supported by contracts NO1-AI95383 and
   HHSN266200700022C/NO1-AI-70022 ( Tuberculosis Prevention and Control
   Research Unit) of the U.S. National Institute of Allergy and Infectious
   Diseases, National Institutes of Health.
CR Alcala L, 2003, ANTIMICROB AGENTS CH, V47, P416, DOI 10.1128/AAC.47.1.416-417.2003
   Bozdogan B, 2004, INT J ANTIMICROB AG, V23, P113, DOI 10.1016/j.ijantimicag.2003.11.003
   Bustad A, 2006, CLIN PHARMACOKINET, V45, P365, DOI 10.2165/00003088-200645040-00003
   Condos Rany, 2008, Chest, V134, P187, DOI 10.1378/chest.07-1988
   Cynamon MH, 1999, ANTIMICROB AGENTS CH, V43, P1189, DOI 10.1128/AAC.43.5.1189
   Dietze R, 2008, AM J RESP CRIT CARE, V178, P1180, DOI 10.1164/rccm.200806-892OC
   DODGE WF, 1994, THER DRUG MONIT, V16, P552, DOI 10.1097/00007691-199412000-00004
   Fortun J, 2005, J ANTIMICROB CHEMOTH, V56, P180, DOI 10.1093/jac/dki148
   Gabrielsson J, 2001, PHARMACOKINETIC PHAR
   Meagher AK, 2003, ANTIMICROB AGENTS CH, V47, P548, DOI 10.1128/AAC.47.2.548-553.2003
   Molicotti P, 2006, NEW MICROBIOL, V29, P275
   Park IN, 2006, J ANTIMICROB CHEMOTH, V58, P701, DOI 10.1093/jac/dkl298
   Rayner CR, 2004, INFECTION, V32, P8, DOI 10.1007/s15010-004-3029-9
   RITSCHEL WA, 2004, HDB BASIC PHARMACOKI
   Sood R., 2006, Infectious Disorders - Drug Targets, V6, P343, DOI 10.2174/187152606779025860
   Stalker DJ, 2003, CLIN PHARMACOKINET, V42, P1129, DOI 10.2165/00003088-200342130-00004
   Tato M, 2006, INT J ANTIMICROB AG, V28, P75, DOI 10.1016/j.ijantimicag.2006.02.011
   TSUJI BT, 2005, ANTIMICROBIAL CHEMOT, V2, P223
   von der Lippe B, 2006, J INFECTION, V52, P92, DOI 10.1016/j.jinf.2005.04.007
   Yew WW, 2008, INT J TUBERC LUNG D, V12, P345
NR 20
TC 35
Z9 36
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD SEP
PY 2009
VL 53
IS 9
BP 3981
EP 3984
DI 10.1128/AAC.01378-08
PG 4
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 496XR
UT WOS:000270014200048
PM 19564361
OA Green Published, Bronze
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   de Araujo, WK
   Giacomin, SS
   de Jesus, FA
   Rodrigues, PM
   Dietze, R
AF Noia Maciel, Ethel Leonor
   de Araujo, Welder Kerr
   Giacomin, Samuel Siquara
   de Jesus, Fernando Antonio
   Rodrigues, Patricia Marques
   Dietze, Reynaldo
TI Knowledge about tuberculosis by doctors and nurses, who work in the
   Family Health Strategy in the city of Vitoria, Espirito Santo State: a
   cross-sectional study
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Tuberculosis (TB); Treatment; Doctors; Nurses; Knowledge; Family health
   strategy
AB Brazil is in 14(th) among the 23 countries responsible for 80% of the tuberculosis (TB) cases in the world. Aiming to understand the maintenance of these indexes, this study was developed to identify if the knowledge about tuberculosis by doctors and nurses, who work in the Family Health Strategy in the city of Vitoria (ES), would be a factor in the mediation of the prevention processes, diagnosis and treatment of the Tuberculosis. This is a cross-sectional study, with a sample size of 50 professionals. The collected data had been analyzed using the Chi-square and Fisher Exact tests with significance level of 0.05. Regarding the transmission and diagnosis of the Tuberculosis, there was no statistically significant difference between doctors and nurses. Only one variable presented a statistical difference: 41% of doctors and 15% of the nurses (p<0,05) mentioned that the patient must be attended in a place of choice of the doctor or nurse, and still, 4% of the total of the sample had answered that the supervision cannot be made by a member of the family. The research proves that doctors and nurses has knowledge to reduce the indexes of Tuberculosis, even so is indispensable the continuous study and qualification of these professionals.
C1 [Noia Maciel, Ethel Leonor; Dietze, Reynaldo] Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, BR-29040091 Vitoria, ES, Brazil.
   [de Araujo, Welder Kerr; Giacomin, Samuel Siquara; de Jesus, Fernando Antonio; Rodrigues, Patricia Marques] Univ Fed Espirito Santo, Dept Enfermagem, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
OI Maciel, Ethel Leonor/0000-0003-4826-3355
CR *BRAS MIN SAUD, 2003, REV BRAS SAUDE MATER, V3, P113
   *BRAS MIN SAUD FUN, 1999, PLAN NAC CONTR TUB
   *BRAS MIN SAUD SEC, 2006, SAUD FAM BRAS AN IND
   *BRAS MIN SAUD SEC, 1997, SAUD FAM ESTR REOR M
   *BRAS MIN SAUD SEC, 2002, MAN TECN CONTR TUB C
   *BRAS MIN SAUD SEC, 2005, AV MELH QUAL QUAL ES
   CAMPINAS LLS, 2004, MUNDO SAUDE, V28, P69
   Cavalcante Maria das Graças Santos, 2006, Rev. Bras. Saude Mater. Infant., V6, P437, DOI 10.1590/S1519-38292006000400011
   Chowdhury AMR, 1997, LANCET, V350, P169, DOI 10.1016/S0140-6736(96)11311-8
   Deruaz J, 2004, SWISS MED WKLY, V134, P552
   Dudley L, 2003, INT J TUBERC LUNG D, V7, pS48
   Hashim D S, 2003, East Mediterr Health J, V9, P718
   KRITSKI AL, 2000, TUBERCULOSE AMBULATO
   Lima M. B. de, 2001, Cadernos de Saude Publica, V17, P877, DOI 10.1590/S0102-311X2001000400021
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P1377, DOI 10.1590/S0102-311X2008000600018
   Ruffino-Netto Antonio, 2002, Rev. Soc. Bras. Med. Trop., V35, P51, DOI 10.1590/S0037-86822002000100010
   TARANTINO AB, 2002, DOENCAS PULMONARES, P371
   2004, JORNAL BRASILEIRO S1, V30, P4
NR 18
TC 5
Z9 7
U1 0
U2 5
PU ABRASCO
PI RIO DE JANEIRO
PA RUA HESPERIA, 16-PARTE MANGUINHOS, RIO DE JANEIRO, 21050-040, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD SEP-OCT
PY 2009
VL 14
SU 1
BP 1395
EP 1402
DI 10.1590/S1413-81232009000800012
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 493OL
UT WOS:000269746800012
PM 19750348
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Brioschi, AP
   Guidoni, LM
   Cerqueira, ACB
   do Prado, TN
   Fregona, G
   Dietze, R
AF Noia Maciel, Ethel Leonor
   Brioschi, Ana Paula
   Guidoni, Leticia Molino
   Barbosa Cerqueira, Anne Caroline
   do Prado, Thiago Nascimento
   Fregona, Geisa
   Dietze, Reynaldo
TI Factors associated with nonadherence to TB chemoprophylaxis in Vitoria,
   Brazil: a historical cohort study
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA Portuguese
DT Article
DE Tuberculosis; Chemoprevention; Isoniazid
ID HEALTH-CARE WORKERS; TUBERCULOSIS; STUDENTS; STATE
AB Objective: To describe the factors associated with nonadherence to TB chemoprophylaxis in patients older than 15 years of age treated via referral TB control programs. Methods: A historical cohort study was carried out based on medical charts related to cases treated via referral TB control programs in the city of Vitoria, Brazil, between 2002 and 2007. Cases of infection with Mycobacterium tuberculosis were Stratified into two groups: health care workers (HCW group); and individuals who were not health care workers (NHCW group). Results: A total of 395 patients were included in the study: 35 in the HCW group and 360 in the NHCW group. The mean age in the HCW and NHCW groups was 34.8 and 32.4 years, respectively (p = 0.36). Of the 35 patients in the HCW group, 29 (82.9%) were female, compared with 180 (50.0%) of the 360 patients in the NHCW group. In the HCW and NHCW groups, respectively, 45 (42.9%) and 169 (46.9%) of the patients were contacts of TB cases. In addition, 9 (25.7%) and 157 (78.5%) the HCW and NHCW group patients, respectively, were HIV-infected. Nonadherence to chemoprophylaxis was 37.1% and 21.9% in the HCW and NHCW groups, respectively (p = 0.045). In the multivariate analysis, the factors associated with nonadherence were being a health care Worker (OR = 8.60; 95% Cl: 2.09-35.41), being HIV-infected (OR = 4.57; 95% Cl: 1.2-17.5) and having had contact with a TB patient (OR = 2.65; 95% Cl: 1.15-6.12). Conclusions: In order to improve adherence to TB chemoprophylaxis, new TB control Program strategies are needed, especially for health care workers and HIV-infected patients.
C1 [Brioschi, Ana Paula; Guidoni, Leticia Molino] Univ Fed Espirito Santo, Acad Enfermagem, BR-29040090 Vitoria, ES, Brazil.
   [Barbosa Cerqueira, Anne Caroline] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, BR-29040090 Vitoria, ES, Brazil.
   [do Prado, Thiago Nascimento] Univ Fed Espirito Santo, Programa Posgrad Doencas Infecciosas, BR-29040090 Vitoria, ES, Brazil.
   [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, BR-29040090 Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Nucleo Doencas Infecciosas, Av Marechal Campos 1468, BR-29040090 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Fregona,
   Geisa/0000-0001-5835-8222
CR COMSTOCK GW, 1974, AM REV RESPIR DIS, V110, P195
   Prado Thiago Nascimento do, 2008, J. bras. pneumol., V34, P607, DOI 10.1590/S1806-37132008000800011
   Driver CR, 2005, AM J INFECT CONTROL, V33, P519, DOI 10.1016/j.ajic.2005.05.016
   Ferreira Silvana Margarida Benevides, 2005, J. bras. pneumol., V31, P427, DOI 10.1590/S1806-37132005000500011
   FRANCO S, 2004, ARQ CIENC SAUDE, V11, P244
   *FUND NAC SAUD, 2002, TUB GUIA VIG EP
   Hosoglu S, 2005, AM J INFECT CONTROL, V33, P23, DOI 10.1016/j.ajic.2004.07.013
   KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991
   Kristensen J, 2000, PHARM DEV TECHNOL, V5, P247, DOI 10.1081/PDT-100100539
   MACIEL EL, 2005, CAD SAUDE COLET RIO, V13, P593
   MACIEL ELN, 2006, CAD SAUDE COLET, V14, P81
   MELO FAF, 2005, TRATADO INFECT, P1139
   MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206
   Moreira Cláudia Maria Marques, 2008, J. bras. pneumol., V34, P225, DOI 10.1590/S1806-37132008000400007
   Maciel EL, 2007, REV SOC BRAS MED TRO, V40, P397, DOI 10.1590/S0037-86822007000400004
   PINEDA IS, 2004, J BRAS PNEUMOL, V30, P485
   Schechter M, 2006, AM J RESP CRIT CARE, V173, P922, DOI 10.1164/rccm.200512-1953OC
   Silva VMC, 2002, INFECT CONT HOSP EP, V23, P591, DOI 10.1086/501976
   Sociedade Brasileira de Pneumologia e Tisiologia, 2004, J PNEUMOL S1, V30, pS4
   *WHO, 2008, WHO REP TUB EP
NR 20
TC 4
Z9 4
U1 0
U2 0
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD SEP
PY 2009
VL 35
IS 9
BP 884
EP 891
DI 10.1590/S1806-37132009000900010
PG 8
WC Respiratory System
SC Respiratory System
GA 499MK
UT WOS:000270224300010
PM 19820815
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   do Prado, TN
   Peres, RL
   Palaci, M
   Johnson, JL
   Dietze, R
AF Noia Maciel, Ethel Leonor
   do Prado, Thiago Nascimento
   Peres, Renata Lyrio
   Palaci, Moises
   Johnson, John L.
   Dietze, Reynaldo
TI Guided sputum sample collection and culture contamination rates in the
   diagnosis of pulmonary TB
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA English
DT Article
DE Tuberculosis/diagnosis; Sputum/microbiology; Culture techniques
ID TUBERCULOSIS; IMPROVE
AB A comparative study to evaluate contamination in cultures of morning sputum samples, comparing those collected at home under currently recommended conditions and those collected under supervision after patient orientation and education. The home and supervised collection groups produced 43 and 76 sputum samples, respectively. The contamination rate was nearly 3-times higher among samples collected at home than among those collected under supervision (37% vs. 13%, p < 0.05; OR = 0.25). The simple educational and hygiene measures described can decrease the contamination rate among sputum samples collected for diagnostic culture.
C1 [do Prado, Thiago Nascimento; Peres, Renata Lyrio] Univ Fed Espirito Santo, Postgrad Program Infect Dis, Vitoria, Brazil.
   [Palaci, Moises] Univ Fed Espirito Santo, Microbiol Lab, Ctr Infect Dis, Vitoria, Brazil.
   [Johnson, John L.] Case Western Reserve Univ, Clin Trial Ctr, TB Res Unit, Cleveland, OH 44106 USA.
RP Maciel, ELN (corresponding author), Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU [NO1-A195383];  [NO1-Al-70022]; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [N01AI095383, N01AI095383,
   N01AI095383, N01AI095383, N01AI095383, N01AI095383] Funding Source: NIH
   RePORTER
FX The laboratory work for this study has been funded in part by contract
   no. NO1-A195383 and NO1-Al-70022
CR Alisjahbana B, 2005, INT J TUBERC LUNG D, V9, P814
   Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012
   Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7
   Macq J, 2005, SALUD PUBLICA MEXICO, V47, P303, DOI 10.1590/s0036-36342005000400008
   Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8
   SUSEMIHL AA, 1993, REV BRAS PAT CLIN, V29, P51
   *WHO, 2006, GLOB TUB CONTR SURV
   *WHO, 2006, WHOHTMTB2006364
NR 8
TC 12
Z9 13
U1 0
U2 0
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD MAY
PY 2009
VL 35
IS 5
BP 460
EP 463
DI 10.1590/S1806-37132009000500012
PG 4
WC Respiratory System
SC Respiratory System
GA 484CC
UT WOS:000269019900012
PM 19547856
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Miranda, AE
   Golub, JE
   Lucena, FD
   Maciel, EN
   Gurgel, MD
   Dietze, R
AF Miranda, Angelica Espinosa
   Golub, Jonathan E.
   Lucena, Francisca de Fatima
   Maciel, Ethel Noia
   Gurgel, Maria de Fatima
   Dietze, Reynaldo
TI Tuberculosis and AIDS Co-Morbidity in Brazil: Linkage of the
   Tuberculosis and AIDS Databases
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE AIDS; tuberculosis; co-infection; secondary data
ID HIV-INFECTED PATIENTS; TRENDS; MORTALITY; EPIDEMIC; TRANSMISSION;
   PROTECTION; IMPACT
AB This study evaluated differences in AIDS patients with and without tuberculosis (TB) in Espirito Santo State, Brazil. Standard regional AIDS (SINAN, SISCEL, SICLOM and SIM) and tuberculosis (SINAN) databases were used. TB and AIDS databases were linked using Reclink software, version 3, with SPSS software support to identify co-infected cases. Data from July 2000 to June 2006 in Espirito Santo State were linked. The results showed 3,523 adult AIDS cases and 9,958 adult TB cases resulted in 430 co-infected patients, who were compared to 1,290 AIDS patients who never developed TB. Among 430 co-infected patients, TB was diagnosed first in 223 (51.9%), AIDS was first in 44 (10.2%), and AIDS and TB were diagnosed concurrently in 163 (37.9%). Median age did not differ between co-infected cases (36 years (interquartile range [IQR] 29-43) and non-co-infected cases (34 years; IQR 28-42). Pulmonary tuberculosis was diagnosed in 239 (55.6%); 109 (25.3%) had extra-pulmonary TB and 82 (19.1%) had both presentations. In the final logistic regression model, living in a metropolitan area [Odds Ratio (OR)=1.43 (95% Confidence Interval (CI) 1.05-1.95)], education ! 3 years [OR=3.03 (95% CI 1.56-5.88)] and CD4 counts <= 200/mm(3) [OR=1.14 (95%CI 1.09-1.18)] were associated with co-infection. This report emphasizes the significance of tuberculosis among AIDS cases in Brazil, and highlights the importance of evaluating secondary data for purposes of improving data quality and developing public health interventions.
C1 [Miranda, Angelica Espinosa] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Infect Dis, BR-29040091 Vitoria, ES, Brazil.
   [Golub, Jonathan E.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD 21218 USA.
   [Lucena, Francisca de Fatima] Minist Hlth, Natl Program STD AIDS, Brasilia, DF, Brazil.
   [Gurgel, Maria de Fatima] Secretaria Estadual Saude Espirito Santo, Dept Epidemiol, Vitoria, ES, Brazil.
RP Miranda, AE (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Infect Dis, Ave Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM espinosa@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Miranda,
   Angelica/0000-0002-5556-8379
FU Innovative approaches for tuberculosis control in Brazil
   [U2RTWO06883-02]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [A166994, A1066994];
   Fogarty International Center/USNIH ICOHRTAUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [U2RTWO06885]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006883, U2RTW006885,
   U2RTW006885, U2RTW006883, U2RTW006885, U2RTW006883, U2RTW006885,
   U2RTW006885, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006885,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006885, U2RTW006885,
   U2RTW006885, U2RTW006883, U2RTW006883] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [K01AI066994, K01AI066994, K01AI066994, K01AI066994, K01AI066994]
   Funding Source: NIH RePORTER
FX This study was supported by the Innovative approaches for tuberculosis
   control in Brazil: Grant#5 U2RTWO06883-02, NIH A166994 Fogarty
   International Center/USNIH #U2RTWO06885 ICOHRTA and Dr. Golub was
   supported by the National Institutes of Health grant A1066994.
CR Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3
   Boerma JT, 1998, AIDS, V12, pS3
   BRAUN MM, 1993, JAMA-J AM MED ASSOC, V269, P2865, DOI 10.1001/jama.269.22.2865
   Camargo K R Jr, 2000, Cad Saude Publica, V16, P439
   Cayla JA, 1996, AIDS, V10, P95, DOI 10.1097/00002030-199610000-00029
   Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009
   DAVID AM, 2007, B NEW YORK ACAD MED, V84, P65
   de Oliveira HB, 2004, REV SAUDE PUBL, V38, P503, DOI 10.1590/S0034-89102004000400004
   Prado Thiago Nascimento do, 2008, J. bras. pneumol., V34, P607, DOI 10.1590/S1806-37132008000800011
   Fonseca Maria Goretti P., 2003, Cad. Saúde Pública, V19, P1351, DOI 10.1590/S0102-311X2003000500013
   Franco J, 1998, INT J TUBERC LUNG D, V2, P663
   Gledovic Z, 2000, INT J TUBERC LUNG D, V4, P32
   Golub JE, 2006, INT J TUBERC LUNG D, V10, P24
   Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441
   Laguardia Josué, 2003, Rev. Esp. Salud Publica, V77, P553, DOI 10.1590/s1135-57272003000500005
   Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1
   Lazaridis EN, 1997, ANN INTERN MED, V127, P696, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00052
   Lonnroth K, 2007, HEALTH POLICY PLANN, V22, P156, DOI 10.1093/heapol/czm007
   Lucena FF, 2006, CADERNOS SAUDE COLET, V14, P305
   Muniyandi M, 2006, J Commun Dis, V38, P204
   PablosMendez A, 1996, JAMA-J AM MED ASSOC, V276, P1223, DOI 10.1001/jama.276.15.1223
   Sacks LV, 1998, ARCH INTERN MED, V158, P1916, DOI 10.1001/archinte.158.17.1916
   Silva JPL, 2006, CADERNOS SAUDE COLET, V14, P197
   Silveira Jussara Maria, 2006, J. bras. pneumol., V32, P48, DOI 10.1590/S1806-37132006000100011
   Song Alice Tung Wan, 2003, Rev. Hosp. Clin., V58, P207, DOI 10.1590/S0041-87812003000400004
   STANDAERT B, 1989, AIDS RES HUM RETROV, V5, P247, DOI 10.1089/aid.1989.5.247
   AIDS B EPIDEMIOLOGIC
NR 27
TC 8
Z9 11
U1 0
U2 2
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD APR
PY 2009
VL 13
IS 2
BP 137
EP 141
DI 10.1590/S1413-86702009000200013
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA 504EG
UT WOS:000270597100013
PM 20140359
OA DOAJ Gold, Green Accepted
DA 2020-12-15
ER

PT J
AU Rodrigues, PM
   Moreira, TR
   de Moraes, AKL
   Vieira, RDA
   Dietze, R
   Lima, RDD
   Maciel, ELN
AF Rodrigues, Patricia Marques
   Moreira, Tiago Ricardo
   Luz de Moraes, Andressa Karla
   Araujo Vieira, Rafael da Cruz
   Dietze, Reynaldo
   Duarte Lima, Rita de Cassia
   Noia Maciel, Ethel Leonor
TI Mycobacterium tuberculosis infection among community health workers
   involved in TB control
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA Portuguese
DT Article
DE Community health aides; Tuberculosis; Tuberculin test
ID BCG REVACCINATION; CALMETTE; CHILDREN; GUERIN; TRIAL; BIRTH
AB Objective: To evaluate the incidence of Mycobacterium tuberculosis infection, using tuberculin skin test, among community health agents (CHAs) monitoring TB patients in the city of Cachoeiro de Itapemirim, Brazil. Methods: We included 30 CHAs acting in the Family Health Program and 30 of their family members residing in the same household. The tuberculin skin test results of each CHA were compared with those of the corresponding family member. Results: Of the 30 CHAs, 27 (90.0%) were female, compared with 23 (76.7%) of the 30 family members (p = 0.299). The mean age of the CHA group and of the family member group was, respectively, 36.8 and 39.7 years. No statistically significant difference was found between the groups regarding the level of education. Regarding M. tuberculosis exposure, the same number of participants in the two groups reported having known or had contact with a TB patient (17 individuals; 56.7%). There was a statistically significant difference regarding positive tuberculin skin test results (26.7% in the CHA groupand 3.3% in the family member group: p = 0,011). Conclusions: M. tuberculosis infection was significantly higher among CHAs than among their family members, fueling the debate on the occupational risk involved in the activities of these professionals.
C1 [Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Lab Epidemiol, Nucleo Doencas Infecciosas, Programa Posgrad Saude Colet, BR-29040090 Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol, Nucleo Doencas Infecciosas, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29040090 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012; Moreira, Tiago/AAJ-6236-2020
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Moreira,
   Tiago/0000-0002-6606-4942
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [5 U2R TW006883-02.] Funding Source: Medline; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883] Funding Source: NIH RePORTER
CR [Anonymous], 1995, Wkly Epidemiol Rec, V70, P229
   [Anonymous], 2007, GLOB TUB CONTR SURV
   Barreto ML, 2002, CONTROL CLIN TRIALS, V23, P540, DOI 10.1016/S0197-2456(02)00216-7
   *BRAS MIN SAUD, 2004, COORD GER DOENC END
   *BRAS MIN SAUD, 2006, SIST NAC VIG SAUD RE
   BRASIL, 2001, PROGR AG COM SAUD
   Campinas LLSL, 2004, B PNEUMOL SANIT, V12, P145
   Ellis JR, 1998, ENFERMAGEM CONT DESA
   Ferraz Lucimare, 2005, Ciênc. saúde coletiva, V10, P347, DOI 10.1590/S1413-81232005000200012
   Ferreira AA, 1996, TUBERCLE LUNG DIS, V77, P476, DOI 10.1016/S0962-8479(96)90123-9
   FRAGA H, 2002, SOC BRASILEIRA PNEUM
   Harries AD, 1999, T ROY SOC TROP MED H, V93, P32, DOI 10.1016/S0035-9203(99)90170-0
   LUGOSI L, 1992, TUBERCLE LUNG DIS, V73, P252, DOI 10.1016/0962-8479(92)90129-8
   Maciel ELN, 2005, REV SOC BRAS MED TRO, V38, P469, DOI 10.1590/S0037-86822005000600004
   MARTINS CL, 1996, REV SAUDE DEBATE, V51, P38
   MAURICIO LB, 2006, J PEDIAT RIO J S, V82, pS45
   Ministerio da Saude, 2002, MAN NORM CONTR TUB
   Muniz J N, 1999, B PNEUMOL SANIT, V7, P33
   Nunes Mônica de Oliveira, 2002, Cad. Saúde Pública, V18, P1639, DOI 10.1590/S0102-311X2002000600018
   Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X
   Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0
   SEPKOWITZ KA, 1996, TUBERCULOSIS, P935
   SEPULVEDA RL, 1988, PEDIATR INFECT DIS J, V7, P578, DOI 10.1097/00006454-198808000-00009
   Vianna ALD, 1998, PHYSIS-REV SAUDE COL, V8, P11, DOI DOI 10.1590/S0103-73311998000200002
   1995, WKLY EPIDEMIOL REC, V70, P246
NR 25
TC 11
Z9 14
U1 0
U2 2
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD APR
PY 2009
VL 35
IS 4
BP 351
EP 358
DI 10.1590/S1806-37132009000400009
PG 8
WC Respiratory System
SC Respiratory System
GA 484CA
UT WOS:000269019700009
PM 19466273
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Vieira, LWH
   Molina, LPD
   Alves, R
   do Prado, TN
   Dietze, R
AF Noia Maciel, Ethel Leonor
   Heringer Vieira, Luiza Werner
   Dutra Molina, Lucilia Pereira
   Alves, Rosana
   do Prado, Thiago Nascimento
   Dietze, Reynaldo
TI Juvenile household contacts aged 15 or younger of patients with
   pulmonary TB in the greater metropolitan area of Vitoria, Brazil: a
   cohort study
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA Portuguese
DT Article
DE Tuberculosis; Mycobacterium tuberculosis; Tuberculosis, pulmonary;
   Child; Adolescent
ID CHILDHOOD TUBERCULOSIS; CHILDREN; DIAGNOSIS; INFECTION; HEALTH; GAMMA;
   ASSAY
AB Objective: To compare clinical, radiological and laboratory aspects of household contacts, aged 15 or Younger, Of patients presenting a positive culture for Mycobacterium tuberculosis. Methods: This was a cohort study comparing children and adolescents (<= 15 years of age) who were household contacts of TB cases presenting positive sputum smear and positive culture results (exposed group, n = 100) or negative sputum smear and positive culture results (unexposed group, n = 55). All of the contacts were evaluated via the TB control program of a university hospital in the city of Vitoria, Brazil, between July of 2003 and December of 2006. Results: Of the 155 minors evaluated, 87 (56.1%) were female and 68 (43.9%) were male. Of those 155, 28 (18%) were aged 5 or younger, 62 (40%) were aged 5-9, and 65 (42%) were aged 10-15. Symptoms of the disease were found in 17 (17%) of the 100 contacts in the exposed group and in 9 (16%) of the 55 in the unexposed group (p = 0.86). Chest X-rays showed alterations in 20 (21%) avid 2 (4%) of the contacts in the exposed and unexposed groups, respectively (RR = 6.9; p = 0.004). In the exposed and unexposed groups, respectively, 35 (38%) and 10 (18%) of the contacts presented positive results in the tuberculin skin test (RR = 2.8; p = 0.01). Of the 100 contacts in the exposed group, 5 (5%) were diagnosed with TB, which was not diagnosed in any of those in the unexposed group (p = 0.08). Conclusions: Although no significant difference was found between the two groups regarding the incidence of TB, it is of note that there is a greater risk of becoming infected with M. tuberculosis if the bacterial load of the index case is high.
C1 [Noia Maciel, Ethel Leonor; Heringer Vieira, Luiza Werner; Dietze, Reynaldo] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
   [Dutra Molina, Lucilia Pereira; do Prado, Thiago Nascimento] Univ Fed Espirito Santo, Programa Posgrad Doencas Infecciosas, BR-29040091 Vitoria, ES, Brazil.
   [Alves, Rosana] UNIVIX, Fac Brasileira, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, Ave Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
OI Maciel, Ethel Leonor/0000-0003-4826-3355
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [5 U2R TW006883-02] Funding Source: Medline; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883] Funding Source: NIH RePORTER
CR [Anonymous], 2006, GUID NAT TUB PROGR M
   Brasil. Ministerio da Saude. Secretaria de Politicas de Saude. Departamento de Atencao Basica, 2002, MAN TECN CONTR TUB C
   Caldeira ZMR, 2004, REV SAUDE PUBL, V38, P339, DOI [10.1590/S0034-89102004000300001, 10.1590/s0034-89102004000300001]
   Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002
   Donald PR, 1999, LANCET, V353, P1001, DOI 10.1016/S0140-6736(99)02010-3
   Hartwig Shaiana Vilella, 2008, J. bras. pneumol., V34, P298, DOI 10.1590/S1806-37132008000500009
   Houwert KAF, 1998, EUR RESPIR J, V11, P1116, DOI 10.1183/09031936.98.11051116
   Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756
   Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2
   MACIEL ELN, 2006, CAD SAUDE COLET, V14, P81
   MARCONDES E, 2003, PEDIAT BASICA
   Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49
   MAZUREK GH, 2005, MMWR-MORBID MORTAL W, V54, P1288
   Morrone N, 1983, AMB Rev Assoc Med Bras, V29, P182
   Maciel ELN, 2008, CAD SAUDE PUBLICA, V24, P402, DOI 10.1590/S0102-311X2008000200019
   Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X
   Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07
   SANTANNA CC, 2007, REV SAUDE PUBL S1, V41, pS117
   SANTANNA CC, 2002, JORNAL PEDIAT RIO S2, V278, pS205
   STARKE JR, 1992, J PEDIATR-US, V120, P839, DOI 10.1016/S0022-3476(05)81949-3
   STARKE JR, 1993, CHEST, V104, P329, DOI 10.1378/chest.104.2.329
   TIDJANI O, 1986, TUBERCLE, V67, P269, DOI 10.1016/0041-3879(86)90016-4
   *WHO, 1998, GLOB TUB CONTR SURV
   *WHO, 2006, GLOB TUB CONTR SURV
   World Health Organization, 2007, RES AG CHILDH TUB IM
NR 25
TC 8
Z9 9
U1 0
U2 0
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD APR
PY 2009
VL 35
IS 4
BP 359
EP 366
DI 10.1590/S1806-37132009000400010
PG 8
WC Respiratory System
SC Respiratory System
GA 484CA
UT WOS:000269019700010
PM 19466274
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Oliveira, CB
   Frechiani, JM
   Silva, FM
   Maciel, ELN
AF Oliveira, Carla Braga
   Frechiani, Janaina Menezes
   Silva, Fatima Maria
   Noia Maciel, Ethel Leonor
TI Actions of education health for child and adolescents in the city of
   Vitoria
SO CIENCIA & SAUDE COLETIVA
LA Portuguese
DT Article
DE Education health; Evaluation; Child and adolescence health promotion
AB This was a cross-sectional study carried in six Family Health Units, for direct observation of educative activities. The objective was to evaluate the actions of Education Health carried through in the informative sessions that approached the following subjects: family planning, breast feeding, families registered in Nutrition Programmes and children in nutritional risk. For the study proposed we establish that al action developed out side the individual approach to resolved heath problems will be considerer as health education. The unprepared of some professionals for the full functioning of the activities can still be observed. The findings of this study disclose the little participation of these Units in the accomplishment of educative activities on family planning come back toward the adolescents. Concerning the activities developed for the families registered in Nutrition Programmes, excellent subjects as the importance to appear the educative activities of the unit had been boarded in the most part of the lectures. The social activities for children in nutritional risk are carried out together with the families of the Nutrition Programmes. Although we observed several activities we still need to improved the multidisciplinary work to implement the heath promotion.
C1 [Oliveira, Carla Braga; Frechiani, Janaina Menezes; Silva, Fatima Maria; Noia Maciel, Ethel Leonor] Univ Federal Espirito Santo, Dept Enfermagem, BR-29040091 Vitoria, ES, Brazil.
RP Oliveira, CB (corresponding author), Univ Federal Espirito Santo, Dept Enfermagem, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM carlaenfermagem@yahoo.com.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR ALVES CRL, 2003, SAUDE FAMILIA CUIDAN
   AMORIM VL, 2006, REV BRAS PROMOC SAUD, V19, P240
   ARAUJO FM, 2004, ACOES ED SAUDE PLANE
   BOCARDI MIB, 2004, THESIS U SAO PAULO
   *BRAS MIN SAUD, 1991, PROGR SAUD AD PROSAD
   *BRAS MIN SAUD, 2005, NORM MAN TECN MARC L
   *BRAS MIN SAUD, PSF PSF
   Brasil. Ministerio da Saude, 2000, IMPL UN SAUD FAM
   Del Ciampo Luiz Antonio, 2006, Rev. Bras. Saude Mater. Infant., V6, P391, DOI 10.1590/S1519-38292006000400005
   FELISBERTO E, 2001, THESIS CTR PESQUISAS
   Gomez JC, 2006, CONCURR COMP-PRACT E, V18, P1, DOI 10.1002/cpe.904
   LEVY S, PROGRAMA ED SAUDE
   Minayo M. C., 1993, PESQUISA SOCIAL TEOR
   MONTE CMG, 2000, J PEDIAT S3, V76, P285, DOI DOI 10.2223/JPED.165
   Moura Escolástica Rejane Ferreira, 2002, Cad. Saúde Pública, V18, P1809, DOI 10.1590/S0102-311X2002000600038
   *PREF MUN VIT SECR, 2003, PROTOCOLO SAUD CRIAN
   SEGRE CAM, 2001, PEDIAT DIRETRIZES BA
   YAMAMOTO RM, 1998, PEDIATRIA, V20, P399
NR 18
TC 6
Z9 9
U1 0
U2 2
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD MAR-APR
PY 2009
VL 14
IS 2
BP 635
EP 644
DI 10.1590/S1413-81232009000200032
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 404AE
UT WOS:000263122300032
PM 19197438
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Bastos, MDRP
   Pereira, JD
   Smarzaro, DC
   Costa, EF
   Bossanel, RCL
   Oliosa, DMS
   Pereira, JGP
   Feitosa, HN
   da Costa, MF
   de Oliveira, FJP
   Favero, JL
   Maciel, ELN
AF Rocha Pereira Bastos, Marcia de Jesus
   Pereira, Jacira dos Anjos
   Smarzaro, Dorian Chim
   Costa, Everaldo Francisco
   Lobo Bossanel, Regina Celia
   Sesari Oliosa, Durvalina Maria
   Poltronieri Pereira, Joseanny Gomes
   Feitosa, Hideko Nagatani
   da Costa, Marcilene Favarato
   Pereira de Oliveira, Fabiano Jose
   Favero, Juliana Lopes
   Noia Maciel, Ethel Leonor
TI Ecological analysis of accidents and lethal violence in Vitoria,
   Southeastern Brazil
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
AB OBJECTIVE: To analyze the socioeconomic background and its relationship with spatial distribution of mortality due to violence.
   METHODS: Ecological study conducted to explore the space distribution of mortality due to violence in the city of Vitoria, Southeastern Brazil, between 2000 and 2003, based on population and socioeconomic information. Mortality data were correlated with information on victim's place of residence, type of violence, gender, and skin color. Data were analyzed using space average, odds ratio, and cluster analysis.
   RESULTS: There were reported 828 deaths due to violence during the study period, accounting for 17% of all deaths in the city. Of these, 72% were homicides, 21.8% traffic accidents, and 6% suicides. Violence victims were mostly young black males, living in poorer areas of the city. In contrast, as for suicide and traffic accidents, the victims were older white females living in the wealthiest area of the city.
   CONCLUSIONS: The study showed that violence is a phenomenon occurring in all socioeconomic levels but black people at the lowest level are more likely to die from homicides while white well-off people are more likely to die from suicide and traffic accidents.
C1 [Rocha Pereira Bastos, Marcia de Jesus; Pereira, Jacira dos Anjos; Smarzaro, Dorian Chim; Pereira de Oliveira, Fabiano Jose] Secretaria Municipal Saude Prefeitura Municipal V, Vitoria, ES, Brazil.
   [Costa, Everaldo Francisco] Secretaria Cidadania Direitos Humanos Prefeitura, Vitoria, ES, Brazil.
   [Lobo Bossanel, Regina Celia] Secretaria Transportes & Infra Estrut Urbana, Vitoria, ES, Brazil.
   [Sesari Oliosa, Durvalina Maria] Secretaria Seguranca Urbana, Vitoria, ES, Brazil.
   [Poltronieri Pereira, Joseanny Gomes; Feitosa, Hideko Nagatani; da Costa, Marcilene Favarato] Secretaria Fazenda, Vitoria, ES, Brazil.
   [Favero, Juliana Lopes; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Saude Colet, Av Marechal Campos,1-468 Maruipe, BR-29040090 Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Saude Colet, Av Marechal Campos,1-468 Maruipe, BR-29040090 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR Assis S., 1997, CRESCER SEM VIOLENCI
   Barata RB, 1999, REV BRAS EPIDEMIOL, V2, P50, DOI DOI 10.1590/S1415-790X1999000100005
   Beato Filho CC, 2001, CAD SAUDE PUBLICA, V17, P1163, DOI [10. 1590/ S0102- 311X2001000500017, DOI 10.1590/S0102-311X2001000500017]
   de Lima M L, 1998, Cad Saude Publica, V14, P829
   de Souza Minayo M. C., 1990, CAD SAUDE PUBLICA, V6, P278, DOI [10.1590/S0102-311X1990000300005, DOI 10.1590/S0102-311X1990000300005]
   Gawryszewski Vilma Pinheiro, 2004, Cad. Saúde Pública, V20, P995, DOI 10.1590/S0102-311X2004000400014
   Jorge M H, 1981, Rev Saude Publica, V15, P165
   Jorge MHPD, 1997, REV SAUDE PUBL, V31, P5, DOI 10.1590/S0034-89101997000500002
   Latorre MRDO, 1994, CAD SAUDE PUBLICA S1, V10, pS19, DOI [10.1590/S0102-311X1994000500003, DOI 10.1590/S0102-311X1994000500003]
   Laurenti Ruy, 2005, Ciênc. saúde coletiva, V10, P35, DOI 10.1590/S1413-81232005000100010
   Marin-Leon L, 2003, REV SAUDE PUBL, V37, P357, DOI 10.1590/s0034-89102003000300015
   Mello Jorge MHP, 1997, SAO PAULO SEM MEDO D, P97
   Mello Jorge MHP, 1986, B SANIT PANAM, V100, P590
   Moraes José Ribamar, 2003, Rev. bras. epidemiol., V6, P245
   Organizacao Mundial de Saude, 1985, MAN CLASS EST INT DO
   Organizacion Mundial de La Salud, 1995, SAL AD JOV IAS AM ES, P6
   Ruzany Maria Helena, 2002, Cad. Saúde Pública, V18, P639, DOI 10.1590/S0102-311X2002000300013
   Santos S M, 2001, Cad Saude Publica, V17, P1141, DOI 10.1590/S0102-311X2001000500015
   Souza Edinilsa Ramos de, 2006, Ciênc. saúde coletiva, V11, P363, DOI 10.1590/S1413-81232006000200014
   Souza ER, 1994, CAD SAUDE PUBLICA S1, V10, P45, DOI [10.1590/S0102-311X1994000500004, DOI 10.1590/S0102-311X1994000500004]
   Spagnol Antonio Sergio, 2005, Tempo soc., V17, P275, DOI 10.1590/S0103-20702005000200012
   Veronese Andréa Márian, 2006, Cad. Saúde Pública, V22, P2717, DOI 10.1590/S0102-311X2006001200021
   Waiselfisz JJ, 2004, MAPA DA VIOLENCIA
NR 23
TC 11
Z9 11
U1 0
U2 0
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD FEB
PY 2009
VL 43
IS 1
BP 123
EP 132
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V45KQ
UT WOS:000209815900017
PM 19169584
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   do Prado, TN
   Favero, JL
   Moreira, TR
   Dietze, R
AF Noia Maciel, Ethel Leonor
   do Prado, Thiago Nascimento
   Favero, Juliana Lopes
   Moreira, Tiago Ricardo
   Dietze, Reynaldo
TI Tuberculosis in health professionals: a new perspective on an old
   problem
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA Portuguese
DT Article
DE Tuberculosis; Cross infection; Health personnel
ID RESISTANT MYCOBACTERIUM-TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; CARE
   WORKERS; ESPIRITO-SANTO; STUDENTS; CONVERSION; RISK; INFECTIONS;
   PHYSICIANS; PERSONNEL
AB The objective of this review was to contribute to the debate on the nosocomial transmission of TB among health professionals in a country where TB is endemic. Prior to 1900, there was no reason to believe that health Professionals interacting with TB patients were More susceptible to becoming infected with the bacillus than was the general population. Between 1920 and 1930, various studies showed significant findings regarding the rates of positive tuberculin skin tests among students in the area of health care. However, most clinicians remained skeptical about the susceptibility of health professionals to becoming infected with TB. In the various locales where the treatment of patients with TB has been implemented, health professionals have been described as an especially predisposed population to becoming infected with and developing active TB. It is urgent that the scientific community and health professionals become mobilized, recognizing themselves as a population at risk of developing TB, and that actions be taken in order to minimize the potential risks of acquiring the disease at locales where patients with TB are treated.
C1 [do Prado, Thiago Nascimento] Univ Fed Espirito Santo, Prograrna Posgrad Doencas Infecciosas, Vitoria, ES, Brazil.
   [Favero, Juliana Lopes; Dietze, Reynaldo] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Vitoria, ES, Brazil.
   [Moreira, Tiago Ricardo] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Ave Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012; Moreira, Tiago/AAJ-6236-2020
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Moreira,
   Tiago/0000-0002-6606-4942
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883,
   U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883, U2RTW006883] Funding
   Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [TW 006883-02] Funding Source: Medline
CR ABRUZZI WA, 1953, NEW ENGL J MED, V248, P722, DOI 10.1056/NEJM195304232481705
   [Anonymous], 1994, MMWR Recomm Rep, V43, P1
   [Anonymous], 1972, Chest, V61, P405
   BARREIRA IA, 1993, THESIS U FEDERAL RIO
   BARRETTCONNOR E, 1979, JAMA-J AM MED ASSOC, V241, P33, DOI 10.1001/jama.241.1.33
   BASS JB, 1985, AM REV RESPIR DIS, V132, P379
   BECKSAGUE C, 1992, JAMA-J AM MED ASSOC, V268, P1280, DOI 10.1001/jama.268.10.1280
   Brudney K, 1991, Semin Respir Infect, V6, P261
   CHILDRESS WG, 1951, JAMA-J AM MED ASSOC, V146, P1188, DOI 10.1001/jama.1951.03670130010004
   CRAVEN RB, 1975, ANN INTERN MED, V82, P628, DOI 10.7326/0003-4819-82-5-628
   D'Agata EMC, 2001, INFECT CONT HOSP EP, V22, P10, DOI 10.1086/501817
   DAVIS AL, 1996, TUBERCULOSIS, P935
   de Oliveira HB, 2004, REV PANAM SALUD PUBL, V15, P194, DOI 10.1590/S1020-49892004000300008
   DESOUZA GRM, 2002, PULMAO RJ, V11, P64
   DIEHL HS, 1948, JAMA-J AM MED ASSOC, V138, P8, DOI 10.1001/jama.1948.02900010010003
   Prado Thiago Nascimento do, 2008, J. bras. pneumol., V34, P607, DOI 10.1590/S1806-37132008000800011
   Dooley S W Jr, 1990, MMWR Recomm Rep, V39, P1
   DOOLEY SW, 1997, PREVENTION CONTROL N, P357
   Dublin LI, 1914, J OUTDOOR LIFE, P204
   DUNLAP NE, 1994, INFECT AGENT DIS, V3, P245
   FISHBERG M, 1915, AM MED, V21, P607
   GALDSTON I, 1948, AM REV RESPIR DIS, P609
   Garner JS, 1996, INFECT CONT HOSP EP, V17, P54, DOI 10.1017/S0195941700006123
   Garner JS, 1996, INFECT CONT HOSP EP, V17, P214
   HUTTON MD, 1990, J INFECT DIS, V161, P286, DOI 10.1093/infdis/161.2.286
   ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108
   JAFFERIAN PA, 1977, REV BRAS SAUDE OCUP, V5, P30
   KLITZMAN S, 1994, OCCUP MED, V9, P723
   KRITSKI AL, 1996, TRATADO INFECTOLOGIA, P947
   LAFORCE FM, 1993, PREVENTION CONTROL N, P1
   LEVINE I, 1968, ARCH INTERN MED, V121, P545, DOI 10.1001/archinte.121.6.545
   Maciel EL, 1999, THESIS U FEDERAL RIO
   Maciel ELN, 2005, REV SOC BRAS MED TRO, V38, P469, DOI 10.1590/S0037-86822005000600004
   MALASKY C, 1990, AM REV RESPIR DIS, V142, P505, DOI 10.1164/ajrccm/142.3.505
   MEADE GM, 1948, AM REV TUBERC PULM, V58, P675
   MELO FA, 1995, B PNEUMOL SANIT, V3, P56
   *MIN SAUD COORD PN, 1995, MAN NORM CONTR TUB
   MYERS JA, 1957, AM REV TUBERC PULM, V75, P442
   NASCIMENTO DR, 2005, COLECAO HIST SAUDE
   Nightingale F., 1989, NOTAS ENFERMAGEM
   Maciel EL, 2007, REV SOC BRAS MED TRO, V40, P397, DOI 10.1590/S0037-86822007000400004
   PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191
   RODRIGUES PM, 2009, REV SAUDE P IN PRESS
   Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335
   Ruffino-Netto Antonio, 2002, Rev. Soc. Bras. Med. Trop., V35, P51, DOI 10.1590/S0037-86822002000100010
   SEPKOWITZ KA, 1994, ANN INTERN MED, V120, P71, DOI 10.7326/0003-4819-120-1-199401010-00012
   SEPKOWITZ KA, 1996, TUBERCULOSIS, P935
   Silva Jr. Jarbas Barbosa da, 2004, J. bras. pneumol., V30, pS57, DOI 10.1590/S1806-37132004000700003
   Silva VMC, 2002, INFECT CONT HOSP EP, V23, P591, DOI 10.1086/501976
   SNIDER DE, 1994, J INFECT DIS, V169, P1189, DOI 10.1093/infdis/169.6.1189
   Soares Luiz Clovis Parente, 2004, J. bras. pneumol., V30, P350, DOI 10.1590/S1806-37132004000400009
   *SOC BRAS PNEUM TI, 2002, CONTR TUB PROP INT E
   SOKOLOVE PE, 1994, ANN EMERG MED, V24, P418, DOI 10.1016/S0196-0644(94)70178-4
   SOUZA GR, 1997, PULMAO RJ, V6, P220
   [Universidade Federal do Rio de Janeiro Secretaria Municipal Saude Cidade Rio Janeiro], 2004, REC ID TUB CLIN PSIQ
   Wenzel R.P., 1997, PREVENTION CONTROL N
   Williams CT, 1909, BRIT MED J, V1909, P433, DOI 10.1136/bmj.2.2538.433
   WILLIAMS CT, 1982, BRIT MED J, V1, P618
   ZAZA S, 1995, J INFECT DIS, V172, P1542, DOI 10.1093/infdis/172.6.1542
NR 59
TC 7
Z9 9
U1 0
U2 1
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD JAN
PY 2009
VL 35
IS 1
BP 83
EP 90
DI 10.1590/S1806-37132009000100012
PG 8
WC Respiratory System
SC Respiratory System
GA 482VK
UT WOS:000268917200012
PM 19219335
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Dietze, R
   Hadad, DJ
   Mcgee, B
   Molino, LPD
   Maciel, ELN
   Peloquin, CA
   Johnson, DF
   Debanne, SM
   Eisenach, K
   Boom, WH
   Palaci, M
   Johnson, JL
AF Dietze, Reynaldo
   Hadad, David Jamil
   McGee, Bryan
   Molino, Lucilia Pereira Dutra
   Maciel, Ethel Leonor Noia
   Peloquin, Charles A.
   Johnson, Denise F.
   Debanne, Sara M.
   Eisenach, Kathleen
   Boom, W. Henry
   Palaci, Moises
   Johnson, John L.
TI Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary
   Tuberculosis
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Article
DE tuberculosis; oxazolidinones; linezolid; pharmacokinetics;
   antituberculosis agents
ID MULTIDRUG-RESISTANT TUBERCULOSIS; IN-VITRO ACTIVITIES;
   MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; OXAZOLIDINONES;
   EFFICACY; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; COMPLEX
AB Rationale: Linezolid, the first oxazolidinone approved for clinical use, has effective in vitro and promising in vivo activity against Mycobacterium tuberculosis.
   Objectives: To evaluate the early and extended early bactericidal activity of linezolid in patients with pulmonary tuberculosis.
   Methods: Randomized open label trial. Thirty patients with newly diagnosed smear-positive pulmonary tuberculosis (10 per arm) were assigned to receive isoniazid (300 mg daily) and linezolid (600 mg twice daily or 600 mg once daily) for 7 days. Sputum for quantitative culture was collected for 2 days before and then daily during 7 days of study drug administration. Bactericidal activity was estimated by measuring the decline in bacilli during the first 2 days (early bactericidal activity) and the last 5 days of study drug administration (extended early bactericidal activity).
   Measurements and Main Results: The mean early bactericidal activity of isoniazid (0.67 log(10) cfu/ml/d) was greater than that of linezolid twice and once daily (0.26 and 0.18 log(10) cfu/ml/d, respectively). The extended early bactericidal activity of linezolid between Days 2 and 7 was minimal.
   Conclusions: Linezolid has modest early bactericidal activity against rapidly dividing tubercle bacilli in patients with cavitary pulmonary tuberculosis during the first 2 days of administration, but little extended early bactericidal activity. Clinical trial registered with www.clinicaltrials.gov (NCT00396084).
C1 [Dietze, Reynaldo; Hadad, David Jamil; Molino, Lucilia Pereira Dutra; Maciel, Ethel Leonor Noia; Palaci, Moises] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
   [McGee, Bryan; Peloquin, Charles A.] Natl Jewish Med & Res Ctr, Div Mycobacterial & Resp Infect, Denver, CO USA.
   [McGee, Bryan; Peloquin, Charles A.] Natl Jewish Med & Res Ctr, Infect Dis Pharmacokinet Lab, Denver, CO USA.
   [Johnson, Denise F.; Boom, W. Henry; Johnson, John L.] Case Western Reserve Univ, Sch Med, Dept Med, TB Res Unit, Cleveland, OH USA.
   [Johnson, Denise F.; Boom, W. Henry; Johnson, John L.] Univ Hosp Case Med Ctr, Cleveland, OH USA.
   [Debanne, Sara M.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH USA.
   [Eisenach, Kathleen] Univ Arkansas Med Sci, Little Rock, AR 72205 USA.
RP Dietze, R (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, Av Marechal Campos,1468 Maruipe, BR-29040091 Vitoria, ES, Brazil.
EM rdietze@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Dietze,
   Reynaldo/0000-0002-6995-8001
FU Tuberculosis Research Unit (TBRU); United States National Institutes of
   Allergy and Infectious DiseasesUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID); National Institutes
   of Health and Human ServicesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Human
   Genome Research Institute (NHGRI) [NO1-A195383,
   HHSN266200700022C/NO1-Al-70022]; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [N01AI095383, N01AI095383,
   N01AI095383, N01AI095383, N01AI095383, N01AI095383] Funding Source: NIH
   RePORTER
FX Supported by the Tuberculosis Research Unit (TBRU) at Case Western
   Reserve University (CWRU), established with funds from the United States
   National Institutes of Allergy and Infectious Diseases, National
   Institutes of Health and Human Services, under contract no. NO1-A195383
   and HHSN266200700022C/ NO1-Al-70022.
CR Alcala L, 2003, ANTIMICROB AGENTS CH, V47, P416, DOI 10.1128/AAC.47.1.416-417.2003
   Bozdogan B, 2004, INT J ANTIMICROB AG, V23, P113, DOI 10.1016/j.ijantimicag.2003.11.003
   Brindle R, 2001, BMC Pulm Med, V1, P2, DOI 10.1186/1471-2466-1-2
   Burman WJ, 2003, AM J RESP CRIT CARE, V167, P1299, DOI 10.1164/rccm.2302003
   Condos Rany, 2008, Chest, V134, P187, DOI 10.1378/chest.07-1988
   Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P1475, DOI 10.1128/AAC.46.5.1475-1480.2002
   Cynamon MH, 1999, ANTIMICROB AGENTS CH, V43, P1189, DOI 10.1128/AAC.43.5.1189
   Donald P R, 2003, Expert Rev Anti Infect Ther, V1, P141, DOI 10.1586/14787210.1.1.141
   Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141
   Falk A., 1969, DIAGNOSTIC STANDARDS, P68
   Fortun J, 2005, J ANTIMICROB CHEMOTH, V56, P180, DOI 10.1093/jac/dki148
   Honeybourne D, 2003, J ANTIMICROB CHEMOTH, V51, P1431, DOI 10.1093/jac/dkg262
   Huang TS, 2008, ANTIMICROB AGENTS CH, V52, P2226, DOI 10.1128/AAC.00414-07
   JINDANI A, 1980, AM REV RESPIR DIS, V121, P939
   Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC
   Johnson JL, 2006, INT J TUBERC LUNG D, V10, P605
   Molicotti P, 2006, NEW MICROBIOL, V29, P275
   Nuermberger E, 2004, EUR J CLIN MICROBIOL, V23, P243, DOI 10.1007/s10096-004-1109-5
   Park IN, 2006, J ANTIMICROB CHEMOTH, V58, P701, DOI 10.1093/jac/dkl298
   Peloquin CA, 1997, ANTIMICROB AGENTS CH, V41, P2670, DOI 10.1128/AAC.41.12.2670
   PELOQUIN CA, 2008, 1 INT WORKSH CLIN PH
   Rayner CR, 2004, INFECTION, V32, P8, DOI 10.1007/s15010-004-3029-9
   Rayner CR, 2003, CLIN PHARMACOKINET, V42, P1411, DOI 10.2165/00003088-200342150-00007
   Rodriguez JC, 2002, INT J ANTIMICROB AG, V20, P464, DOI 10.1016/S0924-8579(02)00239-X
   Shinabarger D, 1999, Expert Opin Investig Drugs, V8, P1195, DOI 10.1517/13543784.8.8.1195
   SIDDIQI SH, 1992, CLIN MICROBIOLOGY PR
   Sirgel FA, 2000, J ANTIMICROB CHEMOTH, V45, P859, DOI 10.1093/jac/45.6.859
   Sood R., 2006, Infectious Disorders - Drug Targets, V6, P343, DOI 10.2174/187152606779025860
   Sood R, 2005, INT J ANTIMICROB AG, V25, P464, DOI 10.1016/j.ijantimicag.2005.01.021
   Tato M, 2006, INT J ANTIMICROB AG, V28, P75, DOI 10.1016/j.ijantimicag.2006.02.011
   Vera-Cabrera L, 2006, ANTIMICROB AGENTS CH, V50, P3170, DOI 10.1128/AAC.00571-06
   von der Lippe B, 2006, J INFECTION, V52, P92, DOI 10.1016/j.jinf.2005.04.007
   Yew WW, 2008, INT J TUBERC LUNG D, V12, P345
   Zurenko GE, 1996, ANTIMICROB AGENTS CH, V40, P839, DOI 10.1128/AAC.40.4.839
NR 34
TC 103
Z9 115
U1 0
U2 8
PU AMER THORACIC SOC
PI NEW YORK
PA 61 BROADWAY, FL 4, NEW YORK, NY 10006 USA
SN 1073-449X
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PD DEC 1
PY 2008
VL 178
IS 11
BP 1180
EP 1185
DI 10.1164/rccm.200806-892OC
PG 6
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA 378GO
UT WOS:000261309400012
PM 18787216
OA Green Published
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Vierira, RDA
   Milani, EC
   Brasil, M
   Fregona, G
   Dietze, R
AF Noia Maciel, Ethel Leonor
   Araujo Vierira, Rafael da Cruz
   Milani, Eliani Carrara
   Brasil, Mario
   Fregona, Geisa
   Dietze, Reynaldo
TI Community health workers and tuberculosis control: knowledge and
   perceptions
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE attitude of health personnel; tuberculosis; knowledge
AB This study analyzes the knowledge of community health workers in tuberculosis control and their self-perceived knowledge and the importance they ascribe to their role infighting the disease, in Vitoria, Espirito Santo State, Brasil. The study adopted a cross-sectional design, with a pre-tested, semi-structured questionnaire completed by 105 randomly selected health workers. The comparison of proportions between the groups formed by stratification according to time-on-the-job used the chi-squared test with 5% significance. Mean age was 34.5 ( +/- 9.7) years. Sixty-six community health workers (62.9%) had worked on the job for three years or less. Longer time on the job was positively associated with increased understanding of the disease and activities actually performed in TB control. Still, numerous flaws were observed in TB knowledge and control measures among community health workers. Improvements in continuing education. for these workers could foster a more effective contribution to detecting new TB cases in the community and improved treatment adherence by patients.
C1 [Noia Maciel, Ethel Leonor; Araujo Vierira, Rafael da Cruz; Milani, Eliani Carrara; Brasil, Mario; Fregona, Geisa; Dietze, Reynaldo] Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, BR-29040090 Vitoria, ES, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Nucleo Doencas Infecciosas, Ctr Ciencias Saude, Av Marechal Campos 1468, BR-29040090 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Fregona,
   Geisa/0000-0001-5835-8222
CR [Anonymous], 2007, GLOB TUB CONTR SURV
   ARAUJO MBS, CIENC SAUDE COLETIVA, P136
   Castelo Filho Adauto, 2004, J. bras. pneumol., V30, pS57, DOI 10.1590/S1806-37132004000700002
   Chowdhury AMR, 1997, LANCET, V350, P169, DOI 10.1016/S0140-6736(96)11311-8
   Dudley L, 2003, INT J TUBERC LUNG D, V7, pS48
   Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677
   GIFFIN K., 1989, CAD SAUDE PUBLICA, V5, P24
   Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0
   Hashim D S, 2003, East Mediterr Health J, V9, P718
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494
   Kluthcovsky Ana Cláudia Garabeli Cavalli, 2006, Rev. Latino-Am. Enfermagem, V14, P957, DOI 10.1590/S0104-11692006000600019
   Levy Flávia Mauad, 2004, Cad. Saúde Pública, V20, P197, DOI 10.1590/S0102-311X2004000100036
   MACIEL ELN, CIENC SAUDE COLETIVA
   Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P28
   *MIN SAUD CTR REF, 2002, CONTR TUB PROP INT E
   *MIN SAUD SECR POL, 2001, TUB INF AG COMM SAUD
   *MIN SAUD SECR POL, 2002, MAN TECN CONTR TUB C
   *MIN SAUD SECR VIG, 2002, PROGR NAC CONTR TUB
   Muniz Jordana Nogueira, 2005, Ciênc. saúde coletiva, V10, P315, DOI 10.1590/S1413-81232005000200009
   Nunes Mônica de Oliveira, 2002, Cad. Saúde Pública, V18, P1639, DOI 10.1590/S0102-311X2002000600018
   Ruffino-Netto A, 1999, BOL PNEUMOL SANIT, V7, P7
   [Secretaria de Vigilancia em Saude Ministerio da Saude], 2006, SIST NAC VIG SAUD RE
   Silva Joana Azevedo da, 2002, Interface (Botucatu), V6, P75, DOI 10.1590/S1414-32832002000100007
   SIMONNET F, 1988, LANCET, V2, P792
   WHO, 2007, COMM HLTH WORK WHAT
   *WHO, 1993, TB GLOB EM
   WITMER A, 1995, AM J PUBLIC HEALTH, V85, P1055, DOI 10.2105/AJPH.85.8_Pt_1.1055
NR 27
TC 18
Z9 21
U1 0
U2 4
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JUN
PY 2008
VL 24
IS 6
BP 1377
EP 1386
DI 10.1590/S0102-311X2008000600018
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 316UD
UT WOS:000256974300018
PM 18545763
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Dietze, R
   Silva, RECD
   Hadad, DJ
   Struchiner, CJ
AF Noia Maciel, Ethel Leonor
   Dietze, Reynaldo
   Checon de Freitas Silva, Rita Elizabeth
   Hadad, David Jamil
   Struchiner, Claudio Jose
TI Evaluation of a scoring system recommended by the Brazilian Ministry of
   Health for the diagnosis of childhood tuberculosis
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE tuberculosis; diagnosis; child
ID PULMONARY TUBERCULOSIS; CHILDREN; CRITERIA
AB Tuberculosis is currently one of the main causes of death in the world. One of the difficulties for tuberculosis diagnosis in childhood is the bacteriological identification of Mycobacterium tuberculosis. This nested case-control study aimed to compare the diagnostic values of a scoring system proposed by the Brazilian Ministry of Heath for diagnosis of childhood tuberculosis using gastric washing samples taken in the outpatient and hospital settings. A total of 108 children underwent gastric washing (53 with and 55 without tuberculosis). The scoring system proposed by the Brazilian Ministry of Heath for diagnosis of tuberculosis in children with negative sputum smears showed good sensitivity in both groups, and the best cutoff point was "1" (possible tuberculosis), with 92% sensitivity, thus feasible for use as an ancillary diagnostic test in children submitted to gastric washing. Our recommendation is that the Ministry of Health scoring system be used by health services to assist the physician in deciding on whether to continue the investigation of childhood tuberculosis, and not only in children who have already undergone the procedure and who have shown negative results.
C1 [Dietze, Reynaldo; Checon de Freitas Silva, Rita Elizabeth; Hadad, David Jamil] Univ Fed Espirito Santo, Lab Epidemiol Nucl Doencas Infecciosas, Ctr Ciencias Saude, BR-29040091 Vitoria, ES, Brazil.
   [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil.
   [Struchiner, Claudio Jose] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
RP Maciel, ELN (corresponding author), Univ Fed Espirito Santo, Lab Epidemiol Nucl Doencas Infecciosas, Ctr Ciencias Saude, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012; Struchiner, Claudio J/M-9360-2013
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Struchiner, Claudio
   J/0000-0003-2114-847X
CR Couto Sant'Anna Clemax, 2002, J. Pediatr. (Rio J.), V78, P205, DOI 10.1590/S0021-75572002000800011
   Donald P R, 2000, Curr Opin Pulm Med, V6, P187, DOI 10.1097/00063198-200005000-00004
   FARHART CK, 1999, INFECTOLOGIA PEDIAT
   FLETCHER RH, 1996, CLIN EPIDEMIOLOGY
   Fourie PB, 1998, INT J TUBERC LUNG D, V2, P116
   Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4
   Houwert KAF, 1998, EUR RESPIR J, V11, P1116, DOI 10.1183/09031936.98.11051116
   LAVEN GT, 1977, AM REV RESPIR DIS, V115, P743
   MACIEL ELN, 2004, THESIS U ESTADO RIO
   MACIEL ELN, 2006, CAD SAUDE COLET, V14, P81
   MARCONDES E, 2003, PEDIAT BASICA
   MIGLIORI GB, 1992, TUBERCLE LUNG DIS, V73, P145, DOI 10.1016/0962-8479(92)90148-D
   *MIN SAUD, 1995, MAN NORM CONTR TUB
   *MIN SAUD, 2002, CONTR TUB PRP INT EN
   *MIN SAUD, 2000, NORM TECN PROGR CONT
   Nair P H, 1981, Indian Pediatr, V18, P299
   Sant'Anna Clemax Couto, 2004, Braz J Infect Dis, V8, P305, DOI 10.1590/S1413-86702004000400006
   Sant'Anna Clemax Couto, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P103, DOI 10.1590/S0036-46652003000200010
   SOMU N, 1995, TUBERCLE LUNG DIS, V76, P295, DOI 10.1016/S0962-8479(05)80027-9
   STARKE JR, 1992, J PEDIATR-US, V120, P839, DOI 10.1016/S0022-3476(05)81949-3
   STARKE JR, 1993, CHEST, V104, P329, DOI 10.1378/chest.104.2.329
   STEGEN G, 1969, PEDIATRICS, V43, P260
   TIDJANI O, 1986, TUBERCLE, V67, P269, DOI 10.1016/0041-3879(86)90016-4
NR 23
TC 11
Z9 11
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD FEB
PY 2008
VL 24
IS 2
BP 402
EP 408
DI 10.1590/S0102-311X2008000200019
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 271SA
UT WOS:000253807800019
PM 18278287
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Vieira, RDA
   do Prado, TN
   Siqueira, MG
   Dietze, R
   Maciel, ELN
AF Araujo Vieira, Rafael da Cruz
   do Prado, Thiago Nascimento
   Siqueira, Maria Guimaraes
   Dietze, Reynaldo
   Noia Maciel, Ethel Leonor
TI Spatial distribution of new tuberculosis cases in Vitoria, State of
   Espirito Santo, between 2000 and 2005
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Article
DE tuberculosis; prevention; spatial distribution; epidemiological
   surveillance
ID TRANSMISSION; PATTERNS; BRAZIL
AB We carried out an ecological study in which the spatial distribution of 979 new tuberculosis cases between 2000 and 2005 were analyzed. The risk was estimated using the local empirical Bayesian method. The local indicators of spatial association were calculated to evaluate autocorrelations of incidence between adjoining districts. We found that the tuberculosis cases were heterogeneously distributed between districts, and it was possible to identify regions in which there was a high risk of becoming ill.
C1 [Araujo Vieira, Rafael da Cruz; do Prado, Thiago Nascimento; Siqueira, Maria Guimaraes; Dietze, Reynaldo; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, CCS, Lab Epidemiol, BR-29043091 Vitoria, ES, Brazil.
RP Vieira, RDA (corresponding author), Univ Fed Espirito Santo, CCS, Lab Epidemiol, Av Marechal Campos 1648, BR-29043091 Vitoria, ES, Brazil.
EM rcavieira@ndi.ufes.br
CR Assuncao R M, 1998, Cad Saude Publica, V14, P713, DOI 10.1590/S0102-311X1998000400013
   Barcellos, 1996, Cad Saude Publica, V12, P389
   Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679
   BRASIL. Ministerio da Saude  Ministerio da Saude, 2005, SAUD BRAS 2005 AN SI
   Carvalho Marilia Sá, 2005, Cad. Saúde Pública, V21, P361, DOI 10.1590/S0102-311X2005000200003
   Costa, 1998, Cad Saude Publica, V14, P409
   Cressie N., 1993, STAT SPATIAL DATA
   MACIEL ELN, 2007, SISTEMA INFORM GEOPR
   *MIN SAUD, 2006, REL SIT ESP SANT SIS
   Molina Serpa Ivette, 2003, Cad. Saúde Pública, V19, P1305, DOI 10.1590/S0102-311X2003000500009
   Moonan PK, 2004, INT J HEALTH GEOGR, V3, P23, DOI DOI 10.1186/1476-072X-3-23
   Xavier MIM, 2007, CAD SAUDE PUBLICA, V23, P445, DOI 10.1590/S0102-311X2007000200021
   Munch Z, 2003, INT J TUBERC LUNG D, V7, P271
   Neto O L, 2001, Cad Saude Publica, V17, P1241
   Ruffino-Netto Antonio, 2002, Rev. Soc. Bras. Med. Trop., V35, P51, DOI 10.1590/S0037-86822002000100010
   Souza W V, 2000, Rev Panam Salud Publica, V8, P403, DOI 10.1590/S1020-49892000001100005
   Souza WV, 2005, REV SAUDE PUBL, V39, P82, DOI [10.1590/S0034-89102005000100011, 10.1590/s0034-89102005000100011]
   *WHO, 2006, GLOB TUB CONTR SURV
NR 18
TC 17
Z9 17
U1 0
U2 4
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2008
VL 41
IS 1
BP 82
EP 86
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 279XC
UT WOS:000254387500017
PM 18368278
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Palaci, M
   Dietze, R
   Hadad, DJ
   Ribeiro, FKC
   Peres, RL
   Vinhas, SA
   Maciel, ELN
   Dettoni, VD
   Horter, L
   Boom, WH
   Johnson, JL
   Eisenach, KD
AF Palaci, Moises
   Dietze, Reynaldo
   Hadad, David Jamil
   Ribeiro, Fabiola Karla Correa
   Peres, Renata Lyrio
   Vinhas, Solange Alves
   Maciel, Ethel Leonor Noia
   Dettoni, Valedrio do Valle
   Horter, Libby
   Boom, W. Henry
   Johnson, John L.
   Eisenach, Kathleen D.
TI Cavitary disease and quantitative sputum bacillary load in cases of
   pulmonary tuberculosis
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ACTIVITY; CULTURE
AB We examined sputum bacterial loads in adults with newly diagnosed tuberculosis using quantitative culture and time-until-positive (DTP) culture in BACTEC 460. Patients with cavitary disease had higher CFU levels than those without cavities and shorter DTPs. Within radiographic strata of moderately and far advanced tuberculosis, higher CFU counts were associated with cavitary disease.
C1 [Palaci, Moises; Dietze, Reynaldo; Hadad, David Jamil; Ribeiro, Fabiola Karla Correa; Peres, Renata Lyrio; Vinhas, Solange Alves; Maciel, Ethel Leonor Noia; Dettoni, Valedrio do Valle] Univ Fed Espirito Santo, Ctr Ciencias Saude, BR-29040091 Vitoria, Brazil.
   [Horter, Libby; Boom, W. Henry; Johnson, John L.] Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA.
   [Horter, Libby; Boom, W. Henry; Johnson, John L.] Univ Hosp Case Med Ctr, Cleveland, OH USA.
   [Eisenach, Kathleen D.] Univ Arkansas Med Sci, Dept Pathol & Microbiol, Dept Immunol, Little Rock, AR 72205 USA.
RP Palaci, M (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Saude, Av Marechal Campos,1468 Maruipe, BR-29040091 Vitoria, Brazil.
EM mpalaci@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Dietze,
   Reynaldo/0000-0002-6995-8001
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [N01AI095383, N01AI095383, N01AI095383, N01AI095383, N01AI095383,
   N01AI095383] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [N01AI95383] Funding Source: Medline
CR Andreu J, 2004, EUR J RADIOL, V51, P139, DOI 10.1016/j.ejrad.2004.03.009
   Benator D, 2002, LANCET, V360, P528
   CANETTI G, 1965, AM REV RESPIR DIS, V92, P687
   Canetti G., 1955, TUBERCLE BACILLUS PU
   Dietze R, 2001, ANTIMICROB AGENTS CH, V45, P1972, DOI 10.1128/AAC.45.7.1972-1976.2001
   Donald PR, 1997, AM J RESP CRIT CARE, V156, P895, DOI 10.1164/ajrccm.156.3.9609132
   Epstein MD, 1998, CHEST, V113, P379, DOI 10.1378/chest.113.2.379
   Falk A., 1969, DIAGNOSTIC STANDARDS, P68
   Gomes Mauro, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P275, DOI 10.1590/S0036-46652003000500007
   GREENBAUM M, 1980, AM REV RESPIR DIS, V121, P477, DOI 10.1164/arrd.1980.121.3.477
   HOWARD WL, 1949, AM REV TUBERC PULM, V59, P391
   Matsuoka S, 2004, CLIN IMAG, V28, P119, DOI 10.1016/S0899-7071(03)00148-7
   MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062
   PERRIN FM, 2006, PROGRAM ABSTRACTS AM, P505
   Rathman G, 2003, INT J TUBERC LUNG D, V7, P942
   Wallis RS, 1999, ANTIMICROB AGENTS CH, V43, P2600, DOI 10.1128/AAC.43.11.2600
   *WHO, 1998, 98258 WHO TB
   Wilcke JTR, 1998, RESP MED, V92, P493, DOI 10.1016/S0954-6111(98)90297-9
   ZIERSKI M, 1980, AM REV RESPIR DIS, V122, P879
NR 19
TC 94
Z9 94
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD DEC
PY 2007
VL 45
IS 12
BP 4064
EP 4066
DI 10.1128/JCM.01780-07
PG 3
WC Microbiology
SC Microbiology
GA 241AT
UT WOS:000251630000035
PM 17928422
OA Green Published, Bronze
DA 2020-12-15
ER

PT J
AU Maciel, EL
   Meireles, W
   Silva, AP
   Fiorotti, K
   Dietze, R
AF Noia Maciel, Ethel Leonor
   Meireles, Waleska
   Silva, Ana Paula
   Fiorotti, Karina
   Dietze, Reynaldo
TI Nosocomial Mycobacterium tuberculosis transmission among healthcare
   students in a high incidence region, in Vitoria, State of Espirito Santo
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE students; tuberculosis; tuberculin test; health care students;
   nosocomial transmission
AB This open comparitive study for evaluating hypersensitivily totuberculin among medical students (n=441), nursing students (n=178) and economics students (n=230) in Viloria, State of Espirito Santo, bad The aim of assessing whether the prevalence of positive tuberculin tests among healthcare students could be used as a senlinel event for nosocoinial transini'ssion in localities with high eudendcil) Mere was a significant change in the frequency of purified protein derivative reactivity, in the nursing students (20.3%) and inedicalstudents (18.4%), in comparison with the economics students (6%) (p < 0. 001). As expected, The inedical and nursing students bad inore knowledge about tuberculosis than did The economics students 0) <0. 001). Our data suggest then the incidence qfMycobacteriurn tuberculosis infection aniong 11111-sing and inedical students in our region, which has high endemicit)) of tuberculosis, does not differfroin what isfound in low-incidence countries. These data reinforce The needfor imPlenzenting biosafet),prograinsfor this laigetpopulation.
C1 UFES, Nucl Doencas Infecciosas CCS, Maruipe, Vitoria, Estonia.
RP Maciel, ELN (corresponding author), UFES, Nucl Doencas Infecciosas CCS, Marechal Campos 1468, Maruipe, Vitoria, Estonia.
EM eniacicl@ndj.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR Brudney K, 1991, Semin Respir Infect, V6, P261
   DIEHL HS, 1948, JAMA-J AM MED ASSOC, V138, P8, DOI 10.1001/jama.1948.02900010010003
   Esteban J, 2001, INT J TUBERC LUNG D, V5, P583
   KRITSKI AL, 1996, TRATADO INFECT, V1, P947
   MEADE GM, 1948, AM REV TUBERC PULM, V58, P675
   Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120
   *MIN SAUD, 1994, CONTR TUBERC PROP IN
   *MIN SAUD, 1995, MAN NORM CONTR TUB C
   MYERS JA, 1957, AM REV TUBERC PULM, V75, P442
   National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1
   SEPKOWITZ KA, 1995, CLIN MICROBIOL REV, V8, P180, DOI 10.1128/CMR.8.2.180
   SEPKOWITZ KA, 1996, TUBERCULOSIS BROWAND, V77, P935
   Silva VMC, 2000, INT J TUBERC LUNG D, V4, P420
   Teixeira L, 2000, INT J TUBERC LUNG D, V4, P1074
   *WHO, 1995, WHO REP TUB EPID
NR 15
TC 16
Z9 20
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2007
VL 40
IS 4
BP 397
EP 399
DI 10.1590/S0037-86822007000400004
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 206UW
UT WOS:000249209400004
PM 17876458
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Johnson, JL
   Hadad, DJ
   Boom, WH
   Daley, CL
   Peloquin, CA
   Eisenach, KD
   Jankus, DD
   Debanne, SM
   Charlebois, ED
   Maciel, E
   Palaci, M
   Dietze, R
AF Johnson, J. L.
   Hadad, D. J.
   Boom, W. H.
   Daley, C. L.
   Peloquin, C. A.
   Eisenach, K. D.
   Jankus, D. D.
   Debanne, S. M.
   Charlebois, E. D.
   Maciel, E.
   Palaci, M.
   Dietze, R.
TI Early and extended early bactericidal activity of levofloxacin,
   gatifloxacin and moxifloxacin in pulmonary tuberculosis
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE tuberculosis; fluoroquinolones; moxifloxacin; levofloxacin;
   gatifloxacin; antitubercular agents; early bactericidal activity
ID MULTIDRUG-RESISTANT TUBERCULOSIS; IN-VITRO ACTIVITY; STERILIZING
   ACTIVITIES; 4 FLUOROQUINOLONES; SAFETY; PHARMACOKINETICS; CIPROFLOXACIN;
   REGIMENS; RIFAMPIN; DRUGS
AB OBJECTIVE: To evaluate the early bactericidal activity (EBA) of the new fluoroquinolones levofloxacin, gatifloxacin and moxifloxacin in patients with pulmonary tuberculosis (PTB).
   DESIGN: Randomized, open-label trial. Forty adults with newly diagnosed smear-positive PTB (10 per arm) were assigned to receive isoniazid (INH) 300 mg, levofloxacin 1000 mg, gatifloxacin 400 mg, or moxifloxacin 400 mg daily for 7 days. Sputum for quantitative culture was collected for 2 days before and daily during 7 days of monotherapy. Bactericidal activity was estimated by measuring the decline in bacilli during the first 2 days (EBA 0-2) and last 5 days of monotherapy (extended EBA, EBA 2-7). Laboratory staff were blinded to treatment assignment.
   RESULTS: The EBA 0-2 of INH(0.67 log(10) cfu/ml/day) was greater than that of moxifloxacin and gatifloxacin (0.33 and 0.35 log(10) cfu/ml/day, respectively), but not of levofloxacin 1000 mg daily (0.45 log(10) cfu/ml/day) (P = 0.14). Bactericidal activity between days 2 and 7 was similar for all three fluoroquinolones. In a pooled comparison, the EBA 2-7 of the fluoroquinolones was greater than for INH.
   CONCLUSION: Moxifloxacin, gatifloxacin, and high-dose levofloxacin have excellent EBA, only slightly less than for INH, and greater extended EBA. These drugs warrant further study in the treatment of drug-susceptible TB.
C1 Univ Hosp Cleveland, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA.
   Univ Fed Espirito Santo, Ctr Biomed, Vitoria, Brazil.
   Natl Jewish Med & Res Ctr, Div Mycobacterial & Resp Infect, Denver, CO USA.
   Natl Jewish Med & Res Ctr, Infect Dis Pharmacokinet Lab, Denver, CO USA.
   Univ Colorado, Sch Pharm, Denver, CO 80202 USA.
   Univ Colorado, Sch Med, Denver, CO 80202 USA.
   Univ Arkansas Med Sci, Little Rock, AR 72205 USA.
   Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.
   Univ Calif San Francisco, AIDS Res Inst, San Francisco, CA 94143 USA.
RP Johnson, JL (corresponding author), Univ Hosp Cleveland, Dept Med, Div Infect Dis, Room 406,Foley Bldg,Mailstop Foley 5083,11100 Euc, Cleveland, OH 44106 USA.
EM jlj@case.edu
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [N01-AI95383] Funding Source: Medline;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [N01AI095383, N01AI095383, N01AI095383, N01AI095383, N01AI095383,
   N01AI095383] Funding Source: NIH RePORTER
CR Alvirez-Freites EJ, 2002, ANTIMICROB AGENTS CH, V46, P1022, DOI 10.1128/AAC.46.4.1022-1025.2002
   BAOHONG J, 1995, ANTIMICROB AGENTS CH, V39, P1341
   Burman WJ, 2003, AM J RESP CRIT CARE, V167, P1299, DOI 10.1164/rccm.2302003
   Chien SC, 1998, ANTIMICROB AGENTS CH, V42, P885, DOI 10.1128/AAC.42.4.885
   Dietze R, 2001, ANTIMICROB AGENTS CH, V45, P1972, DOI 10.1128/AAC.45.7.1972-1976.2001
   Donald P R, 2003, Expert Rev Anti Infect Ther, V1, P141, DOI 10.1586/14787210.1.1.141
   Falk A., 1969, DIAGNOSTIC STANDARDS, P68
   Firsov AA, 2003, ANTIMICROB AGENTS CH, V47, P1604, DOI 10.1128/AAC.47.5.1604-1613.2003
   Gillespie SH, 1999, J ANTIMICROB CHEMOTH, V44, P393, DOI 10.1093/jac/44.3.393
   Goldstein EJC, 2002, CLIN INFECT DIS, V35, P1505, DOI 10.1086/344768
   Gosling RD, 2003, AM J RESP CRIT CARE, V168, P1342, DOI 10.1164/rccm.200305-682OC
   Hu YM, 2003, ANTIMICROB AGENTS CH, V47, P653, DOI 10.1128/AAC.47.2.653-657.2003
   JINDANI A, 1980, AM REV RESPIR DIS, V121, P939
   Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC
   Kennedy N, 1996, CLIN INFECT DIS, V22, P827, DOI 10.1093/clinids/22.5.827
   Miller RGJ, 1981, SIMULTANEOUS STAT IN
   Nuermberger E, 2004, EUR J CLIN MICROBIOL, V23, P243, DOI 10.1007/s10096-004-1109-5
   Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC
   Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC
   Peloquin CA, 1998, ANN PHARMACOTHER, V32, P268, DOI 10.1345/aph.17167
   Piscitelli SC, 1999, ANTIMICROB AGENTS CH, V43, P2323, DOI 10.1128/AAC.43.9.2323
   Pletz MWR, 2004, ANTIMICROB AGENTS CH, V48, P780, DOI 10.1128/AAC.48.3.780-782.2004
   Richeldi L, 2002, Monaldi Arch Chest Dis, V57, P39
   Rodriguez JC, 2002, INT J ANTIMICROB AG, V20, P464, DOI 10.1016/S0924-8579(02)00239-X
   Rodriguez JC, 2001, INT J ANTIMICROB AG, V17, P229, DOI 10.1016/S0924-8579(00)00337-X
   Sanders CA, 2004, J CLIN MICROBIOL, V42, P5225, DOI 10.1128/JCM.42.11.5225-5228.2004
   Schentag JJ, 2001, CLIN INFECT DIS, V32, pS39, DOI 10.1086/319375
   SIDDIQI SH, 1992, CLIN MICROBIOLOGY PR
   Sirgel FA, 2005, AM J RESP CRIT CARE, V172, P128, DOI 10.1164/rccm.200411-1557OC
   Sirgel FA, 1997, AM J RESP CRIT CARE, V156, P901, DOI 10.1164/ajrccm.156.3.9611066
   Sirgel FA, 2000, J ANTIMICROB CHEMOTH, V45, P859, DOI 10.1093/jac/45.6.859
   Telzak EE, 1999, INT J TUBERC LUNG D, V3, P337
   *TUB RES CTR, 2002, INDIAN J TUBERC, V49, P27
   Yew WW, 2003, CHEST, V124, P1476, DOI 10.1378/chest.124.4.1476
   Yoshimatsu T, 2002, ANTIMICROB AGENTS CH, V46, P1875, DOI 10.1128/AAC.46.6.1875-1879.2002
NR 35
TC 155
Z9 165
U1 0
U2 5
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
EI 1815-7920
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD JUN
PY 2006
VL 10
IS 6
BP 605
EP 612
PG 8
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 045VP
UT WOS:000237771100004
PM 16776446
DA 2020-12-15
ER

PT J
AU Ribeiro-Rodrigues, R
   Co, TR
   Rojas, R
   Toossi, Z
   Dietze, R
   Boom, WH
   Maciel, E
   Hirsch, CS
AF Ribeiro-Rodrigues, R
   Co, TR
   Rojas, R
   Toossi, Z
   Dietze, R
   Boom, WH
   Maciel, E
   Hirsch, CS
TI A role for CD4(+)CD25(+) T cells in regulation of the immune response
   during human tuberculosis
SO CLINICAL AND EXPERIMENTAL IMMUNOLOGY
LA English
DT Article
DE anti-TB therapy; immune activation; IFN-gamma; regulatory T cells;
   tuberculosis
ID HUMAN-IMMUNODEFICIENCY-VIRUS; INTERFERON-GAMMA PRODUCTION;
   MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; IN-VITRO; INFECTED
   INDIVIDUALS; LEISHMANIA-MAJOR; DENDRITIC CELLS; CD4(+); APOPTOSIS
AB Active tuberculosis (TB) is associated with prolonged suppression of Mycobacterium tuberculosis (MTB)-specific immune responses, but mechanisms involved are understood incompletely. We investigated a potential role for CD4(+)CD25(+) regulatory T cells in depressed anti-MTB immunity by evaluating serially CD4 cell phenotype and interferon (IFN)-gamma production by mononuclear cells from patients with TB. At diagnosis, frequencies of CD4(+)CD25(+) T cells were increased in blood from TB patients compared to healthy purified protein derivative (PPD)-positive controls (with a history of prior TB exposure), and remained elevated at completion of therapy (6 months). By contrast, expression of another activation marker, CD69, by CD4 T cells was increased at diagnosis, but declined rapidly to control levels with treatment. Among CD4(+)CD25(+) T cells from TB patients at diagnosis those expressing high levels of CD25, probably representing regulatory T cells, were increased 2.9-fold when compared to control subjects, while MTB-stimulated IFN-gamma levels in whole blood supernatants were depressed. A role for CD4(+)CD25(+) T cells in depressed IFN-gamma production during TB was substantiated in depletion experiments, where CD25(+)-depleted CD4 T cells produced increased amounts of IFN-gamma upon MTB stimulation compared to unseparated T cells. At follow-up, IFN-gamma production improved most significantly in blood from TB patients with high baseline frequencies of CD4(+)CD25(+) T cells (more than threefold higher than controls for both total and CD25(hi+) CD4 T cells), who also had a significant drop in frequencies of both total and 'regulatory' CD4(+)CD25(+) T cells in response to treatment. Expansion of CD4(+)CD25(+) regulatory T cells during active TB may play a role in depressed T cell IFN-gamma production.
C1 Univ Fed Espirito Santo, Vitoria, ES, Brazil.
   Case Western Reserve Univ, Univ Hosp Cleveland, Cleveland, OH 44106 USA.
   Vet Affairs Med Ctr, Cleveland, OH USA.
RP Hirsch, CS (corresponding author), Dept Med, Div Infect Dis, 10900 Euclid Ave BRB 10 W, Cleveland, OH 44106 USA.
EM cxh40@po.cwru.edu
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [N01AI095383, N01AI045244, N01AI095383, N01AI095383, N01AI045244,
   N01AI095383, N01AI045244, N01AI095383, N01AI045244, N01AI045244,
   N01AI045244, N01AI045244, N01AI095383, N01AI045244, N01AI045244,
   N01AI045244] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [N01AI95383, AI-45244, AI-95383] Funding Source: Medline
CR Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004
   Akbar AN, 2003, IMMUNOLOGY, V109, P319, DOI 10.1046/j.1365-2567.2003.01678.x
   [Anonymous], 2003, Wkly Epidemiol Rec, V78, P122
   Baecher-Allan C, 2005, CLIN IMMUNOL, V115, P10, DOI 10.1016/j.clim.2005.02.018
   Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245
   Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152
   Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497
   Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032
   Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918
   Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407
   Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016
   Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996
   GREEN DR, 1983, ANNU REV IMMUNOL, V1, P439, DOI 10.1146/annurev.iy.01.040183.002255
   Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114
   Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193
   Hirsch CS, 1997, P NATL ACAD SCI USA, V94, P3926, DOI 10.1073/pnas.94.8.3926
   Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667
   Hirsch CS, 2001, J INFECT DIS, V183, P779, DOI 10.1086/318817
   HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x
   Jonuleit H, 2001, INT J CANCER, V93, P243, DOI 10.1002/ijc.1323
   Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285
   Jonuleit H, 2001, TRENDS IMMUNOL, V22, P394, DOI 10.1016/S1471-4906(01)01952-4
   Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069
   Kony SJ, 2000, J INFECTION, V41, P167, DOI 10.1053/jinf.2000.0721
   Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295
   McGuirk P, 2002, TRENDS IMMUNOL, V23, P450, DOI 10.1016/S1471-4906(02)02288-3
   Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298
   Mills KHG, 2004, SEMIN IMMUNOL, V16, P107, DOI 10.1016/j.smim.2003.12.006
   Mitterbauer-Hohendanner G, 2004, EUR J CLIN INVEST, V34, P12, DOI 10.1111/j.0960-135X.2004.01366.x
   Mustafa T, 2001, SCAND J IMMUNOL, V54, P630, DOI 10.1046/j.1365-3083.2001.01020.x
   Oldenhove G, 2003, J EXP MED, V198, P259, DOI 10.1084/jem.20030654
   Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217
   Ribeiro-Rodrigues R, 2002, CLIN DIAGN LAB IMMUN, V9, P818, DOI 10.1128/CDLI.9.4.818-823.2002
   Sakaguchi S, 2003, NAT IMMUNOL, V4, P10, DOI 10.1038/ni0103-10
   Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122
   Satoguina J, 2002, MICROBES INFECT, V4, P1291, DOI 10.1016/S1286-4579(02)00014-X
   Sereti I, 2004, BLOOD, V104, P775, DOI 10.1182/blood-2003-12-4355
   Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769
   Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P
   Taams LS, 2002, EUR J IMMUNOL, V32, P1621, DOI 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q
   TOOSSI Z, 1986, J EXP MED, V163, P1162, DOI 10.1084/jem.163.5.1162
   TORRES M, 1994, CLIN EXP IMMUNOL, V96, P75, DOI 10.1111/j.1365-2249.1994.tb06233.x
   Vanham G, 1997, TUBERCLE LUNG DIS, V78, P145, DOI 10.1016/S0962-8479(97)90021-6
   Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365
   Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165
   ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611
   1969, CLASSIFICATION PULMO, P68
NR 47
TC 171
Z9 188
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9104
EI 1365-2249
J9 CLIN EXP IMMUNOL
JI Clin. Exp. Immunol.
PD APR
PY 2006
VL 144
IS 1
BP 25
EP 34
DI 10.1111/j.1365-2249.2006.03027.x
PG 10
WC Immunology
SC Immunology
GA 021YT
UT WOS:000236022500004
PM 16542361
OA Green Published, Bronze
DA 2020-12-15
ER

PT J
AU Maciel, ELN
   Viana, MC
   Zeitoune, RCG
   Ferreira, C
   Fregona, G
   Dietze, R
AF Maciel, ELN
   Viana, MC
   Zeitoune, RCG
   Ferreira, C
   Fregona, G
   Dietze, R
TI Prevalence and incidence of Mycobacterium tuberculosis infection in
   nursing students in Vitoria, Espirito Santo
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE nursing students; tuberculosis; purified protein derivative
ID HEALTH-CARE WORKERS; NOSOCOMIAL TRANSMISSION; RISK
AB This prospective study evaluated the incidence of Mycobacterium tuberculosis infection among nursing students at the Federal University of Espirito Santo, using the purified protein derivative test. In parallel, we evaluated whether knowledge on tuberculosis transmission mechanisms had any impact on nursing students' attitudes in relation to the risk of tuberculosis infection. The incidence of tuberculin conversion was 10.5% per year (p=0.035, 95% CI = 3.63-17.43), whereas the expected conversion rate in the overall population in Brazil is 0.5% per year These results indicate nursing students as a group at risk for TB infection. Among the risk factors studied only the use of NIOSH95 masks was associated with protection against infection (RR=0.2). Furthermore there was no statistical difference among students that PPD converted and those who remained negative regarding disease knowledge and the existence of adequate facilities for patient hospitalization. Our data reinforces the need for implementing special biosafety programs targeting this professional group.
C1 UFES, CBM, Nucleo Doencas Infecciosas, BR-29040091 Vitoria, ES, Brazil.
   Escola Med Santa Casa Misericordia, Vitoria, ES, Brazil.
   Univ Fed Rio de Janeiro, Escola Enfermagem Ana Nery, Rio De Janeiro, Brazil.
RP Maciel, ELN (corresponding author), UFES, CBM, Nucleo Doencas Infecciosas, Av Marechal Campos 1468, BR-29040091 Vitoria, ES, Brazil.
EM emaciel@ndi.ufes.br
RI Maciel, Ethel Leonor LN/G-1027-2012; Silva, Ilce/AAV-4956-2020;
   ZEITOUNE, REGINA/AAR-2222-2020; Viana, Maria Carmen/B-6047-2013
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Silva,
   Ilce/0000-0002-7134-3030; Fregona, Geisa/0000-0001-5835-8222; Viana,
   Maria Carmen/0000-0002-0464-4845
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-95383, AI-45244] Funding Source:
   Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [N01AI095383, N01AI095383, N01AI095383, N01AI045244,
   N01AI095383, N01AI045244, N01AI045244, N01AI095383, N01AI045244,
   N01AI045244, N01AI045244, N01AI095383, N01AI045244, N01AI045244,
   N01AI045244, N01AI045244] Funding Source: NIH RePORTER
CR ABRUZZI WA, 1953, NEW ENGL J MED, V248, P722, DOI 10.1056/NEJM195304232481705
   [Anonymous], 1994, MMWR Recomm Rep, V43, P1
   ELLNER JJ, 1993, J INFECT DIS, V168, P537, DOI 10.1093/infdis/168.3.537
   Esteban J, 2001, INT J TUBERC LUNG D, V5, P583
   KLITZMAN S, 1994, OCCUP MED, V9, P723
   KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M
   LAFORCE FM, 1997, PREVENTION CONTROL N, V1, P4
   MCGOWAN JE, 1995, CLIN INFECT DIS, V21, P489, DOI 10.1093/clinids/21.3.489
   MEADE GM, 1948, AM REV TUBERC PULM, V58, P675
   Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120
   *MIN SAUD, 1994, CONTR TUB PROP INT E
   *MIN SAUD, 1995, MAN NORM PAR CONTR T
   MYERS JA, 1957, AM REV TUBERC PULM, V75, P442
   PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191
   Ruffino-Netto A, 1977, Rev Saude Publica, V11, P188, DOI 10.1590/S0034-89101977000200004
   SEPKOWITZ KA, 1995, CLIN INFECT DIS, V20, P232, DOI 10.1093/clinids/20.2.232
   SEPULVEDA RL, 1990, AM REV RESPIR DIS, V142, P24, DOI 10.1164/ajrccm/142.1.24
   Silva VMC, 2000, INT J TUBERC LUNG D, V4, P420
   *SOC BRAS PNEUM, 1997, J PNEUMOLOGIA, V23, P339
   SOKOLOVE PE, 1994, ANN EMERG MED, V24, P418, DOI 10.1016/S0196-0644(94)70178-4
   Teixeira L, 2000, INT J TUBERC LUNG D, V4, P1074
   ZAZA S, 1995, J INFECT DIS, V172, P1542, DOI 10.1093/infdis/172.6.1542
NR 22
TC 24
Z9 26
U1 0
U2 1
PU SOCIEDADE BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2005
VL 38
IS 6
BP 469
EP 472
DI 10.1590/S0037-86822005000600004
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 000KU
UT WOS:000234461500004
PM 16410920
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Ribeiro-Rodrigues, R
   Co, TR
   Johnson, JL
   Ribeiro, F
   Palaci, M
   Sa, RT
   Maciel, EL
   Lima, FEP
   Dettoni, V
   Toossi, Z
   Boom, WH
   Dietze, R
   Ellner, JJ
   Hirsch, CS
AF Ribeiro-Rodrigues, R
   Co, TR
   Johnson, JL
   Ribeiro, F
   Palaci, M
   Sa, RT
   Maciel, EL
   Lima, FEP
   Dettoni, V
   Toossi, Z
   Boom, WH
   Dietze, R
   Ellner, JJ
   Hirsch, CS
TI Sputum cytokine levels in patients with pulmonary tuberculosis as early
   markers of mycobacterial clearance
SO CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
LA English
DT Article
ID INTERFERON-GAMMA; BRONCHOALVEOLAR LAVAGE; DISEASE; SARCOIDOSIS;
   INDUCTION; INFECTION; APOPTOSIS; CELLS; BLOOD; MICE
AB Sputum and serum from patients with active pulmonary tuberculosis (TB), healthy purified protein derivative-positive adults, and patients with bacterial pneumonia were collected to simultaneously assess local immunity in the lungs and peripheral blood. To determine whether cytokine profiles in sputum from TB patients and control subjects were a reflection of its cellular composition, cytospin slides were prepared in parallel and assessed for the presence of relative proportions of epithelial cells, neutrophils, macrophages, and T cells. Gamma interferon (IFN-gamma) in sputum from TB patients was markedly elevated over levels for both control groups. With anti-TB therapy, IFN-gamma levels in sputum from TB patients decreased rapidly and by week 4 of treatment were comparable to those in sputum from controls. Further, IFN-gamma levels in sputum closely followed mycobacterial clearance. Although detected at fourfold-lower levels, IFN-gamma immunoreactivities in serum followed kinetics in sputum. TNF-alpha, interleukin 8 (IL-8) and IL-6 also were readily detected in sputum from TB patients at baseline and responded to anti-TB therapy. In contrast to IFN-gamma, however, TNF-alpha and IL-8 levels also were elevated in sputum from pneumonia controls. These data indicate that sputum cytokines correlate with disease activity during active TB of the lung and may serve as potential early markers for sputum conversion and response to anti-TB therapy.
C1 Univ Fed Espirito Santo, Vitoria, ES, Brazil.
   Case Western Reserve Univ, Univ Hosp Cleveland, Cleveland, OH 44106 USA.
   Vet Affairs Med Ctr, Cleveland, OH 44106 USA.
   Univ Med & Dent New Jersey, Newark, NJ 07103 USA.
RP Hirsch, CS (corresponding author), Dept Med, Div Infect Dis, BRB 10W,10900 Euclid Ave, Cleveland, OH 44106 USA.
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355; Ellner,
   Jerrold/0000-0001-6150-0082; Dietze, Reynaldo/0000-0002-6995-8001
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-01514, N01AI95383, AI-45244, AI-95383]
   Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [N01AI045244, N01AI045244, N01AI045244,
   N01AI045244, K08AI001514, N01AI045244, N01AI045244, K08AI001514,
   N01AI095383, K08AI001514, N01AI095383, N01AI095383, N01AI045244,
   N01AI045244, N01AI045244, N01AI095383, N01AI045244, N01AI095383,
   N01AI095383] Funding Source: NIH RePORTER
CR Alexis N, 2000, CLIN IMMUNOL, V97, P21, DOI 10.1006/clim.2000.4911
   Bhowmik A, 1998, THORAX, V53, P953, DOI 10.1136/thx.53.11.953
   Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9
   COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243
   D'Ippolito R, 1999, CHEST, V115, P1611, DOI 10.1378/chest.115.6.1611
   Desjardin LE, 1999, AM J RESP CRIT CARE, V160, P203, DOI 10.1164/ajrccm.160.1.9811006
   FAHY JV, 1995, AM J RESP CRIT CARE, V152, P53, DOI 10.1164/ajrccm.152.1.7599862
   FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249
   Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com
   Henig NR, 2001, THORAX, V56, P306, DOI 10.1136/thorax.56.4.306
   Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667
   Hirsch CS, 2001, J INFECT DIS, V183, P779, DOI 10.1086/318817
   Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092
   Li BQ, 1998, J IMMUNOL, V161, P1558
   MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062
   Moodley YP, 2000, THORAX, V55, P696, DOI 10.1136/thorax.55.8.696
   Schwander SK, 1998, J INFECT DIS, V178, P1434, DOI 10.1086/314454
   Schwander SK, 1996, J INFECT DIS, V173, P1267, DOI 10.1093/infdis/173.5.1267
   Somoskovi A, 1999, EUR CYTOKINE NETW, V10, P135
   TOOSSI Z, 1995, J IMMUNOL, V154, P465
   1969, DIAGNOSTIC STANDARDS, P68
NR 21
TC 70
Z9 76
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1071-412X
J9 CLIN DIAGN LAB IMMUN
JI Clin. Diagn. Lab. Immunol.
PD JUL
PY 2002
VL 9
IS 4
BP 818
EP 823
DI 10.1128/CDLI.9.4.818-823.2002
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 575CW
UT WOS:000176929600013
PM 12093679
OA Bronze, Green Published
DA 2020-12-15
ER

PT J
AU Wallis, RS
   Phillips, M
   Johnson, JL
   Teixeira, L
   Rocha, LMMC
   Maciel, E
   Rose, L
   Wells, C
   Palaci, M
   Dietze, R
   Eisenach, K
   Ellner, JJ
AF Wallis, RS
   Phillips, M
   Johnson, JL
   Teixeira, L
   Rocha, LMMC
   Maciel, E
   Rose, L
   Wells, C
   Palaci, M
   Dietze, R
   Eisenach, K
   Ellner, JJ
TI Inhibition of isoniazid-induced expression of Mycobacterium tuberculosis
   antigen 85 in sputum: Potential surrogate marker in tuberculosis
   chemotherapy trials
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID EARLY BACTERICIDAL ACTIVITY; PULMONARY TUBERCULOSIS; COMPLEX
AB Mycobacterium tuberculosis antigen 85 is induced in vitro by isoniazid (INH); its sustained induction in sputum during tuberculosis (TB) therapy predicts relapse. In this trial, rifampin or rifalazil inhibited the induction of sputum antigen 85 by INH in a dose-dependent fashion. This approach may facilitate the evaluation of new TB drugs.
C1 Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA.
   Case Western Reserve Univ, Cleveland, OH 44106 USA.
   Univ Fed Espirito Santo, Vitoria, Brazil.
   Univ Arkansas Med Sci, Little Rock, AR 72205 USA.
   PathoGenesis Corp, Seattle, WA USA.
RP Wallis, RS (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, 185 S Orange Ave,MSB I-503, Newark, NJ 07103 USA.
RI Wallis, Robert/A-8018-2009; Maciel, Ethel Leonor LN/G-1027-2012
OI Wallis, Robert/0000-0001-6152-5183; Maciel, Ethel Leonor
   LN/0000-0003-4826-3355; Ellner, Jerrold/0000-0001-6150-0082; Dietze,
   Reynaldo/0000-0002-6995-8001
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [N01AI045244, R01AI041911, N01AI045244, N01AI045244, N01AI045244,
   N01AI045244, N01AI045244, R01AI041911, R01AI041911, N01AI045244,
   N01AI045244, N01AI045244, N01AI045244, R01AI041911] Funding Source: NIH
   RePORTER; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [N01 AI045244, N01-AI45244,
   R01-AI41911] Funding Source: Medline
CR Botha FJH, 1996, S AFR MED J, V86, P155
   Donald PR, 1997, AM J RESP CRIT CARE, V156, P895, DOI 10.1164/ajrccm.156.3.9609132
   Garbe TR, 1996, ANTIMICROB AGENTS CH, V40, P1754, DOI 10.1128/AAC.40.7.1754
   MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6
   MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423
   SIRGEL FA, 1993, J ANTIMICROB CHEMOTH, V32, P867, DOI 10.1093/jac/32.6.867
   Wallis RS, 1998, J INFECT DIS, V178, P1115, DOI 10.1086/515701
   Wallis RS, 2000, AM J RESP CRIT CARE, V161, P1076, DOI 10.1164/ajrccm.161.4.9903087
NR 8
TC 27
Z9 27
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD APR
PY 2001
VL 45
IS 4
BP 1302
EP 1304
DI 10.1128/AAC.45.4.1302-1304.2001
PG 3
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 414BX
UT WOS:000167647000046
PM 11257053
OA Green Published, Bronze
DA 2020-12-15
ER

PT J
AU Teixeira, L
   Maciel, E
   Dutra, ME
   Perkins, MD
   Johnson, JL
   Dettoni, VD
AF Teixeira, L
   Maciel, E
   Dutra, ME
   Perkins, MD
   Johnson, JL
   Dettoni, VD
TI Simultaneous comparison of reactivity to purified protein derivative
   RT-23 and Tubersol (R) in health care workers in Vitoria, Brazil
SO INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
LA English
DT Article
DE tuberculin; purified protein derivative; tuberculin RT-23; Tubersol (R);
   potency
ID INTRAVENOUS-DRUG-USERS; TUBERCULIN PPD RT23; SKIN; ANERGY; PREVALENCE;
   INFECTION
AB Questions have recently been raised regarding the potency of purified protein derivative (PPD) RT-23, the tuberculin most widely used world-wide for skin testing. We performed simultaneous testing with PPD RT-23 and Tubersol(R) to compare these reagents during a tuberculin survey of 202 adult health care workers at a large teaching hospital in 1997. Individuals were tested with 2 tuberculin units (TU) PPD RT-23 and 5 TU Tubersol(R) using the Mantoux method. Using a 10 mm cut-point for a positive PPD test, 39% of the health care workers were positive when tested with Tubersol(R) and 35% were positive when tested with PPD RT-23, The median PPD size with Tubersol(R) was 4 mm (interquartile range = 0-12 mm) compared to 2 mm (interquartile range = 0-12 mm) with PPD RT-23. PPD skin test reactivity with the two reagents was highly correlated (Spearman's rank coefficient, rho = 0.92; P = 0.01, two tailed). Concordance between the skin test reaction size with the two antigens did not differ based on age, sex or prior BCG vaccination. Mantoux skin test reactivity in health care workers in an area with a high prevalence of tuberculosis was comparable with PPD RT-23 and Tubersol(R).
C1 Case Western Reserve Univ, Sch Med, Div Infect Dis, TB Res Unit, Cleveland, OH 44106 USA.
   Univ Fed Espirito Santo, Hosp Univ Cassiano Antonio de Moraes, Vitoria, Espirito Santo, Brazil.
   Duke Univ, Med Ctr, Div Infect Dis, Durham, NC USA.
RP Teixeira, L (corresponding author), Case Western Reserve Univ, Sch Med, Div Infect Dis, TB Res Unit, Room E-202,10900 Euclid Ave, Cleveland, OH 44106 USA.
RI Maciel, Ethel Leonor LN/G-1027-2012
OI Maciel, Ethel Leonor LN/0000-0003-4826-3355
CR Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6
   *BRAZ MIN HLTH, 1997, INF EP SIST UN SAUD
   COMSTOCK GW, 1964, B WORLD HEALTH ORGAN, V31, P161
   Duchin JS, 1997, CLIN INFECT DIS, V25, P661, DOI 10.1086/513771
   GRAHAM NMH, 1992, JAMA-J AM MED ASSOC, V267, P369, DOI 10.1001/jama.267.3.369
   Haslov K, 1998, INT J TUBERC LUNG D, V2, P793
   Janis EM, 1996, AM J MED, V100, P186, DOI 10.1016/S0002-9343(97)89457-0
   Kim SJ, 1998, INT J TUBERC LUNG D, V2, P857
   LANDI S, 1984, MYCOBACTERIA SOURCEB, V1, P505
   LIFSON AR, 1993, J INFECT DIS, V168, P1048, DOI 10.1093/infdis/168.4.1048
   *MIN HLTH, 1994, CONTR TUB UM PROP IN
   *MIN SAUD FUND NAC, 1999, PLAN NAC CONTR TUB
   RUPP ME, 1994, J INFECT DIS, V169, P1174, DOI 10.1093/infdis/169.5.1174
   Yanai H, 1997, INT J TUBERC LUNG D, V1, P427
NR 14
TC 12
Z9 13
U1 0
U2 0
PU INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)
PI PARIS
PA 68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE
SN 1027-3719
J9 INT J TUBERC LUNG D
JI Int. J. Tuberc. Lung Dis.
PD NOV
PY 2000
VL 4
IS 11
BP 1074
EP 1077
PG 4
WC Infectious Diseases; Respiratory System
SC Infectious Diseases; Respiratory System
GA 372AY
UT WOS:000165212500015
PM 11092721
DA 2020-12-15
ER

EF